// peepdf comment: Javascript code located in object 3 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 45 750 Tm(53256) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
ET
q
1 0 0 1 222 311.8000031 cm
0.5 w 
0 0 m
50 0 l
S
Q
BT
/T1_1
1 Tf
0 Tw 5.446 0 0 4.55 229 304.9091 Tm(1) Tj - 0.0028 Tw 7 0 0 7 233.1677 303.1 Tm(\221\221Institution\222\222 was defined under 42 CFR part 50, ) Tj - 1.595 - 1.143 Td(subpart F, as any domestic or foreign, public or) Tj
0 - 1.143 TD(private, entity or organization\ (excluding a Federal) Tj
T * (agency\), and under 45 CFR part 94 as any public) Tj
T * (or private entity or organization\ (excluding a) Tj
T * (Federal agency\)\ (1\) that submits a proposal
for a) Tj
T * (research contract whether in response to a) Tj
T * (solicitation from the PHS or otherwise, or\ (2\) that) Tj
T * (assumes the legal obligation to carry out the) Tj - 0.0029 Tw T * (research required under the contract.42 CFR) Tj - 0.0028 Tw T * (50.603; 45 CFR 94.3.) Tj
0 Tw 5.446 0 0 4.55 229 215.9092 Tm(2) Tj - 0.0028 Tw 7 0 0 7 233.1677 214.1001 Tm(\221\221Investigator\222\222 was defined under the 1995) Tj - 1.595 - 1.143 Td(regulations as the Principal Investigator and any) Tj
T * (other person who is responsible
for the design, ) Tj
T * (conduct, or reporting of research\ (or, in the
case of) Tj
T * (PHS contracts, a research project\) funded by PHS, ) Tj
T * (or proposed
for such funding.For purposes of the) Tj - 0.0029 Tw T * (regulatory requirements relating to financial) Tj - 0.0028 Tw T * (interests, the term\221\221Investigator\222\222 includes the) Tj
T * (Investigator\222s spouse and dependent children.42) Tj
T * (CFR 50.603; 45 CFR 94.3.) Tj
0 Tw 5.446 0 0 4.55 229 134.9091 Tm(3) Tj - 0.0028 Tw 7 0 0 7 233.1677 133.1001 Tm(\221\221Significant Financial Interest\222\222 was defined) Tj - 1.595 - 1.143 Td(under the 1995 regulations as anything of monetary) Tj
T * (value, including but not limited to, salary or other) Tj
T * (payments
for services\ () Tj / T1_2 1 Tf
0 Tw(e.g.) Tj / T1_1 1 Tf - 0.0028 Tw(, consulting fees or) Tj - 0.0029 Tw T * (honoraria\); equity interests\ () Tj / T1_2 1 Tf
0 Tw(e.g.) Tj / T1_1 1 Tf - 0.0028 Tw(, stocks, stock) Tj
T * (options or other ownership interests\); and) Tj
T * (intellectual property rights\ () Tj / T1_2 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf - 0.0028 Tw 15.043 0 Td(patents, copyrights) Tj - 15.043 - 1.143 Td(and royalties from such rights\).The term does not) Tj
T * (include: \ (1\) Salary,
royalties,
or other remuneration) Tj
T * (from the applicant Institution;\ (2\) any ownership) Tj
T * (interests in the Institution,
if the Institution is an) Tj
ET
q
1 0 0 1 399 270.8999939 cm
0.5 w
0 0 m
50 0 l
S
Q
BT / T1_1 1 Tf
7 0 0 7 399 262.2 Tm(applicant under the SBIR / STTR programs;\ (3\)) Tj - 0.0029 Tw 0 - 1.114 TD(income from seminars, lectures, or teaching) Tj - 0.0028 Tw T * (engagements sponsored by public or nonprofit) Tj - 0.0029 Tw T * (entities;\ (4\) income from service on advisory) Tj - 0.0028 Tw 0 - 1.129 TD(committees or review panels
for public or nonprofit) Tj
T * (entities;\ (5\) an equity interest that when aggregated) Tj
T * (
for the Investigator and the Investigator\222s spouse) Tj - 0.0029 Tw T * (and dependent children meets both of the following) Tj - 0.0028 Tw T * (tests: does not exceed $10,
000 in value as) Tj
T * (determined through reference to public prices or) Tj
T * (other reasonable measures of fair market value, and) Tj
T * (does not represent more than a five percent) Tj
T * (ownership interest in any single entity; or\ (6\) salary, ) Tj - 0.0029 Tw T * (royalties, or other payments that when aggregated) Tj - 0.0028 Tw T * (
for the Investigator and the Investigator\222s spouse) Tj - 0.0029 Tw T * (and dependent children over the next twelve) Tj - 0.0028 Tw T * (months, are not expected\ (or, in the
case of PHS) Tj - 0.0029 Tw T * (contracts, are not reasonably expected\) to exceed) Tj
T * ($10, 000.42 CFR 50.603; 45 CFR 94.3.) Tj
0 Tw 5.446 0 0 4.55 406 113.209 Tm(4) Tj - 0.0028 Tw 7 0 0 7 410.1677 111.4 Tm(\221\221PHS Awarding Component\222\222 was defined as an) Tj - 1.595 - 1.129 Td(organizational unit of the PHS that funds research) Tj
T * (that is subject to these regulations.42 CFR 50.603, ) Tj - 0.0029 Tw T * (45 CFR 94.3.) Tj
0 Tw 5.446 0 0 4.55 406 80.609 Tm(5) Tj - 0.0029 Tw 7 0 0 7 410.1677 78.7999 Tm(Moses H) Tj / T1_2 1 Tf - 0.0028 Tw(et al.) Tj / T1_1 1 Tf - 0.0029 Tw(, JAMA; 2005; 294: 1333\2261342.) Tj
0 Tw 5.446 0 0 4.55 406 71.709 Tm(6) Tj - 0.0029 Tw 7 0 0 7 410.1677 69.8999 Tm(Blumenthal D) Tj / T1_2 1 Tf(et al.) Tj / T1_1 1 Tf - 0.0028 Tw(, N Engl J Med; 1996;) Tj
0 Tw - 1.595 - 1.129 Td(335: 1734\2269.) Tj
5.446 0 0 4.55 406 54.9089 Tm(7) Tj - 0.0028 Tw 7 0 0 7 410.1677 53.0999 Tm(Zinner DE) Tj / T1_2 1 Tf(et al.) Tj / T1_1 1 Tf - 0.0029 Tw(, Health Aff; 2009; 28: 1814\22625.) Tj / T1_3 1 Tf - 0.0045 Tw 9 0 0 9 45 724 Tm(DEPARTMENT OF HEALTH AND) Tj
0 - 1.111 TD(HUMAN SERVICES) Tj
0 - 2 TD(42 CFR Part 50) Tj
0 - 2.222 TD(45 CFR Part 94) Tj - 0.0025 Tw 8 0 0 8 45 661.6001 Tm([Docket Number NIH\2262010\2260001]) Tj
0 - 1.8 TD(RIN 0925\226AA53) Tj - 0.0045 Tw 9 0 0 9 45 629.2001 Tm(Responsibility of Applicants
for) Tj
0 - 1.111 TD(Promoting Objectivity in Research
for) Tj
T * (which Public Health Service Funding is) Tj
T * (Sought and Responsible Prospective) Tj
0 Tw T * (Contractors) Tj
7.2 0 0 7.4409 45 573.6001 Tm(AGENCY) Tj
9 0 0 9 75.8003 573.6001 Tm(: ) Tj / T1_1 1 Tf - 0.0045 Tw 0.607 0 Td(Department of Health and) Tj - 4.029 - 1.111 Td(Human Services.) Tj / T1_3 1 Tf
0 Tw 7.2 0 0 7.4409 45 552.0001 Tm(ACTION) Tj
9 0 0 9 72.5965 552.0001 Tm(: ) Tj / T1_1 1 Tf - 0.0045 Tw 0.607 0 Td(Final rule.) Tj
ET
q
1 0 0 1 45 546.8399963 cm
0.3 w
0 0 m
168 0 l
S
Q
BT / T1_3 1 Tf
0 Tw 7.2 0 0 7.4409 45 535.1001 Tm(SUMMARY) Tj
9 0 0 9 82.1937 535.1001 Tm(: ) Tj / T1_1 1 Tf - 0.0045 Tw 0.607 0 Td(This final rule implements) Tj - 4.739 - 1.111 Td(changes to the regulations on the) Tj
T * (Responsibility of Applicants
for) Tj
T * (Promoting Objectivity in Research
for) Tj
T * (which Public Health Service Funding is) Tj
T * (Sought and Responsible Prospective) Tj
T * (Contractors.Since the promulgation of) Tj
T * (the regulations in 1995, biomedical and) Tj
T * (behavioral research and the resulting) Tj
T * (interactions among government, ) Tj
T * (research Institutions, and the private) Tj
T * (sector have become increasingly) Tj
T * (complex.This complexity, as well as a) Tj
T * (need to strengthen accountability, led to) Tj
T * (changes that expand and add) Tj
T * (transparency to Investigators\222 disclosure) Tj
T * (of Significant Financial Interests\ (SFIs\), ) Tj
T * (enhance regulatory compliance and) Tj
T * (effective institutional oversight and) Tj
T * (management of Investigators\222 financial) Tj
T * (conflicts of interests, as well as increase) Tj
T * (the Department of Health and Human) Tj
T * (Services\222\ (HHS\) compliance oversight.) Tj / T1_3 1 Tf
0 Tw 7.2 0 0 7.4409 45 303.5002 Tm(DATES) Tj
9 0 0 9 69.3998 303.5002 Tm(: ) Tj / T1_2 1 Tf - 0.0045 Tw 0.607 0 Td(Effective Date: ) Tj / T1_1 1 Tf(This final rule is) Tj - 3.318 - 1.111 Td(effective as of September 26, 2011.) Tj / T1_2 1 Tf
1 - 1.078 Td(Compliance Date: ) Tj / T1_1 1 Tf(An Institution) Tj - 1 - 1.111 Td(applying
for or receiving PHS funding) Tj
T * (from a grant, cooperative agreement, or) Tj
T * (contract that is covered by this rule) Tj
T * (must be in full compliance with all of) Tj
T * (the regulatory requirements herein: ) Tj / T1_4 1 Tf
0 Tw 1 - 1.078 Td(\200) Tj / T1_1 1 Tf - 0.0045 Tw 1.016 0 Td(No later than August 24, 2012; and) Tj / T1_4 1 Tf
0 Tw - 1.016 - 1.078 Td(\200) Tj / T1_1 1 Tf - 0.0045 Tw 1.016 0 Td(Immediately upon making its) Tj - 2.016 - 1.111 Td(institutional Financial Conflict of) Tj
T * (Interest\ (FCOI\) policy publicly) Tj
T * (accessible as described herein.) Tj
1 - 1.078 Td(In the interim, Institutions should) Tj - 1 - 1.111 Td(
continue to comply with the 1995) Tj
T * (regulations and report Investigator) Tj
T * (FCOIs to the Public Health Service) Tj
T * (\ (PHS\) Awarding Component as required) Tj
T * ( in the 1995 regulations.) Tj / T1_3 1 Tf
0 Tw 7.2 0 0 7.4409 45 113.0002 Tm[(FOR) - 342(FURTHER) - 342(INFORMATION) - 342(CONTACT)] TJ
9 0 0 9 187.9577 113.0002 Tm(: ) Tj / T1_1 1 Tf
0.607 0 Td(Jerry) Tj - 0.0045 Tw - 16.491 - 1.111 Td(Moore, NIH Regulations Officer, Office) Tj
T * (of Management Assessment, National) Tj
T * (Institutes of Health, 6011 Executive) Tj
T * (Boulevard, Suite 601, MSC 7669, ) Tj
T * (Rockville, MD 20852\2267669, telephone) Tj
T * (301\226496\2264607, fax 301\226402\2260169, ) Tj
0 Tw 19.667 74.667 Td(e - mail) Tj / T1_2 1 Tf
3.161 0 Td(jm40z@nih.gov) Tj / T1_1 1 Tf - 0.0045 Tw(, concerning) Tj - 3.161 - 1.111 Td(questions about the rulemaking process;) Tj
T * (and Dr.Sally Rockey, NIH Deputy) Tj
T * (Director
for Extramural Research, ) Tj
T * (concerning substantive questions about) Tj
T * (the rule, e - mail) Tj / T1_2 1 Tf
0 Tw T * (FCOICompliance@mail.nih.gov.) Tj / T1_3 1 Tf
7.2 0 0 7.4409 222 651.0002 Tm[(SUPPLEMENTARY) - 342(INFORMATION)] TJ
9 0 0 9 339.6553 651.0002 Tm(: ) Tj / T1_0 1 Tf - 0.0045 Tw - 13.073 - 1.667 Td(I.Background) Tj / T1_1 1 Tf
1 - 1.556 Td(In 1995, the PHS and the Office of the) Tj - 1 - 1.111 Td(Secretary of HHS published regulations) Tj
T * (at 42 CFR part 50, subpart F and 45 CFR) Tj
T * (part 94\ (the 1995 regulations\), that are) Tj
T * (designed to promote objectivity in PHS - ) Tj
T * (funded research.The 1995 regulations) Tj
T * (cover Institutions that apply
for or seek) Tj
T * (PHS funding
for research\ (except
for) Tj
T * (Small Business Innovation Research) Tj
T * (\ (SBIR\) / Small Business Technology) Tj
T * (Transfer Research\ (STTR\) Phase I) Tj
T * (applications\) and, through) Tj
T * (implementation of the regulations by) Tj
T * (these Institutions, to each Investigator) Tj
T * (participating in the research.) Tj
1 - 1.111 Td(Generally, under the 1995 regulations: ) Tj / T1_4 1 Tf
0 Tw T * (\200) Tj / T1_1 1 Tf - 0.0045 Tw 1.016 0 Td(The Institution) Tj
0 Tw 7.002 0 0 5.85 303.5803 464.3282 Tm(1) Tj - 0.0045 Tw 9 0 0 9 309.9334 462.0003 Tm(is responsible
for) Tj - 9.77 - 1.111 Td(complying with the regulations, ) Tj
T * (including maintaining a written and) Tj
T * (enforced FCOI policy; managing, ) Tj
T * (reducing, or eliminating identified) Tj
T * (conflicts; and reporting identified) Tj
T * (conflicts to the PHS Awarding) Tj
T * (Component.The reports denote the) Tj
T * (existence of an FCOI and the) Tj
T * (Institution\222s assurance that it has been) Tj
T * (managed, reduced, or eliminated.) Tj / T1_4 1 Tf
0 Tw 1 - 1.111 Td(\200) Tj / T1_1 1 Tf
1.016 0 Td(Investigators) Tj
7.002 0 0 5.85 294.1257 354.3282 Tm(2) Tj - 0.0045 Tw 9 0 0 9 300.4788 352.0003 Tm(are responsible
for) Tj - 8.72 - 1.111 Td(complying with their Institution\222s) Tj
T * (written FCOI policy and
for disclosing) Tj
T * (their SFIs) Tj
0 Tw 7.002 0 0 5.85 263.4454 324.3282 Tm(3) Tj - 0.0045 Tw 9 0 0 9 269.7984 322.0003 Tm(to the Institution.) Tj / T1_4 1 Tf
0 Tw 15.356 44.778 Td(\200) Tj / T1_1 1 Tf - 0.0045 Tw 1.016 0 Td(Maintaining objectivity in research) Tj - 2.016 - 1.1 Td(requires a commitment from Institutions) Tj
0 - 1.1 TD(and their Investigators to completely) Tj
T * (disclose, appropriately review, and) Tj
T * (robustly manage identified conflicts.) Tj / T1_4 1 Tf
0 Tw 1 - 1.022 Td(\200) Tj / T1_1 1 Tf - 0.0045 Tw 1.016 0 Td(The PHS Awarding Components) Tj
0 Tw 7.002 0 0 5.85 553.0193 678.528 Tm(4) Tj
9 0 0 9 556.9124 676.2001 Tm() Tj - 0.0045 Tw - 17.546 - 1.1 Td(are responsible
for overseeing) Tj
T * (institutional compliance with the) Tj
0 Tw T * (regulations.) Tj - 0.0045 Tw 1 - 1.022 Td(The purpose of the 1995 regulations) Tj - 1 - 1.1 Td(was to ensure that there is no reasonable) Tj
T * (expectation that the design, conduct, or) Tj
T * (reporting of PHS - funded research will) Tj
T * (be biased by any Investigator FCOI.) Tj
T * (Since the publication of the 1995) Tj
T * (regulations, the pace by which new) Tj
T * (discoveries are translated from the) Tj
T * (research bench into effective treatment) Tj
T * (of patients has accelerated significantly, ) Tj
T * (and the biomedical and behavioral) Tj
T * (research enterprise in the United States) Tj
T * (has grown in size and complexity.For) Tj
T * (example, an analysis of financial) Tj
T * (support of biomedical research from) Tj
T * (1994 to 2004) Tj
0 Tw 7.002 0 0 5.85 453.4548 491.128 Tm(5) Tj - 0.0045 Tw 9 0 0 9 459.8079 488.8001 Tm(showed that funding) Tj - 6.756 - 1.1 Td(increased from $37.1 billion in 1994 to) Tj
T * ($94.3 billion in 2003.Fifty seven) Tj
T * (percent of the funding in 2003 came) Tj
T * (from industry sources.At the same time, ) Tj
T * (relationships between individual) Tj
T * (academic researchers and industry have) Tj
T * (also increased from 28 % in a 1996) Tj
0 Tw T * (survey) Tj
7.002 0 0 5.85 428.0029 411.928 Tm(6) Tj - 0.0045 Tw 9 0 0 9 434.356 409.6001 Tm(to 52.8 % in a survey conducted) Tj - 3.928 - 1.1 Td( in 2007.) Tj
0 Tw 7.002 0 0 5.85 432.4746 402.028 Tm(7) Tj - 0.0045 Tw 9 0 0 9 438.8277 399.7001 Tm(Researchers frequently work) Tj - 4.425 - 1.1 Td( in multidisciplinary teams to develop) Tj
T * (new strategies and approaches
for) Tj
T * (translating basic research into clinical) Tj
T * (application, thus hastening discovery) Tj
T * (and advancing human health.In) Tj
T * (addition, these newer translational) Tj
T * (strategies often involve complex) Tj
T * (collaborations between Investigators) Tj
T * (and the private sector.) Tj
1 - 1.022 Td(Recent studies from several sources) Tj - 1 - 1.1 Td(have also highlighted the increasing) Tj
T * (complexity of the financial relationships) Tj
1 g / T1_5 1 Tf
0 Tw 6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(17: 26 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00002) - 1077(Fmt 4701) - 1077(Sfmt 4700) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

// peepdf comment: Javascript code located in object 33 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 536.42 750 Tm(53257) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
ET
q
1 0 0 1 45 134.8000031 cm
0.5 w 
0 0 m
50 0 l
S
Q
BT
/T1_1
1 Tf
0 Tw 5.446 0 0 4.55 52 127.9091 Tm(8) Tj - 0.0029 Tw 7 0 0 7 56.1677 126.1 Tm(Protecting Patients, Preserving Integrity, ) Tj - 0.0028 Tw - 1.595 - 1.143 Td(Advancing Health: Accelerating the Implementation) Tj - 0.0029 Tw 0 - 1.143 TD(of COI Policies in Human Subjects Research, A) Tj
T * (Report of the AAMC\226AAU Advisory Committee on) Tj
T * (Financial Conflicts of Interest in Human Subjects) Tj
T * (Research, February 2008 p1.) Tj
0 Tw 5.446 0 0 4.55 52 78.9091 Tm(9) Tj - 0.0029 Tw 7 0 0 7 56.1677 77.1 Tm(Lo, B & Field, M.J.\ (Eds.\).\ (2009\)) Tj / T1_2 1 Tf
14.982 0 Td(Conflict of) Tj - 16.578 - 1.143 Td(interest in medical research, education, and) Tj
0 Tw T * (practice.) Tj / T1_1 1 Tf - 0.0028 Tw 4.257 0 Td(Washington, DC: National Academies) Tj - 0.0029 Tw - 4.257 - 1.143 Td(Press.p2.) Tj
ET
q
1 0 0 1 222 85.8000031 cm
0.5 w
0 0 m
50 0 l
S
Q
BT / T1_1 1 Tf
0 Tw 5.446 0 0 4.55 229 78.9091 Tm(10) Tj - 0.0029 Tw 7 0 0 7 236.1954 77.1 Tm(HHS OIG report OEI\22603\22607\22600700\221\221How) Tj - 0.0028 Tw - 2.028 - 1.143 Td(Grantees Manage Financial Conflicts of Interest in ) Tj
T * (Research Funded by the National Institutes of) Tj - 0.0029 Tw T * (Health\222\222, November 2009 p12.) Tj - 0.0045 Tw 9 0 0 9 45 725 Tm(between biomedical researchers and) Tj
0 - 1.111 TD(industry and the possible ramifications) Tj
T * (of those relationships.For example, a) Tj
T * (2008 report by the Association of) Tj
T * (American Medical Colleges and the) Tj
T * (Association of American Universities) Tj
0 Tw T * (\ (AAMC / AAU\)) Tj
7.002 0 0 5.85 105.5016 667.3281 Tm(8) Tj - 0.0045 Tw 9 0 0 9 111.8547 665.0002 Tm(states: \221\221The promises of) Tj - 7.428 - 1.111 Td(translational research, the challenges of) Tj
T * (technology transfer, and intense) Tj
T * (expectations at all levels of government) Tj
T * (that universities and their academic) Tj
T * (medical centers
function as engines of) Tj
T * (socio - economic development generate) Tj
T * (new pressures on institutions and their) Tj
T * (faculty members to expand their) Tj
T * (relationships and deepen their) Tj
T * (engagement with industry.These) Tj
T * (relationships, now encouraged in many) Tj
T * (forms, may involve financial linkages) Tj
T * (that are entirely benign but will in other) Tj
T * (cases carry the potential to create) Tj
T * (serious conflicts of interest.Moreover, ) Tj
T * (these financial ties are occurring in a) Tj
T * (context of dramatically increased public) Tj
T * (sensitivity to and concern with) Tj
T * (allegations of financial conflicts of) Tj
T * (interest more broadly in university) Tj
T * (business transactions and across diverse) Tj
T * (sectors of industry.\222\222 A recent study of) Tj
T * (the Institute of Medicine\ (IOM\) on) Tj
T * (Conflict of Interest in Medical Research, ) Tj
T * (Education, and Practice states: ) Tj
T * (\221\221Physicians and researchers must) Tj
T * (exercise judgment in complex situations) Tj
T * (that are fraught with uncertainty.) Tj
T * (Colleagues, patients, students, and the) Tj
T * (public need to trust that these) Tj
T * (judgments are not compromised by) Tj
T * (physicians\222 or researchers\222 financial ties) Tj
T * (to pharmaceutical, medical device, and) Tj
T * (biotechnology companies.Ties with) Tj
T * (industry are common in medicine.) Tj
T * (Some have produced important benefits, ) Tj
T * (particularly through research) Tj
T * (collaborations that improve individual) Tj
T * (and public health.At the same time, ) Tj
T * (widespread relationships with industry) Tj
T * (have created significant risks that) Tj
T * (individual and institutional financial) Tj
T * (interests may unduly influence) Tj
T * (professionals\222 judgments about the) Tj
T * (primary interests or goals of medicine.) Tj
T * (Such conflicts of interest threaten the) Tj
T * (integrity of scientific investigations, the) Tj
T * (objectivity of medical education, and) Tj
T * (the quality of patient care.They may) Tj
T * (also jeopardize public trust in ) Tj
0 Tw T * (medicine.\222\222) Tj
7.002 0 0 5.85 92.4971 157.3283 Tm(9) Tj - 0.0045 Tw 9 0 0 9 98.8502 155.0004 Tm(A 2009 report from the) Tj - 5.983 - 1.111 Td(HHS Office of Inspector General\ (OIG\)) Tj
19.667 64.444 Td(stated\221\221Vulnerabilities exist at grantee) Tj
T * (institutions regarding conflicts.\222\222) Tj
0 Tw 7.002 0 0 5.85 357.8835 717.3279 Tm(10) Tj
9 0 0 9 365.6697 715 Tm() Tj - 0.0045 Tw - 14.963 - 1.089 Td(The growing complexity of) Tj - 1 - 1.111 Td(biomedical and behavioral research; the) Tj
T * (increased interaction among) Tj
T * (Government, research Institutions, and) Tj
T * (the private sector in attaining common) Tj
T * (public health goals
while meeting) Tj
T * (public expectations
for research) Tj
T * (integrity; as well as increased public) Tj
T * (scrutiny, all have raised questions as to) Tj
T * (whether a more rigorous approach to) Tj
T * (Investigator disclosure, institutional) Tj
T * (management of financial conflicts, and) Tj
T * (Federal oversight is required.HHS) Tj
T * (decided to explore the need
for) Tj
T * (revisions to the 1995 regulations by) Tj
T * (publishing an Advance Notice of) Tj
T * (Proposed Rulemaking on May 8, 2009) Tj
T * (\ (74 FR 21610, hereafter\221\221the ANPRM\222\222\).) Tj
1 - 1.089 Td(After analyzing public comments, ) Tj - 1 - 1.111 Td(HHS published a Notice of Proposed) Tj
T * (Rulemaking\ (75 FR 28688, hereafter) Tj
T * (\221\221the NPRM\222\222\) on May 21, 2010, to) Tj
T * (amend the 1995 regulations by) Tj
T * (expanding and adding transparency to) Tj
T * (Investigators\222 disclosure of SFIs, ) Tj
T * (enhancing regulatory compliance and) Tj
T * (effective institutional oversight and) Tj
T * (management of Investigators\222 financial) Tj
T * (conflicts of interests, as well as HHS\222) Tj
T * (compliance oversight.) Tj
1 - 1.089 Td(Major changes to the 1995 regulations) Tj - 1 - 1.111 Td(proposed in the NPRM included: ) Tj / T1_3 1 Tf
0 Tw 1 - 1.089 Td(\200) Tj / T1_1 1 Tf - 0.0045 Tw 1.016 0 Td(Expanding the scope of the) Tj - 2.016 - 1.111 Td(regulations to include SBIR / STTR Phase) Tj
T * (I applications.) Tj / T1_3 1 Tf
0 Tw 1 - 1.089 Td(\200) Tj / T1_1 1 Tf - 0.0045 Tw 1.016 0 Td(Amending the definition of SFI to) Tj - 2.016 - 1.111 Td(include a de minimis threshold of) Tj
T * ($5, 000
for disclosure that generally) Tj
T * (applies to payments and / or equity) Tj
T * (interests as well as any equity interest) Tj
T * ( in non - publicly traded entities.) Tj / T1_3 1 Tf
0 Tw 1 - 1.089 Td(\200) Tj / T1_1 1 Tf - 0.0045 Tw 1.016 0 Td(Excluding income from government) Tj - 2.016 - 1.111 Td(agencies or Institutions of higher) Tj
T * (education
for seminars, lectures, ) Tj
T * (teaching, or service on advisory or) Tj
T * (review panels.) Tj / T1_3 1 Tf
0 Tw 1 - 1.089 Td(\200) Tj / T1_1 1 Tf - 0.0045 Tw 1.016 0 Td(Expanding Investigator disclosure) Tj - 2.016 - 1.111 Td(requirements to include SFIs that are) Tj
T * (related to an Investigator\222s institutional) Tj
T * (responsibilities, with Institutions) Tj
T * (responsible
for determining whether a) Tj
T * (disclosed SFI relates to the research
for) Tj
T * (which PHS funding is sought and) Tj
T * (constitutes an FCOI.) Tj / T1_3 1 Tf
0 Tw 1 - 1.1 Td(\200) Tj / T1_1 1 Tf - 0.0045 Tw 1.016 0 Td(Enhancing the information on an) Tj - 2.016 - 1.111 Td(FCOI reported by the Institution to the) Tj
T * (PHS Awarding Component to include) Tj
T * (the information required under the 1995) Tj
T * (regulations plus the value of the) Tj
T * (financial interest or a statement that a) Tj
T * (value cannot be readily determined, the) Tj
T * (nature of the FCOI, a description of how) Tj
19.667 69.833 Td(the FCOI relates to PHS - funded) Tj
0 - 1.1 TD(research, and key elements of the) Tj
T * (Institution\222s management plan.) Tj / T1_3 1 Tf
0 Tw 1 - 1.022 Td(\200) Tj / T1_1 1 Tf - 0.0045 Tw 1.016 0 Td(Requiring that before spending) Tj - 2.016 - 1.1 Td(funds
for PHS - supported research, an) Tj
T * (Institution shall post on a publicly) Tj
T * (accessible Web site information on SFIs) Tj
T * (of senior / key personnel that the) Tj
T * (Institution determines are related to the) Tj
T * (PHS - funded research and constitute an) Tj
0 Tw T * (FCOI.) Tj - 0.0045 Tw 1 - 1.022 Td(In addition to these major proposed) Tj - 1 - 1.1 Td(changes, the NPRM incorporated minor) Tj
T * (proposed changes that reflect technical) Tj
T * (updates from the 1995 regulations\ () Tj / T1_2 1 Tf
0 Tw(e.g.) Tj / T1_1 1 Tf(, ) Tj - 0.0045 Tw - 0 - 1.1 Td( in the reference to authority
for the) Tj
T * (regulations, 42 U.S.C.299c\2264 replaces) Tj
T * (42 U.S.C.299c\2263, and,
for the) Tj
T * (regulations
for grants and cooperative) Tj
0 - 1.111 TD(agreements, we added section 219, Title) Tj
T * (II, Division D of Public Law 111\226117, ) Tj
T * (the Consolidated Appropriations Act) Tj
T * (2010\), or that reflect efforts to improve) Tj
T * (the overall clarity and accuracy of the) Tj
T * (regulations\ () Tj / T1_2 1 Tf
0 Tw(e.g.) Tj / T1_1 1 Tf - 0.0045 Tw(, the title of the) Tj - 0 - 1.111 Td(regulations
for grants and cooperative) Tj
T * (agreements was changed to\221\221Promoting) Tj
T * (Objectivity in Research, \222\222 to reinforce) Tj
T * (the ongoing nature of the obligations) Tj
T * (under this subpart\).The final rule also) Tj
T * (incorporates such changes.) Tj
1 - 1.022 Td(On July 21, 2010, HHS published a) Tj - 1 - 1.111 Td(Notice\ (75 FR 42362, hereafter\221\221the) Tj
T * (Extension Notice\222\222\) extending the 60 day) Tj
T * (comment period
for the NPRM by) Tj
T * (another 30 days and seeking comment) Tj
T * (on whether HHS should clarify its) Tj
T * (authority to enforce compliance with) Tj
T * (the regulations by Institutions and) Tj
T * (Investigators, and whether HHS should) Tj
T * (clarify how the regulations apply in ) Tj
T * (circumstances in which an Investigator) Tj
T * (or a PHS - funded research project) Tj
T * (transfers from one Institution to another.) Tj / T1_0 1 Tf
0 - 1.644 TD(II.Discussion of General Public) Tj
0 Tw 0 - 1.111 TD(Comments) Tj / T1_1 1 Tf - 0.0045 Tw 1 - 1.467 Td(During the 90 day comment period) Tj - 1 - 1.111 Td(that ended on August 19, 2010, we) Tj
T * (received 136 unique comments on the) Tj
T * (NPRM and the Extension Notice.Many) Tj
T * (respondents were generally supportive) Tj
T * (of the overall goal of promoting) Tj
T * (objectivity in biomedical research.A) Tj
T * (few cited the importance of such) Tj
T * (objectivity in maintaining the public\222s) Tj
T * (and particularly patients\222 trust in ) Tj
T * (treatments, drugs and devices that result) Tj
T * (from PHS - funded biomedical research.) Tj
T * (Responses to comments in this section) Tj
T * (are of a general nature
while comments) Tj
T * (on specific provisions of the NPRM are) Tj
T * (addressed in the next section.) Tj / T1_2 1 Tf
0 - 1.644 TD(Balancing the Benefits of Relationships) Tj
0 - 1.111 TD(With Industry and Possible Conflicts of) Tj
0 Tw T * (Interest) Tj / T1_1 1 Tf - 0.0045 Tw 1 - 1.467 Td(As stated by several respondents, it is) Tj - 1 - 1.111 Td(important to emphasize that translating) Tj
1 g / T1_4 1 Tf
0 Tw 6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(17: 26 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00003) - 1077(Fmt 4701) - 1077(Sfmt 4700) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

// peepdf comment: Javascript code located in object 54 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 536.42 750 Tm(53259) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
-0.0045 Tw 9 0 0 9 45 725 Tm
(respondent to question whether the )Tj
0 -1.1 TD
(regulations set forth in 45 CFR part 94 )Tj
T*
(remain \221\221in force.\222\222 This concern is )Tj
T*
(unfounded; the regulations at 45 CFR )Tj
T*
(part 94 remain in effect in addition to, )Tj
T*
(and not in conflict with, the HHS )Tj
T*
(Acquisition Regulation \(HHSAR\) )Tj
T*
(codified at 48 CFR part 301 )Tj
/T1_2
1 Tf(et seq.) Tj / T1_1 1 Tf
T * (Additionally, the respondent questioned) Tj
T * (the authority of NIH / PHS / HHS\221\221to set) Tj
T * (HHS acquisition policy.\222\222 As noted in ) Tj
T * (the final rule promulgating the 1995) Tj
T * (regulations, published on July 11, 1995) Tj
T * (\ (60 FR 132\), the PHS and the Office of) Tj
T * (the Secretary are acting in accordance) Tj
T * (with the legislative directive in 42) Tj
T * (U.S.C.289b\2261\ (a\).We have also declined) Tj
T * (this respondent\222s suggestion to place the) Tj
T * (revisions to the regulations at 45 CFR) Tj
T * (part 94 in the HHSAR; the revisions) Tj
T * (expressly pertain to the regulations at 45) Tj
T * (CFR part 94 and not to 48 CFR part 301) Tj / T1_2 1 Tf
T * (et seq.) Tj / T1_1 1 Tf
1 - 1.022 Td(Another respondent suggested that) Tj - 1 - 1.1 Td(there is a need to develop a specific) Tj
T * (HHSAR provision and / or standard) Tj
T * (language in the Request
for Proposals) Tj
T * (\ (RFP\) regarding the requirement of) Tj
T * (certification by the contractor in the) Tj
T * (regulations.We disagree; 45 CFR 94.4\ (k\)) Tj
T * (provides standard language that is) Tj
T * (appropriate
for each contract proposal) Tj
T * (subject to these regulations.) Tj
1 - 1.022 Td(Another respondent suggested that) Tj - 1 - 1.1 Td(contractors should be exempt from the) Tj
T * (regulatory requirements to disclose or) Tj
T * (report FCOIs, because the respondent) Tj
T * (believes that contractors are acting as) Tj
T * (independent vendors and the Institution) Tj
T * (has no effective means of monitoring) Tj
T * (their compliance with the policy.We) Tj
T * (disagree with this comment.All Federal) Tj
T * (contractors are required to have an) Tj
T * (effective means of complying with the) Tj
T * (terms and conditions of their contract, ) Tj
T * (including regulatory obligations) Tj
T * (designed to promote objectivity in PHS - ) Tj
T * (funded research.The regulation) Tj
T * (specifically provides
for enforcement of) Tj
T * (these obligations, stating at 94.6\ (b\) that) Tj - 0.0002 Tc - 0.0043 Tw T * [(\221\221 * ) - 556( * ) - 556( * the PHS Awarding Component)] TJ
0 Tc - 0.0045 Tw T * (may decide that a particular financial) Tj
T * (conflict of interest will bias the) Tj
T * (objectivity of the PHS - funded research) Tj
T * (to such an extent that further corrective) Tj
T * (action is needed or that the Institution) Tj
T * (has not managed the financial conflict) Tj
T * (of interest in accordance with this part.) Tj
T * (The PHS Awarding Component may) Tj
0 - 1.111 TD(determine that issuance of a Stop Work) Tj
T * (Order by the Contracting Officer or) Tj
T * (other enforcement action is necessary) Tj
T * (until the matter is resolved.\222\222) Tj
1 - 1.022 Td(One respondent stated that the) Tj - 1 - 1.111 Td(language under 45 CFR part 94 is) Tj
T * (confusing because it refers to) Tj
T * (\221\221applications
for research, \222\222 and) Tj
T * (\221\221awarding component\222\222 which seem) Tj
T * (more like grant terms than contract) Tj
19.667 74.667 Td(terms; additionally, the respondent) Tj
0 - 1.1 TD(noted that the language is inconsistent) Tj
T * (with HHS regulations which refer to) Tj
T * (OPDIVs or Agencies.We appreciate the) Tj
T * (opportunity to clarify that the) Tj
T * (regulations at 45 CFR part 94 apply to) Tj
T * (Institutions that solicit or receive PHS) Tj
T * (research funding by means of a contract) Tj
T * (
for research, as distinguished from the) Tj
T * (regulations at 42 CFR part 50 subpart F) Tj
T * (which are applicable to Institutions that) Tj
T * (apply
for or receive PHS research) Tj
T * (funding by means of a grant or) Tj
T * (cooperative agreement.The revised) Tj
T * (regulations under 45 CFR part 94 do not) Tj
T * (include any references to\ (grant\)) Tj
T * (applications, but rather to contract) Tj
T * (proposals.Furthermore, the references) Tj
T * (to\221\221awarding component\222\222 in 45 CFR) Tj
T * (part 94 are appropriate in the context of) Tj
T * (research contracts, and such references) Tj
T * (are not inconsistent with references to) Tj
T * (\221\221OPDIVs or Agencies\222\222 in the HHSAR.) Tj
T * (These terms have a similar meaning, ) Tj
T * (though the HHSAR applies to all) Tj
T * (operating divisions within HHS, ) Tj
T * (whereas 45 CFR part 94 only applies to) Tj
T * (the Public Health Service of HHS.) Tj
1 - 1.022 Td(Another respondent expressed) Tj - 1 - 1.1 Td(concern about inconsistency between) Tj
T * (the requirements under 45 CFR part 94) Tj
T * (and the treatment of organizational) Tj
T * (conflicts of interest\ (OCIs\) by the) Tj
T * (Federal Acquisition Regulation\ (FAR\), ) Tj
T * (Subpart 9.5.We are not aware of any) Tj
T * (direct conflict\ (s\) between the two sets of) Tj
T * (regulations at this time; 45 CFR part 94) Tj
T * (focuses on financial conflicts of interest) Tj
T * (of Investigators, whereas Subpart 9.5 of) Tj
T * (the FAR focuses on organizational) Tj
T * (conflicts of interest.In response to a) Tj
T * (related question by the same) Tj
T * (respondent, we note that neither 45 CFR) Tj
T * (part 94 nor Subpart 9.5 of the FAR) Tj
T * (require coordination with legal counsel) Tj
T * (on conflict of interest issues.The FAR) Tj
T * (provides only in Part 9.504\ (b\) that) Tj
T * (\221\221Contracting officers should obtain the) Tj
T * (advice of counsel\222\222 in consideration of) Tj
T * (OCIs.The use of the word\221\221should\222\222) Tj
T * (suggests that this step is a matter of) Tj
T * (policy, and not a legal requirement.To) Tj
T * (address a final concern by the same) Tj
T * (respondent, we note that the de minimis) Tj
0 - 1.111 TD(reporting level of $5, 000 does not imply) Tj
T * (that no conflict under that amount) Tj
T * (exists; as discussed further below, that) Tj
T * (amount is used only as a monetary) Tj
T * (threshold
for the definition of reportable) Tj
T * (SFIs under 45 CFR part 94.) Tj / T1_2 1 Tf
0 - 1.644 TD(General Comments on Cost and Burden) Tj / T1_1 1 Tf
1 - 1.467 Td(Several respondents suggested that) Tj - 1 - 1.111 Td(the analysis of the impact of the) Tj
0 - 1.111 TD(proposed revisions in the NPRM) Tj
T * (underestimated the burden and cost of) Tj
T * (implementation, particularly regarding) Tj
T * (the potential number of Investigators, ) Tj
T * (SFI disclosures, and FCOI reports.By) Tj
19.667 74.667 Td(publishing both an ANPRM and an) Tj
0 - 1.122 TD(NPRM, we have endeavored to involve) Tj
T * (the community and carefully consider) Tj
T * (the public\222s concerns.This final rule) Tj
T * (incorporates our best efforts to balance) Tj
T * (the increased burden that results from) Tj
T * (any regulatory action with the need to) Tj
T * (respond to demands
for greater) Tj
T * (transparency and accountability from) Tj
T * (the public and Congress, including a) Tj
T * (legislative mandate[Pub.L.111\226117, ) Tj
T * (Div.D, Tit.II, sec.219, 123 Stat.3034) Tj
T * (\ (2009\)].We will evaluate the effect of) Tj
T * (provisions of the regulations such as the) Tj
T * (de minimis and the public accessibility) Tj
T * (requirement within three years after) Tj
T * (implementation of the final rule.) Tj
1 - 1.467 Td(Our burden estimates were based on) Tj - 1 - 1.122 Td(the current pool of PHS - funded) Tj
T * (Investigators as well as our experience) Tj
T * (with FCOI reports under the 1995) Tj
T * (regulations.We note that the revised) Tj
T * (definition of Investigator is not) Tj
T * (significantly different from that in the) Tj
T * (1995 regulations; therefore, the number) Tj
T * (of Investigators should not change) Tj
T * (substantially.We recognize that the) Tj
T * (scope of Investigator SFI disclosures,
if) Tj
T * (not the actual numbers, will increase) Tj
T * (under the revised regulations, and that) Tj
T * (the number of FCOI reports may) Tj
T * (increase as well.We made a good faith) Tj
T * (estimate in the NPRM as to the extent) Tj
T * (of these increases.Nonetheless, we have) Tj
T * (taken these comments into) Tj
T * (consideration as we revised the) Tj
T * (Regulatory Impact Analysis in section V) Tj
T * (to accommodate the content of this final) Tj
T * (rule.Specifically, we have increased the) Tj
T * (estimated time
for Institutions to adapt) Tj
T * (NIH training materials to incorporate) Tj
T * (their policies, the time
for Investigator) Tj
T * (disclosures and updates, and the time) Tj
T * (
for reviewing disclosures.We also) Tj
T * (added an estimated time
for completing) Tj
T * (a retrospective review, and clarified that) Tj
T * (the time estimated
for Institutions to) Tj
T * (monitor Investigator compliance with a) Tj
T * (management plan in the NPRM was) Tj
T * (calculated on a monthly rather than) Tj
T * (annual basis.) Tj
1 - 1.467 Td(In addition, several respondents) Tj - 1 - 1.122 Td(objected to the statement in the NPRM) Tj
T * (that the cost of implementing the) Tj
T * (amended regulations is an allowable) Tj
T * (cost eligible
for reimbursement as a) Tj
T * (Facilities and Administrative cost on) Tj
T * (PHS - supported grants, cooperative) Tj
T * (agreements, and contracts, citing) Tj
0 - 1.111 TD(limitations in these reimbursements.We) Tj
T * (recognize that in some instances current) Tj
T * (cost principles may limit an) Tj
T * (Institution\222s ability to recover costs) Tj
T * (under the Facilities and Administrative) Tj
T * (cost mechanism.However, this does not) Tj
T * (render those costs ineligible
for) Tj
0 Tw T * (recovery.) Tj
1 g / T1_3 1 Tf
6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(17: 26 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00005) - 1077(Fmt 4701) - 1077(Sfmt 4700) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

// peepdf comment: Javascript code located in object 57 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 45 750 Tm(53260) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
ET
q
1 0 0 1 45 125.8000031 cm
0.5 w 
0 0 m
50 0 l
S
Q
BT
/T1_1
1 Tf
0 Tw 5.446 0 0 4.55 52 118.9091 Tm(12) Tj - 0.0029 Tw 7 0 0 7 59.1954 117.1 Tm(The Patient Protection and Affordable Care Act) Tj - 2.028 - 1.143 Td(\ (the Affordable Care Act\), Public Law 111\226148, was) Tj
0 - 1.143 TD(enacted on March 23, 2010; the Health Care and) Tj
T * (Education Reconciliation Act\ (the Reconciliation) Tj - 0.0028 Tw T * (Act\), Public Law 111\226152, was enacted on March) Tj
T * (30, 2010.The Affordable Care Act and the) Tj - 0.0029 Tw T * (Reconciliation Act reorganize, amend, and add to) Tj
T * (the provisions of part A of title XXVII of the Public) Tj
T * (Health Service Act.) Tj
ET
q
1 0 0 1 222 61.8000031 cm
0.5 w
0 0 m
50 0 l
S
Q
BT / T1_1 1 Tf
0 Tw 5.446 0 0 4.55 229 54.9091 Tm(13) Tj - 0.0028 Tw 7 0 0 7 236.1954 53.1 Tm(75 FR 28689\ (May 21, 2010\).) Tj
ET
q
1 0 0 1 399 134.8000031 cm
0.5 w
0 0 m
50 0 l
S
Q
BT / T1_1 1 Tf
0 Tw 5.446 0 0 4.55 406 127.9091 Tm(14) Tj - 0.0029 Tw 7 0 0 7 413.1954 126.1 Tm(Consistent with the 1995 regulations, in those) Tj - 2.028 - 1.143 Td(few cases where an individual, rather than an) Tj - 0.0028 Tw T * (Institution, is an applicant
for PHS grants or) Tj - 0.0029 Tw T * (cooperative agreements
for research, PHS Awarding) Tj - 0.0028 Tw T * (Components will make
case -by -
case determinations) Tj
T * (on the steps to be taken to ensure that the design, ) Tj
T * (conduct, and reporting of the research will not be) Tj - 0.0029 Tw T * (biased by any conflicting financial interest of the) Tj
0 Tw T * (individual.) Tj
5.446 0 0 4.55 406 54.9091 Tm(15) Tj - 0.0028 Tw 7 0 0 7 413.1954 53.1 Tm(60 FR 35814\ (July 11, 1995\).) Tj / T1_2 1 Tf - 0.0045 Tw 9 0 0 9 45 725 Tm(General Comments on Implementation) Tj / T1_1 1 Tf
1 - 1.667 Td(Several respondents suggested that) Tj - 1 - 1.111 Td(HHS provide assistance to Institutions) Tj
0 - 1.111 TD(
for the implementation of new policies) Tj
T * (and procedures to comply with the) Tj
T * (revised regulations.HHS recognizes the) Tj
T * (need to support implementation and is) Tj
T * (developing implementation guidance, ) Tj
T * (which may include,
for example, ) Tj
T * (Frequently Asked Questions and other) Tj
T * (updates to NIH\222s Financial Conflicts of) Tj
T * (Interest Web site, ) Tj / T1_2 1 Tf
0 Tw(http: //grants.nih.gov/ )Tj
T * (grants / policy / coi / .) Tj / T1_1 1 Tf - 0.0045 Tw 8.738 0 Td(General inquires) Tj - 8.738 - 1.111 Td(about the FCOI regulations, and requests) Tj
T * (to consider additional assistance efforts, ) Tj
T * (may be directed to: ) Tj / T1_2 1 Tf
0 Tw T * (FCOICompliance@mail.nih.gov.) Tj / T1_1 1 Tf - 0.0045 Tw 1 - 1.222 Td(Many respondents requested that the) Tj - 1 - 1.111 Td(implementation of the revised) Tj
T * (regulations be staggered and proposed) Tj
T * (time periods ranging from one to five) Tj
T * (years.In particular, respondents) Tj
T * (suggested that the implementation of) Tj
T * (the public accessibility requirement in ) Tj
T * (42 CFR 50.605\ (a\)\ (5\) and 45 CFR) Tj
T * (94.5\ (a\)\ (5\) should be postponed to) Tj
T * (October 2013 to coincide with the) Tj
T * (disclosure provisions under Title VI, ) Tj
T * (Section 6002, of the recently enacted) Tj
T * (Patient Protection and Affordable Care) Tj
T * (Act, Public Law 111\226148\ (hereafter, ) Tj
T * (Affordable Care Act) Tj
0 Tw 7.002 0 0 5.85 128.4247 411.3282 Tm(12) Tj - 0.0045 Tw 9 0 0 9 136.2108 409.0003 Tm(\).We agree that it) Tj - 10.134 - 1.111 Td(is important to balance the desire to) Tj
T * (implement the revised regulations as) Tj
T * (soon as possible with the need to) Tj
T * (provide sufficient time
for Institutions) Tj
T * (and Investigators to comply.We have) Tj
T * (done so by providing a compliance date) Tj
T * (of up to 365 days from publication of) Tj
T * (this final rule, as described in the Dates) Tj
T * (section above.We considered a) Tj
T * (staggered approach but thought this) Tj
T * (would create added burden
for) Tj
T * (Institutions and Investigators, and) Tj
T * (confusion
for the public.) Tj
1 - 1.222 Td(One respondent suggested that we) Tj - 1 - 1.111 Td(assemble an advisory board of) Tj
T * (administrators at Institutions to assist in ) Tj
T * (our deliberations in drafting the final) Tj
T * (rule.We encouraged all stakeholders) Tj
T * (including Institutions to submit) Tj
T * (comments to the ANPRM and to the) Tj
T * (NPRM; such comments have been) Tj
T * (instrumental to our deliberations.) Tj
T * (Additionally, we convened a committee) Tj
T * (of NIH / HHS staff with expertise in ) Tj
T * (different types of research funded by the) Tj
T * (PHS to consider the comments to the) Tj
T * (NPRM and the ANPRM.) Tj
20.667 65.222 Td(A few respondents suggested that we) Tj - 1 - 1.1 Td(postpone revising the regulations and) Tj
0 - 1.1 TD(conduct additional discussion with the) Tj
T * (research community.Again, we note) Tj
T * (that by publishing both an ANPRM and) Tj
T * (an NPRM, and by encouraging public) Tj
T * (comment through public outreach) Tj
T * (initiatives, we have involved the) Tj
T * (community throughout this process, and) Tj
T * (we have carefully considered the) Tj
T * (comments that have been raised.) Tj / T1_0 1 Tf
0 - 1.644 TD(III.Discussion of Public Comments) Tj
0 - 1.1 TD(Related to Specific Provisions of the) Tj
T * (Revised Regulations) Tj / T1_1 1 Tf
1 - 1.467 Td(Public comments regarding revisions) Tj - 1 - 1.1 Td(to specific provisions of the 1995) Tj
T * (regulations are summarized below, ) Tj
T * (along with a description of HHS\222) Tj
0 - 1.111 TD(deliberations and any change made to) Tj
T * (the final rule in response to the) Tj
0 Tw T * (comments.) Tj / T1_2 1 Tf - 0.0045 Tw 0 - 1.644 TD(Purpose\ (42 CFR 50.601; 45 CFR 94.1\)) Tj / T1_1 1 Tf
1 - 1.467 Td(As proposed in the NPRM, ) Tj
0 Tw 7.002 0 0 5.85 341.3375 492.828 Tm(13) Tj - 0.0045 Tw 9 0 0 9 351.5837 490.5001 Tm(we have) Tj - 14.398 - 1.111 Td(made minor revisions to this section to) Tj
0 - 1.111 TD(improve internal consistency with) Tj
T * (regard to the use of various terms and) Tj
T * (phrases throughout the regulations.One) Tj
T * (respondent questioned the removal of) Tj
T * (the words\221\221to ensure\222\222 in the reference) Tj
T * (to standards that provide a reasonable) Tj
T * (expectation that the design, conduct, ) Tj
T * (and reporting of research funded under) Tj
T * (PHS grants or cooperative agreements is) Tj
T * (free from bias resulting from) Tj
T * (Investigator FCOI.We have) Tj
T * (implemented our proposed language, ) Tj
T * (which focuses on the phrase) Tj
T * (\221\221reasonable expectation, \222\222 because we) Tj
T * (believe it sets a more accurate and) Tj
T * (realistic objective
for the regulations; as) Tj
T * (another respondent noted, it can be) Tj
T * (perceived as unrealistic from an) Tj
T * (enforcement perspective to\221\221ensure\222\222 the) Tj
T * (elimination of bias.The respondent also) Tj
T * (suggested replacing the phrase\221\221design, ) Tj
T * (conduct, or reporting of research\222\222 with) Tj
T * (\221\221design, conduct, analysis, ) Tj
T * (management, administration, reporting, ) Tj
T * (and distribution of research\222\222 throughout) Tj
T * (the rule.We have not made this change, ) Tj
T * (because we believe that\221\221design, ) Tj
T * (conduct or reporting\222\222 covers the major) Tj
T * (responsibilities related to the PHS - ) Tj
T * (funded research and that the term) Tj
T * (\221\221conduct\222\222 encompasses many of the) Tj
T * (additional terms suggested by the) Tj
0 Tw T * (respondent.) Tj / T1_2 1 Tf - 0.0045 Tw 0 - 1.644 TD(Applicability\ (42 CFR 50.602, 45 CFR) Tj
0 Tw 0 - 1.111 TD(94.2\)) Tj / T1_1 1 Tf - 0.0045 Tw 1 - 1.467 Td(The 1995 regulations were applicable) Tj - 1 - 1.111 Td(to each Institution that seeks or receives) Tj
T * (PHS funding
for research and, through) Tj
T * (implementation of the regulations by) Tj
T * (each Institution, to each Investigator) Tj
19.667 72.5 Td(participating in such research.) Tj
0 Tw 7.002 0 0 5.85 524.3529 727.3279 Tm(14) Tj
9 0 0 9 532.139 725 Tm() Tj - 0.0045 Tw - 14.793 - 1.111 Td(However, the 1995 regulations excluded) Tj
T * (SBIR / STTR Phase I applications because) Tj
T * (of the expectation that such applications) Tj
T * (\221\221are
for limited amounts.\222\222) Tj
0 Tw 7.002 0 0 5.85 509.8785 687.328 Tm(15) Tj - 0.0045 Tw 9 0 0 9 520.1247 685.0001 Tm(As we) Tj - 13.458 - 1.111 Td(discussed in the NPRM, since 1995 the) Tj
T * (size of these awards has increased, such) Tj
T * (that the amounts constitute a significant) Tj
T * (expenditure of public funds.For) Tj
T * (example, the median amount of an NIH) Tj
T * (Phase I award increased from) Tj
T * (approximately $99, 000 in 1995 to) Tj
T * (approximately $182, 000 in 2009.) Tj
T * (Therefore, we proposed in the NPRM to) Tj
T * (include SBIR / STTR Phase I applications) Tj
T * ( in the revised regulations.) Tj
1 - 1.111 Td(We only received a small number of) Tj - 1 - 1.111 Td(comments on this component of the) Tj
T * (proposal.While a few respondents) Tj
T * (agreed that including these applications) Tj
T * (is reasonable, one respondent suggested) Tj
T * (that including these applicants in the) Tj
T * (final rule\221\221could present difficulties
for) Tj
T * (start - up and emerging companies forced) Tj
T * (to adhere to the rule\222s extensive) Tj
T * (requirements
for reporting and) Tj
T * (managing conflicts of interest) Tj
T * (requirements\227the same rules with) Tj
T * (which large research institutions with) Tj
T * (substantially more resources will be) Tj
0 Tw T * (complying.\222\222) Tj - 0.0045 Tw 1 - 1.111 Td(We have taken this comment into) Tj - 1 - 1.111 Td(account in our reevaluation of the) Tj
T * (proposed inclusion of the SBIR / STTR) Tj
T * (Phase I program and we ultimately) Tj
T * (determined that this change from the) Tj
T * (1995 regulations could indeed create an) Tj
T * (undue burden.In particular, SBIR / STTR) Tj
T * (companies are small in size\ (eligible) Tj
T * (companies must have fewer than 500) Tj
T * (employees, but,
for example, the average) Tj
T * (NIH SBIR / STTR company has) Tj
T * (approximately 20 employees and many) Tj
T * (have only 1\2263 employees\), and these) Tj
T * (companies tend to be limited in ) Tj
T * (resources.Accordingly, we found the) Tj
T * (argument to be compelling that the) Tj
T * (investment required to comply with the) Tj
T * (regulations could create a) Tj
T * (disproportionate burden on small) Tj
T * (businesses.Moreover, approximately) Tj
T * (56 % of Phase I awardees will apply
for) Tj
T * (Phase II funding, at which point they) Tj
T * (will be covered by the regulations.) Tj
T * (Therefore, the regulations will still) Tj
T * (capture the benefits of compliance from) Tj
T * (a significant number of these companies) Tj
T * (without imposing an undue burden that) Tj
T * (could create a disincentive to applicants) Tj
1 g / T1_3 1 Tf
0 Tw 6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(17: 26 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00006) - 1077(Fmt 4701) - 1077(Sfmt 4700) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

// peepdf comment: Javascript code located in object 70 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 45 750 Tm(53262) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
ET
q
1 0 0 1 45 61.8000031 cm
0.5 w 
0 0 m
50 0 l
S
Q
BT
/T1_1
1 Tf
0 Tw 5.446 0 0 4.55 52 54.9091 Tm(18) Tj - 0.0029 Tw 7 0 0 7 59.1954 53.1 Tm(42 CFR 50.603 and 45 CFR 94.3.) Tj
ET
q
1 0 0 1 222 61.8000031 cm
0.5 w
0 0 m
50 0 l
S
Q
BT / T1_1 1 Tf
0 Tw 5.446 0 0 4.55 229 54.9091 Tm(19) Tj - 0.0028 Tw 7 0 0 7 236.1954 53.1 Tm(42 CFR 50.605\ (a\) and 45 CFR 94.5\ (a\).) Tj - 0.0045 Tw 9 0 0 9 45 725 Tm(such funding, which may include,
for) Tj
0 - 1.1 TD(example, collaborators or consultants..) Tj
T * (Several respondents suggested that this) Tj
T * (definition is overly broad and will result) Tj
T * ( in disclosures from people who are only) Tj
T * (peripherally associated with the PHS - ) Tj
T * (funded research.We note that the) Tj
T * (definition is not substantially different) Tj
T * (from the definition in the 1995) Tj
0 Tw T * (regulations) Tj
7.002 0 0 5.85 92.4881 638.228 Tm(18) Tj - 0.0045 Tw 9 0 0 9 102.7343 635.9 Tm(and is consistent with) Tj - 6.415 - 1.1 Td(regulatory guidance that NIH has issued) Tj
0 Tw T * (\ () Tj / T1_2 1 Tf(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 2.441 0 Td(see\221\221Investigator - Specific) Tj - 2.441 - 1.1 Td(Questions\222\222 section of NIH\222s\221\221Frequently) Tj
T * (Asked Questions\222\222 resource at) Tj / T1_2 1 Tf
0 Tw(http: // )Tj
T * (grants.nih.gov / grants / policy / ) Tj
T * (coifaq.htm\).) Tj / T1_1 1 Tf - 0.0045 Tw 5.811 0 Td(In response to questions) Tj - 5.811 - 1.1 Td(about whether this definition includes) Tj
T * (unfunded collaborators, we note that the) Tj
T * (definition refers to the
function of the) Tj
T * (individual on the PHS - funded project;) Tj / T1_2 1 Tf
0 Tw T * (i.e., ) Tj / T1_1 1 Tf - 0.0045 Tw 1.923 0 Td(his / her responsibility
for the design, ) Tj - 1.923 - 1.1 Td(conduct, or reporting of the PHS - funded) Tj
T * (research, and not to his / her title or the) Tj
T * (amount or source of remuneration.) Tj
1 - 1.022 Td(Other respondents suggested the) Tj - 1 - 1.1 Td(definition should be expanded to) Tj
T * (include other types of activities, or to) Tj
T * (include people in a position to) Tj
T * (influence the design, conduct, or) Tj
T * (reporting of the research.We have) Tj
T * (retained the focus of the definition on) Tj
T * (Investigators who are responsible
for the) Tj
T * (design, conduct, or reporting of research) Tj
T * (
for the reasons discussed above.) Tj
1 - 1.022 Td(Consistent with our proposal in the) Tj - 1 - 1.1 Td(NPRM, we have also eliminated the) Tj
T * (reference to the Investigator\222s spouse) Tj
T * (and dependent children in this) Tj
T * (definition, as we believe that such) Tj
T * (reference is more appropriate to include) Tj
T * ( in the SFI definition, below.) Tj / T1_2 1 Tf
1 - 1.022 Td(9.Key personnel.) Tj / T1_1 1 Tf(In parallel to the use) Tj - 1 - 1.1 Td(of the term\221\221senior / key personnel\222\222 in ) Tj
T * (making FCOI information publicly) Tj
T * (accessible
for research grants and) Tj
T * (cooperative agreements under 42 CFR) Tj
T * (50.605, the term\221\221key personnel\222\222 is) Tj
0 - 1.111 TD(used
for research contracts under 45) Tj
T * (CFR 94.5.Therefore, we thought it) Tj
T * (would be useful to include a separate) Tj
T * (definition
for this term in the final rule, ) Tj
T * (to clarify the exact meaning: the PD / PI) Tj
T * (and any other personnel considered to) Tj
T * (be essential to work performance in ) Tj
T * (accordance with HHSAR subpart) Tj
T * (352.242\22670 and identified as key) Tj
T * (personnel in the contract proposal and) Tj
0 Tw T * (contract.) Tj / T1_2 1 Tf - 0.0045 Tw 1 - 1.022 Td(10.Manage.) Tj / T1_1 1 Tf(We proposed this) Tj - 1 - 1.111 Td(definition in the NPRM to mean taking) Tj
T * (action to address an FCOI, which) Tj
T * (includes reducing or eliminating the) Tj
T * (FCOI, to ensure that the design, ) Tj
T * (conduct, and reporting of research will) Tj
T * (be free from bias or the appearance of) Tj
T * (bias.Consistent with our discussion in ) Tj
T * (the NPRM, we have included a modified) Tj
19.667 72.5 Td(version of this definition in the final) Tj
0 - 1.1 TD(rule as part of a wider reconsideration) Tj
T * (of the concepts of managing, reducing, ) Tj
T * (and eliminating an FCOI.In the 1995) Tj
T * (regulations, these concepts were) Tj
T * (typically listed separately;) Tj
0 Tw 7.002 0 0 5.85 332.3965 677.8279 Tm(19) Tj
9 0 0 9 342.6427 675.5 Tm(suggesting) Tj - 0.0045 Tw - 13.405 - 1.1 Td(that reducing or eliminating an FCOI) Tj
T * (may not be the same as managing an) Tj
T * (FCOI.We believe that it is more) Tj
T * (appropriate to consider the reduction or) Tj
T * (elimination of an FCOI as alternate) Tj
T * (means of managing an FCOI, depending) Tj
T * (on the circumstances.) Tj
1 - 1.022 Td(This revision is not intended, as) Tj - 1 - 1.1 Td(suggested by one respondent, to imply) Tj
T * (that reduction or elimination is the only) Tj
T * (acceptable means of managing an FCOI.) Tj
T * (To address this concern, we have) Tj
T * (changed the definition in the final rule) Tj
T * [(to read\221\221 * ) - 555( * ) - 555( * ) - 829(to take action to)] TJ
T * (address a financial conflict of interest, ) Tj
T * (which can include reducing or) Tj
T * (eliminating the financial conflict of) Tj
T * [(interest * ) - 555( * ) - 555( * \222\222 Another respondent)] TJ
T * (agreed with the definition,
while a third) Tj
T * (thought it should be expanded to) Tj
T * (include activities beyond the design, ) Tj
T * (conduct, or reporting of research and to) Tj
T * (state that the ultimate goal is) Tj
T * (elimination.Another respondent) Tj
T * (thought that certain types of SFIs should) Tj
T * (be specified as requiring elimination or) Tj
T * (reduction.In response to these related) Tj
T * (comments, we want to clarify that we do) Tj
T * (not intend to imply that every FCOI) Tj
T * (must be eliminated; the goal of the) Tj
T * (regulations is to ensure appropriate) Tj
T * (management so as to maintain) Tj
T * (objectivity of the research.Additionally, ) Tj
T * (as discussed above, we believe\221\221design, ) Tj
T * (conduct, or reporting\222\222 covers the major) Tj
T * (responsibilities related to the PHS - ) Tj
T * (funded research, so we have not) Tj
T * (expanded the scope of the definition.) Tj
T * (One respondent suggested that\221\221ensure\222\222) Tj
T * (is impossible to enforce.To address this) Tj
T * (concern, we have included the phrase) Tj
T * (\221\221to the extent possible\222\222 in the) Tj
T * (definition.Finally, respondents) Tj
T * (suggested the deletion of the phrase) Tj
T * (\221\221appearance of bias.\222\222 We have made) Tj
T * (this change, as we agree that this phrase) Tj
T * (can be interpreted as overly broad and) Tj
0 Tw 0 - 1.111 TD(ambiguous.) Tj / T1_2 1 Tf - 0.0045 Tw 1 - 1.022 Td(11.PD / PI.) Tj / T1_1 1 Tf(We proposed this) Tj - 1 - 1.111 Td(definition in the NPRM to mean a) Tj
T * (Project Director or Principal Investigator) Tj
T * (of a PHS - funded research project.In the) Tj
T * (final rule, to improve clarity, we have) Tj
T * (noted that the PD / PI is included in the) Tj
T * (definition of senior / key personnel in 42) Tj
T * (CFR 50.603, and in the definition of key) Tj
T * (personnel in 45 CFR 94.3.) Tj / T1_2 1 Tf
1 - 1.022 Td(12.PHS.) Tj / T1_1 1 Tf(Consistent with our proposal) Tj - 1 - 1.111 Td( in the NPRM, we have revised the) Tj
T * (definition of\221\221PHS\222\222 to include a specific) Tj
T * (reference to NIH in order to clarify that) Tj
19.667 72.5 Td(Institutions applying
for, or receiving, ) Tj
0 - 1.1 TD(research funding from NIH are subject to) Tj
T * (the regulations.This language remains) Tj
T * (unchanged from that proposed in the) Tj
T * (NPRM; however, as a technical) Tj
T * (correction to improve clarity and) Tj
T * (accuracy, we have deleted the reference) Tj
T * (to\221\221an operating division.\222\222) Tj / T1_2 1 Tf
1 - 1.022 Td(13.Research.) Tj / T1_1 1 Tf(Consistent with our) Tj - 1 - 1.1 Td(proposal in the NPRM, we have revised) Tj
T * (the definition of\221\221research\222\222 to include) Tj
T * (a non - exhaustive list of examples of) Tj
T * (different types of PHS funding) Tj
T * (mechanisms to which the definition) Tj
T * (applies.As revised, the definition under) Tj
T * (42 CFR 50.603 includes any activity
for) Tj
T * (which research funding is available) Tj
T * (from a PHS Awarding Component) Tj
T * (through a grant or cooperative) Tj
T * (agreement, whether authorized under) Tj
T * (the PHS Act or other statutory authority, ) Tj
T * (such as a research grant, career) Tj
T * (development award, center grant, ) Tj
T * (individual fellowship award, ) Tj
T * (infrastructure award, institutional) Tj
T * (training grant, program project, or) Tj
T * (research resources award.The) Tj
T * (definition under 45 CFR 94.3 includes) Tj
T * (any activity
for which research funding) Tj
T * (is available from a PHS Awarding) Tj
T * (Component through a contract, whether) Tj
T * (authorized under the PHS Act or other) Tj
T * (statutory authority.We also added the) Tj
T * (terms\221\221study or experiment\222\222 to enhance) Tj
T * (clarity.A few respondents requested) Tj
T * (that the definition exclude certain types) Tj
T * (of grants such as those
for educational) Tj
T * (activities, training, or construction.We) Tj
T * (note that PHS funds a wide variety of) Tj
T * (award types and there may be some) Tj
T * (research components within award) Tj
T * (types that are not specifically labeled) Tj
T * (\221\221research\222\222 awards.It is important that) Tj
T * (the information on SFI related to such) Tj
T * (activities be provided to the Institution) Tj
T * (
for evaluation of the relatedness to PHS - ) Tj
T * (funded research and the possibility of) Tj
T * (an FCOI.Therefore, we believe it would) Tj
T * (not be prudent to limit the types of PHS - ) Tj
T * (funded research activities that are) Tj
T * (subject to these regulations and we did) Tj
T * (not make this change.) Tj
1 - 1.022 Td(One respondent suggested the) Tj - 1 - 1.1 Td(addition of examples
for the term) Tj
T * (\221\221product development\222\222 in the) Tj
T * (definition.We agree that this is useful) Tj
T * (and have added the examples of product) Tj
T * (development\ (a diagnostic test or drug\)) Tj
T * (and of products of basic and applied) Tj
T * (research\ (a published article, book, or) Tj
T * (book chapter\).Another respondent) Tj
T * (suggested that reference to the) Tj
T * (regulations be included in specific) Tj
T * (Requests
for Applications or Requests) Tj
T * (
for Proposals to clarify exactly when the) Tj
T * (regulations are applicable.We believe) Tj
T * (this comment is addressed by the) Tj
0 - 1.111 TD(general provision of Web links to and) Tj
T * (citations of applicable policy) Tj
1 g / T1_3 1 Tf
0 Tw 6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(17: 26 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00008) - 1077(Fmt 4701) - 1077(Sfmt 4700) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

// peepdf comment: Javascript code located in object 80 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 536.42 750 Tm(53263) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
ET
q
1 0 0 1 45 295.8000031 cm
0.5 w 
0 0 m
50 0 l
S
Q
BT
/T1_1
1 Tf
0 Tw 5.446 0 0 4.55 52 288.9091 Tm(20) Tj - 0.0029 Tw 7 0 0 7 59.1954 287.1 Tm(75 FR 28705\ (May 21, 2010\).) Tj
0 Tw 5.446 0 0 4.55 52 279.9091 Tm(21) Tj - 0.0029 Tw 7 0 0 7 59.1954 278.1 Tm(Under the 1995 regulations, an SFI means) Tj - 2.028 - 1.143 Td(anything of monetary value, including but not) Tj
0 - 1.143 TD(limited to, salary or other payments
for services) Tj
0 Tw T * (\ () Tj / T1_2 1 Tf(e.g., ) Tj / T1_1 1 Tf - 0.0029 Tw 2.442 0 Td(consulting fees or honoraria\); equity interests) Tj
0 Tw - 2.442 - 1.143 Td(\ () Tj / T1_2 1 Tf(e.g., ) Tj / T1_1 1 Tf - 0.0029 Tw 2.442 0 Td(stocks, stock options or other ownership) Tj - 0.0028 Tw - 2.442 - 1.143 Td(interests\); and intellectual property rights\ () Tj / T1_2 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf - 0.0029 Tw T * (patents, copyrights and royalties from such rights\).) Tj
T * (The term does not include: \ (1\) Salary,
royalties,
or) Tj - 0.0028 Tw T * (other remuneration from the applicant Institution;) Tj - 0.0029 Tw T * (\ (2\) any ownership interests in the Institution,
if the) Tj - 0.0028 Tw T * (Institution is an applicant under the SBIR / STTR) Tj
T * (programs;\ (3\) income from seminars, lectures, or) Tj
T * (teaching engagements sponsored by public or) Tj
T * (nonprofit entities;\ (4\) income from service on) Tj - 0.0029 Tw T * (advisory committees or review panels
for public or) Tj
T * (nonprofit entities;\ (5\) an equity interest that when) Tj
T * (aggregated
for the Investigator and the Investigator\222s) Tj
T * (spouse and dependent children meets both of the) Tj - 0.0028 Tw T * (following tests: does not exceed $10,
000 in value) Tj
T * (as determined through reference to public prices or) Tj - 0.0029 Tw T * (other reasonable measures of fair market value, and) Tj
T * (does not represent more than a five percent) Tj
T * (ownership interest in any single entity; or\ (6\) salary, ) Tj
T * (royalties, or other payments that when aggregated) Tj
T * (
for the Investigator and the Investigator\222s spouse) Tj
T * (and dependent children over the next 12 months, ) Tj - 0.0028 Tw T * (are not expected\ (or, in the
case of PHS contracts, ) Tj
T * (are not reasonably expected\) to exceed $10, 000.) Tj
0 Tw 5.446 0 0 4.55 52 54.9091 Tm(22) Tj - 0.0029 Tw 7 0 0 7 59.1954 53.1 Tm(42 CFR 50.604\ (c\)\ (1\) and 45 CFR 94.4\ (c\)\ (1\)) Tj
ET
q
1 0 0 1 399 93.3999939 cm
0.5 w
0 0 m
50 0 l
S
Q
BT / T1_1 1 Tf
0 Tw 5.446 0 0 4.55 406 86.5091 Tm(23) Tj - 0.0029 Tw 7 0 0 7 413.1954 84.7 Tm(Alternatively,
if the commenter is concerned) Tj - 0.0028 Tw - 2.028 - 1.129 Td(about\ (improper\) payment to an Institution under) Tj
0 - 1.129 TD(these circumstances, we note that institutional) Tj
T * (conflicts of interest are addressed in section IV of) Tj - 0.0029 Tw T * (this final rule.) Tj - 0.0045 Tw 9 0 0 9 45 725 Tm(requirements and terms and conditions) Tj
0 - 1.111 TD(of awards on Notices of Award
for all) Tj
T * (PHS funded grants and cooperative) Tj
T * (agreements and in all contracts awarded) Tj
T * (by the PHS that are
for research.) Tj / T1_2 1 Tf
1 - 1.056 Td(14.Senior / key personnel.) Tj / T1_1 1 Tf(The NPRM) Tj - 1 - 1.111 Td(uses this term in the proposal and) Tj
T * (discussion of the management and) Tj
T * (posting of FCOI under 42 CFR 50.605.) Tj
T * (Therefore, we thought it would be) Tj
T * (useful to include a separate definition) Tj
T * (
for this term in the final rule, to clarify) Tj
T * (the exact meaning: the PD / PI and any) Tj
T * (other person who the Institution) Tj
T * (identifies as senior / key personnel in the) Tj
T * (grant application progress report, and) Tj
T * (any other report submitted to the PHS) Tj
T * (by the Institution under this subpart.) Tj
T * (This definition is in parallel to that of) Tj
T * (the term\221\221key personnel\222\222 used in ) Tj
T * (making FCOI information publicly) Tj
T * (accessible
for research contracts under) Tj
T * (45 CFR 94.5.) Tj / T1_2 1 Tf
1 - 1.056 Td(15.Significant Financial Interest.) Tj / T1_1 1 Tf
0 Tw(In) Tj - 0.0045 Tw - 1 - 1.111 Td(the NPRM, we proposed to revise) Tj
T * (substantially the SFI definition, ) Tj
0 Tw 7.002 0 0 5.85 175.8427 478.3282 Tm(20) Tj
9 0 0 9 183.6288 476.0003 Tm() Tj - 0.0045 Tw - 15.403 - 1.111 Td(incorporating the proposed definitions) Tj
T * (of\221\221financial interest\222\222 and\221\221institutional) Tj
T * (responsibilities\222\222 described above.) Tj
T * (Below is a discussion of public) Tj
T * (comments related to the implementation) Tj
T * (of these changes, using the categories) Tj
T * (referenced in the NPRM to highlight) Tj
T * (differences from the 1995 regulations.) Tj
0 Tw 7.002 0 0 5.85 201.3346 398.3282 Tm(21) Tj
9 0 0 9 209.1208 396.0003 Tm() Tj - 0.0045 Tw - 17.236 - 1.056 Td(Institutional responsibilities: Some) Tj - 1 - 1.111 Td(respondents suggested that the) Tj
T * (disclosure requirement in the 1995) Tj
0 Tw T * (regulations, ) Tj
7.002 0 0 5.85 93.49 358.8282 Tm(22) Tj / T1_2 1 Tf
9 0 0 9 103.7362 356.5003 Tm(i.e., ) Tj / T1_1 1 Tf - 0.0045 Tw 1.923 0 Td(SFIs that Investigators) Tj - 8.449 - 1.111 Td(deem related to the PHS - funded) Tj
T * (research, is sufficient.We note that the) Tj
T * (NPRM\222s proposal to expand the) Tj
T * (definition of SFI was influenced by the) Tj
T * (suggestions of many respondents to the) Tj
19.667 46.5 Td(ANPRM who supported this change.A) Tj
T * (few respondents agreed that expanding) Tj
T * (SFIs subject to disclosure by an) Tj
T * (Investigator to an Institution to include) Tj
T * (those that reasonably appear to be) Tj
T * (related to the Investigator\222s) Tj
T * (\221\221institutional responsibilities\222\222 is) Tj
T * (warranted.Many others, however, ) Tj
T * (suggested that the SFIs to be disclosed) Tj
T * (should be limited to those that) Tj
T * (reasonably appear to be related to the) Tj
T * (Investigator\222s\221\221research) Tj
T * (responsibilities.\222\222 We have considered) Tj
T * (this suggestion and believe that since) Tj
T * (the definition of\221\221research) Tj
T * (responsibilities\222\222 is not clear - cut, this) Tj
T * (change would once again place the) Tj
T * (responsibility on the Investigator
for) Tj
T * (deciding which SFIs should be) Tj
T * (disclosed to the Institution\ (similar to) Tj
T * (the 1995 regulations\) and may not) Tj
T * (provide the Institutions with the full) Tj
T * (complement of information needed to) Tj
T * (evaluate the potential
for FCOI.For) Tj
T * (example, an Investigator is on the board) Tj
T * (of a pharmaceutical company and) Tj
T * (believes that this service draws on the) Tj
T * (Investigator\222s clinical expertise rather) Tj
T * (than research knowledge.If the SFI) Tj
T * (definition is confined to\221\221research) Tj
T * (responsibilities\222\222, the Investigator may) Tj
T * (not disclose the income from this) Tj
T * (activity to the Investigator\222s Institution.) Tj
T * (Such income definitely would fall) Tj
T * (under\221\221institutional responsibilities\222\222, ) Tj
T * (however, as the Investigator is on the) Tj
T * (clinical faculty of the Institution.) Tj
1 - 1.222 Td(Moreover, we note that the scope of) Tj - 1 - 1.111 Td(activities that need to be disclosed by) Tj
T * (the Investigator is limited by the fact) Tj
T * (that the SFI definition excludes income) Tj
T * (from seminars, lectures, or teaching) Tj
T * (engagements sponsored by a Federal, ) Tj
T * (state, or local government agency, an) Tj
T * (Institution of higher education as) Tj
T * (defined at 20 U.S.C.1001\ (a\), an) Tj
T * (academic teaching hospital, a medical) Tj
T * (center, or a research institute that is) Tj
T * (affiliated with an Institution of higher) Tj
T * (education; or income from service on) Tj
T * (advisory committees or review panels) Tj
T * (
for a Federal, state, or local government) Tj
T * (agency, an Institution of higher) Tj
T * (education as defined at 20 U.S.C.) Tj
T * (1001\ (a\), an academic teaching hospital, ) Tj
T * (a medical center, or a research institute) Tj
T * (that is affiliated with an Institution of) Tj
T * (higher education.) Tj
1 - 1.222 Td(One respondent proposed that the) Tj - 1 - 1.111 Td(regulations specify particular) Tj
T * (relationships and types of interests that) Tj
T * (should be disclosed.We have) Tj
T * (considered this suggestion and believe) Tj
T * (that limiting the scope of SFIs that an) Tj
T * (Investigator is required to disclose to his) Tj
T * (or her Institution may exclude SFIs in ) Tj
T * (activities that have the potential to) Tj
T * (affect the objectivity of PHS - funded) Tj
19.667 74.667 Td(research.Therefore, we have retained) Tj
0 - 1.1 TD(the language proposed in the NPRM.) Tj
1 - 1.022 Td(One respondent suggested that PHS) Tj - 1 - 1.1 Td(funding could change an Investigator\222s) Tj
T * (institutional responsibilities and) Tj
T * (suggested that SFI disclosures should be) Tj
T * (based on the anticipated responsibilities) Tj
T * (
if funding is awarded.We have not) Tj
T * (changed the regulations in this regard, ) Tj
T * (because we believe this concern would) Tj
T * (be addressed by the Institution\222s FCOI) Tj
0 Tw T * (policy;) Tj / T1_2 1 Tf
3.44 0 Td(i.e., ) Tj / T1_1 1 Tf - 0.0045 Tw 1.923 0 Td(any time there is a) Tj - 5.363 - 1.1 Td(significant change in an Investigator\222s) Tj
T * (institutional responsibilities\ (whether in ) Tj
T * (relation to PHS funding or not\), ) Tj
T * (Institutions should consider whether) Tj
T * (this would require the Investigator to) Tj
T * (update his or her SFI disclosures.) Tj
1 - 1.022 Td(Other respondents questioned) Tj - 1 - 1.1 Td(whether specific types of income, such) Tj
T * (as clinical work within private or) Tj
T * (university practice or teaching a craft, ) Tj
T * (would need to be disclosed.Income) Tj
T * (from any activity that is related to the) Tj
T * (Investigator\222s institutional) Tj
T * (responsibilities as defined by the) Tj
T * (Institution that meets the monetary) Tj
T * (threshold must be disclosed.Another) Tj
T * (suggested that payment related to the) Tj
T * (accrual of patients to clinical trials) Tj
T * (should be included in the definition.If) Tj
T * (the individual receiving the payment) Tj
T * (meets the definition of\221\221Investigator\222\222) Tj
T * (under the regulations, such payment) Tj
T * (would be included in the SFI definition) Tj
T * (and should be disclosed.) Tj
0 Tw 7.002 0 0 5.85 501.3678 382.228 Tm(23) Tj
9 0 0 9 509.154 379.9001 Tm() Tj - 0.0045 Tw - 11.239 - 1.022 Td(Monetary threshold: Respondents) Tj - 1 - 1.1 Td(submitted a wide range of comments on) Tj
T * (the monetary threshold proposed in the) Tj
T * (NPRM.Some supported the $5, 000) Tj
T * (threshold; others suggested that the) Tj
T * (threshold of $10, 000 in the 1995) Tj
T * (regulations should be retained; and) Tj
T * (many suggested that the threshold be) Tj
T * (lowered even further to $100 or zero.) Tj
T * (We have considered all the comments) Tj
T * (and we believe that the $5, 000 threshold) Tj
T * (proposed in the NPRM provides the) Tj
T * (appropriate balance between the) Tj
T * (administrative burden associated with) Tj
T * (disclosure and review of SFIs and the) Tj
T * (intended benefit in promoting) Tj
T * (objectivity in research.) Tj
1 - 1.022 Td(Some respondents requested that the) Tj - 1 - 1.1 Td(disclosure thresholds be harmonized) Tj
T * (with those of other Federal agencies) Tj
T * (such as the FDA and the National) Tj
T * (Science Foundation or with the) Tj
T * (disclosure provisions of the Affordable) Tj
T * (Care Act.While there may be some) Tj
T * (similarity in intent, the numerous) Tj
T * (disclosure requirements of other Federal) Tj
T * (laws, regulations, or policies are not) Tj
T * (necessarily comparable to those) Tj
1 g / T1_3 1 Tf
0 Tw 6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(17: 26 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00009) - 1077(Fmt 4701) - 1077(Sfmt 4700) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

// peepdf comment: Javascript code located in object 83 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 45 750 Tm(53264) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
ET
q
1 0 0 1 45 70.8000031 cm
0.5 w 
0 0 m
50 0 l
S
Q
BT
/T1_1
1 Tf
0 Tw 5.446 0 0 4.55 52 63.9091 Tm(24) Tj - 0.0029 Tw 7 0 0 7 59.1954 62.1 Tm(21 CFR 54.2\ (f\).) Tj
0 Tw 5.446 0 0 4.55 52 54.9091 Tm(25) Tj - 0.0029 Tw 7 0 0 7 59.1954 53.1 Tm(74 FR 21612\ (May 8, 2009\).) Tj
ET
q
1 0 0 1 399 61.8000031 cm
0.5 w
0 0 m
50 0 l
S
Q
BT / T1_1 1 Tf
0 Tw 5.446 0 0 4.55 406 54.9091 Tm(26) Tj - 0.0028 Tw 7 0 0 7 413.1954 53.1 Tm(75 FR 28705\ (May 21, 2010\).) Tj - 0.0045 Tw 9 0 0 9 45 725 Tm(specified in these regulations.For) Tj
0 - 1.1 TD(example, Title VI, Section 6002 of the) Tj
T * (Affordable Care Act requires disclosure) Tj
T * (by the entities providing the payment.) Tj
T * (FDA,
for purposes of financial) Tj
T * (disclosure by clinical investigators, has) Tj
0 Tw T * (defined) Tj / T1_2 1 Tf - 0.0045 Tw 3.772 0 Td(significant payment of other) Tj
0 Tw - 3.772 - 1.1 Td(sorts) Tj / T1_1 1 Tf - 0.0045 Tw 2.439 0 Td(as payments made by the sponsor) Tj - 2.439 - 1.1 Td(of a covered study to the investigator or) Tj
T * (the institution to support activities of) Tj
T * (the investigator that have a monetary) Tj
T * (value of more than $25, 000, exclusive of) Tj
T * (the costs of conducting the clinical) Tj
T * (study or other clinical studies.) Tj
0 Tw 7.002 0 0 5.85 170.8169 598.6279 Tm(24) Tj - 0.0045 Tw 9 0 0 9 181.063 596.3 Tm(Due to) Tj - 15.118 - 1.1 Td(the extent of potential differences in the) Tj
T * (nature, scope, and applicability of) Tj
T * (Federal disclosure requirements, we do) Tj
T * (not agree that it is feasible to harmonize) Tj
T * (all requirements at this time, although) Tj
T * (we believe these regulations could serve) Tj
T * (as a basis
for ongoing collaboration and) Tj
T * (coordination regarding the topic of) Tj
T * (conflicts of interest.) Tj
1 - 1.022 Td(Other respondents suggested that) Tj - 1 - 1.1 Td(different disclosure thresholds should) Tj
T * (be instituted
for research depending on) Tj
T * (whether it involves human participants, ) Tj
T * (drugs, or devices.As discussed in the) Tj
T * (NPRM, we posed a number of questions) Tj
T * ( in the ANPRM on the issue of whether) Tj
T * (the regulations should be amended to) Tj
T * (require specific approaches related to) Tj
T * (certain types of research or) Tj
T * (alternatively, specific types of financial) Tj
T * (interests or FCOI.) Tj
0 Tw 7.002 0 0 5.85 117.412 391.428 Tm(25) Tj - 0.0045 Tw 9 0 0 9 127.6582 389.1001 Tm(The majority of the) Tj - 9.184 - 1.1 Td(respondents to the ANPRM thought that) Tj
T * (this approach would not account
for the) Tj
T * (full range of research projects as well as) Tj
T * (the large variation in circumstances in ) Tj
T * (which FCOI may arise.We agree and) Tj
T * (note that the monetary threshold is the) Tj
T * (same regardless of the type of research, ) Tj
T * (financial interest, or identified FCOI at) Tj
0 Tw T * (issue.) Tj - 0.0045 Tw 1 - 1.022 Td(Timing: The NPRM proposed to) Tj - 1 - 1.1 Td(change the timing
for determining) Tj
T * (whether remuneration represents an) Tj
T * (SFI.The 1995 regulations excluded) Tj
T * (aggregated payments\ (including salary) Tj
T * (and royalties\) that are\221\221not expected to) Tj
T * (exceed\222\222\ (or, in the
case of PHS) Tj
T * (contracts, are\221\221not reasonably expected) Tj
0 - 1.111 TD(to exceed\222\222\) the monetary threshold) Tj
T * (\221\221over the next 12 months.\222\222 Under the) Tj
T * (revised definition proposed in the) Tj
T * (NPRM, at issue is remuneration) Tj
T * (\ (including salary and any payment
for) Tj
T * (services not otherwise identified as) Tj
T * (salary\) received from an entity\221\221in the) Tj
T * (12 months preceding the disclosure.\222\222) Tj
T * (We have included this change in the) Tj
T * (final rule; we believe it will help) Tj
T * (Institutions and Investigators to) Tj
T * (determine more accurately whether or) Tj
T * (not a financial interest represents an SFI) Tj
T * (because the payments have already) Tj
19.667 71.5 Td(occurred and are likely to have been) Tj
0 - 1.1 TD(documented.Moreover, to the extent an) Tj
T * (Investigator receives additional) Tj
T * (remuneration from an entity after) Tj
T * (completing an initial SFI disclosure, ) Tj
T * (such remuneration would be subject to) Tj
T * (the Investigator\222s ongoing disclosure) Tj
T * (obligations assuming the monetary) Tj
T * (threshold was met or exceeded.) Tj
1 - 1.022 Td(Several respondents suggested that) Tj - 1 - 1.1 Td(the 1995 regulations\222 disclosure period) Tj
T * (is more consistent with the aim of) Tj
T * (maintaining objectivity in research.) Tj
T * (Some suggested that the time period
for) Tj
T * (disclosure include both the preceding) Tj
T * (and the next 12 months, and one) Tj
T * (suggested that the period cover the) Tj
T * (duration of the award.We do not agree) Tj
T * (with these suggestions.In addition to) Tj
T * (disclosing SFIs received in the 12) Tj
T * (months preceding the disclosure, ) Tj
T * (Investigators are required to disclose) Tj
T * (new SFIs to the Institution within 30) Tj
T * (days, and
if payments received after the) Tj
T * (initial disclosure give rise to an SFI that) Tj
T * (is determined to be an FCOI by the) Tj
T * (institutional official\ (s\), the Institution is) Tj
T * (required to submit an FCOI report to the) Tj
T * (PHS Awarding Component.Consistent) Tj
T * (with our proposal in the NPRM, the) Tj
T * (final rule also includes a requirement) Tj
T * (
for annual updates.We believe this) Tj
T * (combination of provisions provides) Tj
T * (reasonable coverage of an Investigator\222s) Tj
T * (SFIs related to the PHS - funded research) Tj
T * (project, and allows a more accurate) Tj
T * (listing of SFIs by Investigators.) Tj
T * (Institutions are free to expand upon) Tj
T * (these requirements in their institutional) Tj
T * (policies and when considering whether) Tj
T * (an SFI is an FCOI with regard to the) Tj
T * (PHS - funded research.) Tj
1 - 1.022 Td(Some respondents inquired how a) Tj - 1 - 1.1 Td(payment or reimbursement that) Tj
T * (occurred before a PHS award should be) Tj
T * (reviewed in relation to the PHS - funded) Tj
T * (research.Although such considerations) Tj
T * (are dependent on the context of the SFI, ) Tj
T * (the regulations do not prevent) Tj
T * (Institutions from taking into account) Tj
T * (whether the Investigator has an ongoing) Tj
T * (financial relationship with the entity) Tj
T * (providing the payment or) Tj
T * (reimbursement or whether the payment) Tj
T * (or reimbursement was limited in ) Tj
0 Tw T * (duration.) Tj - 0.0045 Tw 1 - 1.022 Td(One respondent suggested that) Tj - 1 - 1.1 Td(different disclosure periods should be) Tj
T * (instituted
for different types of research.) Tj
T * (As discussed in the NPRM and above, ) Tj
0 - 1.111 TD(we posed a number of questions in the) Tj
T * (ANPRM on the issue of whether the) Tj
T * (regulations should be amended to) Tj
T * (require specific approaches related to) Tj
T * (certain types of research or) Tj
T * (alternatively, specific types of financial) Tj
T * (interests or FCOI.The majority of the) Tj
T * (respondents to the ANPRM thought that) Tj
T * (this approach would not account
for the) Tj
19.667 74.667 Td(full range of research projects as well as) Tj
0 - 1.1 TD(the large variation in circumstances in ) Tj
T * (which FCOI may arise.As a result, the) Tj
T * (regulations impose uniform) Tj
T * (requirements, regardless of the type of) Tj
T * (research, financial interest, or identified) Tj
T * (FCOI at issue.) Tj
1 - 1.022 Td(Examples of payment
for services: ) Tj - 1 - 1.1 Td(The definition of SFI under the 1995) Tj
T * (regulations referenced as examples of) Tj
T * (payments
for services, receipt of) Tj
T * (consulting fees, or honoraria.In the) Tj
T * (NPRM, we proposed to add\221\221paid) Tj
T * (authorship\222\222 and\221\221travel) Tj
T * (reimbursement\222\222 as additional) Tj
0 Tw T * (examples.) Tj
7.002 0 0 5.85 440.4973 579.528 Tm(26) Tj
9 0 0 9 448.2834 577.2001 Tm() Tj - 0.0045 Tw - 4.476 - 1.022 Td(With regard to\221\221paid authorship, \222\222) Tj - 1 - 1.1 Td(although it should be clear that receipt) Tj
T * (of payment from an entity in exchange) Tj
T * (
for drafting a publication constitutes) Tj
T * (payment
for services, we believe it is) Tj
T * (important to reference this form of) Tj
T * (payment specifically in the regulations.) Tj
T * (We are particularly concerned about) Tj
T * (situations in which Investigators may) Tj
T * (have accepted payment from private) Tj
T * (entities, in
return for allowing their) Tj
T * (names to be used as authors on) Tj
T * (publications
for which they had very) Tj
T * (limited input.This practice has come) Tj
T * (under increasing scrutiny in recent) Tj
T * (years and we wish to make it clear to) Tj
T * (Institutions and Investigators that such) Tj
T * (activity may be subject to the disclosure) Tj
T * (and reporting requirements depending) Tj
T * (on the circumstances of a given
case, ) Tj
T * (such as the amount of payment.One) Tj
T * (respondent noted that remuneration) Tj
T * (from authorship of textbooks is not) Tj
T * (considered an FCOI at their Institution.) Tj
T * (We note that the regulations only) Tj
T * (require disclosure of such SFI by the) Tj
T * (Investigator to his or her Institution.The) Tj
T * (Institution makes the determination as) Tj
T * (to whether the SFI constitutes an FCOI, ) Tj
T * (based on its review of the specific) Tj
T * (circumstances.Another respondent) Tj
T * (suggested that payments to faculty) Tj
T * (authors from publishers should be) Tj
T * (excluded from the SFI definition
while) Tj
T * (payments from companies not engaged) Tj
T * (primarily in publishing should be) Tj
T * (included.We do not agree with this) Tj
T * (suggestion, because we believe that it) Tj
0 - 1.111 TD(may be difficult to draw a distinction) Tj
T * (between companies engaged primarily) Tj
T * ( in publishing\ () Tj / T1_2 1 Tf
0 Tw(i.e., ) Tj / T1_1 1 Tf - 0.0045 Tw 8.689 0 Td(\221\221publishers\222\222\) and) Tj - 8.689 - 1.111 Td(those that are not, leading to) Tj
T * (inconsistent disclosures.Therefore, we) Tj
T * (retained the\221\221paid authorship\222\222 example) Tj
T * ( in the definition, as proposed in the) Tj
0 Tw T * (NPRM.) Tj - 0.0045 Tw 1 - 1.022 Td(With regard to\221\221travel) Tj - 1 - 1.111 Td(reimbursement, \222\222
while one respondent) Tj
T * (agreed that this should be included in ) Tj
T * (the SFI definition, many objected to its) Tj
T * (inclusion on the grounds that such) Tj
1 g / T1_3 1 Tf
0 Tw 6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(17: 26 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00010) - 1077(Fmt 4701) - 1077(Sfmt 4700) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

// peepdf comment: Javascript code located in object 89 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 45 750 Tm(53266) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
ET
q
1 0 0 1 222 135.8000031 cm
0.5 w 
0 0 m
50 0 l
S
Q
BT
/T1_1
1 Tf
0 Tw 5.446 0 0 4.55 229 128.9091 Tm(27) Tj / T1_2 1 Tf
7 0 0 7 236.1954 127.1001 Tm(http: //grants.nih.gov/grants/policy/ )Tj
- 2.028 - 1.143 Td(coifaq.htm #427)Tj
/T1_1 1 Tf
(. )Tj
-0.0028 Tw 1 -1.286 Td
(Am I required to disclose interests in mutual )Tj
0 Tw -1 -1.143 Td
(funds? )Tj
-0.0028 Tw 1 -1.286 Td
(Please refer to your Institution\222s policy. An )Tj
-1 -1.143 Td
(interest in a pooled fund such as a diversified )Tj
0 -1.143 TD
(mutual fund may be sufficiently remote that it )Tj
T*
(would not reasonably be expected to create a )Tj
T*
(conflict of interest for an Investigator funded by the )Tj
0 Tw T*
(NIH. )Tj
-0.0045 Tw 9 0 0 9 45 725 Tm
(evaluating such SFI. Therefore, it would )Tj
0 -1.1 TD
(seem preferable for the Institution to )Tj
T*
(receive and evaluate the information. )Tj
1 -1.022 Td
(Nonetheless, we agree with )Tj
-1 -1.1 Td
(respondents that limiting exclusions )Tj
T*
(from disclosure to income from Federal, )Tj
T*
(state, or local government agencies, and )Tj
T*
(Institutions of higher education as )Tj
T*
(defined at 20 U.S.C. 1001\(a\) is )Tj
T*
(unnecessarily narrow. Therefore, we )Tj
T*
(have revised the SFI definition in the )Tj
T*
(final rule to exclude salary, royalties, or )Tj
T*
(other remuneration paid by the )Tj
T*
(Institution to the Investigator if the )Tj
T*
(Investigator is currently employed or )Tj
T*
(otherwise appointed by the Institution; )Tj
T*
(any ownership interest in the Institution )Tj
T*
(held by the Investigator, if the )Tj
T*
(Institution is a commercial or for-profit )Tj
T*
(organization; income from seminars, )Tj
T*
(lectures, or teaching engagements )Tj
T*
(sponsored by a Federal, state, or local )Tj
T*
(government agency, an Institution of )Tj
T*
(higher education as defined at 20 U.S.C. )Tj
T*
(1001\(a\), an academic teaching hospital, )Tj
T*
(a medical center, or a research institute )Tj
T*
(that is affiliated with an Institution of )Tj
T*
(higher education; or income from )Tj
T*
(service on advisory committees or )Tj
T*
(review panels for a Federal, state, or )Tj
T*
(local government agency, an Institution )Tj
T*
(of higher education as defined at 20 )Tj
T*
(U.S.C. 1001\(a\), an academic teaching )Tj
T*
(hospital, a medical center, or a research )Tj
T*
(institute that is affiliated with an )Tj
T*
(Institution of higher education. )Tj
1 -1.022 Td
(One respondent inquired whether )Tj
-1 -1.1 Td
(income received from seminars, )Tj
T*
(lectures, or teaching engagements )Tj
T*
(sponsored by a Federal, state, or local )Tj
T*
(government agency; or income from )Tj
T*
(service on advisory committees or )Tj
T*
(review panels for a Federal, state, or )Tj
T*
(local government agency, but paid by a )Tj
T*
(private contract organization acting for )Tj
T*
(that government agency, is excluded )Tj
T*
(from the SFI definition. If a private )Tj
T*
(organization is acting as a contractor to )Tj
T*
(the Federal, state, or local government )Tj
T*
(agency, for the purposes of these )Tj
T*
(regulations, such income is excluded )Tj
T*
(from the definition. )Tj
1 -1.022 Td
(The 1995 regulations excluded from )Tj
-1 -1.1 Td
(the SFI definition any ownership )Tj
T*
(interests in the Institution, if the )Tj
T*
(Institution is an applicant under the )Tj
T*
(SBIR Program. As proposed in the )Tj
T*
(NPRM, we have broadened the )Tj
T*
(exclusion to cover any ownership )Tj
T*
(interests in the Institution if the )Tj
0 -1.111 TD
(Institution is a commercial or for-profit )Tj
T*
(organization \(whether or not the )Tj
T*
(Institution is an applicant under the )Tj
T*
(SBIR Program\). A few respondents )Tj
T*
(requested further clarification, of )Tj
T*
(situations in which an Investigator is )Tj
T*
(employed by an Institution and also has )Tj
T*
(equity in a for-profit company. In those )Tj
T*
(cases, his or her equity would only be )Tj
19.667 74.667 Td
(excluded from disclosure requirements )Tj
T*
(when the for-profit company is the )Tj
T*
(Institution that is applying for, or that )Tj
T*
(receives, the PHS research funding in )Tj
T*
(which the Investigator is participating. )Tj
1 -1.022 Td
(As proposed in the NPRM, we have )Tj
-1 -1.111 Td
(also limited the exclusion in the 1995 )Tj
T*
(regulations for salary, royalties, or other )Tj
T*
(remuneration paid by the Institution to )Tj
T*
(the Investigator to circumstances in )Tj
T*
(which the Investigator is currently )Tj
T*
(employed or otherwise appointed by the )Tj
T*
(Institution. In response to questions )Tj
T*
(from a number of respondents, we have )Tj
T*
(also clarified that intellectual property )Tj
T*
(rights assigned to the Institution and )Tj
T*
(agreements to share in royalties related )Tj
T*
(to such rights are also excluded from the )Tj
T*
(SFI definition. Other respondents )Tj
T*
(suggested that royalties and intellectual )Tj
T*
(property rights that are provided by the )Tj
T*
(Institution should not be excluded from )Tj
T*
(the definition as they could affect the )Tj
T*
(objectivity of the PHS-funded research. )Tj
T*
(We do not believe it would be useful to )Tj
T*
(increase the disclosure burden on the )Tj
T*
(Investigator by requiring disclosure to )Tj
T*
(the Institution of information the )Tj
T*
(Institution already has available. )Tj
T*
(However, we note that Institutions have )Tj
T*
(the flexibility to require such )Tj
T*
(disclosures in their own policies. One )Tj
T*
(respondent suggested that such royalties )Tj
T*
(continue to be excluded from the SFI )Tj
T*
(definition if an Investigator transfers to )Tj
T*
(another Institution. In that case, )Tj
T*
(however, the new Institution is not the )Tj
T*
(source of the royalties and the exclusion )Tj
T*
(would not apply; therefore such )Tj
T*
(royalties would be included in the SFI )Tj
0 Tw T*
(definition. )Tj
-0.0045 Tw 1 -1.033 Td
(Many respondents requested that )Tj
-1 -1.111 Td
(income from mutual funds and )Tj
T*
(retirement accounts be explicitly )Tj
T*
(excluded from Investigator disclosure )Tj
T*
(requirements, to the extent that )Tj
T*
(Investigators do not control the )Tj
T*
(investment decisions made in these )Tj
T*
(vehicles. We have provided guidance in )Tj
T*
(the form of Frequently Asked Questions )Tj
T*
(on the NIH Web site recognizing that )Tj
T*
(interests in a pooled fund such as a )Tj
T*
(diversified mutual fund may be )Tj
T*
(sufficiently remote that it would not )Tj
T*
(reasonably be expected to create a )Tj
T*
(conflict of interest for a PHS-funded )Tj
0 Tw T*
(Investigator.)Tj
7.002 0 0 5.85 272.9919 168.8283 Tm
(27)Tj
-0.0045 Tw 9 0 0 9 283.2381 166.5004 Tm
(We have revised the )Tj
-6.804 -1.111 Td
(regulations in accordance with this )Tj
T*
(guidance to exclude income from )Tj
19.667 64.278 Td
(investment vehicles, such as mutual )Tj
0 -1.1 TD
(funds and retirement accounts, as long )Tj
T*
(as the Investigator does not directly )Tj
T*
(control the investment decisions made )Tj
T*
(in these vehicles. )Tj
1 -1.022 Td
(One respondent requested that the )Tj
-1 -1.1 Td
(definition cover any \221\221security,\222\222 as )Tj
T*
(defined by reference to the Securities )Tj
T*
(Act of 1933, as amended, and suggested )Tj
T*
(that there is no reason to exclude debt )Tj
T*
(instruments. Although we have not )Tj
T*
(implemented this suggestion in the final )Tj
T*
(rule, we note that our definition )Tj
T*
(addresses stock, a specific element of )Tj
T*
(the definition of \221\221security\222\222 under the )Tj
T*
(Securities Act of 1933, 15 U.S.C. 77a )Tj
/T1_2 1 Tf
0 Tw (et )Tj
T*
(seq., )Tj
/T1_1 1 Tf
-0.0045 Tw 2.33 0 Td
(and that the regulations do not )Tj
-2.33 -1.1 Td
(expressly exclude debt instruments. A )Tj
T*
(few respondents suggested that the )Tj
T*
(definition should go beyond the )Tj
T*
(Investigator\222s spouse and dependent )Tj
T*
(children to include interests held by )Tj
T*
(more distant family members and/or )Tj
T*
(friends. We have not made this change, )Tj
T*
(because we believe that it would expand )Tj
T*
(the scope of the regulations )Tj
T*
(unnecessarily and create ambiguity. )Tj
T*
(Some respondents suggested that the )Tj
T*
(SFI definition include payments from )Tj
T*
(individuals, as well as entities. We have )Tj
T*
(not made this change because we )Tj
T*
(typically would expect individual )Tj
T*
(payors to be acting on behalf of or in )Tj
T*
(connection to entities, and because the )Tj
T*
(source of payment is not the primary )Tj
T*
(focus of the SFI definition. )Tj
1 -1.022 Td
(Several respondents requested that we )Tj
-1 -1.1 Td
(revise the SFI definition to include )Tj
T*
(\221\221domestic partners.\222\222 Although we )Tj
T*
(appreciate the interest in identifying )Tj
T*
(individuals who share assets with, or )Tj
T*
(control assets on behalf of, the )Tj
T*
(Investigator through civil unions, )Tj
T*
(powers of attorney, or other )Tj
T*
(arrangements, we have not made that )Tj
T*
(specific change to the final rule because )Tj
T*
(we believe it is beyond the scope of )Tj
T*
(these regulations to define the term )Tj
T*
(\221\221domestic partners.\222\222 However, we note )Tj
T*
(that Institutions have the flexibility to )Tj
T*
(incorporate this suggestion into their )Tj
0 Tw 0 -1.111 TD
(policies. )Tj
-0.0045 Tw 1 -1.022 Td
(Finally, as a technical correction to )Tj
-1 -1.111 Td
(the language proposed in the NPRM, we )Tj
T*
(have deleted the reference to \221\221except as )Tj
T*
(otherwise specified in this definition,\222\222 )Tj
T*
(to improve the overall clarity of the SFI )Tj
0 Tw T*
(definition. )Tj
/T1_2 1 Tf
-0.0045 Tw 1 -1.022 Td
(16. Small Business Innovation )Tj
-1 -1.111 Td
(Research \(SBIR\) Program. )Tj
/T1_1 1 Tf
(In the NPRM )Tj
T*
(we removed the definition in the 1995 )Tj
T*
(regulations for the SBIR Program since, )Tj
T*
(in the proposed regulations this )Tj
T*
(program was no longer excluded, and )Tj
T*
(we had not separately defined other )Tj
T*
(HHS research programs that were )Tj
T*
(subject to the proposed regulations. As )Tj
T*
(the SBIR Phase I applications are )Tj
T*
(excluded from the final rule \(see )Tj
1 g
/T1_3 1 Tf
0 Tw 6.5 0 0 6.5 25 20 Tm
[(VerDate Mar<15>2010 )-1077(17:26 Aug 24, 2011)-1077(Jkt 223001)-1077(PO 00000)-1077(Frm 00012)-1077(Fmt 4701)-1077(Sfmt 4700)-1077(E:\\FR\\FM\\25AUR3.SGM)-1077(25AUR3)]TJ
0.0001 Tc -0.0001 Tw 0 5 -5 0 22 18 Tm
(mstockstill on DSK4VPTVN1PROD with RULES3)Tj
ET

// peepdf comment: Javascript code located in object 98 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 536.42 750 Tm(53267) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
ET
q
1 0 0 1 45 61.8000031 cm
0.5 w 
0 0 m
50 0 l
S
Q
BT
/T1_1
1 Tf
0 Tw 5.446 0 0 4.55 52 54.9091 Tm(28) Tj - 0.0029 Tw 7 0 0 7 59.1954 53.1 Tm(42 CFR 50.604\ (a\) and 45 CFR 94.4\ (a\).) Tj
ET
q
1 0 0 1 222 69.8000031 cm
0.5 w
0 0 m
50 0 l
S
Q
BT / T1_1 1 Tf
0 Tw 5.446 0 0 4.55 229 62.9091 Tm(29) Tj - 0.0028 Tw 7 0 0 7 236.1954 61.1001 Tm(NIH\221\221Frequently Asked Question\222\222 B.4 at) Tj / T1_2 1 Tf
0 Tw - 2.028 - 1.143 Td(http: //grants.nih.gov/grants/policy/coifaq.htm)Tj
/T1_1 1 Tf
(. )Tj
-0.0045 Tw 9 0 0 9 45 725 Tm
(discussion above\), we are including the )Tj
0 -1.1 TD
(definition in the final rule. )Tj
/T1_2
1 Tf
0 - 1.644 TD(Responsibilities of Institutions) Tj
0 - 1.1 TD(Regarding Investigator Financial) Tj
T * (Conflicts of Interest\ (42 CFR 50.604, 45) Tj
T * (CFR 94.4\)) Tj / T1_1 1 Tf
1 - 1.467 Td(Consistent with the NPRM, we have) Tj - 1 - 1.1 Td(substantially revised the responsibilities) Tj
T * (of Institutions regarding Investigator) Tj
0 Tw T * (FCOI.) Tj - 0.0045 Tw 1 - 1.022 Td(The 1995 regulations provided that) Tj - 1 - 1.1 Td(each Institution must maintain an) Tj
T * (appropriate written, enforced policy on) Tj
T * (conflicts of interest that complies with) Tj
T * (the regulations.) Tj
0 Tw 7.002 0 0 5.85 108.9474 581.228 Tm(28) Tj - 0.0045 Tw 9 0 0 9 119.1936 578.9001 Tm(In the NPRM we) Tj - 8.244 - 1.1 Td(proposed revising this provision to) Tj
T * (require an Institution not only to) Tj
T * (maintain an up - to - date, written, ) Tj
T * (enforced FCOI policy that complies) Tj
T * (with the regulations, but also to make) Tj
T * (such policy available via a publicly) Tj
T * (accessible Web site.We have included) Tj
T * (this requirement in the revised) Tj
T * (regulations at 42 CFR 50.604\ (a\) and 45) Tj
T * (CFR 94.4\ (a\), because we believe that it) Tj
T * (fosters greater transparency and) Tj
T * (accountability with regard to) Tj
T * (institutional policies.Moreover, we) Tj
T * (have clarified that
if an Institution does) Tj
T * (not have a current presence on a) Tj
T * (publicly accessible Web site\ (and only) Tj
T * ( in those cases\), the Institution may) Tj
T * (make the information available in ) Tj
T * (writing within five business days of any) Tj
T * (request.If, however, the Institution) Tj
T * (acquires a presence on a publicly) Tj
T * (accessible Web site during the time of) Tj
T * (the PHS award, the requirement to post) Tj
T * (the information on that Web site will) Tj
T * (apply within 30 calendar days.) Tj
1 - 1.022 Td(One respondent suggested that) Tj - 1 - 1.1 Td(Institutions\222 policies should be filed) Tj
T * (with the PHS.We believe the) Tj
T * (requirement to make the policies) Tj
0 - 1.111 TD(publicly available renders this) Tj
T * (suggestion unnecessary.One respondent) Tj
T * (suggested that Institutions should be) Tj
T * (required to\221\221prominently\222\222 post their) Tj
T * (FCOI policy on the Institution\222s Web) Tj
T * (site so that it would be easily accessible.) Tj
T * (We have not revised the regulations to) Tj
T * (include this requirement, because we) Tj
T * (understand that term could create) Tj
T * (ambiguity.We have used the term) Tj
T * (\221\221publicly accessible\222\222 to communicate) Tj
T * (our intention that the public can readily) Tj
T * (obtain the information required under) Tj
T * (these regulations.In the event of any) Tj
T * (questions, we encourage members of the) Tj
T * (public to contact Institutions
for) Tj
T * (instructions as to the location of their) Tj
T * (policy, and to report any enforcement) Tj
T * (concerns to the PHS Awarding) Tj
T * (Component.One respondent inquired as) Tj
T * (to whether this provision applies to) Tj
T * (subrecipients.We note that) Tj
19.667 72.5 Td(subrecipients that rely on their own) Tj
0 - 1.1 TD(policies would be subject to this) Tj
T * (requirement.However,
if the) Tj
T * (subrecipient is relying on the policies of) Tj
T * (the awardee Institution, that Institution) Tj
T * (would be responsible
for posting the) Tj
0 Tw T * (policy.) Tj - 0.0045 Tw 1 - 1.022 Td(Consistent with the NPRM, we have) Tj - 1 - 1.1 Td(also revised this section to clarify that) Tj
T * (
if an Institution\222s policy on FCOI) Tj
T * (includes standards that are more) Tj
T * (stringent than the regulations, the) Tj
T * (Institution shall adhere to its policy and) Tj
T * (shall provide FCOI reports regarding) Tj
T * (identified FCOI to the PHS Awarding) Tj
T * (Component in accordance with the) Tj
T * (Institution\222s own standards within the) Tj
T * (time periods required in the regulations.) Tj
T * (Many respondents indicated that this) Tj
T * (provision would provide a substantial) Tj
T * (disincentive to Institutions to adopt) Tj
T * (more stringent standards than those set) Tj
T * (forth in the regulations, and could lead) Tj
T * (to a lack of consistency in reporting and) Tj
T * (increased confusion.) Tj
1 - 1.022 Td(We appreciate the concerns raised) Tj - 1 - 1.1 Td(and discussed them carefully before) Tj
T * (making the final decision to retain this) Tj
T * (language in the final rule because of) Tj
T * (several mitigating factors.For example, ) Tj
T * (the 1995 regulations indicated that the) Tj
T * (regulations constituted a minimum) Tj
0 Tw T * (standard;) Tj / T1_2 1 Tf
4.55 0 Td(i.e., ) Tj / T1_1 1 Tf - 0.0045 Tw 1.923 0 Td(the Institution retained) Tj - 6.473 - 1.1 Td(flexibility to add requirements to those) Tj
T * ( in the regulations, as long as such) Tj
T * (requirements are consistent with the) Tj
T * (regulations.Specifically, 42 CFR 50.605) Tj
T * (and 45 CFR 94.5 state: \221\221In addition to) Tj
T * (the types of conflicting financial) Tj
T * (interests described in this paragraph) Tj
T * (that must be managed, reduced, or) Tj
T * (eliminated, an Institution may require) Tj
0 - 1.111 TD(the management of other conflicting) Tj
T * (financial interests in its policy on) Tj
T * (financial conflicts of interest, as the) Tj
T * (Institution deems appropriate.\222\222) Tj
T * (Moreover, in regulatory guidance on) Tj
T * (this issue with regard to grants and) Tj
T * (cooperative agreements, NIH stated that) Tj
T * (Institutions could impose more) Tj
T * (stringent requirements than those in the) Tj
T * (regulation as long as the Institution\222s) Tj
T * (policies meet the minimum) Tj
T * (requirements of the regulation and each) Tj
T * (Investigator is informed of the) Tj
T * (Institution\222s policies; of the) Tj
T * (Investigator\222s disclosure) Tj
T * (responsibilities; and of the regulation.) Tj
0 Tw 7.002 0 0 5.85 378.8116 162.8279 Tm(29) Tj
9 0 0 9 386.5978 160.5 Tm() Tj - 0.0045 Tw - 18.289 - 1.111 Td(In addition, the principle that an) Tj
T * (Institution must follow its own policies, ) Tj
T * (even
if they go beyond\227but as long as) Tj
T * (they are consistent with\227Federal) Tj
T * (policies and regulations, is an) Tj
T * (established standard of NIH grants) Tj
T * (policies and applies to the) Tj
T * (implementation of all terms and) Tj
19.667 71.611 Td(conditions of award
for grants and) Tj
0 - 1.1 TD(cooperative agreements.Finally, we) Tj
T * (weighed the possible inconsistency in ) Tj
T * (reporting resulting from implementation) Tj
T * (of this provision against the possible) Tj
T * (ramifications of the PHS Awarding) Tj
T * (Component being unaware of an FCOI) Tj
T * (related to PHS - funded research that was) Tj
T * (identified by the Institution.We) Tj
T * (concluded that full reporting of all) Tj
T * (Institution - identified FCOIs related to) Tj
T * (PHS - funded research is necessary
for) Tj
T * (appropriate accountability by the) Tj
T * (Institution and
for robust oversight by) Tj
T * (the PHS Awarding Component.) Tj
T * (Although the regulations do not specify) Tj
T * (a standardized Federal reporting form, ) Tj
T * (as suggested by one respondent, the) Tj
T * (regulations identify necessary elements) Tj
T * (of the report\ () Tj / T1_2 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 8.372 0 Td(42 CFR 50.605\ (b\)\ (3\)) Tj - 8.372 - 1.1 Td(and 45 CFR 94.5\ (b\)\ (3\)\), and NIH) Tj
T * (provides a framework
for reporting) Tj
T * (those elements through its online) Tj
T * (reporting system.) Tj
1 - 1.022 Td(Also consistent with the NPRM, we) Tj - 1 - 1.1 Td(are incorporating the requirement in the) Tj
T * (1995 regulations that each Institution) Tj
T * (must inform each Investigator of its) Tj
T * (policy on conflicts of interest, of the) Tj
T * (Investigator\222s disclosure) Tj
T * (responsibilities, and of these) Tj
T * (regulations.This requirement is) Tj
T * (addressed as a new paragraph\ (b\), and, ) Tj
T * (as proposed in the NPRM, it includes an) Tj
T * (Investigator training requirement.) Tj
T * (However, we have modified the training) Tj
T * (requirement to accommodate) Tj
T * (suggestions raised in public comments.) Tj
T * (Specifically, the NPRM proposed that) Tj
T * (Institutions require Investigators to) Tj
T * (complete training regarding the) Tj
T * (Institution\222s FCOI policy, the) Tj
T * (Investigator\222s responsibilities regarding) Tj
T * (disclosure of SFI, and the regulations, ) Tj
T * (prior to engaging in PHS - funded) Tj
T * (research and, thereafter, at least once) Tj
T * (every two years.) Tj
1 - 1.022 Td(Although some respondents agreed) Tj - 1 - 1.1 Td(with the training requirements as) Tj
T * (proposed, many other respondents) Tj
T * (raised reasonable alternatives.For) Tj
T * (example, most of the respondents on) Tj
T * (this topic agreed with the requirement) Tj
T * (
for initial training of Investigators prior) Tj
T * (to engaging in PHS - funded research but) Tj
T * (thought that the Institution should) Tj
T * (determine the training frequency) Tj
T * (thereafter or that a period longer than) Tj
T * (two years should be specified.We) Tj
T * (considered the comments carefully and) Tj
T * (agree that every two years may be too) Tj
T * (frequent; however, we believe it is) Tj
T * (important to ensure that Investigators) Tj
T * (receive training beyond the initial) Tj
T * (period in order to maintain objectivity) Tj
T * ( in PHS - funded research over the long) Tj
T * (term.Therefore, we have revised the) Tj
0 - 1.111 TD(provision in 42 CFR 50.604\ (b\) and 45) Tj
T * (CFR 94.4\ (b\) to require Institutions to) Tj
1 g / T1_3 1 Tf
0 Tw 6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(17: 26 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00013) - 1077(Fmt 4701) - 1077(Sfmt 4700) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

// peepdf comment: Javascript code located in object 104 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 45 750 Tm(53268) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
ET
q
1 0 0 1 399 69.8000031 cm
0.5 w 
0 0 m
50 0 l
S
Q
BT
/T1_1
1 Tf
0 Tw 5.446 0 0 4.55 406 62.9091 Tm(30) Tj - 0.0028 Tw 7 0 0 7 413.1954 61.1001 Tm(The term\221\221awardee Institution\222\222 is used here to) Tj - 0.0029 Tw - 2.028 - 1.143 Td(distinguish it from the subrecipient Institution.) Tj - 0.0045 Tw 9 0 0 9 45 725 Tm(train Investigators prior to engaging in ) Tj
0 - 1.1 TD(research related to any PHS - funded) Tj
T * (grant or contract, and at least every four) Tj
T * (years\ (a typical period of a PHS - funded) Tj
T * (research grant\), and immediately when) Tj
T * (any of the following circumstances) Tj
T * (apply: \ (1\) The Institution revises its) Tj
T * (financial conflicts of interest policies or) Tj
T * (procedures in any manner that affects) Tj
T * (the requirements of Investigators;\ (2\) an) Tj
T * (Investigator moves to a new Institution;) Tj
T * (or\ (3\) an Institution finds that an) Tj
T * (Investigator is not in compliance with) Tj
T * (the regulations or with the Institution\222s) Tj
T * (financial conflicts of interest policy or) Tj
T * (management plan.) Tj
1 - 1.022 Td(One respondent proposed that) Tj - 1 - 1.1 Td(training be required only of those PHS - ) Tj
T * (funded Investigators who have FCOIs.) Tj
T * (We disagree with this suggestion, as this) Tj
T * (change would not fulfill the purpose of) Tj
T * (the training requirement, which is to) Tj
T * (inform all Investigators conducting) Tj
T * (PHS - funded research of the Institution\222s) Tj
T * (FCOI policy, their responsibilities) Tj
T * (regarding disclosure of SFI, and the) Tj
T * (regulations.A few respondents) Tj
T * (suggested that the mandated training) Tj
T * (include a discussion of ethical issues) Tj
T * (surrounding FCOI.We note that as long) Tj
T * (as the training covers the Institution\222s) Tj
T * (FCOI policy, the Investigator\222s) Tj
T * (responsibilities regarding disclosure of) Tj
T * (SFI, and the regulations, Institutions are) Tj
T * (free to adopt this suggestion, and to) Tj
T * (include any other issues they deem) Tj
T * (essential to accomplishing the stated) Tj
T * (objective of the training.One) Tj
T * (respondent suggested that the) Tj
T * (Institution\222s training materials be) Tj
T * (submitted to the PHS Awarding) Tj
T * (Component and that Investigators be) Tj
T * (required to certify completion of) Tj
T * (training to the PHS Awarding) Tj
T * (Component.We believe that this) Tj
T * (suggestion is addressed by the existing) Tj
T * (HHS requirement that institutional) Tj
T * (officials are responsible
for ensuring) Tj
T * (compliance with all applicable Federal) Tj
T * (laws and regulations, including required) Tj
T * (certifications and assurances; such) Tj
T * (officials must provide a certification) Tj
T * (regarding compliance with the) Tj
T * (regulation\227including the training) Tj
T * (requirement\227with each application
for) Tj
0 Tw T * (funding.) Tj - 0.0045 Tw 1 - 1.022 Td(Finally, several respondents requested) Tj - 1 - 1.1 Td(that HHS provide training materials that) Tj
T * (Institutions can use to fulfill this) Tj
T * (requirement, as well as seminars or) Tj
T * (workshops that address implementation) Tj
T * (of the revised regulations.As in the) Tj
T * (past, NIH / HHS will
continue to engage) Tj
T * ( in outreach activities to promote) Tj
T * (compliance with the regulations, and) Tj
T * (will make resources available online, ) Tj
T * (including guidance on policy) Tj
0 - 1.111 TD(development and a regulatory training) Tj
T * (module
for Institutions and) Tj
19.667 74.667 Td(Investigators.Institutions should adapt) Tj
0 - 1.1 TD(these resources to incorporate) Tj
T * (information related to their specific) Tj
T * (policies and procedures, as needed.) Tj
1 - 1.022 Td(Consistent with the NPRM, we have) Tj - 1 - 1.1 Td(also implemented clarifications to the) Tj
T * (requirement in the 1995 regulations) Tj
T * (that,
if the Institution carries out the) Tj
T * (PHS - funded research through) Tj
T * (subrecipients\ () Tj / T1_2 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 8.879 0 Td(subcontractors or) Tj - 8.879 - 1.1 Td(consortium members\), the Institution) Tj
T * (must take reasonable steps to ensure) Tj
T * (that Investigators working
for) Tj
T * (subrecipients comply with the) Tj
T * (regulations, either by requiring those) Tj
T * (Investigators to comply with the) Tj
T * (Institution\222s policy or by requiring the) Tj
T * (subrecipients to provide assurances to) Tj
T * (the Institution that will enable the) Tj
T * (Institution to comply with the) Tj
T * (regulations.As proposed in the NPRM, ) Tj
T * (we are addressing these changes in a) Tj
T * (new subsection\ (c\), though we are) Tj
T * (implementing minor changes to the) Tj
T * (proposed language to improve overall) Tj
T * (clarity as follows: An Institution that) Tj
T * (carries out the PHS - funded research) Tj
T * (through a subrecipient must incorporate) Tj
T * (as part of a written agreement with the) Tj
T * (subrecipient terms that establish) Tj
T * (whether the FCOI policy of the awardee) Tj
T * (Institution or that of the subrecipient) Tj
T * (will apply to the subrecipient\222s) Tj
T * (Investigators.If the subrecipient\222s) Tj
T * (Investigator must comply with the) Tj
T * (subrecipient\222s FCOI policy, the) Tj
T * (subrecipient shall certify as part of the) Tj
T * (agreement referenced above that its) Tj
T * (policy complies with the regulations.If) Tj
T * (the subrecipient cannot provide such) Tj
T * (certification, the agreement shall state) Tj
T * (that subrecipient Investigators are) Tj
T * (subject to the FCOI policy of the) Tj
T * (awardee Institution
for significant) Tj
T * (financial interests that are directly) Tj
T * (related to the subrecipient\222s work
for the) Tj
T * (awardee Institution.) Tj
1 - 1.022 Td(Additionally,
if the subrecipient\222s) Tj - 1 - 1.1 Td(Investigators must comply with the) Tj
T * (subrecipient\222s FCOI policy, the) Tj
T * (agreement referenced above shall) Tj
T * (specify time period\ (s\) for the) Tj
T * (subrecipient to report all identified) Tj
T * (FCOI to the awardee Institution.Such) Tj
T * (time period\ (s\) shall be sufficient to) Tj
T * (enable the awardee Institution to) Tj
T * (provide timely FCOI reports, as) Tj
T * (necessary, to the PHS as required by the) Tj
T * (regulations.Alternatively,
if the) Tj
T * (subrecipient\222s Investigators must) Tj
T * (comply with the awardee Institution\222s) Tj
T * (FCOI policy, the agreement referenced) Tj
T * (above shall specify time period\ (s\) for) Tj
T * (the subrecipient to submit all) Tj
T * (Investigator disclosures of SFIs to the) Tj
T * (awardee Institution.Such time period\ (s\)) Tj
T * (shall be sufficient to enable the awardee) Tj
0 - 1.111 TD(Institution to comply timely with its) Tj
T * (review, management, and reporting) Tj
19.667 74.667 Td(obligations under the regulations.) Tj
0 - 1.1 TD(Subsection\ (c\) also requires that the) Tj
T * (Institution provide FCOI reports to the) Tj
T * (PHS regarding all FCOIs of all) Tj
T * (subrecipient Investigators consistent) Tj
T * (with the regulations.We believe these) Tj
T * (changes will clarify
for Institutions and) Tj
T * (their subrecipients the requirements of) Tj
T * (both parties, which will promote greater) Tj
T * (compliance with the regulations.) Tj
1 - 1.022 Td(Many respondents were concerned) Tj - 1 - 1.1 Td(that these provisions would be difficult) Tj
T * (to operationalize as written in the) Tj
T * (NPRM, particularly in the
case of) Tj
T * (foreign organizations.They suggested) Tj
T * (that awardee Institutions would not) Tj
T * (reasonably be able to evaluate the FCOI) Tj
T * (policies of the subrecipient Institution.) Tj
T * (We believe that this concern is) Tj
T * (alleviated by the requirement of a) Tj
T * (written agreement to reinforce a clear) Tj
T * (understanding of the expectations of the) Tj
T * (subrecipient and awardee Institution, ) Tj
0 Tw 7.002 0 0 5.85 553.8447 510.228 Tm(30) Tj
9 0 0 9 561.6309 507.9001 Tm() Tj - 0.0045 Tw - 18.07 - 1.1 Td(depending on whose policy will apply.) Tj
T * (To address a concern raised by another) Tj
0 - 1.111 TD(respondent, we have also added) Tj
T * (language to limit the SFI reported to the) Tj
T * (awardee Institution to those that are) Tj
T * (directly related to the subrecipient\222s) Tj
T * (work
for the awardee Institution.) Tj
1 - 1.022 Td(Some respondents suggested that the) Tj - 1 - 1.111 Td(subrecipients report FCOIs identified
for) Tj
T * (their Investigators directly to the PHS) Tj
T * (Awarding Component.Others proposed) Tj
T * (that subrecipients that are the direct) Tj
T * (recipients of other awards from the PHS) Tj
T * (Awarding Component be exempt from) Tj
T * (the certification process.We disagree) Tj
T * (with both suggestions.The PHS) Tj
T * (Awarding Component has a direct) Tj
T * (relationship only with the awardee) Tj
T * (Institution.Therefore, the awardee) Tj
T * (Institution is responsible
for providing) Tj
T * (FCOI reports to the PHS regarding all) Tj
T * (financial conflicts of interest of all) Tj
T * (subrecipient Investigators, consistent) Tj
T * (with the regulations.These expectations) Tj
T * (apply whether or not the subrecipient) Tj
T * (serves as an awardee Institution to the) Tj
T * (PHS Awarding Component on other) Tj
T * (awards, as each award is considered) Tj
T * (separately
for purposes of compliance) Tj
T * (with the regulations.) Tj
1 - 1.022 Td(One respondent noted that there is no) Tj - 1 - 1.111 Td(timeline specified
for Institutions to) Tj
T * (provide the PHS all FCOI reports of all) Tj
T * (subrecipient Investigators.We have) Tj
T * (clarified our expectation that) Tj
T * (Institutions report subrecipient - ) Tj
T * (identified FCOIs prior to the) Tj
T * (expenditure of funds and within 60) Tj
T * (days of any subsequently identified) Tj
T * (FCOI by adding this language to) Tj
T * (subsection\ (c\)\ (2\).) Tj
1 - 1.022 Td(One respondent proposed that the) Tj - 1 - 1.111 Td(agreement between the awardee and) Tj
1 g / T1_3 1 Tf
0 Tw 6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(17: 26 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00014) - 1077(Fmt 4701) - 1077(Sfmt 4700) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

// peepdf comment: Javascript code located in object 107 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 536.42 750 Tm(53269) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
-0.0045 Tw 9 0 0 9 45 725 Tm
(subrecipient Institutions, and the )Tj
0 -1.1 TD
(subrecipients\222 FCOI policies should be )Tj
T*
(filed with the PHS. We believe that the )Tj
T*
(submission of this information is not )Tj
T*
(necessary unless specifically requested )Tj
T*
(by the PHS Awarding Component since )Tj
T*
(applicable HHS policy requires )Tj
T*
(Institutions to certify compliance with )Tj
T*
(the requirements of this and other )Tj
T*
(regulations in each application or )Tj
T*
(solicitation for funding. An Institution\222s )Tj
T*
(failure to comply with the terms and )Tj
T*
(conditions of award, including this )Tj
T*
(regulation, may cause HHS to take one )Tj
T*
(or more enforcement actions, depending )Tj
T*
(on the severity and duration of the )Tj
0 Tw T*
(noncompliance. )Tj
-0.0045 Tw 1 -1.022 Td
(Paragraph \(d\) of the NPRM required )Tj
-1 -1.1 Td
(that an Institution designate an )Tj
T*
(institutional official\(s\) to solicit and )Tj
T*
(review disclosures of SFIs from each )Tj
T*
(Investigator who is planning to )Tj
T*
(participate in PHS-funded research. A )Tj
T*
(few respondents suggested that the )Tj
T*
(regulations be revised to stipulate the )Tj
T*
(requirements for the designated )Tj
T*
(official\(s\) and how the Institution )Tj
T*
(should ensure that the designated )Tj
T*
(official\(s\) do not themselves have )Tj
T*
(conflicts of interest. We have not )Tj
T*
(implemented those changes because we )Tj
T*
(believe that the Institution is in the best )Tj
T*
(position to determine the qualifications )Tj
T*
(and characteristics of the designated )Tj
T*
(official\(s\) in the Institution\222s policy. )Tj
1 -1.022 Td
(The 1995 regulations required that, by )Tj
-1 -1.1 Td
(the time an application or contract )Tj
T*
(proposal is submitted to the PHS, each )Tj
T*
(Investigator who is planning to )Tj
T*
(participate in the PHS-funded research )Tj
T*
(has submitted to the designated )Tj
T*
(official\(s\) a listing of his/her
known) Tj
T * (SFIs\ (and those of his / her spouse and) Tj
T * (dependent children\): \ (i\) That would) Tj
T * (reasonably appear to be affected by the) Tj
T * (research
for which PHS funding is) Tj
T * (sought; and\ (ii\) in entities whose) Tj
T * (financial interests would reasonably) Tj
T * (appear to be affected by the research.) Tj
T * (All financial disclosures must be) Tj
T * (updated during the period of award, ) Tj
T * (either on an annual basis or as new) Tj
T * (reportable SFIs are obtained.As) Tj
T * (discussed above, the revised SFI) Tj
T * (definition includes SFIs that reasonably) Tj
T * (appear related to the Investigator\222s) Tj
T * (\221\221institutional responsibilities.\222\222) Tj
T * (Therefore, the requirement in the 1995) Tj
T * (regulations to disclose SFIs, which we) Tj
T * (have adopted in paragraph\ (e\) of the) Tj
T * (final rule, incorporates this revised) Tj
T * (definition, such that the scope of) Tj
T * (Investigator disclosures is no longer) Tj
T * (project specific, but rather pertains to) Tj
T * (the Investigator\222s institutional) Tj
T * (responsibilities.In response to a) Tj
T * (suggestion from a respondent, we have) Tj
0 - 1.111 TD(clarified that Investigators who have not) Tj
T * (previously disclosed their SFIs to the) Tj
19.667 74.667 Td(Institution\222s designated official\ (s\) must) Tj
0 - 1.1 TD(do so no later than the time of) Tj
T * (application or date of contract proposal) Tj
T * (submitted
for PHS - funded research.) Tj
1 - 1.022 Td(One respondent suggested that) Tj - 1 - 1.1 Td(Institutions should establish an internal) Tj
T * (database
for disclosures of Investigator) Tj
T * (SFI which could be easily updated.We) Tj
T * (have not included this requirement) Tj
T * (because we are concerned that it could) Tj
T * (impose an unnecessary administrative) Tj
T * (burden and expense to Institutions.As) Tj
T * (long as Institutions have a process in ) Tj
T * (place to comply fully with all regulatory) Tj
T * (requirements, they may collect) Tj
T * (disclosures from Investigators in the) Tj
T * (manner that is most appropriate
for) Tj
T * (their policies and procedures.) Tj
1 - 1.022 Td(Consistent with our proposal in the) Tj - 1 - 1.1 Td(NPRM, as part of paragraph\ (e\), we have) Tj
T * (also revised and clarified an) Tj
T * (Investigator\222s annual and ongoing, ) Tj
0 Tw T * (including) Tj / T1_2 1 Tf - 0.0045 Tw 4.716 0 Td(ad hoc, ) Tj / T1_1 1 Tf
0 Tw(disclosure) Tj - 0.0045 Tw - 4.716 - 1.1 Td(obligations.Specifically, in addition to) Tj
T * (requiring that each Investigator who is) Tj
T * (planning to participate in the PHS - ) Tj
T * (funded research disclose to the) Tj
T * (Institution\222s designated official\ (s\) the) Tj
T * (Investigator\222s SFIs\ (and those of the) Tj
T * (Investigator\222s spouse and dependent) Tj
T * (children\), the Institution must also) Tj
T * (require each Investigator who is) Tj
T * (participating in the PHS - funded) Tj
T * (research to submit an updated SFI) Tj
0 Tw T * (disclosure: ) Tj - 0.0045 Tw 1 - 1.022 Td(\ (1\) At least annually during the period) Tj - 1 - 1.1 Td(of the award, including disclosure of) Tj
T * (any information that was not disclosed) Tj
T * (initially to the Institution or in a) Tj
T * (subsequent SFI disclosure, and) Tj
T * (disclosure of updated information) Tj
T * (regarding any previously disclosed SFI) Tj
0 Tw T * (\ () Tj / T1_2 1 Tf(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 2.441 0 Td(the updated value of a previously) Tj - 2.441 - 1.1 Td(disclosed equity interest\).A number of) Tj
T * (respondents agreed that annual) Tj
T * (disclosure by Investigators is necessary) Tj
T * (but suggested that the Institution should) Tj
T * (be free to determine the specific timing.) Tj
T * (We have revised paragraph\ (e\)\ (2\) to) Tj
T * (adopt this suggestion.Because of this) Tj
T * (change, we have declined the suggestion) Tj
T * (of another respondent to link the annual) Tj
0 - 1.111 TD(disclosure period to the Fiscal Year) Tj
T * (calendar.Another respondent suggested) Tj
T * (that the disclosure period should be) Tj
T * (event - driven, rather than annual.While) Tj
T * (we
continue to believe that annual) Tj
T * (disclosure is appropriate, we note that) Tj
T * (the requirement
for disclosing updated) Tj
T * (SFIs in subsection\ (e\)\ (3\), as described) Tj
T * (below, should address this concern by) Tj
T * (providing Institutions with information) Tj
T * (about Investigator SFIs that arise) Tj
T * (between the annual disclosure periods.) Tj
1 - 1.022 Td(\ (2\) Within 30 days of discovering or) Tj - 1 - 1.111 Td(acquiring\ () Tj / T1_2 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 7.047 0 Td(through purchase, ) Tj - 7.047 - 1.111 Td(marriage, or inheritance\) a new SFI.A) Tj
T * (few respondents suggested that 30 days) Tj
T * (is too short a period
for disclosure of) Tj
19.667 74.667 Td(new SFIs, and one respondent suggested) Tj
T * (that this requirement be changed to 60) Tj
T * (days, consistent with the time - period) Tj
T * (specified in other parts of the) Tj
T * (regulations.After carefully considering) Tj
T * (the appropriate balance between) Tj
T * (affording Investigators sufficient time to) Tj
T * (disclose new SFIs as they arise and the) Tj
T * (need to review SFIs related to PHS - ) Tj
T * (funded research in a timely manner, we) Tj
T * (have retained the 30 day period in ) Tj
T * (subsection\ (e\)\ (3\).) Tj
1 - 1.189 Td(A respondent suggested that requiring) Tj - 1 - 1.111 Td(disclosure when an Investigator is) Tj
T * (planning to participate in PHS - funded) Tj
T * (research is too imprecise and requested) Tj
T * (that this phrase be revised.We have) Tj
T * (revised subsection\ (e\)\ (1\) to specify that) Tj
T * (disclosures must occur no later than the) Tj
T * (time of application or date of contract) Tj
T * (proposal submitted
for PHS - funded) Tj
0 Tw T * (research.) Tj - 0.0045 Tw 1 - 1.189 Td(The 1995 regulations required an) Tj - 1 - 1.111 Td(Institution to provide guidelines) Tj
T * (consistent with the regulations
for the) Tj
T * (designated official\ (s\) to identify) Tj
T * (conflicting interests and take such) Tj
T * (actions as necessary to ensure that such) Tj
T * (conflicting interests will be managed, ) Tj
T * (reduced, or eliminated.Consistent with) Tj
T * (our proposal in the NPRM, we have) Tj
T * (reorganized and expanded this) Tj
T * (requirement in a re - designated) Tj
T * (paragraph\ (f\), to clarify an Institution\222s) Tj
T * (obligations.First, the guidelines must) Tj
T * (address two related tasks, specifically, ) Tj
T * (determination of whether an) Tj
T * (Investigator\222s SFI is related to the PHS - ) Tj
T * (funded research and,
if so related, ) Tj
T * (whether the SFI is an FCOI.Under the) Tj
T * (1995 regulations, the Investigator bore) Tj
T * (the responsibility
for determining the) Tj
T * (relatedness of an SFI to the PHS - funded) Tj
T * (research as part of the disclosure) Tj
0 Tw T * (process.) Tj - 0.0045 Tw 1 - 1.178 Td(As discussed above, however, we) Tj - 1 - 1.111 Td(have revised the definition of SFI to) Tj
T * (address\221\221institutional responsibilities\222\222;) Tj
T * (consistent with this change, we have) Tj
T * (shifted the responsibility
for) Tj
T * (determining whether an Investigator\222s) Tj
T * (SFI is related to PHS - funded research to) Tj
T * (the Institution.Specifically, an) Tj
T * (Investigator\222s SFI is related to PHS - ) Tj
T * (funded research when the Institution, ) Tj
T * (through its designated official\ (s\), ) Tj
T * (reasonably determines that the SFI: ) Tj
T * (could be affected by the PHS - funded) Tj
T * (research; or is in an entity whose) Tj
T * (financial interest could be affected by) Tj
T * (the research.Although one respondent) Tj
T * (suggested that this definition is not) Tj
T * (sufficiently inclusive, we believe it) Tj
T * (encompasses the range of relationships) Tj
T * (between an Investigator\222s SFI and PHS - ) Tj
T * (funded research.We note that this) Tj
T * (definition has been in effect since the) Tj
T * (1995 regulations and remains consistent) Tj
1 g / T1_3 1 Tf
0 Tw 6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(17: 26 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00015) - 1077(Fmt 4701) - 1077(Sfmt 4700) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

// peepdf comment: Javascript code located in object 110 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 45 750 Tm(53270) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
-0.0045 Tw 9 0 0 9 45 725 Tm
(with the guidance that NIH/HHS
has) Tj
0 - 1.1 TD(offered on this issue since that time.) Tj
1 - 1.022 Td(Many respondents agreed that the) Tj - 1 - 1.1 Td(responsibility
for determining whether) Tj
T * (an Investigator\222s SFI is related to the) Tj
T * (PHS - funded research should ultimately) Tj
T * (rest with the Institution; however, they) Tj
T * (were concerned that the proposed) Tj
T * (revisions in the NPRM did not allow) Tj
T * (Institutions to involve the Investigator) Tj
T * ( in this process.They suggested that) Tj
T * (requiring Institutions to make this) Tj
T * (determination without the input of the) Tj
T * (Investigator would make the decision - ) Tj
T * (making process more challenging.) Tj
T * (Because this was not the intent of the) Tj
T * (proposed language, we have revised) Tj
T * (paragraph\ (f\) to explicitly state that the) Tj
T * (Institution may involve the Investigator) Tj
T * ( in the designated official\ (s\)\222s) Tj
T * (determination of whether an SFI is) Tj
T * (related to the PHS - funded research.A) Tj
T * (few respondents suggested this) Tj
T * (responsibility should remain with the) Tj
T * (Investigator.We have weighed this) Tj
T * (suggestion and believe that the revised) Tj
T * (language strikes the appropriate balance) Tj
T * (between the Institution\222s ultimate) Tj
T * (responsibility
for reviewing Investigator) Tj
T * (disclosures and the Investigator\222s) Tj
T * (responsibility to disclose all SFIs related) Tj
T * (to his or her institutional) Tj
0 Tw T * (responsibilities.) Tj - 0.0045 Tw 1 - 1.022 Td(In the Extension Notice, we requested) Tj - 1 - 1.1 Td(comment as to whether the regulations) Tj
T * (should further clarify that, as part of the) Tj
T * (Institution\222s FCOI determination) Tj
T * (process, institutional officials must) Tj
T * (consider whether an Investigator\222s SFI) Tj
T * (was previously determined to be an) Tj
T * (FCOI at another Institution and subject) Tj
T * (to a management plan with regard to) Tj
T * (other PHS - funded research project\ (s\).) Tj
T * (Many respondents suggested that) Tj
T * (requiring institutional officials to) Tj
T * (consider information on an FCOI from) Tj
T * (another Institution is unnecessary, as) Tj
T * (information regarding FCOIs would be) Tj
T * (available on a public Web site, as per) Tj
T * (the proposed revisions in the NPRM.) Tj
T * (They suggested that Institutions should) Tj
T * (be free to use their own policies and) Tj
T * (procedures to comply with the) Tj
T * (regulations.We have considered these) Tj
T * (comments and agree.With the) Tj
T * (expansion of Investigator disclosure to) Tj
T * (include all SFIs related to their) Tj
T * (institutional responsibilities and the) Tj
T * (requirement to ensure public) Tj
0 - 1.111 TD(accessibility of information about FCOIs) Tj
T * (of senior / key personnel
for research) Tj
T * (grants and cooperative agreements and) Tj
T * (key personnel
for research contracts, the) Tj
T * (likelihood of an Institution not receiving) Tj
T * (information about a particular SFI or) Tj
T * (FCOI is minimized.) Tj
1 - 1.022 Td(One respondent suggested the) Tj - 1 - 1.111 Td(following alternative approach: in a
case) Tj
T * (where an Investigator moves from one) Tj
19.667 74.667 Td(Institution to another, the PHS) Tj
0 - 1.1 TD(Awarding Component would mediate) Tj
T * (the transfer of information related to any) Tj
T * (identified FCOI from the previous) Tj
T * (Institution to the new one, and the) Tj
T * (receiving Institution,
while not bound) Tj
T * (by any previous management plan, ) Tj
T * (would have to advise the PHS Awarding) Tj
T * (Component of its decision regarding) Tj
T * (that FCOI.Another suggested that) Tj
T * (Institutions should be required to notify) Tj
T * (the PHS Awarding Component of the) Tj
T * (imposition of a penalty on Investigators) Tj
T * (that limits their participation in PHS - ) Tj
T * (funded research, and that the PHS) Tj
T * (Awarding Component should create a) Tj
T * (registry of these Investigators.In light of) Tj
T * (these comments, we have specified that) Tj
T * (updated disclosures should include any) Tj
T * (FCOI identified on a PHS - funded) Tj
T * (project that was transferred from) Tj
T * (another Institution.We also note that, as) Tj
T * (specified in 42 CFR 50.606\ (b\) and 45) Tj
T * (CFR 94.6\ (b\), the HHS may inquire at) Tj
T * (any time\ (before, during, or after award\)) Tj
T * (into any Investigator disclosure of) Tj
T * (financial interests and the Institution\222s) Tj
T * (review of, and response to, such) Tj
T * (disclosure, whether or not the) Tj
T * (disclosure resulted in the Institution\222s) Tj
T * (determination of an FCOI.This would) Tj
T * (include situations in which an) Tj
T * (Investigator moves from one Institution) Tj
T * (to another.) Tj
1 - 1.022 Td(To provide clarification regarding the) Tj - 1 - 1.1 Td(determination of whether an) Tj
T * (Investigator\222s SFI is an FCOI, the re - ) Tj
T * (designated paragraph\ (f\) incorporates) Tj
T * (modified language moved from) Tj
T * (paragraph\ (a\)\ (1\) of the 1995 regulations, ) Tj
T * (consistent with the NPRM.Specifically, ) Tj
T * (this paragraph provides that an FCOI) Tj
T * (exists when the Institution, through its) Tj
T * (designated official\ (s\), reasonably) Tj
T * (determines that the SFI could directly) Tj
T * (and significantly affect the design, ) Tj
T * (conduct, or reporting of the PHS - funded) Tj
T * (research.As discussed above, the) Tj
T * (regulations also incorporate a revised) Tj
T * (definition of FCOI that is based on this) Tj
0 Tw T * (language.) Tj - 0.0045 Tw 1 - 1.022 Td(Consistent with our proposal in the) Tj - 1 - 1.1 Td(NPRM, we have included the) Tj
T * (requirement in the 1995 regulations) Tj
T * (regarding FCOI management) Tj
T * (responsibilities in a separate paragraph) Tj
T * (\ (g\), in which we clarified that the) Tj
T * (requirement includes management of) Tj
T * (any financial conflicts of a subrecipient) Tj
T * (Investigator pursuant to paragraph\ (c\) of) Tj
T * (the revised regulations described above.) Tj
T * (We have also cross - referenced the) Tj
T * (Institution\222s revised management) Tj
T * (responsibilities specified in 42 CFR) Tj
T * (50.605\ (a\) and 45 CFR 94.5\ (a\), including) Tj
T * (the development and implementation of) Tj
T * (a management plan and,
if necessary, a) Tj
0 - 1.111 TD(retrospective review and a mitigation) Tj
T * (report regarding how any identified bias) Tj
19.667 74.667 Td(was addressed, as discussed in further) Tj
0 - 1.1 TD(detail below.As a related matter, we) Tj
T * (have included a new paragraph\ (h\) that) Tj
T * (cross - references the Institution\222s revised) Tj
T * (and expanded reporting requirements in ) Tj
T * (the new paragraphs 42 CFR 50.605\ (b\)) Tj
T * (and 45 CFR 94.5\ (b\).) Tj
1 - 1.022 Td(Consistent with our proposal in the) Tj - 1 - 1.1 Td(NPRM, we have retained, but re - ) Tj
T * (designated, the requirement of) Tj
T * (paragraph\ (e\) of the 1995 regulations, ) Tj / T1_2 1 Tf
0 Tw T * (i.e., ) Tj / T1_1 1 Tf - 0.0045 Tw 1.923 0 Td(Institutions must maintain records) Tj - 1.923 - 1.1 Td(of all financial disclosures and all) Tj
T * (actions taken by the Institution with) Tj
T * (respect to each FCOI
for at least three) Tj
T * (years from the date of submission of the) Tj
T * (final expenditures report or final) Tj
T * (payment, or where applicable,
for the) Tj
T * (other time periods specified in 45 CFR) Tj
T * (74.53\ (b\) or 48 CFR part 4, subpart 4.7.) Tj
T * (Specifically, in paragraph\ (i\) of 42 CFR) Tj
T * (50.604 and 45 CFR 94.4, we have) Tj
T * (included a responsibility to maintain) Tj
T * (records relating to all Investigator) Tj
T * (disclosures of financial interests and the) Tj
T * (Institution\222s review of, and response to, ) Tj
T * (such disclosures\ (whether or not a) Tj
T * (disclosure resulted in the Institution\222s) Tj
T * (determination of an FCOI\) and actions) Tj
T * (under the Institution\222s policy or) Tj
T * (retrospective review,
if applicable,
for) Tj
T * (that time period.We believe that this) Tj
T * (revision helps clarify
for Institutions our) Tj
T * (intent
for the record retention obligation) Tj
T * (to apply not only in cases in which the) Tj
T * (Institution has identified an FCOI, but) Tj
T * (to all Investigator SFI disclosures, ) Tj
T * (whether or not such disclosure) Tj
T * (generated a response by the Institution.) Tj
1 - 1.022 Td(One respondent suggested that) Tj - 1 - 1.1 Td(retaining records
for three years is) Tj
T * (insufficient.We disagree; this) Tj
T * (requirement is not substantially) Tj
T * (different from the requirement in the) Tj
T * (1995 regulations, and is consistent with) Tj
T * (the PHS record retention policy.) Tj
T * (Another suggested that, since some) Tj
T * (awards
continue
for many years and) Tj
T * (disclosures now relate to the) Tj
T * (institutional responsibilities of) Tj
T * (Investigator, all records would have to) Tj
T * (be retained indefinitely.We disagree; as) Tj
T * (described in the NIH grants policy) Tj
T * (statement\ () Tj / T1_2 1 Tf
0 Tw(http: //grants.nih.gov/grants/ )Tj
T * (policy / nihgps) Tj / T1_3 1 Tf(_) Tj / T1_2 1 Tf(2010 / ) Tj
T * (nihgps) Tj / T1_3 1 Tf(_) Tj / T1_2 1 Tf(ch8.htm #) Tj / T1_3 1 Tf(_) Tj / T1_2 1 Tf(Toc271264975) Tj / T1_1 1 Tf(\),
) Tj - 0.0045 Tw T * (records relating to all Investigator) Tj
T * (disclosures of financial interests and the) Tj
T * (Institution\222s review of, and response to, ) Tj
T * (such disclosures, do not need to be) Tj
T * (retained indefinitely.Instead, the) Tj
T * (information must be retained
for each) Tj
T * (competitive segment
for a period of) Tj
T * (three years following the date the final) Tj
T * (expenditures report or final invoice is) Tj
T * (submitted to the PHS Awarding) Tj
T * (Component.In response to another) Tj
0 - 1.111 TD(comment, we also note that the record) Tj
T * (retention requirements in this paragraph) Tj
1 g / T1_4 1 Tf
0 Tw 6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(17: 26 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00016) - 1077(Fmt 4701) - 1077(Sfmt 4700) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

// peepdf comment: Javascript code located in object 120 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 536.42 750 Tm(53271) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
-0.0045 Tw 9 0 0 9 45 725 Tm
(apply to records of all financial )Tj
0 -1.1 TD
(disclosures and actions under the )Tj
T*
(Institution\222s policy, even if the policy is )Tj
T*
(more stringent than the regulations. )Tj
1 -1.022 Td
(Additionally, the 1995 regulations )Tj
-1 -1.1 Td
(required at paragraph \(f\) that )Tj
T*
(Institutions establish adequate )Tj
T*
(enforcement mechanisms and provide )Tj
T*
(for sanctions where appropriate. )Tj
T*
(Consistent with our proposal in the )Tj
T*
(NPRM, we have revised this obligation )Tj
T*
(in a re-designated paragraph \(j\) to )Tj
T*
(require an Institution not only to )Tj
T*
(establish adequate enforcement )Tj
T*
(mechanisms and provide for employee )Tj
T*
(sanctions, but also to provide for other )Tj
T*
(administrative actions to ensure )Tj
T*
(Investigator compliance as appropriate. )Tj
T*
(One respondent suggested that the )Tj
T*
(choice of enforcement mechanisms be )Tj
T*
(left to the discretion of each Institution, )Tj
T*
(and that the PHS should not prescribe )Tj
T*
(specific enforcement mechanisms for )Tj
T*
(use in any type of situation. We note )Tj
T*
(that the revised language strikes a )Tj
T*
(balance between preserving the )Tj
T*
(Institution\222s discretion in this regard )Tj
T*
(and in enabling the PHS Awarding )Tj
T*
(Component to exercise proper oversight; )Tj
/T1_2
1 Tf
0 Tw T * (e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 2.108 0 Td(the language does not specify) Tj - 2.108 - 1.1 Td(particular actions as\221\221adequate\222\222 or) Tj
T * (\221\221appropriate, \222\222 implicitly recognizing) Tj
T * (that the Institution and the PHS) Tj
T * (Awarding Component make those) Tj
T * (judgments on a
case -by -
case basis.) Tj
T * (Another respondent suggested that we) Tj
T * (consider revising the regulations to) Tj
T * (specify that FCOI committees, ) Tj / T1_2 1 Tf
0 Tw(i.e., ) Tj / T1_1 1 Tf - 0.0045 Tw T * (institutional official\ (s\), can disapprove) Tj
T * (or suspend PHS funding of Investigators) Tj
T * (who are not in compliance with these) Tj
T * (regulations.While this example may) Tj
T * (indeed account
for appropriate action\ (s\)) Tj
T * (under this provision and / or under the) Tj
T * (Remedies sections, we have not) Tj
T * (specified any one action in this) Tj
T * (particular context because of the need) Tj
T * (
for discretion by the Institutions and the) Tj
T * (PHS Awarding Components, to account) Tj
T * (
for the specific circumstances at issue.) Tj
T * (Additionally, providing this example in ) Tj
T * (the regulatory text could create) Tj
T * (confusion between the suspension of an) Tj
T * (Investigator by an Institution under) Tj
T * (these regulations and the suspension or) Tj
T * (debarment of an Investigator by the PHS) Tj
T * (Awarding Component under 2 CFR part) Tj
0 Tw T * (376.) Tj - 0.0045 Tw 1 - 1.022 Td(One respondent suggested that the) Tj - 1 - 1.1 Td(PHS / HHS should be given enforcement) Tj
T * (power over any disclosure of significant) Tj
T * (financial interest that, although in ) Tj
T * (technical compliance with the) Tj
T * (regulations is part of a plan or scheme) Tj
T * (to avoid the disclosure requirements, ) Tj
T * (and referenced the Securities Act of) Tj
T * (1933, as amended.We have not) Tj
0 - 1.111 TD(implemented this suggestion because) Tj
T * (we believe this concern is mitigated by) Tj
19.667 74.667 Td(the aforementioned revisions to this) Tj
0 - 1.1 TD(section and by the ability of the HHS to) Tj
T * (inquire at any time\ (before, during, or) Tj
T * (after award\) into any Investigator) Tj
T * (disclosure of financial interests and the) Tj
T * (Institution\222s review of, and response to, ) Tj
T * (such disclosure, whether or not the) Tj
T * (disclosure resulted in the Institution\222s) Tj
T * (determination of an FCOI.) Tj
1 - 1.022 Td(Finally, consistent with the NPRM, ) Tj - 1 - 1.1 Td(we have revised the certification) Tj
T * (requirement that was set forth in ) Tj
T * (paragraph\ (g\) of the 1995 regulations.) Tj
T * (Re - designated paragraph\ (k\) requires an) Tj
T * (Institution to certify that the Institution) Tj
T * (\ (1\) Has in effect at that Institution an up - ) Tj
T * (to - date, written, and enforced) Tj
T * (administrative process to identify and) Tj
T * (manage FCOI with respect to all) Tj
T * (research projects
for which funding is) Tj
T * (sought or received from the PHS;\ (2\)) Tj
T * (shall promote and enforce Investigator) Tj
T * (compliance with the regulations\222) Tj
T * (requirements including those pertaining) Tj
T * (to disclosure of SFIs;\ (3\) shall manage) Tj
T * (FCOI and provide initial and ongoing) Tj
T * (FCOI reports to the PHS consistent with) Tj
T * (the regulations;\ (4\) agrees to make) Tj
T * (information available, promptly upon) Tj
T * (request, to the HHS relating to any) Tj
T * (Investigator disclosure of financial) Tj
T * (interests and the Institution\222s review of, ) Tj
T * (and response to, such disclosure, ) Tj
T * (whether or not the disclosure resulted) Tj
T * ( in the Institution\222s determination of an) Tj
T * (FCOI; and\ (5\) shall fully comply with) Tj
T * (the requirements of the regulations.) Tj
T * (Notably, this revised paragraph) Tj
T * (eliminates much of the certification) Tj
T * (language in the 1995 regulations) Tj
T * (regarding an Institution\222s reporting) Tj
T * (obligations.This change is consistent) Tj
T * (with other critical changes to the) Tj
T * (regulations that we have implemented;) Tj
T * (specifically, we have substantially) Tj
T * (revised and expanded the reporting) Tj
0 - 1.111 TD(requirements, and included a discussion) Tj
T * (of such requirements in the revisions to) Tj
T * (42 CFR 50.605\ (b\) and 45 CFR 94.5\ (b\), as) Tj
T * (discussed below.) Tj / T1_2 1 Tf
0 - 1.644 TD(Management and Reporting of Financial) Tj
0 - 1.111 TD(Conflicts of Interest\ (42 CFR 50.605, 45) Tj
T * (CFR 94.5\)) Tj / T1_1 1 Tf
1 - 1.467 Td(Consistent with the NPRM, we have) Tj - 1 - 1.111 Td(revised and expanded substantially the) Tj
T * (provisions of the 1995 regulations) Tj
T * (regarding management of FCOI to) Tj
T * (address requirements
for both) Tj
T * (management and reporting of FCOI.) Tj
1 - 1.022 Td(The 1995 regulations require at) Tj - 1 - 1.111 Td(paragraph\ (a\), that an Institution\222s) Tj
T * (designated official\ (s\) review all) Tj
T * (financial disclosures and determine) Tj
T * (whether a conflict of interest exists;) Tj / T1_2 1 Tf
0 Tw(i.e., ) Tj / T1_1 1 Tf - 0.0045 Tw T * (the designated official\ (s\) reasonably) Tj
T * (determines that an SFI could directly) Tj
T * (and significantly affect the design, ) Tj
T * (conduct, or reporting of the PHS - funded) Tj
19.667 74.667 Td(research.If a conflict is identified, the) Tj
0 - 1.1 TD(official\ (s\) must determine what actions) Tj
T * (should be taken by the Institution to) Tj
T * (manage, reduce, or eliminate it.) Tj
T * (Paragraph\ (a\) also provides examples of) Tj
T * (conditions or restrictions that might be) Tj
T * (imposed to manage conflicts of interest, ) Tj
T * (specifically public disclosure of SFIs, ) Tj
T * (monitoring of research by independent) Tj
T * (reviewers, modification of the research) Tj
T * (plan, disqualification from participation) Tj
T * ( in all or a portion of the research funded) Tj
T * (by the PHS, divestiture of SFIs, or) Tj
T * (severance of relationships that create) Tj
T * (actual or potential conflicts.) Tj
1 - 1.022 Td(Per our proposal in the NPRM, we) Tj - 1 - 1.1 Td(have revised the above language as part) Tj
T * (of a re - designated paragraph\ (a\)\ (1\) to) Tj
T * (require that, prior to the Institution\222s) Tj
T * (expenditure of any funds under a PHS - ) Tj
T * (funded research project, the designated) Tj
T * (official\ (s\) of an Institution shall, ) Tj
T * (consistent with paragraph\ (f\) of the) Tj
T * (preceding section\ (42 CFR 50.604 or 45) Tj
T * (CFR 94.4\): review all Investigator) Tj
T * (disclosures of SFIs; determine whether) Tj
T * (any SFIs relate to PHS - funded research;) Tj
T * (determine whether an FCOI exists; and, ) Tj
T * (
if so, develop and implement a) Tj
T * (management plan that shall specify the) Tj
T * (actions that have been, and shall be, ) Tj
T * (taken to manage such FCOI.As noted in ) Tj
T * (the preceding section, the Institution) Tj
T * (may involve the Investigator in ) Tj
T * (determining whether an SFI is related to) Tj
T * (PHS - funded research.) Tj
1 - 1.022 Td(One respondent suggested that this) Tj - 1 - 1.1 Td(provision would require an Institution) Tj
T * (to identify and manage FCOI in advance) Tj
T * (of the Notice of Award and suggested a) Tj
T * (transition period of 60 days after award) Tj
T * (
for the implementation of this) Tj
T * (provision, with an interim management) Tj
T * (plan in place during that time.In) Tj
T * (response, we note that this requirement) Tj
T * (refers to actions that need to be taken) Tj
T * (prior to expenditure of funds, not) Tj
T * (necessarily in advance of the award) Tj
T * (itself.In addition, development and) Tj
T * (implementation of an interim) Tj
T * (management plan
for all identified) Tj
T * (FCOIs\ (instead of only those identified) Tj
T * (after the retrospective review discussed) Tj
T * (below\) would seem to place an) Tj
T * (additional burden on the process of) Tj
T * (managing an identified FCOI, so we) Tj
T * (have declined that suggestion.) Tj
1 - 1.022 Td(Some respondents suggested that the) Tj - 1 - 1.1 Td(PHS Awarding Component or some) Tj
T * (other outside agency, but not) Tj
0 - 1.111 TD(Institutions, should have the) Tj
T * (responsibility
for reviewing Investigator) Tj
T * (SFIs and identifying and managing) Tj
T * (FCOI, citing possible conflicts of) Tj
T * (interest of the designated institutional) Tj
T * (official\ (s\), or the Institutions) Tj
T * (themselves.After considering this, we) Tj
T * (believe that the revisions that we have) Tj
T * (made to the regulations strike the) Tj
1 g / T1_3 1 Tf
0 Tw 6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(17: 26 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00017) - 1077(Fmt 4701) - 1077(Sfmt 4700) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

// peepdf comment: Javascript code located in object 123 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 45 750 Tm(53272) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
-0.0045 Tw 9 0 0 9 45 725 Tm
(appropriate balance between the )Tj
0 -1.111 TD
(responsibilities of the Institution for )Tj
T*
(determining and managing Investigator )Tj
T*
(FCOI and the oversight responsibilities )Tj
T*
(of the PHS Awarding Component. We )Tj
T*
(believe that our revisions will )Tj
T*
(strengthen the roles of all involved in )Tj
T*
(this process. Additionally, we have )Tj
T*
(included a discussion of institutional )Tj
T*
(conflicts of interest in section IV of this )Tj
T*
(final rule. )Tj
1 -1.189 Td
(The most significant change that we )Tj
-1 -1.111 Td
(have made to this section is the )Tj
T*
(management plan requirement that we )Tj
T*
(introduced in the NPRM. Although the )Tj
T*
(1995 regulations required Institutions to )Tj
T*
(manage FCOI, the term \221\221management )Tj
T*
(plan\222\222 was not used. As we noted in the )Tj
T*
(NPRM, many Institutions already have )Tj
T*
(been developing and implementing )Tj
T*
(management plans as a means of )Tj
T*
(fulfilling their FCOI management )Tj
T*
(responsibilities; explicitly incorporating )Tj
T*
(this requirement in the regulations )Tj
T*
(acknowledges the value of this practice )Tj
T*
(as an important means to maintain )Tj
T*
(objectivity in PHS-funded research )Tj
T*
(across the research community. As )Tj
T*
(indicated in the discussion of paragraph )Tj
T*
(\(b\) below, the expanded reporting )Tj
T*
(requirements include an obligation to )Tj
T*
(report, at a minimum, a description of )Tj
T*
(\221\221key elements\222\222 of the Institution\222s )Tj
T*
(management plan in certain FCOI )Tj
0 Tw T*
(reports. )Tj
-0.0045 Tw 1 -1.189 Td
(As discussed in the NPRM, and for )Tj
-1 -1.111 Td
(reasons explained above, we also have )Tj
T*
(deleted the sentence in this section from )Tj
T*
(the 1995 regulations that describes )Tj
T*
(when an FCOI exists. A modified )Tj
T*
(version of this sentence has been moved )Tj
T*
(to the re-designated paragraph \(f\) of 42 )Tj
T*
(CFR 50.604 and 45 CFR 94.4, as well as )Tj
T*
(incorporated into a definition of FCOI in )Tj
T*
(42 CFR 50.603 and 45 CFR 94.3. )Tj
1 -1.178 Td
(In the revised paragraph \(a\)\(1\), we )Tj
-1 -1.111 Td
(have also included the following )Tj
T*
(updated and expanded list of examples )Tj
T*
(of conditions or restrictions that might )Tj
T*
(be imposed to manage an FCOI: public )Tj
T*
(disclosure of FCOI \()Tj
/T1_2
1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf
11.26 0 Td(when) Tj - 0.0045 Tw - 11.26 - 1.111 Td(presenting or publishing the research\);) Tj
T * (disclosure of FCOI directly to) Tj
T * (participants in research projects) Tj
T * (involving human subjects research;) Tj
T * (appointment of an independent monitor) Tj
T * (capable of taking measures to protect) Tj
T * (the design, conduct, or reporting of the) Tj
T * (research against bias resulting from the) Tj
T * (FCOI; modification of the research plan;) Tj
T * (change of personnel or personnel) Tj
T * (responsibilities, or disqualification of) Tj
T * (personnel from participation in all or a) Tj
T * (portion of the research; reduction or) Tj
T * (elimination of a financial interest\ () Tj / T1_2 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw T * (sale of an equity interest\); or severance) Tj
T * (of relationships that create financial) Tj
0 Tw T * (conflicts.) Tj - 0.0045 Tw 20.667 74.667 Td(One respondent suggested that) Tj - 1 - 1.1 Td(disclosure alone is not sufficient
for) Tj
0 - 1.1 TD(management of FCOI.Others suggested) Tj
T * (that the regulations should define a) Tj
T * (specific standard
for acceptable conduct) Tj
T * (of research when an FCOI with PHS - ) Tj
T * (funded research has been identified) Tj
0 Tw T * (\ () Tj / T1_2 1 Tf(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 2.441 0 Td(adopting the guidelines
for) Tj - 2.441 - 1.1 Td(conducting medical research published) Tj
T * (by AAMC and AAU\), which could) Tj
T * (include defining the SFI that would) Tj
T * (preclude an Investigator from being a) Tj
T * (PD / PI on PHS - funded projects or) Tj
T * (requiring the Institution to consider the) Tj
T * (interests of patients explicitly.Another) Tj
T * (suggested that the risk of advancing) Tj
T * (potentially conflicted research should) Tj
T * (be weighed against the risk of not) Tj
T * (advancing the research.Given the wide) Tj
T * (range of contexts in which a conflict) Tj
T * (with PHS - funded research may arise, we) Tj
T * (believe that specifying particular) Tj
T * (standards or specific criteria may not) Tj
T * (cover all types of FCOI.Therefore, we) Tj
T * (have declined these suggestions, though) Tj
T * (we note that Institutions may choose a) Tj
T * (variety of measures, including those) Tj
T * (proposed by the respondents, in their) Tj
T * (evaluation of SFIs and in any specific) Tj
T * (management plan.In addition, as) Tj
T * (discussed in the NPRM and above, we) Tj
T * (posed a number of questions in the) Tj
T * (ANPRM on the issue of whether the) Tj
T * (regulations should be amended to) Tj
T * (require specific approaches to) Tj
T * (management of FCOI related to certain) Tj
T * (types of research or alternatively, ) Tj
T * (specific types of financial interests or) Tj
T * (FCOI.Many of the respondents to the) Tj
T * (ANPRM thought that this approach) Tj
T * (would not account
for the full range of) Tj
T * (research projects as well as the large) Tj
T * (variation in circumstances in which) Tj
T * (FCOI may arise.Moreover, the) Tj
T * (regulations do not include specific) Tj
T * (provisions related to the type of) Tj
T * (research, financial interest, or identified) Tj
T * (FCOI at issue.) Tj
1 - 1.022 Td(Finally, respondents were concerned) Tj - 1 - 1.1 Td(that the flexibility afforded to) Tj
T * (Institutions in determining how to) Tj
T * (manage SFIs that were determined to be) Tj
T * (FCOIs will lead to a lack of consistency) Tj
T * (across Institutions in the evaluation and) Tj
T * (management of Investigator FCOIs.) Tj
T * (Given the wide variety of contexts in ) Tj
T * (which FCOIs can arise and the) Tj
T * (differences among Institutions, some) Tj
T * (variation across Institutions is expected.) Tj
T * (We believe that Institutions are in the) Tj
T * (best position to evaluate the) Tj
T * (circumstances and determine the most) Tj
T * (appropriate management strategies
for) Tj
T * (specific cases.) Tj
1 - 1.022 Td(Additionally, we have included the) Tj - 1 - 1.1 Td(two paragraphs that we introduced in ) Tj
T * (the NPRM\ (paragraphs\ (a\)\ (2\) and\ (a\)\ (3\)\), ) Tj
0 - 1.111 TD(with modifications, to clarify an) Tj
T * (Institution\222s obligations in situations in ) Tj
19.667 74.667 Td(which an Institution becomes aware of) Tj
T * (an SFI after the PHS - funded research is) Tj
T * (already underway.Specifically, ) Tj
T * (paragraph\ (a\)\ (2\) states that whenever, in ) Tj
T * (the course of an ongoing PHS - funded) Tj
T * (research project, a new Investigator) Tj
T * (participating in the research project) Tj
T * (discloses an SFI or an existing) Tj
T * (Investigator discloses a new SFI to the) Tj
T * (Institution, the designated official\ (s\) of) Tj
T * (the Institution shall, within 60 days: ) Tj
T * (Review the SFI disclosure; determine) Tj
T * (whether it is related to PHS - funded) Tj
T * (research; determine whether an FCOI) Tj
T * (exists; and,
if so, implement, on at least) Tj
T * (an interim basis, a management plan) Tj
T * (that shall specify the actions that have) Tj
T * (been, and will be, taken to manage the) Tj
T * (FCOI.Depending on the nature of the) Tj
T * (SFI, an Institution may determine that) Tj
T * (additional interim measures are) Tj
T * (necessary with regard to the) Tj
T * (Investigator\222s participation in the PHS - ) Tj
T * (funded research project between the) Tj
T * (date of disclosure and the completion of) Tj
T * (the Institution\222s review.) Tj
1 - 1.111 Td(Paragraph\ (a\)\ (3\) states that whenever) Tj - 1 - 1.111 Td(an Institution identifies an SFI that was) Tj
T * (not disclosed timely by an Investigator) Tj
T * (or,
for whatever reason, was not) Tj
T * (previously reviewed by the Institution) Tj
T * (during an ongoing PHS - funded research) Tj
T * (project\ () Tj / T1_2 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 5.881 0 Td(was not timely reviewed or) Tj - 5.881 - 1.111 Td(reported by a subrecipient\), the) Tj
T * (designated official\ (s\) shall, within 60) Tj
T * (days: review the SFI;
determine whether) Tj
T * (it is related to PHS - funded research;) Tj
T * (determine whether an FCOI exists; and, ) Tj
T * (
if so: \ (i\) Implement,
on at least an) Tj
T * (interim basis, a management plan that) Tj
T * (shall specify the actions that have been, ) Tj
T * (and will be, taken to manage such FCOI) Tj
T * (going forward; and\ (ii\) In addition, ) Tj
T * (whenever an FCOI is not identified or) Tj
T * (managed timely including: ) Tj / T1_3 1 Tf
0 Tw 1 - 1.111 Td(\200) Tj / T1_1 1 Tf - 0.0045 Tw 1.016 0 Td(Failure by the Investigator to) Tj - 2.016 - 1.111 Td(disclose an SFI that is determined by) Tj
T * (the Institution to constitute an FCOI;) Tj / T1_3 1 Tf
0 Tw 1 - 1.111 Td(\200) Tj / T1_1 1 Tf - 0.0045 Tw 1.016 0 Td(Failure by the Institution to review) Tj - 2.016 - 1.111 Td(or manage such an FCOI; or) Tj / T1_3 1 Tf
0 Tw 1 - 1.111 Td(\200) Tj / T1_1 1 Tf - 0.0045 Tw 1.016 0 Td(Failure by the Investigator to) Tj - 2.016 - 1.111 Td(comply with an FCOI management plan;) Tj
0 - 1.333 TD(the Institution shall, within 120 days of) Tj
0 - 1.111 TD(the Institution\222s determination of) Tj
T * (noncompliance, complete a) Tj
T * (retrospective review of the Investigator\222s) Tj
T * (activities and the PHS - funded research) Tj
T * (project to determine whether any PHS - ) Tj
T * (funded research, or portion thereof, ) Tj
T * (conducted during the time period of the) Tj
T * (noncompliance, was biased in the) Tj
T * (design, conduct, or reporting of such) Tj
0 Tw T * (research.) Tj - 0.0045 Tw 1 - 1.111 Td(The Institution is required to) Tj - 1 - 1.111 Td(document the retrospective review; such) Tj
T * (documentation shall include, but not) Tj
T * (necessarily be limited to, all of the) Tj
T * (following key elements: ) Tj
1 g / T1_4 1 Tf
0 Tw 6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(17: 26 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00018) - 1077(Fmt 4701) - 1077(Sfmt 4700) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

// peepdf comment: Javascript code located in object 126 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 536.42 750 Tm(53273) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
ET
q
1 0 0 1 45 61.8000031 cm
0.5 w 
0 0 m
50 0 l
S
Q
BT
/T1_1
1 Tf
0 Tw 5.446 0 0 4.55 52 54.9091 Tm(31) Tj - 0.0029 Tw 7 0 0 7 59.1954 53.1 Tm(75 FR 28697\ (May 21, 2010\).) Tj
ET
q
1 0 0 1 222 61.8000031 cm
0.5 w
0 0 m
50 0 l
S
Q
BT / T1_1 1 Tf
0 Tw 5.446 0 0 4.55 229 54.9091 Tm(32) Tj - 0.0028 Tw 7 0 0 7 236.1954 53.1 Tm(75 FR 28707\ (May 21, 2010\).) Tj - 0.0045 Tw 9 0 0 9 54 725 Tm(1.Project number;) Tj
0 - 1.022 TD(2.Project title;) Tj
T * (3.PD / PI or contact PD / PI
if a multiple) Tj - 1 - 1.111 Td(PD / PI model is used;) Tj
1 - 1.022 Td(4.Name of the Investigator with the) Tj
0 Tw - 1 - 1.111 Td(FCOI;) Tj - 0.0045 Tw 1 - 1.022 Td(5.Entity with which the Investigator) Tj - 1 - 1.111 Td(has a financial conflict of interest;) Tj
1 - 1.022 Td(6.Reason\ (s\) for the retrospective) Tj
0 Tw - 1 - 1.111 Td(review;) Tj - 0.0045 Tw 1 - 1.033 Td(7.Detailed methodology used
for the) Tj - 1 - 1.111 Td(retrospective review\ () Tj / T1_2 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf
12.042 0 Td(methodology) Tj - 0.0045 Tw - 12.042 - 1.111 Td(of the review process, composition of) Tj
0 - 1.111 TD(the review panel, documents reviewed\);) Tj
1 - 1.033 Td(8.Findings of the review\ () Tj / T1_2 1 Tf
0 Tw(i.e., ) Tj / T1_1 1 Tf
13.955 0 Td(facts) Tj - 0.0045 Tw - 14.955 - 1.111 Td(and observations\); and) Tj
1 - 1.033 Td(9.Conclusions of the review\ () Tj / T1_2 1 Tf
0 Tw(i.e., ) Tj / T1_1 1 Tf - 0.0045 Tw - 1 - 1.111 Td(determination and recommended) Tj
0 Tw T * (actions\).) Tj - 0.0045 Tw 1 - 1.033 Td(If bias is found, the Institution is) Tj - 1 - 1.111 Td(required to notify the PHS Awarding) Tj
T * (Component promptly and submit a) Tj
T * (mitigation report to the PHS Awarding) Tj
T * (Component.The mitigation report must) Tj
T * (include, at a minimum, the key) Tj
T * (elements documented in the) Tj
T * (retrospective review above and a) Tj
T * (description of the impact of the bias on) Tj
T * (the research project and the Institution\222s) Tj
T * (plan of action or actions taken to) Tj
T * (eliminate or mitigate the effect of the) Tj
T * (bias\ () Tj / T1_2 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 4.547 0 Td(impact on the research) Tj - 4.547 - 1.111 Td(project; extent of harm done, including) Tj
T * (any qualitative and quantitative data to) Tj
T * (support any actual or future harm;) Tj
T * (analysis of whether the research project) Tj
T * (is salvageable\).Thereafter, the) Tj
T * (Institution will submit FCOI reports) Tj
T * (annually, as specified elsewhere in the) Tj
T * (regulations.Depending on the nature of) Tj
T * (the FCOI, an Institution may determine) Tj
T * (that additional interim measures are) Tj
T * (necessary with regard to the) Tj
T * (Investigator\222s participation in the PHS - ) Tj
T * (funded research project between the) Tj
T * (date that the FCOI or the Investigator\222s) Tj
T * (noncompliance is determined and the) Tj
T * (completion of the Institution\222s) Tj
T * (retrospective review.) Tj
1 - 1.033 Td(As we explained in the NPRM, ) Tj
0 Tw 7.002 0 0 5.85 181.2888 244.8282 Tm(31) Tj
9 0 0 9 191.535 242.5003 Tm(these) Tj - 0.0045 Tw - 16.282 - 1.111 Td(revisions are based, at least in part, on) Tj
T * (our experience working with) Tj
T * (Institutions and our observation that) Tj
T * (some Institutions may be more diligent) Tj
T * (about addressing potential FCOI at the) Tj
T * (onset of a PHS - funded research project) Tj
T * (than after the work is already underway.) Tj
T * (We also believe it is important to) Tj
T * (address in the regulations circumstances) Tj
T * ( in which an Institution,
for whatever) Tj
T * (reason, has not timely reviewed an SFI, ) Tj
T * (particularly when such SFI is later) Tj
T * (determined to be an FCOI.In such) Tj
T * (circumstances, it is of course important) Tj
T * (
for an Institution to manage the FCOI) Tj
T * (going forward; however, there is also a) Tj
T * (critical need to review and determine) Tj
19.667 72.5 Td(whether any bias was introduced into) Tj
0 - 1.1 TD(the research during the period of time) Tj
T * (prior to review and management of the) Tj
T * (FCOI.In the NPRM we proposed to) Tj
T * (address this need in paragraph\ (a\)\ (3\) by) Tj
T * (the introduction of a\221\221mitigation plan\222\222) Tj
0 Tw T * (requirement, ) Tj
7.002 0 0 5.85 274.9988 667.9279 Tm(32) Tj - 0.0045 Tw 9 0 0 9 285.245 665.6 Tm(which we have clarified) Tj - 7.027 - 1.1 Td( in the revised regulations as a) Tj
T * (\221\221retrospective review\222\222 and\221\221mitigation) Tj
T * (report, \222\222 as provided above.) Tj
1 - 1.022 Td(While one respondent agreed with the) Tj - 1 - 1.1 Td(requirement
for a mitigation plan in the) Tj
T * (
case of a newly identified SFI that the) Tj
T * (Institution determines is an FCOI, many) Tj
T * (suggested that the proposed requirement) Tj
T * (
for a mitigation plan was unnecessary.) Tj
T * (They thought that the goal of such a) Tj
T * (plan would be achieved by the review) Tj
T * (and management plan that Institutions) Tj
T * (are required to implement when they) Tj
T * (determine that an Investigator\222s SFI) Tj
T * (constitutes an FCOI, and that) Tj
T * (determining
if there was bias in the) Tj
T * (design, conduct, or reporting of the) Tj
T * (PHS - funded research would be very) Tj
T * (difficult.Some respondents agreed, ) Tj
T * (however, that it seems reasonable to) Tj
T * (expect the Institution to determine) Tj
T * (whether a mitigation plan is necessary.) Tj
T * (We have considered the comments and) Tj
T * (agree that the requirement
for a) Tj
T * (mitigation plan may have been stated) Tj
T * (too broadly in the NPRM.Mitigation) Tj
T * (reports should only be used in cases) Tj
T * (where the Institution determines that a) Tj
T * (newly identified FCOI has resulted in ) Tj
T * (bias in the design, conduct, or reporting) Tj
T * (of PHS - funded research.Respondents) Tj
T * (also suggested that the elements of the) Tj
T * (mitigation plan in the NPRM were) Tj
T * (unclear and requested additional) Tj
T * (guidance.To address these comments, ) Tj
T * (we have revised the requirement, as) Tj
T * (provided above.) Tj
1 - 1.022 Td(Paragraph\ (a\)\ (4\) requires the) Tj - 1 - 1.1 Td(Institution to monitor Investigator) Tj
T * (compliance with the management plan) Tj
T * (on an ongoing basis until the) Tj
T * (completion of the PHS - funded research) Tj
T * (project.This paragraph dovetails with) Tj
T * (the new paragraphs\ (a\)\ (2\) and\ (a\)\ (3\), ) Tj
T * (described above, by ensuring that the) Tj
T * (management actions taken by an) Tj
T * (Institution at the time an FCOI is) Tj
0 - 1.111 TD(identified
continue to be followed by) Tj
T * (the Investigator\ (s\) involved
for the) Tj
T * (duration of the project.) Tj
1 - 1.022 Td(In the NPRM we proposed to) Tj - 1 - 1.111 Td(introduce at paragraph\ (a\)\ (5\) a new) Tj
T * (requirement to help the biomedical and) Tj
T * (behavioral research community as well) Tj
T * (as the public, Congress, and other) Tj
T * (interested parties monitor the integrity) Tj
T * (and credibility of PHS - funded research, ) Tj
T * (and underscore our commitment to) Tj
T * (fostering transparency, accountability, ) Tj
T * (and public trust.Specifically, we) Tj
19.667 72.5 Td(proposed a new requirement that, prior) Tj
0 - 1.1 TD(to the Institution\222s expenditure of any) Tj
T * (funds under a PHS - funded research) Tj
T * (project, the Institution shall make) Tj
T * (available via a publicly accessible Web) Tj
T * (site information concerning any SFI that) Tj
T * (meets the following three criteria: \ (A\)) Tj
T * (The SFI was disclosed and is still held) Tj
T * (by the PD / PI or any other Investigator) Tj
T * (who has been identified by the) Tj
T * (Institution as senior / key personnel
for) Tj
T * (the PHS - funded research project in the) Tj
T * (grant application, contract proposal, ) Tj
T * (contract, progress report, or other) Tj
T * (required report submitted to the PHS;) Tj
T * (\ (B\) the Institution determines that the) Tj
T * (SFI is related to the PHS - funded) Tj
T * (research; and\ (C\) the Institution) Tj
T * (determines that the SFI is an FCOI.) Tj
1 - 1.022 Td(We proposed to require that the) Tj - 1 - 1.1 Td(information posted include, at a) Tj
T * (minimum, the following: ) Tj / T1_3 1 Tf
0 Tw 1 - 1.022 Td(\200) Tj / T1_1 1 Tf - 0.0045 Tw 1.016 0 Td(The Investigator\222s name;) Tj / T1_3 1 Tf
0 Tw - 1.016 - 1.022 Td(\200) Tj / T1_1 1 Tf - 0.0045 Tw 1.016 0 Td(The Investigator\222s position with) Tj - 2.016 - 1.1 Td(respect to the research project;) Tj / T1_3 1 Tf
0 Tw 1 - 1.022 Td(\200) Tj / T1_1 1 Tf - 0.0045 Tw 1.016 0 Td(The nature of the SFI;) Tj / T1_3 1 Tf
0 Tw - 1.016 - 1.022 Td(\200) Tj / T1_1 1 Tf - 0.0045 Tw 1.016 0 Td(And the approximate dollar value) Tj - 2.016 - 1.1 Td(of the SFI\ (dollar ranges would be) Tj
T * (permissible; less than $20, 000; less than) Tj
T * ($50, 000; less than $100, 000; less than or) Tj
0 - 1.111 TD(equal to $250, 000; greater than) Tj
T * ($250, 000\), or a statement that the) Tj
T * (interest is one whose value cannot be) Tj
T * (readily determined through reference to) Tj
T * (public prices or other reasonable) Tj
T * (measures of fair market value.) Tj
1 - 1.022 Td(We proposed a requirement that the) Tj - 1 - 1.111 Td(Institution update the posted) Tj
T * (information at least annually, and) Tj
T * (update the Web site within 60 days of) Tj
T * (the Institution\222s receipt or identification) Tj
T * (of information concerning any) Tj
T * (additional SFI that was not previously) Tj
T * (disclosed by the senior / key personnel) Tj
T * (
for the PHS - funded research project, or) Tj
T * (upon the disclosure of an SFI by new) Tj
T * (senior / key personnel,
if the Institution) Tj
T * (determines that the SFI is related to the) Tj
T * (PHS - funded research and is an FCOI.) Tj
T * (We proposed that information) Tj
T * (concerning the SFIs of an individual) Tj
T * (subject to this requirement shall remain) Tj
T * (available via the Institution\222s publicly) Tj
T * (accessible Web site
for at least five years) Tj
T * (from the date that the information was) Tj
T * (most recently updated.) Tj
1 - 1.022 Td(We received many comments on this) Tj - 1 - 1.111 Td(proposed requirement.Some) Tj
T * (respondents did not support this) Tj
T * (requirement, as they were concerned) Tj
T * (about privacy issues.A few respondents) Tj
T * (suggested that posting information) Tj
T * (about Investigator FCOI without the) Tj
T * (appropriate context would foster a) Tj
T * (negative perception of FCOI, and a) Tj
T * (couple of comments indicated that the) Tj
T * (requirements might conflict with state) Tj
T * (laws.Others suggested this requirement) Tj
T * (is unnecessary, given the disclosure) Tj
1 g / T1_4 1 Tf
0 Tw 6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(17: 26 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00019) - 1077(Fmt 4701) - 1077(Sfmt 4700) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

// peepdf comment: Javascript code located in object 129 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 45 750 Tm(53274) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
-0.0045 Tw 9 0 0 9 45 725 Tm
(provisions required under the recently )Tj
0 -1.1 TD
(enacted Affordable Care Act. One )Tj
T*
(respondent proposed that this )Tj
T*
(information should be included in )Tj
T*
(applications or proposals for PHS- )Tj
T*
(funded research but not posted on a )Tj
T*
(publicly accessible Web site. Several )Tj
T*
(suggested that additional discussion of )Tj
T*
(this provision is needed and requested )Tj
T*
(that this requirement be omitted from )Tj
T*
(the final rule at this time. )Tj
1 -1.022 Td
(We are strongly committed to the )Tj
-1 -1.1 Td
(value of transparency to the public, and )Tj
T*
(we also appreciate the concerns raised )Tj
T*
(by these respondents. In keeping with )Tj
T*
(the increasing number and range of )Tj
T*
(public disclosure initiatives, including )Tj
T*
(those in the aforementioned Affordable )Tj
T*
(Care Act, we believe it is important to )Tj
T*
(make available to the public critical )Tj
T*
(information affecting PHS-funded )Tj
T*
(research. Consistent with statutory goals )Tj
T*
(and Executive Order 13563, we believe )Tj
T*
(the language that we have finalized in )Tj
T*
(this rule strikes a reasonable balance of )Tj
T*
(the public and private interests at issue. )Tj
1 -1.022 Td
(Some respondents suggested that the )Tj
-1 -1.1 Td
(information be made available upon )Tj
T*
(request, rather than posted on a publicly )Tj
T*
(available Web site. We carefully )Tj
T*
(considered this suggestion and agree )Tj
T*
(that making the information available )Tj
T*
(upon request is in accordance with the )Tj
T*
(overall goal of enhanced transparency. )Tj
T*
(The chosen approach promotes such )Tj
T*
(transparency without imposing undue )Tj
T*
(burdens. Therefore, we have revised the )Tj
T*
(regulations to state that the Institution )Tj
T*
(must make the information publicly )Tj
T*
(accessible and may do so by posting the )Tj
T*
(information on a public Web site or by )Tj
T*
(making the information available in )Tj
T*
(writing within five business days of any )Tj
0 Tw T*
(request. )Tj
-0.0045 Tw 1 -1.022 Td
(Several respondents thought that the )Tj
-1 -1.1 Td
(requirement would constitute a )Tj
T*
(substantial burden and cited the )Tj
T*
(necessity of setting up a database )Tj
T*
(structure. We note that the final rule )Tj
T*
(does not require the information to be )Tj
T*
(provided in a specific format. Therefore, )Tj
T*
(an Institution could choose to provide )Tj
0 -1.111 TD
(the information as a simple document or )Tj
0 Tw T*
(spreadsheet. )Tj
-0.0045 Tw 1 -1.022 Td
(A few respondents suggested that all )Tj
-1 -1.111 Td
(Investigator SFIs or all payments from )Tj
T*
(pharmaceutical companies, not only )Tj
T*
(those that were determined to constitute )Tj
T*
(an FCOI with PHS-funded research, )Tj
T*
(should be provided. We disagree; we )Tj
T*
(continue to believe that providing )Tj
T*
(information on only those SFIs )Tj
T*
(determined to be FCOIs with PHS- )Tj
T*
(funded research provides the )Tj
T*
(appropriate level of transparency, )Tj
T*
(particularly as not all SFIs are )Tj
T*
(determined to relate to PHS-funded )Tj
T*
(research. However, Institutions are free )Tj
T*
(to expand upon this requirement by )Tj
19.667 74.667 Td
(providing information on all SFIs of )Tj
0 -1.1 TD
(their Investigators. One respondent )Tj
T*
(suggested that there should be a grading )Tj
T*
(system to denote levels of conflicts of )Tj
T*
(interest. We note that the determination )Tj
T*
(of an FCOI by an Institution requires an )Tj
T*
(assessment of how an SFI may cause an )Tj
T*
(FCOI with the PHS-funded research, )Tj
T*
(and how any such FCOI must be )Tj
T*
(managed. It is at that point the )Tj
T*
(Institution is judging the SFI and its )Tj
T*
(potential to create an FCOI; there is no )Tj
T*
(gradient associated with an FCOI itself. )Tj
T*
(Additionally, we are concerned that this )Tj
T*
(suggestion would undermine the )Tj
T*
(premise that an Investigator\222s FCOI with )Tj
T*
(PHS-funded research is not necessarily )Tj
T*
(negative or prohibitive; the intent of the )Tj
T*
(regulations is to ensure the appropriate )Tj
T*
(management of such FCOIs in order to )Tj
T*
(protect the objectivity of the research. )Tj
1 -1.022 Td
(Other respondents supported the )Tj
-1 -1.1 Td
(requirement for making information )Tj
T*
(about Investigator\222s SFIs that were )Tj
T*
(determined to be FCOIs with PHS- )Tj
T*
(funded research publicly accessible. )Tj
T*
(Many suggested that the PHS should )Tj
T*
(host the information on a central Web )Tj
T*
(site. Although we considered this )Tj
T*
(suggestion at length, we continue to )Tj
T*
(believe that Institutions are in a better )Tj
T*
(position to provide and maintain this )Tj
T*
(information. For example, the )Tj
T*
(Institution will be able to put the )Tj
T*
(information into context, as suggested )Tj
T*
(by some respondents, )Tj
/T1_2
1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 12.317 0 Td(by relating) Tj - 12.317 - 1.1 Td(the information to the Institution\222s FCOI) Tj
T * (policies or to other information about) Tj
T * (the Investigator, as the Institution deems) Tj
0 Tw T * (appropriate.) Tj - 0.0045 Tw 1 - 1.022 Td(Several respondents requested that) Tj - 1 - 1.1 Td(the regulations provide additional) Tj
T * (guidance as to exactly which) Tj
T * (Investigators are covered by this) Tj
T * (provision.Consistent with our proposal) Tj
T * ( in the NPRM, we have applied the) Tj
T * (requirement to senior / key personnel
for) Tj
T * (research grants and cooperative) Tj
T * (agreements and key personnel
for) Tj
T * (research contracts.To provide further) Tj
T * (clarity, we also have included a new) Tj
T * (definition of senior / key personnel in 42) Tj
T * (CFR 50.603 and of key personnel in 45) Tj
T * (CFR 94.3.Because these definitions of) Tj
T * (\221\221senior / key personnel\222\222 and\221\221key) Tj
T * (personnel\222\222 include the PD / PI, we have) Tj
T * (limited the references in this section to) Tj
T * (\221\221senior / key personnel\222\222 or\221\221key) Tj
T * (personnel\222\222 to avoid confusion and) Tj
T * (redundancy.Others requested that this) Tj
T * (provision apply only to Investigators) Tj
T * (and not to their spouse or dependent) Tj
T * (children, or at least that the names of) Tj
T * (the spouse and dependent children not) Tj
T * (be posted.We note that, consistent with) Tj
T * (the proposal in the NPRM, the) Tj
T * (information provided must include the) Tj
0 - 1.111 TD(name of the Investigator and the nature) Tj
T * (of the SFI.Any SFIs of the Investigator\222s) Tj
19.667 74.667 Td(spouse and dependent children will be) Tj
0 - 1.1 TD(attributed to the Investigator, such that) Tj
T * (only the Investigator\222s name would be) Tj
0 Tw T * (provided.) Tj - 0.0045 Tw 1 - 1.022 Td(Some respondents suggested that the) Tj - 1 - 1.1 Td(dollar ranges included in this provision) Tj
T * (be the same as those required in reports) Tj
T * (of FCOI to the PHS Awarding) Tj
T * (Component.We agree with this) Tj
T * (suggestion and have revised the) Tj
T * (language accordingly.Although one) Tj
T * (respondent requested that no dollar) Tj
T * (amounts should be provided,
while) Tj
T * (another suggested that the top range of) Tj
T * ($250, 000 is too low, we believe that the) Tj
T * (revised ranges provide the appropriate) Tj
T * (level of information.Respondents made) Tj
T * (several suggestions as to the length of) Tj
T * (time the information should remain) Tj
T * (available, ranging from two to three) Tj
T * (years.We agree with the specific) Tj
T * (comments that it would be useful to) Tj
T * (align the duration of the requirement
for) Tj
T * (providing this information with the PHS) Tj
T * (records retention policy.Accordingly, ) Tj
T * (we have revised the regulations to) Tj
T * (require that information concerning the) Tj
T * (SFIs that were determined to constitute) Tj
T * (FCOIs shall remain available
for at least) Tj
T * (three years from the date that the) Tj
T * (information was most recently updated.) Tj
1 - 1.022 Td(One respondent asked
for clarification) Tj - 1 - 1.1 Td(of how the criterion
for providing) Tj
T * (information on an SFI that is still held) Tj
T * (by the Investigator would apply to) Tj
T * (payments or reimbursements.We note) Tj
T * (that the requirements
for making) Tj
T * (information publicly accessible relate to) Tj
T * (those SFIs that were determined to be) Tj
T * (FCOIs.The regulations do not prevent) Tj
T * (Institutions from taking into account, ) Tj
T * (during that evaluation process, whether) Tj
T * (the Investigator has an ongoing financial) Tj
T * (relationship with the entity providing) Tj
T * (the payment or reimbursement or) Tj
T * (whether the payment or reimbursement) Tj
T * (was limited in duration.) Tj
1 - 1.022 Td(Finally, several respondents suggested) Tj - 1 - 1.1 Td(that time is needed to allow Institutions) Tj
T * (to set up systems required to comply) Tj
T * (with the requirements in this paragraph.) Tj
T * (In particular, many suggested that) Tj
T * (implementation should be delayed to) Tj
T * (October 2013 to coincide with the) Tj
T * (implementation of the disclosure) Tj
T * (provisions of the Affordable Care Act.) Tj
T * (As specified in the\221\221Compliance Date\222\222) Tj
T * (paragraph in the Dates section above, ) Tj
T * (we have provided time
for) Tj
T * (implementation of the revised) Tj
0 - 1.111 TD(regulations such that 365 days after) Tj
T * (publication of the final rule, Institutions) Tj
T * (receiving PHS funding will be required) Tj
T * (to ensure public accessibility of) Tj
T * (information on FCOIs of senior / key) Tj
T * (personnel on research grants and) Tj
T * (cooperative agreements and of key) Tj
T * (personnel on research contracts via a) Tj
T * (publicly accessible Web site or by) Tj
1 g / T1_3 1 Tf
0 Tw 6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(17: 26 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00020) - 1077(Fmt 4701) - 1077(Sfmt 4700) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

// peepdf comment: Javascript code located in object 132 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 536.42 750 Tm(53275) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
ET
q
1 0 0 1 222 61.8000031 cm
0.5 w 
0 0 m
50 0 l
S
Q
BT
/T1_1
1 Tf
0 Tw 5.446 0 0 4.55 229 54.9091 Tm(33) Tj - 0.0028 Tw 7 0 0 7 236.1954 53.1 Tm(75 FR 28708\ (May 21, 2010\).) Tj
ET
q
1 0 0 1 399 109.8000031 cm
0.5 w
0 0 m
50 0 l
S
Q
BT / T1_1 1 Tf
0 Tw 5.446 0 0 4.55 406 102.9091 Tm(34) Tj - 0.0028 Tw 7 0 0 7 413.1954 101.1 Tm(AAMC Task Force on Financial Conflicts of) Tj - 2.028 - 1.143 Td(Interest in Clinical Research: ) Tj / T1_2 1 Tf - 0.0029 Tw(Protecting Subjects, ) Tj - 0.0028 Tw 0 - 1.143 TD(Preserving Trust, Promoting Progress\227Policy and) Tj - 0.0029 Tw T * (Guidelines
for the Oversight of Individual Financial) Tj - 0.0028 Tw T * (Interests in Human Subjects Research, ) Tj / T1_1 1 Tf
0 Tw(December) Tj
T * (2001) Tj / T1_2 1 Tf
2.499 0 Td(https: //www.aamc.org/download/75302/data/ )Tj
- 2.499 - 1.143 Td(firstreport.pdf.) Tj / T1_1 1 Tf - 0.0045 Tw 9 0 0 9 45 725 Tm(making the information available in ) Tj
0 - 1.1 TD(writing within five business days of any) Tj
T * (request, as required by 42 CFR 50.605) Tj
T * (\ (a\)\ (5\) and 45 CFR 94.5\ (a\)\ (5\).) Tj
1 - 1.022 Td(Additionally, as proposed in the) Tj - 1 - 1.1 Td(NPRM and discussed above, we have) Tj
T * (maintained the requirement of) Tj
T * (paragraph\ (b\) of the 1995 regulations but) Tj
T * (restated it as follows: \221\221In addition to the) Tj
T * (types of conflicting financial interests as) Tj
T * (defined in this subpart that must be) Tj
T * (managed pursuant to this section, an) Tj
T * (Institution may require the management) Tj
T * (of other financial conflicts of interests in ) Tj
T * (its policy on financial conflicts of) Tj
T * (interest, as the Institution deems) Tj
0 Tw T * (appropriate.\222\222) Tj - 0.0045 Tw 1 - 1.022 Td(As we also proposed in the NPRM, we) Tj - 1 - 1.1 Td(have included a substantial revision and) Tj
T * (expansion of Institutions\222 existing FCOI) Tj
T * (reporting requirements.Specifically, ) Tj
T * (paragraph\ (b\)\ (1\) discusses the timing of) Tj
T * (initial FCOI reports and references the) Tj
T * (proposed management plan) Tj
T * (requirements addressed in the above) Tj
T * (discussion of paragraph\ (a\): Prior to the) Tj
T * (Institution\222s expenditure of any funds) Tj
T * (under a PHS - funded research project, ) Tj
T * (the Institution shall provide to the PHS) Tj
T * (Awarding Component an FCOI report) Tj
T * (regarding any Investigator\222s SFI found) Tj
T * (by the Institution to be an FCOI and) Tj
T * (ensure that the Institution has) Tj
T * (implemented a management plan in ) Tj
T * (accordance with this subpart.We have) Tj
T * (clarified that, in cases in which the) Tj
T * (Institution identifies an FCOI and) Tj
T * (eliminates it prior to the expenditure of) Tj
T * (PHS - awarded funds, the Institution) Tj
T * (shall not submit an FCOI report to the) Tj
T * (PHS Awarding Component.) Tj
1 - 1.022 Td(Similarly, paragraph\ (b\)\ (2\) discusses) Tj - 1 - 1.1 Td(the timing of follow - up FCOI reports, ) Tj
T * (with examples of when such reports) Tj
T * (may be required as well as references to) Tj
T * (the proposed management plan and) Tj
T * (retrospective review requirements) Tj
T * (addressed above in the discussion of) Tj
T * (paragraph\ (a\): for any SFI that the) Tj
T * (Institution identifies as conflicting) Tj
T * (subsequent to the Institution\222s initial) Tj
T * (FCOI report during an ongoing PHS - ) Tj
T * (funded research project\ () Tj / T1_2 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 13.538 0 Td(upon the) Tj - 13.538 - 1.1 Td(participation of an Investigator who is) Tj
T * (new to the research project\), the) Tj
T * (Institution shall provide to the PHS) Tj
T * (Awarding Component, within 60 days, ) Tj
T * (a report regarding the FCOI and ensure) Tj
T * (that the Institution has implemented a) Tj
T * (management plan in accordance with) Tj
0 - 1.111 TD(the regulations.Where such an FCOI) Tj
T * (report involves an SFI that was not) Tj
T * (disclosed timely by an Investigator or, ) Tj
T * (
for whatever reason, was not previously) Tj
T * (reviewed by the Institution\ () Tj / T1_2 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf
15.143 0 Td(was) Tj - 0.0045 Tw - 15.143 - 1.111 Td(not timely reviewed or reported by a) Tj
T * (subrecipient\), the Institution also is) Tj
T * (required to complete a retrospective) Tj
T * (review to determine whether any PHS - ) Tj
19.667 74.667 Td(funded research, or portion thereof, ) Tj
0 - 1.1 TD(conducted prior to the identification) Tj
T * (and management of the FCOI was biased) Tj
T * ( in the design, conduct, or reporting of) Tj
T * (such research.Additionally,
if bias is) Tj
T * (found, the Institution is required to) Tj
T * (notify the PHS Awarding Component) Tj
T * (promptly and submit a mitigation report) Tj
T * (to the PHS Awarding Component.) Tj
1 - 1.022 Td(Consistent with our proposal in the) Tj - 1 - 1.1 Td(NPRM, paragraph\ (b\)\ (3\) discusses) Tj
T * (information that must be included in ) Tj
T * (the FCOI reports required under) Tj
T * (paragraphs\ (b\)\ (1\) and\ (b\)\ (2\), described) Tj
T * (above.Specifically, such FCOI reports) Tj
T * (must include sufficient information to) Tj
T * (enable the PHS Awarding Component to) Tj
T * (understand the nature and extent of the) Tj
T * (financial conflict, and to assess the) Tj
T * (appropriateness of the Institution\222s) Tj
T * (management plan.In addition to the) Tj
T * (minimum specific elements of the FCOI) Tj
T * (report that we proposed in the NPRM, ) Tj
0 Tw 7.002 0 0 5.85 379.2536 510.228 Tm(33) Tj
9 0 0 9 387.0398 507.9 Tm() Tj - 0.0045 Tw - 18.338 - 1.1 Td(we have included a requirement to) Tj
T * (name the entity with which the) Tj
T * (Investigator has a financial conflict of) Tj
T * (interest, to enhance transparency and) Tj
0 Tw T * (accountability.) Tj - 0.0045 Tw 1 - 1.022 Td(The majority of respondents) Tj - 1 - 1.1 Td(supported the requirement that) Tj
T * (Institutions provide this additional) Tj
T * (information to the PHS Awarding) Tj
T * (Component, although one respondent) Tj
T * (thought this was unnecessary.Another) Tj
T * (respondent thought that requiring) Tj
T * (Institutions to report key elements of the) Tj
T * (management plan would include) Tj
T * (information that Investigators might) Tj
T * (want to keep private.We have retained) Tj
T * (this requirement because we believe) Tj
T * (that receiving information on specific) Tj
T * (aspects of the management plan is) Tj
T * (necessary to ensure appropriate) Tj
T * (oversight by the PHS Awarding) Tj
T * (Component.We note that the) Tj
T * (regulations state under 42 CFR 50.606\ (b\)) Tj
T * (and 45 CFR 94.6\ (b\) that to the extent) Tj
T * (permitted by law, HHS will maintain) Tj
T * (the confidentiality of all records of) Tj
T * (financial interests.Another suggested) Tj
T * (the regulations require reporting of the) Tj
T * (exact dollar amount of the financial) Tj
T * (interest, rather than ranges.We did not) Tj
T * (make this change; the exact amount of) Tj
0 - 1.111 TD(some types of financial interests, such) Tj
T * (as equity, may change frequently, which) Tj
T * (could create ambiguity and intensify the) Tj
T * (administrative burden.) Tj
1 - 1.022 Td(One respondent inquired as to) Tj - 1 - 1.111 Td(whether the rationale
for including the) Tj
T * (conflicted Investigator in the research) Tj
T * (project should include application of) Tj
T * (the\221\221rebuttable presumption standard as) Tj
T * (articulated by AAMC\222\222\ () Tj / T1_2 1 Tf
0 Tw(i.e., ) Tj / T1_1 1 Tf - 0.0045 Tw T * (\221\221Institutional policies should establish) Tj
T * (the rebuttable presumption that an) Tj
T * (individual who holds a significant) Tj
19.667 72.5 Td(financial interest in research involving) Tj
0 - 1.1 TD(human subjects may not conduct such) Tj
0 Tw T * (research.\222\222) Tj
7.002 0 0 5.85 442.5013 707.528 Tm(34) Tj - 0.0045 Tw 9 0 0 9 450.2874 705.2 Tm(\) We note that Institutions) Tj - 5.699 - 1.1 Td(have the flexibility to use this standard) Tj
T * ( in their evaluations of Investigator SFI, ) Tj
T * (as long as they comply with the) Tj
T * (regulations.Other respondents) Tj
T * (questioned why the FCOI report should) Tj
T * (contain a rationale
for including the) Tj
T * (conflicted Investigator in the research) Tj
T * (project since the credentials of the) Tj
T * (Investigator are included in the research) Tj
T * (application or proposal and were) Tj
T * (considered during the peer review) Tj
T * (process.Although our intent was to) Tj
T * (include the justification
for permitting) Tj
T * (the Investigator with an FCOI to remain) Tj
T * (on the project, as opposed to the) Tj
T * (scientific rationale
for the Investigator\222s) Tj
T * (involvement in the project, we have) Tj
T * (removed this element from the) Tj
T * (minimum requirements of the FCOI) Tj
T * (report to minimize confusion.) Tj
1 - 1.022 Td(One respondent suggested it would be) Tj - 1 - 1.1 Td(more efficient
for Institutions to) Tj
T * (describe their monitoring measures) Tj
T * (annually
for all FCOI reports rather than) Tj
T * (on a report - specific basis.We disagree;) Tj
T * (because the monitoring measures may) Tj
T * (differ depending on the requirements of) Tj
T * (the specific management plan, we) Tj
T * (believe that retaining that element in ) Tj
T * (each report is important.Several) Tj
T * (respondents recommended deleting the) Tj
T * (requirement
for a description of how the) Tj
T * (management plan will safeguard) Tj
T * (objectivity in the research project, as) Tj
T * (that is inherent in the management plan) Tj
T * (and should be apparent from the other) Tj
T * (information provided.We believe that) Tj
T * (documenting this element is important) Tj
0 - 1.111 TD(to ensure proper oversight; however, to) Tj
T * (address this comment, we have clarified) Tj
T * (this element to describe how the) Tj
T * (management plan is designed to) Tj
T * (safeguard objectivity in PHS - funded) Tj
0 Tw T * (research.) Tj - 0.0045 Tw 1 - 1.022 Td(One respondent suggested that this) Tj - 1 - 1.111 Td(requirement be retained only
for) Tj
T * (research involving human participants.) Tj
T * (As discussed in the NPRM and above, ) Tj
T * (we posed a number of questions in the) Tj
T * (ANPRM on the issue of whether the) Tj
T * (regulations should be amended to) Tj
T * (require specific approaches to) Tj
T * (management of FCOI related to certain) Tj
T * (types of research or alternatively, ) Tj
T * (specific types of financial interests or) Tj
T * (FCOI.The majority of the respondents) Tj
T * (to the ANPRM thought that this) Tj
T * (approach would not account
for the full) Tj
T * (range of research projects as well as the) Tj
1 g / T1_3 1 Tf
0 Tw 6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(17: 26 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00021) - 1077(Fmt 4701) - 1077(Sfmt 4700) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

// peepdf comment: Javascript code located in object 140 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 45 750 Tm(53276) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
ET
q
1 0 0 1 222 61.8000031 cm
0.5 w 
0 0 m
50 0 l
S
Q
BT
/T1_1
1 Tf
0 Tw 5.446 0 0 4.55 229 54.9091 Tm(35) Tj - 0.0028 Tw 7 0 0 7 236.1954 53.1 Tm(OMB No.0925\2260417.) Tj - 0.0045 Tw 9 0 0 9 45 725 Tm(large variation in circumstances in ) Tj
0 - 1.1 TD(which FCOIs may arise.As a result, the) Tj
T * (regulations, including the provisions in ) Tj
T * (this paragraph, impose uniform FCOI) Tj
T * (management responsibilities, regardless) Tj
T * (of the type of research, financial) Tj
T * (interest, or identified FCOI at issue.) Tj
T * (Nonetheless, we note that Institutions) Tj
T * (are free to differentially manage FCOI) Tj
T * (depending on the nature of the research) Tj
T * (as long as they remain in full) Tj
T * (compliance with the regulations.) Tj
1 - 1.022 Td(A few respondents requested that the) Tj - 1 - 1.1 Td(regulations include additional examples) Tj
T * (of appropriate elements of a) Tj
T * (management plan, such as the use of) Tj
T * (independent monitors or a description) Tj
T * (of circumstances in which eliminating) Tj
T * (an FCOI is necessary.Given the wide) Tj
T * (range of circumstances in which FCOI) Tj
T * (may occur and the importance of) Tj
T * (tailoring institutional review and) Tj
T * (determination to each specific
case, we) Tj
T * (believe that including additional) Tj
T * (examples may be interpreted as) Tj
T * (prescriptive and may be misconstrued) Tj
T * (as the only means of managing a) Tj
T * (particular type of conflict.Nonetheless, ) Tj
T * (as described above, a list of examples of) Tj
T * (conditions or restrictions that might be) Tj
T * (imposed to manage an FCOI is) Tj
T * (described in 42 CFR 50.605\ (a\)\ (1\) and 45) Tj
T * (CFR 94.5\ (a\)\ (1\).One respondent) Tj
T * (requested that the HHS develop) Tj
T * (templates
for reporting FCOIs to the) Tj
T * (PHS Awarding Component.Because the) Tj
T * (regulations describe the basic) Tj
T * (information required in these reports, ) Tj
T * (we believe that templates are) Tj
0 Tw T * (unnecessary.) Tj - 0.0045 Tw 1 - 1.022 Td(One respondent noted that the) Tj - 1 - 1.1 Td(regulations do not state how the PHS) Tj
T * (Awarding Component will respond to) Tj
T * (the FCOI reports submitted by) Tj
T * (Institutions and recommended that HHS) Tj
T * (establish a policy on the responsibilities) Tj
T * (of the PHS Awarding Component,
while) Tj
T * (another requested that agency staff) Tj
T * (receive training in the review of FCOI) Tj
T * (reports submitted to the PHS Awarding) Tj
T * (Component to ensure consistency.In) Tj
T * (response to these comments, we want to) Tj
T * (assure stakeholders that we have in ) Tj
T * (place procedures and guidance on how) Tj
T * (staff should respond to FCOI reports) Tj
T * (submitted by Institutions, and we) Tj
T * (provide training on the evaluation of) Tj
T * (information that we receive from) Tj
T * (Institutions about FCOIs with PHS - ) Tj
0 - 1.111 TD(funded research.We have taken and are) Tj
T * (continuing to take steps to increase) Tj
T * (oversight of the FCOI regulations.For) Tj
T * (example, NIH has: ) Tj / T1_2 1 Tf
0 Tw 1 - 1.022 Td(\200) Tj / T1_1 1 Tf - 0.0045 Tw 1.016 0 Td(Conducted a thorough review of its) Tj - 2.016 - 1.111 Td(system of oversight and compliance) Tj
T * (with respect to the FCOI regulations) Tj
T * (with the purpose of ensuring that a) Tj
T * (vigorous and effective oversight system) Tj
T * (is in place.) Tj / T1_2 1 Tf
0 Tw 20.667 74.667 Td(\200) Tj / T1_1 1 Tf - 0.0045 Tw 1.016 0 Td(Developed an FCOI Reporting) Tj - 2.016 - 1.111 Td(Module as a tool
for Institutions to) Tj
T * (electronically manage and submit FCOI) Tj
T * (reports to NIH.This module provides) Tj
T * (consistent reporting of FCOIs to the) Tj
T * (NIH.The system interfaces with the) Tj
T * (Web - based reporting tool
for NIH staff) Tj
T * (already in use and will provide a full) Tj
T * (spectrum of tracking and oversight) Tj
T * (capabilities
for NIH extramural staff.) Tj
T * (Mandatory use of the FCOI Module) Tj
T * (went into effect during FY 2009.) Tj
0 Tw 7.002 0 0 5.85 355.7955 617.3282 Tm(35) Tj
9 0 0 9 363.5817 615.0003 Tm() Tj / T1_2 1 Tf - 14.731 - 1.056 Td(\200) Tj / T1_1 1 Tf - 0.0045 Tw 1.016 0 Td(Developed an FCOI review protocol) Tj - 2.016 - 1.111 Td(
for use by staff in evaluating) Tj
T * (institutional FCOI reports and) Tj
T * (conducted mandatory training
for) Tj
T * (extramural program and grants) Tj
T * (management staff on the use of the) Tj
T * (protocol and other FCOI issues.) Tj / T1_2 1 Tf
0 Tw 1 - 1.056 Td(\200) Tj / T1_1 1 Tf - 0.0045 Tw 1.016 0 Td(Routinely conduct in -depth reviews) Tj - 2.016 - 1.111 Td(of cases of alleged FCOI involving) Tj
T * (extramural grantees and will
continue to) Tj
T * (do so as new allegations arise.) Tj / T1_2 1 Tf
0 Tw 1 - 1.056 Td(\200) Tj / T1_1 1 Tf - 0.0045 Tw 1.016 0 Td(Evaluate and analyze grantee) Tj - 2.016 - 1.111 Td(Institutions\222 FCOI policies and practices) Tj
T * (on an ongoing basis.) Tj / T1_2 1 Tf
0 Tw 1 - 1.056 Td(\200) Tj / T1_1 1 Tf - 0.0045 Tw 1.016 0 Td(Formed an FCOI Liaison group) Tj - 2.016 - 1.111 Td(consisting of representatives from each) Tj
T * (of the NIH Institutes and / or Centers\ (IC\)) Tj
T * (to discuss FCOI issues and guide FCOI) Tj
T * (activities in their respective ICs, with) Tj
T * (assistance from the Office of Extramural) Tj
0 Tw T * (Research.) Tj / T1_2 1 Tf
1 - 1.056 Td(\200) Tj / T1_1 1 Tf - 0.0045 Tw 1.016 0 Td(Developed and included new) Tj - 2.016 - 1.111 Td(language
for NIH\222s\221\221Notice of Award\222\222) Tj
T * (template that highlights FCOI) Tj
0 Tw T * (requirements.) Tj / T1_2 1 Tf
1 - 1.056 Td(\200) Tj / T1_1 1 Tf - 0.0045 Tw 1.016 0 Td(Developed and conducted a number) Tj - 2.016 - 1.111 Td(of initiatives and site visits to evaluate) Tj
T * (institutional FCOI policies
for) Tj
T * (compliance with the regulation.These) Tj
T * (initiatives include: ) Tj / T1_3 1 Tf
0 Tw 1 - 1.056 Td(\306) Tj / T1_1 1 Tf - 0.0045 Tw 1.115 0 Td(NIH Pilot Compliance Program on) Tj
0 Tw - 2.116 - 1.111 Td(FCOI.) Tj / T1_3 1 Tf
1 - 1.056 Td(\306) Tj / T1_1 1 Tf - 0.0045 Tw 1.115 0 Td(NIH Targeted Site Reviews.) Tj / T1_2 1 Tf
0 Tw - 1.115 - 1.056 Td(\200) Tj / T1_1 1 Tf - 0.0045 Tw 1.016 0 Td(Following evaluation of the) Tj - 2.016 - 1.111 Td(institutional FCOI policies, publicized) Tj
T * (on - line\221\221Lessons Learned\222\222 to encourage) Tj
T * (enhanced compliance in the grantee) Tj
0 Tw T * (community.) Tj / T1_2 1 Tf
1 - 1.056 Td(\200) Tj / T1_1 1 Tf - 0.0045 Tw 1.016 0 Td(Issued a number of communications) Tj - 2.016 - 1.111 Td(to remind extramural grant recipients of) Tj
T * (their FCOI compliance responsibilities.) Tj
T * (These communications include: ) Tj / T1_3 1 Tf
0 Tw 1 - 1.056 Td(\306) Tj / T1_1 1 Tf - 0.0045 Tw 1.115 0 Td(Articles\ (NIH OER\221\221Nexus\222\222) Tj
0 Tw - 2.116 - 1.111 Td(newsletter\).) Tj / T1_3 1 Tf
1 - 1.056 Td(\306) Tj / T1_1 1 Tf - 0.0045 Tw 1.115 0 Td(NIH Guide Notices.) Tj / T1_3 1 Tf
0 Tw - 1.115 - 1.056 Td(\306) Tj / T1_1 1 Tf - 0.0045 Tw 1.115 0 Td(E - mails to Institutional officials.) Tj / T1_2 1 Tf
0 Tw - 1.115 - 1.056 Td(\200) Tj / T1_1 1 Tf - 0.0045 Tw 1.016 0 Td(Continue to respond to grantee) Tj - 2.016 - 1.111 Td(questions directed to the OER FCOI) Tj
T * (mailbox concerning compliance with) Tj
T * (the Federal regulation.) Tj / T1_2 1 Tf
0 Tw 1 - 1.056 Td(\200) Tj / T1_1 1 Tf - 0.0045 Tw 1.016 0 Td(Provide education and outreach) Tj - 2.016 - 1.111 Td(activities aimed at raising awareness of) Tj
T * (the issues surrounding FCOI at the) Tj
T * (institutional and Investigator levels) Tj
0 Tw T * (\ () Tj / T1_4 1 Tf(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 2.441 0 Td(NIH Regional Seminars;) Tj
17.226 72.5 Td(presentations at professional) Tj
0 - 1.1 TD(organizations and meetings\).) Tj
1 - 1.022 Td(These policies and guidance will be) Tj - 1 - 1.1 Td(updated to incorporate all revisions) Tj
T * (implemented in this final rule, and we) Tj
T * (will
continue to train the relevant staff, ) Tj
T * (as necessary.) Tj
1 - 1.022 Td(As proposed in the NPRM, paragraph) Tj - 1 - 1.1 Td(\ (b\)\ (4\) includes a requirement to provide) Tj
T * (follow - up reports in cases in which an) Tj
T * (FCOI has been previously identified and) Tj
T * (reported.Specifically,
for any FCOI) Tj
T * (previously reported by the Institution) Tj
T * (with regard to an ongoing PHS - funded) Tj
T * (research project, the Institution shall) Tj
T * (provide to the PHS Awarding) Tj
T * (Component an annual FCOI report that) Tj
T * (addresses the status of the FCOI and any) Tj
T * (changes to the management plan
for the) Tj
T * (duration of the PHS - funded research) Tj
T * (project.The annual FCOI report must) Tj
T * (specify whether the financial conflict is) Tj
T * (still being managed or explain why the) Tj
T * (FCOI no longer exists.The Institution) Tj
T * (must provide annual FCOI reports to the) Tj
T * (PHS Awarding Component
for the) Tj
T * (duration of the project period\ (including) Tj
T * (extensions with or without funds\) in the) Tj
T * (time and manner specified by the PHS) Tj
T * (Awarding Component.) Tj
1 - 1.022 Td(A few respondents suggested that) Tj - 1 - 1.1 Td(providing a report annually when there) Tj
T * (has been no change to the FCOI or its) Tj
T * (management is unnecessary.We have) Tj
T * (considered this suggestion but believe) Tj
T * (that annual notification, even
if there) Tj
T * (are no changes, is necessary to provide) Tj
T * (appropriate assurance to the PHS) Tj
T * (Awarding Component that an identified) Tj
T * (FCOI continues to be managed) Tj
T * (throughout the period of the PHS - ) Tj
T * (funded research.One respondent) Tj
T * (suggested that the regulations allow the) Tj
T * (Institution to determine the frequency of) Tj
T * (reporting on identified FCOIs, ) Tj
T * (depending on the type of PHS - funded) Tj
T * (research and the nature of the conflict.) Tj
T * (As discussed above, the regulations) Tj
T * (impose uniform FCOI management) Tj
T * (responsibilities, regardless of the type of) Tj
T * (research, financial interest, or identified) Tj
T * (FCOI at issue to account
for the full) Tj
0 - 1.111 TD(range of circumstances in which FCOI) Tj
T * (may arise.Finally,
while several) Tj
T * (respondents requested that the timing of) Tj
T * (the annual reports be determined by the) Tj
T * (Institution rather than the PHS) Tj
T * (Awarding Component, we have) Tj
T * (determined that the reports need to be) Tj
T * (provided in the time and manner) Tj
T * (specified by the PHS Awarding) Tj
T * (Component in order to facilitate) Tj
T * (appropriate and efficient oversight.) Tj
1 - 1.022 Td(Finally, as proposed in the NPRM, ) Tj - 1 - 1.111 Td(paragraph\ (b\)\ (5\) includes language with) Tj
T * (regard to FCOI reporting that is similar) Tj
T * (to the language
for FCOI management in ) Tj
T * (the re - designated paragraph\ (a\)\ (6\), ) Tj
T * (described above.Namely, in addition to) Tj
1 g / T1_5 1 Tf
0 Tw 6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(17: 26 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00022) - 1077(Fmt 4701) - 1077(Sfmt 4700) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

// peepdf comment: Javascript code located in object 149 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 536.42 750 Tm(53277) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
ET
q
1 0 0 1 399 141.8000031 cm
0.5 w 
0 0 m
50 0 l
S
Q
BT
/T1_1
1 Tf
0 Tw 5.446 0 0 4.55 406 134.9091 Tm(36) Tj - 0.0028 Tw 7 0 0 7 413.1954 133.1001 Tm(Among other examples of HHS\222 oversight) Tj - 2.028 - 1.143 Td(authority, we note that with regard to grants or) Tj
0 - 1.143 TD(cooperative agreements from HHS to Institution of) Tj
T * (higher education, hospitals, other non - profit) Tj
T * (organizations, and commercial organizations, HHS) Tj
T * (awarding agencies have the right of timely and) Tj
T * (unrestricted access to any books, documents, ) Tj
T * (papers, or other records of recipients that are) Tj
T * (pertinent to its awards, to make audits, ) Tj
T * (examinations, excerpts, transcripts and copies of) Tj
T * (such documents.See 45 CFR 74.53\ (4\)\ (e\).) Tj - 0.0045 Tw 9 0 0 9 45 725 Tm(the types of financial conflicts of) Tj
0 - 1.111 TD(interest that must be reported pursuant) Tj
T * (to this section, an Institution may) Tj
T * (require the reporting of other FCOI in its) Tj
T * (policy on financial conflicts of interest, ) Tj
T * (as the Institution deems appropriate.) Tj / T1_2 1 Tf
0 - 1.667 TD(Remedies\ (42 CFR 50.606, 45 CFR 94.6\)) Tj / T1_1 1 Tf
1 - 1.722 Td(In both the NPRM and the Extension) Tj - 1 - 1.111 Td(Notice, we welcomed public comments) Tj
0 - 1.111 TD(regarding the need to further revise and) Tj
T * (clarify this section, with respect to PHS\222) Tj
T * (enforcement authority in the event of) Tj
T * (noncompliance with the regulations.) Tj
T * (Although we did not receive a high) Tj
T * (volume of comments on this topic, we) Tj
T * (took all feedback into consideration) Tj
T * (when finalizing the rule.We appreciate) Tj
T * (this opportunity to emphasize our) Tj
T * (commitment to effective oversight, ) Tj
T * (which requires a partnership between) Tj
T * (the PHS Awarding Components and the) Tj
T * (Institutions.The regulations make clear) Tj
T * (that Institutions are responsible
for) Tj
T * (ensuring Investigator compliance with) Tj
T * (institutional policies and procedures, ) Tj
T * (and it is necessary
for Institutions to) Tj
T * (establish appropriate consequences
for) Tj
T * (noncompliance.However, it is equally) Tj
T * (essential that the PHS Awarding) Tj
T * (Components consider appropriate) Tj
T * (enforcement action.We believe that the) Tj
T * (revised regulations strike an appropriate) Tj
T * (balance of responsibilities in this regard.) Tj
1 - 1.278 Td(In general, several respondents) Tj - 1 - 1.111 Td(supported our proposal to refine the) Tj
T * (discussion of remedies in the 1995) Tj
T * (regulations.Although one respondent) Tj
T * (expressed concern that the regulations) Tj
T * (seem to lack meaningful enforcement) Tj
T * (mechanisms and remedies, we believe) Tj
T * (that the Remedies section supports a) Tj
T * (range of possible corrective and) Tj
T * (remedial actions
for the PHS Awarding) Tj
T * (Components and the Institutions to) Tj
T * (consider.Additionally, we believe it is) Tj
T * (important to weigh the specific) Tj
T * (circumstances of each particular
case) Tj
T * (when pursuing such action\ (s\) and to) Tj
T * (retain a full range of available options.) Tj
T * (For that reason, we have declined to) Tj
T * (incorporate some of the additional) Tj
T * (\221\221penalties\222\222 that a few respondents) Tj
T * (suggested, such as monetary fines, ) Tj
T * (dismissals, or jail times
for) Tj
T * (Investigators; fines
for Institutions; or, ) Tj
T * (as one respondent suggested, \221\221referrals) Tj - 0.0001 Tc T * [(to the FDA * ) - 556( * ) - 556( * to bar participation by)] TJ
0 Tc T * (the individual in any clinical study) Tj
T * (designed to seek marketing approval.\222\222) Tj
T * (Likewise
for that reason, we have not) Tj
T * (incorporated the suggestion of another) Tj
T * (respondent to include a specific) Tj
T * (requirement that
if an Institution takes) Tj
T * (enforcement action against an) Tj
T * (Investigator, PHS should automatically) Tj
T * (\221\221impose penalties directly on an) Tj
0 Tw T * (Investigator.\222\222) Tj - 0.0045 Tw 20.667 74.667 Td(We did, however, agree with one) Tj - 1 - 1.1 Td(respondent that it would be helpful to) Tj
0 - 1.1 TD(clarify, in the grants context in ) Tj
T * (particular, that institutional sanctions) Tj
T * (against an Investigator can travel with) Tj
T * (the Investigator upon his or her transfer) Tj
T * (to another Institution.Specifically, we) Tj
T * (have revised 42 CFR 50.606, paragraph) Tj
T * (\ (a\), as follows: \221\221If the failure of an) Tj
T * (Investigator to comply with an) Tj
T * (Institution\222s financial conflicts of) Tj
T * (interest policy or a financial conflict of) Tj
T * (interest management plan appears to) Tj
T * (have biased the design, conduct, or) Tj
T * (reporting of the PHS - funded research, ) Tj
T * (the Institution shall promptly notify the) Tj
T * (PHS Awarding Component of the) Tj
T * (corrective action taken or to be taken.) Tj
T * (The PHS Awarding Component will) Tj
T * (consider the situation and, as necessary, ) Tj
T * (take appropriate action, or refer the) Tj
T * (matter to the Institution
for further) Tj
T * (action, which may include directions to) Tj
T * (the Institution on how to maintain) Tj
T * (appropriate objectivity in the PHS - ) Tj
T * (funded research project.The PHS may, ) Tj
T * (
for example, require Institutions) Tj
T * (employing such an Investigator to) Tj
T * (enforce any applicable corrective) Tj
T * (actions prior to a PHS award or when) Tj
T * (the transfer of a PHS grant\ (s\) involves) Tj
T * (such an Investigator.\222\222) Tj
1 - 1.022 Td(This revision is intended to reference) Tj - 1 - 1.1 Td(the range of options
for the PHS) Tj
T * (Awarding Component to consider, ) Tj
T * (depending on the specific) Tj
T * (circumstances at issue.For example, ) Tj
T * (PHS may decide to initiate government - ) Tj
T * (wide suspension or debarment of the) Tj
T * (Investigator under 2 CFR part 376; or to) Tj
T * (use enforcement measures under 45) Tj
T * (CFR 74.62, ) Tj / T1_2 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 7.379 0 Td(perhaps to make the) Tj - 7.379 - 1.1 Td(approval of a transfer contingent upon) Tj
T * (the former Institution\222s disclosure of the) Tj
T * (corrective action\227including the specific) Tj
T * (sanctions against the Investigator\227to) Tj
T * (the new Institution; and / or to use) Tj
T * (special award conditions under 45 CFR) Tj
0 Tw T * (74.14, ) Tj / T1_2 1 Tf
3.053 0 Td(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 2.108 0 Td(perhaps to make the new) Tj - 5.161 - 1.1 Td(Institution agree to take the same or) Tj
T * (similar action against that Investigator) Tj
T * (or explain to the PHS Awarding) Tj
T * (Component in writing why such action) Tj
T * (was not taken and what alternative) Tj
T * (measures will be used to ensure) Tj
0 Tw T * (compliance.) Tj - 0.0045 Tw 1 - 1.022 Td(One respondent suggested that the) Tj - 1 - 1.1 Td(regulations include a description of a) Tj
T * (process to resolve differences of opinion) Tj
T * (between the PHS Awarding Component) Tj
T * (and the Institution regarding evaluation) Tj
T * (and management of FCOIs.We declined) Tj
T * (that change, as we believe it would be) Tj
T * (unnecessary and overly prescriptive to) Tj
T * (impose a particular process as a) Tj
T * (regulatory requirement; we will) Tj
T * (
continue to work collaboratively with) Tj
0 - 1.111 TD(Institutions to resolve any such) Tj
T * (differences on a
case by
case basis, ) Tj
19.667 74.667 Td(taking into consideration the specific) Tj
0 - 1.1 TD(circumstances of each disagreement.We) Tj
T * (note, however, that the Institution may) Tj
T * (have an opportunity
for a hearing, ) Tj
T * (appeal, or other administrative process) Tj
T * (or proceeding to which it is entitled) Tj
T * (under any applicable statute or) Tj
T * (regulation, in the event that the PHS) Tj
T * (Awarding Component takes) Tj
T * (enforcement action against the) Tj
0 Tw T * (Institution.) Tj - 0.0045 Tw 1 - 1.022 Td(As we proposed in NPRM, we also) Tj - 1 - 1.1 Td(have revised paragraph\ (b\) to clarify that) Tj
T * (the HHS may inquire at any time\ () Tj / T1_2 1 Tf
0 Tw(i.e., ) Tj / T1_1 1 Tf - 0.0045 Tw T * (before, during, or after award\) into any) Tj
T * (Investigator disclosure of financial) Tj
T * (interests and the Institution\222s review of, ) Tj
T * (and response to, such disclosure, ) Tj
T * (whether or not the disclosure resulted) Tj
T * ( in the Institution\222s determination of an) Tj
T * (FCOI.Consistent with the 1995) Tj
T * (regulations, an Institution must submit, ) Tj
T * (or permit on site review of, all records) Tj
T * (pertinent to compliance with the) Tj
T * (regulations.One respondent suggested) Tj
T * (that the regulations restrict the period) Tj
T * (during which HHS may inquire to a) Tj
T * (defined number of years after the end of) Tj
T * (the award period.We have not made) Tj
T * (this change because the effects of) Tj
T * (compromising objectivity in PHS - ) Tj
T * (funded research may
continue
for some) Tj
T * (time after the award period.Another) Tj
T * (suggested that the regulations state that) Tj
T * (HHS may request information not) Tj
T * (deemed relevant to a finding of FCOI) Tj
T * (only
for the purpose of investigating an) Tj
T * (allegation of noncompliance with these) Tj
T * (rules.Although we agree that an) Tj
T * (allegation of noncompliance is one) Tj
T * (circumstance that could trigger this) Tj
T * (provision, we disagree that it would be) Tj
T * (appropriate to limit HHS\222 oversight) Tj
T * (authority to this specific event.) Tj
0 Tw 7.002 0 0 5.85 527.3187 302.328 Tm(36) Tj
9 0 0 9 535.1049 300.0001 Tm() Tj - 0.0045 Tw - 14.123 - 1.022 Td(In paragraph\ (b\), we also have) Tj - 1 - 1.1 Td(retained the statement in the 1995) Tj
T * (regulations that, to the extent permitted) Tj
T * (by law, HHS will maintain the) Tj
T * (confidentiality of all records of financial) Tj
T * (interests.In response to a question from) Tj
T * (a respondent, we note that this includes) Tj
T * (the information required under 42 CFR) Tj
T * (50.605\ (b\) and 45 CFR 94.5\ (b\).) Tj
1 - 1.022 Td(As we proposed in the NPRM, we) Tj - 1 - 1.1 Td(have revised paragraph\ (c\) to add that in ) Tj
0 - 1.111 TD(any
case inwhich the HHS determines) Tj
T * (that a PHS - funded project of clinical) Tj
T * (research whose purpose is to evaluate) Tj
T * (the safety or effectiveness of a drug, ) Tj
1 g / T1_3 1 Tf
0 Tw 6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(17: 26 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00023) - 1077(Fmt 4701) - 1077(Sfmt 4700) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

// peepdf comment: Javascript code located in object 152 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 45 750 Tm(53278) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
ET
q
1 0 0 1 45 70.8000031 cm
0.5 w 
0 0 m
50 0 l
S
Q
BT
/T1_1
1 Tf
0 Tw 5.446 0 0 4.55 52 63.9091 Tm(37) Tj - 0.0029 Tw 7 0 0 7 59.1954 62.1 Tm(60 FR 35813\ (July 11, 1995\).) Tj
0 Tw 5.446 0 0 4.55 52 54.9091 Tm(38) Tj - 0.0029 Tw 7 0 0 7 59.1954 53.1 Tm(74 FR 21612\ (May 8, 2009\).) Tj
ET
q
1 0 0 1 399 101.8000031 cm
0.5 w
0 0 m
50 0 l
S
Q
BT / T1_1 1 Tf
0 Tw 5.446 0 0 4.55 406 94.9091 Tm(39) Tj - 0.0028 Tw 7 0 0 7 413.1954 93.1 Tm(All applicant Institution numbers are based on) Tj - 2.028 - 1.114 Td(the number of Institutions that applied
for NIH) Tj - 0.0029 Tw 0 - 1.114 TD(funding in FY 2008.) Tj
0 Tw 5.446 0 0 4.55 406 70.5091 Tm(40) Tj - 0.0028 Tw 7 0 0 7 413.1954 68.7 Tm(All applicant Institution numbers are based on) Tj - 2.028 - 1.114 Td(the number of Institutions that applied
for NIH) Tj - 0.0029 Tw T * (funding in FY 2008.) Tj - 0.0045 Tw 9 0 0 9 45 725 Tm(medical device, or treatment has been) Tj
0 - 1.1 TD(designed, conducted, or reported by an) Tj
T * (Investigator with an FCOI that was not) Tj
T * (managed or reported by the Institution) Tj
T * (as required by the regulations, the) Tj
T * (Institution must not only require the) Tj
T * (Investigator involved to disclose the) Tj
T * (FCOI in each public presentation of the) Tj
T * (results of the research, but also to) Tj
T * (request an addendum to previously) Tj
T * (published presentations.One) Tj
T * (respondent suggested that this) Tj
T * (requirement may not achieve the) Tj
T * (desired aim, as Investigators could) Tj
T * (refrain from publicly presenting their) Tj
T * (results and publishers could refuse to) Tj
T * (publish the addendum or could publish) Tj
T * (it in an inconspicuous manner.We have) Tj
T * (implemented the proposed language) Tj
T * (from the NPRM because we believe the) Tj
T * (disclosure requirements as modified) Tj
T * (further the objective of the regulations) Tj
T * (to promote objectivity in research.) Tj
T * (Institutions are in the position to) Tj
T * (identify other actions that may be) Tj
T * (appropriate in such instances, ) Tj
0 - 1.111 TD(depending on the specific
case.We also) Tj
T * (note that the provision regarding public) Tj
T * (presentations has been in place since) Tj
T * (the 1995 regulations and that the) Tj
T * (revision merely expands the potential) Tj
T * (venues in which the FCOI must be) Tj
T * (disclosed, which is intended to) Tj
T * (strengthen transparency and) Tj
0 Tw T * (accountability.) Tj / T1_2 1 Tf - 0.0045 Tw 0 - 1.644 TD(Other HHS Regulations That Apply\ (42) Tj
0 - 1.111 TD(CFR 50.607\)) Tj / T1_1 1 Tf
1 - 1.467 Td(As we proposed in the NPRM, we) Tj - 1 - 1.111 Td(have revised the list of other HHS) Tj
T * (regulations that apply, to update) Tj
T * (changes that have been made in the CFR) Tj
T * (location or title of the references in this) Tj
T * (section since 1995.In the NPRM, we) Tj
T * (asked
for comment on whether the) Tj
T * (regulations should be further revised to) Tj
T * (delete this section.Only one respondent) Tj
T * (suggested deleting this section; we have) Tj
T * (retained it as a useful point of reference.) Tj / T1_0 1 Tf
0 - 1.644 TD(IV.Institutional Conflict of Interest) Tj / T1_1 1 Tf
1 - 1.467 Td(Institutional conflict of interest is a) Tj - 1 - 1.111 Td(subject that is not specifically addressed) Tj
0 - 1.111 TD( in the 1995 regulations
for reasons) Tj
T * (stated in the 1995 final rule.) Tj
0 Tw 7.002 0 0 5.85 161.2913 193.828 Tm(37) Tj
9 0 0 9 171.5374 191.5001 Tm(Because) Tj - 0.0045 Tw - 14.06 - 1.111 Td(this is a topic of increasing interest to) Tj
T * (HHS as well as in the research) Tj
T * (community, we invited comment in the) Tj
T * (ANPRM on the possible revision of the) Tj
T * (regulations to address institutional) Tj
T * (conflict of interest.In particular, we) Tj
T * (asked\ (a\) How\221\221institutional conflict of) Tj
T * (interest\222\222 would be defined, and\ (b\) what) Tj
T * (an institutional conflict of interest) Tj
T * (policy would address in order to assure) Tj
T * (the PHS of objectivity in research.) Tj
0 Tw 7.002 0 0 5.85 185.3023 83.828 Tm(38) Tj
9 0 0 9 193.0884 81.5001 Tm() Tj - 0.0045 Tw 3.212 71.5 Td(Consistent with the public comments) Tj
0 - 1.1 TD(that we received on this topic, we) Tj
T * (
continue to believe that further careful) Tj
T * (consideration is necessary before PHS) Tj
T * (regulations could be formulated that) Tj
T * (would address the subject of) Tj
T * (institutional conflict of interest in the) Tj
T * (same comprehensive manner as the) Tj
T * (1995 regulations address Investigator) Tj
T * (FCOI.Because we believe it is important) Tj
T * (to revise the 1995 regulations in a) Tj
T * (timely manner, specific revisions that) Tj
T * (we proposed in the NPRM were limited) Tj
T * (to the subject of Investigator FCOI.) Tj
1 - 1.022 Td(In the NPRM, we asked
for public) Tj - 1 - 1.1 Td(comments on whether the regulations) Tj
T * (should be further revised to require) Tj
T * (Institutions, at a minimum, to adopt) Tj
T * (some type of policy on institutional) Tj
T * (conflict of interest, even
if the scope and) Tj
T * (elements of the policy remain undefined) Tj
T * ( in the regulations.We received a wide) Tj
T * (range of responses to this question, with) Tj
T * (some respondents stating that the) Tj
T * (regulations should include a basic) Tj
T * (provision requiring Institutions to have) Tj
0 - 1.111 TD(a policy on institutional conflict of) Tj
T * (interest without specifying the nature or) Tj
T * (scope of such a policy, and others) Tj
T * (suggesting that it would be premature to) Tj
T * (include such a provision in the) Tj
T * (regulations.Respondents in both groups) Tj
T * (urged HHS to engage the biomedical) Tj
T * (research community in discussions on) Tj
T * (the definition of institutional conflict of) Tj
T * (interest and how it should be addressed.) Tj
T * (One respondent suggested that the) Tj
T * (regulations should include a definition) Tj
T * (of institutional conflict of interest and) Tj
T * (specific provisions
for policies) Tj
T * (addressing the issue.) Tj
1 - 1.022 Td(We have considered all the comments) Tj - 1 - 1.111 Td(and believe that requiring Institutions to) Tj
T * (have a policy on institutional conflict of) Tj
T * (interest without providing additional) Tj
T * (guidance as to the nature and scope of) Tj
T * (that policy would lead to confusion and) Tj
T * (inconsistencies across Institutions.We) Tj
T * (also believe that substantial additional) Tj
T * (information and deliberations are) Tj
T * (needed to formulate such guidance.) Tj
T * (Therefore, we have limited the final rule) Tj
T * (to Investigator conflict of interest.HHS) Tj
T * (will
continue to consider the issue of) Tj
T * (institutional conflict of interest together) Tj
T * (with the biomedical research) Tj
T * (community, including the question of) Tj
T * (whether it is appropriate to propose) Tj
T * (specific regulations to address this) Tj
0 Tw T * (subject.) Tj / T1_0 1 Tf - 0.0045 Tw 0 - 1.644 TD(V.Regulatory Impact Analyses\ (RIA\)) Tj / T1_1 1 Tf
1 - 1.467 Td(The following is provided as public) Tj
0 Tw - 1 - 1.111 Td(information.) Tj / T1_2 1 Tf - 0.0045 Tw T * (Analysis of Impacts) Tj / T1_1 1 Tf
1 - 1.467 Td(We have examined the impacts of the) Tj - 1 - 1.111 Td(amendments to 42 CFR part 50 subpart) Tj
0 - 1.111 TD(F and 45 CFR part 94 under Executive) Tj
19.667 74.667 Td(Order 12866, Executive Order 13563, ) Tj
0 - 1.1 TD(the Regulatory Flexibility Act\ (5 U.S.C.) Tj
T * (601\226612\), and the Unfunded Mandates) Tj
T * (Reform Act of 1995\ (Pub.L.104\2264\).) Tj
T * (Executive Orders 13563 and 12866) Tj
T * (direct agencies to assess all costs and) Tj
T * (benefits of available regulatory) Tj
T * (alternatives and,
if regulation is) Tj
T * (necessary, to select regulatory) Tj
T * (approaches that maximize net benefits) Tj
T * (\ (including potential economic, ) Tj
T * (environmental, public health and safety) Tj
T * (effects, distributive impacts, and) Tj
T * (equity\).Executive Order 13563) Tj
T * (emphasizes the importance of) Tj
T * (quantifying both costs and benefits, of) Tj
T * (reducing costs, of harmonizing rules, ) Tj
T * (and of promoting flexibility.This rule) Tj
T * (has been designated a\221\221significant) Tj
T * (regulatory action\222\222 although not) Tj
T * (economically significant, under section) Tj
T * (3\ (f\) of Executive Order 12866.) Tj
T * (Accordingly, the rule has been reviewed) Tj
T * (by the Office of Management and) Tj
0 Tw T * (Budget.) Tj - 0.0045 Tw 1 - 1.022 Td(The Regulatory Flexibility Act) Tj - 1 - 1.1 Td(requires agencies to analyze regulatory) Tj
T * (options that would minimize any) Tj
T * (significant impact of the rule on small) Tj
T * (entities.For the purposes of this) Tj
T * (analysis, small entities include small) Tj
T * (business concerns as defined by the) Tj
T * (SBA, usually businesses with fewer) Tj
T * (than 500 employees.Approximately) Tj
T * (2, 800 such organizations) Tj
0 Tw 7.002 0 0 5.85 502.9258 391.4279 Tm(39) Tj - 0.0045 Tw 9 0 0 9 513.172 389.1 Tm(apply to NIH) Tj - 12.686 - 1.1 Td(
for research funding annually, of which) Tj
T * (approximately 1, 300 Institutions) Tj
0 Tw 7.002 0 0 5.85 535.4145 371.6279 Tm(40) Tj
9 0 0 9 545.6606 369.3 Tm(are) Tj - 0.0045 Tw - 16.296 - 1.1 Td(awarded funds.These regulations do) Tj
T * (not cover SBIR / STTR Program Phase I) Tj
T * (applications or awards.Therefore, the) Tj
T * (provisions of the regulations apply to) Tj
T * (the approximately 800 applicants to the) Tj
T * (SBIR / STTR Phase II program annually, ) Tj
T * (of which approximately 300 Institutions) Tj
T * (receive funding.There is no change to) Tj
T * (the 1995 regulations that pertain) Tj
T * (specifically to applicant organizations.) Tj
T * (Rather, all changes to the regulations) Tj
T * (apply only to the approximately 300) Tj
T * (small business concerns that receive) Tj
T * (Phase II SBIR / STTR PHS funding.The) Tj
T * (cost of implementing the amended) Tj
T * (regulations is an allowable cost that may) Tj
T * (be eligible
for reimbursement as a) Tj
T * (Facilities and Administrative cost on) Tj
T * (PHS - supported grants, cooperative) Tj
T * (agreements and contracts.This could) Tj
T * (offset the cost burdens of) Tj
T * (implementation.Therefore, we do not) Tj
T * (believe that the changes to the) Tj
T * (regulations will have a significant) Tj
T * (economic impact on a substantial) Tj
T * (number of small entities.Our analysis is) Tj
1 g / T1_3 1 Tf
0 Tw 6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(17: 26 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00024) - 1077(Fmt 4701) - 1077(Sfmt 4700) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

// peepdf comment: Javascript code located in object 155 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 536.42 750 Tm(53279) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
ET
q
1 0 0 1 45 57.1000061 cm
0.5 w 
0 0 m
50 0 l
S
Q
BT
/T1_1
1 Tf
0 Tw 5.446 0 0 4.55 52 50.2091 Tm(41) Tj - 0.0029 Tw 7 0 0 7 59.1954 48.4 Tm(Bureau of Labor Statistics inflation calculator.) Tj - 0.0045 Tw 9 0 0 9 45 725 Tm(further supported by the small number) Tj
0 - 1.111 TD(of FCOI reports submitted by small) Tj
T * (business concerns;
for example, ten) Tj
T * (reports by small business concerns were) Tj
T * (submitted to NIH in FY 2009 and eleven) Tj
T * ( in FY 2010.We also considered the) Tj
T * (impact of the requirement
for) Tj
T * (Investigator training on small entities) Tj
T * (and have lowered the frequency of) Tj
T * (training required from every two years) Tj
T * (as proposed in the NPRM to every four) Tj
T * (yours.We believe this expanded) Tj
T * (timeframe will decrease the burden on) Tj
T * (Institutions, including small businesses.) Tj
T * (In addition,
for the 1995 regulations, ) Tj
T * (NIH developed training materials that) Tj
T * (Institutions can use which are available) Tj
T * (on the NIH Web site at) Tj / T1_2 1 Tf
0 Tw(http: // )Tj
T * (grants.nih.gov / grants / policy / coi / ) Tj
T * (index.htm.) Tj / T1_1 1 Tf - 0.0045 Tw 5.255 0 Td(NIH will
continue to update) Tj - 5.255 - 1.111 Td(the training materials to ameliorate the) Tj
T * (burden on Institutions, including small) Tj
0 Tw T * (businesses.) Tj - 0.0045 Tw 1 - 1.167 Td(Section 202\ (a\) of the Unfunded) Tj - 1 - 1.111 Td(Mandates Reform Act of 1995 requires) Tj
T * (that agencies prepare a written) Tj
T * (statement, which includes an) Tj
T * (assessment of anticipated costs and) Tj
T * (benefits, before proposing\221\221any rule that) Tj
T * (includes any Federal mandate that may) Tj
T * (result in the expenditure by State, local, ) Tj
T * (and tribal governments, in the aggregate, ) Tj
T * (or by the private sector, of $100, 000, 000) Tj
T * (or more\ (adjusted annually
for inflation) Tj
T * (with base year of 1995\) in any one) Tj
T * (year.\222\222 The current inflation - adjusted) Tj
T * (statutory threshold is approximately) Tj
T * ($143.5 million.) Tj
0 Tw 7.002 0 0 5.85 107.9754 356.8283 Tm(41) Tj - 0.0045 Tw 9 0 0 9 118.2216 354.5004 Tm(The agency does not) Tj - 8.136 - 1.111 Td(expect that the amendments to the) Tj
T * (regulations will result in any 1 - year) Tj
T * (expenditure that would meet or exceed) Tj
T * (this amount.) Tj
0 Tw 0 - 1.667 TD(Benefits) Tj - 0.0045 Tw 1 - 1.611 Td(The amendments to the regulations) Tj - 1 - 1.111 Td(will expand and add transparency to) Tj
0 - 1.111 TD(Investigator disclosure of Significant) Tj
19.667 51.111 Td(Financial Interests as well as enhance) Tj
T * (regulatory compliance and effective) Tj
T * (oversight of financial conflicts of) Tj
T * (interest.Specifically, the revisions will) Tj
T * (provide Institutions with additional) Tj
T * (information on Investigator financial) Tj
T * (interests so they can make a more) Tj
T * (informed evaluation of whether the) Tj
T * (disclosed SFI constitutes an FCOI with) Tj
T * (PHS - funded research.Also, the) Tj
T * (revisions will provide HHS with) Tj
T * (additional information on an identified) Tj
T * (FCOI to enable improved oversight.) Tj
T * (Finally, the revised regulations will) Tj
T * (provide interested stakeholders such as) Tj
T * (Congress and the public with) Tj
T * (information about Investigator financial) Tj
T * (interests that were identified as an FCOI) Tj
T * (with research funded by PHS, enabling) Tj
T * (increased transparency and) Tj
T * (accountability, with the goal of) Tj
T * (preserving and strengthening public) Tj
T * (trust in the output of the Federal) Tj
T * (investment in biomedical research.) Tj
0 Tw 0 - 1.667 TD(Costs) Tj - 0.0045 Tw 1 - 1.667 Td(Approximately 3000 Institutions that) Tj - 1 - 1.111 Td(apply
for PHS funding annually are) Tj
0 - 1.111 TD(subject to the regulations.As there are) Tj
T * (no changes to the regulations in the) Tj
T * (requirements
for Institutions that are) Tj
T * (applying
for PHS - funding, the) Tj
T * (amendments will affect the) Tj
T * (approximately 2000 organizations) Tj
T * (\ (including small businesses but) Tj
T * (excluding those that receive funding) Tj
T * (through the SBIR / STTR Phase I) Tj
T * (program\) that are awarded PHS funding) Tj
T * (annually and, through the) Tj
T * (implementation of the regulations by) Tj
T * (the Institutions, to the estimated 38, 000) Tj
T * (Investigators\ (using the definition of) Tj
T * (Investigator in the regulations\)) Tj
T * (participating in PHS - funded research) Tj
T * (that have SFIs.Many of the revisions) Tj
T * (expand requirements that already) Tj
T * (existed in the regulations.For instance, ) Tj
19.667 51.111 Td(the number of Investigators who would) Tj
T * (be required to disclose their SFI is) Tj
T * (unchanged under the revised) Tj
T * (regulations as the definition of) Tj
T * (Investigator is not changed) Tj
T * (substantially.That said, however, ) Tj
T * (Investigators would be required to) Tj
T * (disclose a larger number of financial) Tj
T * (interests due to the revisions to the SFI) Tj
T * (definition\ () Tj / T1_2 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 7.268 0 Td(changing the de minimis) Tj - 7.268 - 1.111 Td(from $10, 000 to $5, 000, and including) Tj
T * (income from a subset of non - profit) Tj
T * (Institutions\).Also, Institutions are) Tj
T * (already required to report any identified) Tj
T * (FCOI to the PHS Awarding Component) Tj
T * (under the 1995 regulations.The revised) Tj
T * (regulations will require these reports to) Tj
T * (contain additional information.Several) Tj
T * (new requirements are included in the) Tj
T * (revised regulations, including the) Tj
T * (requirement
for making information) Tj
T * (available upon request and the) Tj
T * (requirement
for a retrospective review) Tj
T * ( in those rare cases in which an) Tj
T * (Institution identifies noncompliance) Tj
T * (with the regulations.We discuss the) Tj
T * (rationale
for each of these requirements) Tj
T * ( in the preamble.In sum, the estimated) Tj
T * (burden
for current implementation of) Tj
T * (the 1995 regulations is approximately) Tj
T * (80 % of the burden estimated
for) Tj
T * (implementing the revised regulations.) Tj
1 - 1.111 Td(The cost of implementing the) Tj - 1 - 1.111 Td(amended regulations is an allowable) Tj
T * (cost that may be eligible
for) Tj
T * (reimbursement as a Facilities and) Tj
T * (Administrative cost on PHS supported) Tj
T * (grants, cooperative agreements and) Tj
T * (contracts.This could offset some) Tj
T * (portion of the cost burdens of) Tj
T * (implementation
for the affected) Tj
T * (Institutions and through their) Tj
T * (implementation of the regulations, to) Tj
T * (the Investigators.Nonetheless, we are) Tj
T * (including a description of the estimated) Tj
T * (costs of the amendments to the) Tj
T * (regulations
for general information.) Tj / T1_3 1 Tf
0.055 Tw 8 0 0 8 48.08 246.2001 Tm(Section of 42 CFR) Tj - 0.333 - 1 Td(part 50 subpart F or) Tj
1 - 1 Td(45 CFR part 94) Tj
12.463 1 Td(Number of respondents) Tj
16.372 0.5 Td(Frequency of) Tj - 1.112 - 1 Td(response\ (annual\)) Tj
9.585 1 Td(Estimated cost per) Tj
0 Tw 1.623 - 1 Td(response) Tj
6.224 0 0 5.2 399.0835 236.3467 Tm(42) Tj
8 0 0 8 406.0043 234.2002 Tm() Tj
0.055 Tw 5.979 0.5 Td(Estimated annual cost) Tj
0 Tw 6.224 0 0 5.2 534.7428 240.3467 Tm(43) Tj
8 0 0 8 541.6636 238.2003 Tm() Tj
ET
q
1 0 0 1 45 256.8000031 cm
0.4 w
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 224.3999939 cm
0.4 w
0 0 m
522 0 l
S
Q
q
1 0 0 1 121.9400024 224.6000061 cm
0.3 w
0 0 m
0 32 l
S
Q
q
1 0 0 1 268.7400055 224.6000061 cm
0.3 w
0 0 m
0 32 l
S
Q
q
1 0 0 1 346.5399933 224.6000061 cm
0.3 w
0 0 m
0 32 l
S
Q
q
1 0 0 1 424.3399963 224.6000061 cm
0.3 w
0 0 m
0 32 l
S
Q
BT / T1_3 1 Tf
0.415 Tw 8 0 0 8 45.3 212.1001 Tm[(50.602) 360(or) 360(94.2) - 557(.......) - 1038(Total: approximately 3,
000 applicant)] TJ
0.06 Tw 11.1 - 1.125 Td(Institutions and 2, 000 awardee Insti - ) Tj
0.405 Tw 0 - 1.125 TD(tutions\ (based on FY 2008 num - ) Tj
0.26 Tw T * (bers\) and an estimated 38, 000 In - ) Tj
0 Tw T * (vestigators.) Tj
17.35 4.5 Td[(NA) - 347(.........................) - 1039(NA.)] TJ
ET
q
1 0 0 1 121.9400024 176.1000061 cm
0.3 w
0 0 m
0 48.5 l
S
Q
q
1 0 0 1 268.7400055 176.1000061 cm
0.3 w
0 0 m
0 48.5 l
S
Q
q
1 0 0 1 346.5399933 176.1000061 cm
0.3 w
0 0 m
0 48.5 l
S
Q
q
1 0 0 1 424.3399963 176.1000061 cm
0.3 w
0 0 m
0 48.5 l
S
Q
BT / T1_3 1 Tf
0.055 Tw 8 0 0 8 45.3 166.4001 Tm(50.604 or 94.4) Tj
ET
q
1 0 0 1 121.9400024 166.3999939 cm
0.3 w
0 0 m
0 9.7 l
S
Q
q
1 0 0 1 268.7400055 166.3999939 cm
0.3 w
0 0 m
0 9.7 l
S
Q
q
1 0 0 1 346.5399933 166.3999939 cm
0.3 w
0 0 m
0 9.7 l
S
Q
q
1 0 0 1 424.3399963 166.3999939 cm
0.3 w
0 0 m
0 9.7 l
S
Q
BT / T1_3 1 Tf
0 Tw 8 0 0 8 61.3 156.7 Tm[(\ (a\)) - 560(...................) - 1036(3, 000)] TJ
6.224 0 0 5.2 147.4357 158.8465 Tm(44) Tj
8 0 0 8 157.8165 156.7 Tm[(................................................) - 1042(1) - 345(............................) - 1040($2, 835) - 342(...................) - 1043($8, 505, 000.)] TJ
ET
q
1 0 0 1 121.9400024 156.6999969 cm
0.3 w
0 0 m
0 9.7 l
S
Q
q
1 0 0 1 268.7400055 156.6999969 cm
0.3 w
0 0 m
0 9.7 l
S
Q
q
1 0 0 1 346.5399933 156.6999969 cm
0.3 w
0 0 m
0 9.7 l
S
Q
q
1 0 0 1 424.3399963 156.6999969 cm
0.3 w
0 0 m
0 9.7 l
S
Q
BT / T1_3 1 Tf
0.055 Tw 8 0 0 8 61.3 147 Tm[(\ (b\)) - 560(...................) - 1036(Institutions: 2,
000)] TJ
0 Tw 6.224 0 0 5.2 190.563 149.1465 Tm(45) Tj
8 0 0 8 202.3038 147 Tm(............................) Tj
0.055 Tw - 9.525 - 1.125 Td(Investigators: 38,
000) Tj
0 Tw 6.224 0 0 5.2 202.1229 140.1465 Tm(46) Tj
8 0 0 8 213.4237 138 Tm(.......................) Tj
0.055 Tw 7.434 1.125 Td[(Institutions: 1) - 515(........)] TJ
0 Tw T * (Investigators) Tj
1 - 1.125 Td(0.25) Tj
6.224 0 0 5.2 297.7878 131.1465 Tm(47) Tj
8 0 0 8 304.7086 129 Tm(.) Tj
0.055 Tw 5.749 2.25 Td[(Institutions: $210) - 515(..)] TJ
0 Tw T * (Investigators: ) Tj
1 - 1.125 Td($17.5) Tj
6.224 0 0 5.2 380.0357 131.1465 Tm(48) Tj
8 0 0 8 386.9565 129 Tm(.) Tj
0.055 Tw - 4.532 - 1.125 Td(Total: $227.5.) Tj
9.725 3.375 Td(Institutions: $420,
000.) Tj
T * (Investigators: $665,
000.) Tj
T * (Total: $1,
085,
000.) Tj
ET
q
1 0 0 1 121.9400024 120 cm
0.3 w
0 0 m
0 36.7 l
S
Q
q
1 0 0 1 268.7400055 120 cm
0.3 w
0 0 m
0 36.7 l
S
Q
q
1 0 0 1 346.5399933 120 cm
0.3 w
0 0 m
0 36.7 l
S
Q
q
1 0 0 1 424.3399963 120 cm
0.3 w
0 0 m
0 36.7 l
S
Q
BT / T1_3 1 Tf
8 0 0 8 61.3 110.3 Tm[(\ (c\)\ (1\)) - 450(..............) - 1037(500)] TJ
0 Tw 6.224 0 0 5.2 140.7638 112.4465 Tm(49) Tj
8 0 0 8 151.1446 110.3 Tm[(...................................................) - 1042(1) - 345(............................) - 1040($35.00) - 342(...................) - 1043($17, 500.)] TJ
ET
q
1 0 0 1 121.9400024 110.3000031 cm
0.3 w
0 0 m
0 9.7 l
S
Q
q
1 0 0 1 268.7400055 110.3000031 cm
0.3 w
0 0 m
0 9.7 l
S
Q
q
1 0 0 1 346.5399933 110.3000031 cm
0.3 w
0 0 m
0 9.7 l
S
Q
q
1 0 0 1 424.3399963 110.3000031 cm
0.3 w
0 0 m
0 9.7 l
S
Q
BT / T1_3 1 Tf
0.715 Tw 8 0 0 8 61.3 100.6 Tm[(\ (c\)\ (2\)) - 505(...............) - 1037(Included in the cost estimate in )] TJ
0 Tw 9.1 - 1.125 Td(50.605 / 94.5\ (b\)\ (3\).) Tj
17.35 1.125 Td[(NA) - 347(.........................) - 1039(NA.)] TJ
ET
q
1 0 0 1 121.9400024 91.6000061 cm
0.3 w
0 0 m
0 18.7 l
S
Q
q
1 0 0 1 268.7400055 91.6000061 cm
0.3 w
0 0 m
0 18.7 l
S
Q
q
1 0 0 1 346.5399933 91.6000061 cm
0.3 w
0 0 m
0 18.7 l
S
Q
q
1 0 0 1 424.3399963 91.6000061 cm
0.3 w
0 0 m
0 18.7 l
S
Q
BT / T1_3 1 Tf
8 0 0 8 61.3 82 Tm[(\ (d\)) - 560(...................) - 1036(3, 000)] TJ
6.224 0 0 5.2 147.4357 84.1465 Tm(50) Tj
8 0 0 8 157.8165 82 Tm[(................................................) - 1042(1) - 345(............................) - 1040($35) - 342(........................) - 1043($105, 000.)] TJ
ET
q
1 0 0 1 121.9400024 82 cm
0.3 w
0 0 m
0 9.6 l
S
Q
q
1 0 0 1 268.7400055 82 cm
0.3 w
0 0 m
0 9.6 l
S
Q
q
1 0 0 1 346.5399933 82 cm
0.3 w
0 0 m
0 9.6 l
S
Q
q
1 0 0 1 424.3399963 82 cm
0.3 w
0 0 m
0 9.6 l
S
Q
BT / T1_3 1 Tf
8 0 0 8 61.3 72.4 Tm[(\ (e\)\ (1\)) - 450(...............) - 1036(38, 000)] TJ
6.224 0 0 5.2 151.8836 74.5465 Tm(51) Tj
8 0 0 8 162.2644 72.4 Tm[(..............................................) - 1042(1) - 342(............................) - 1043($140) - 345(......................) - 1040($5, 320, 000.)] TJ
ET
q
1 0 0 1 121.9400024 72.3999939 cm
0.3 w
0 0 m
0 9.6 l
S
Q
q
1 0 0 1 268.7400055 72.3999939 cm
0.3 w
0 0 m
0 9.6 l
S
Q
q
1 0 0 1 346.5399933 72.3999939 cm
0.3 w
0 0 m
0 9.6 l
S
Q
q
1 0 0 1 424.3399963 72.3999939 cm
0.3 w
0 0 m
0 9.6 l
S
Q
BT
1 g / T1_3 1 Tf
6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(18: 58 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00025) - 1077(Fmt 4701) - 1077(Sfmt 4700) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

// peepdf comment: Javascript code located in object 168 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 536.42 750 Tm(53281) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
/T1_2
1 Tf
0 Tw 6.224 0 0 5.2 53 728.1465 Tm(62) Tj
0.1825 Tw 8 0 0 8 61.2408 726 Tm[(After retrospective review\227the cost of which is accounted
for ina\ (3\\)\ (ii\) above\227we estimate that bias will be found in only a f) 1(raction of)] TJ
0 Tw - 2.03 - 1 Td(cases.) Tj
6.224 0 0 5.2 53 712.1465 Tm(63) Tj
0.055 Tw 8 0 0 8 61.2408 710 Tm(Assumes 950 FCOI reports annually) Tj / T1_3 1 Tf
0 Tw(\327) Tj / T1_2 1 Tf
0.055 Tw 17.524 0 Td(2 hours to prepare the report / complete an NIH - provided Web form.) Tj
0 Tw 6.224 0 0 5.2 53 704.1465 Tm(64) Tj
0.055 Tw 8 0 0 8 61.2408 702 Tm(Assumes it takes less time to update a report than to create a new one\227\1 hour per update.) Tj
0 Tw 6.224 0 0 5.2 53 696.1465 Tm(65) Tj
0.0975 Tw 8 0 0 8 61.2408 694 Tm(This estimate includes inquiries by the PHS Awarding Component as descri\bed in 50.606.\ (b\) and 94.6\ (b\) and in accordance with 50) Tj
0 Tw 60.1 0 Td(.604\ (k\)) Tj
0.055 Tw - 62.13 - 1 Td(and 94.4\ (k\).) Tj
0 Tw 6.224 0 0 5.2 53 680.1465 Tm(66) Tj
0.0725 Tw 8 0 0 8 61.2408 678 Tm[(This burden was originally estimated in the 1995 Final Rule to be no mor\e than 5 instances that the failure of an Investigator) 1(to comply with)] TJ
0.15 Tw - 2.03 - 1 Td[(the Institution\222s conflict of interest policy has biased the design, \conduct or reporting of the research.\221\221Objectivity in Res) 1(earch, Final Rule\222\222 60)] TJ
0.0625 Tw 0 - 1 TD[(Fed.Reg.132\ (July 11, 1995\) pps.35810\22635819.This burden estimat\e, and others was increased in 2002\221\221due to increased numbe) 1(rs of Institu - )] TJ
0.105 Tw T * [(tions and Investigators.\222\222 Although there has been an increase in \the number of cases of noncompliance in the past few years, t) 1(he number has)] TJ
0.055 Tw T * (not approached this estimate so we believe it is still reasonable.) Tj
0 Tw 6.224 0 0 5.2 53 640.1466 Tm(67) Tj
0.08 Tw 8 0 0 8 61.2408 638.0001 Tm[(Based on 50.605 / 94.5\ (a\)\ (3\)\ (i\)\227of those only a fraction will rel\ate to a project of clinical research whose purpose is to evalua) 1(te the safety or)] TJ
0.055 Tw - 2.03 - 1 Td(effectiveness of a drug, medical device, or treatment, but we are calcul\ating the maximum estimated cost.) Tj
0 Tw 6.224 0 0 5.2 53 624.1466 Tm(68) Tj
0.055 Tw 8 0 0 8 61.2408 622.0001 Tm(Assuming an average of 3 publications annually.) Tj / T1_1 1 Tf
0 Tw 9 0 0 9 45 595 Tm(Alternatives) Tj - 0.0045 Tw 1 - 1.911 Td(The key alternative to the amendment) Tj - 1 - 1.156 Td(of these regulations would be to) Tj
0 - 1.156 TD(
continue to operate under the 1995) Tj
T * (regulations.In the intervening years) Tj
T * (since the regulations were promulgated, ) Tj
T * (Investigator collaborations have become) Tj
T * (more complex and public scrutiny has) Tj
T * (increased significantly creating an) Tj
T * (environment that would benefit from) Tj
T * (regulation with more effective means
for) Tj
0 - 1.144 TD(management and oversight.If we) Tj
T * (
continue to operate under the 1995) Tj
T * (regulations, we would then lose the) Tj
T * (opportunity to implement enhanced) Tj
T * (Institutional management of Investigator) Tj
T * (FCOIs related to PHS - funded research, ) Tj
T * (increased oversight by the PHS) Tj
T * (Awarding Component, and enhanced) Tj
T * (transparency.In addition, Congress has) Tj
T * (expressly directed and supported the) Tj
T * (ongoing regulation of FCOI\ (42 U.S.C.) Tj
T * (216, 289b\2261, 299c\2264; Sec.219, Tit.II, ) Tj
T * (Div.D, Pub.L.111\226117, 123 Stat.3034\), ) Tj
T * (and we agree that strengthening such) Tj
T * (regulation is necessary to enhance) Tj
19.667 29.478 Td(public trust and ensure the responsible) Tj
0 - 1.1 TD(stewardship of Federal funds.) Tj / T1_4 1 Tf
0 - 1.644 TD(Paperwork Reduction Act) Tj / T1_1 1 Tf
1 - 1.467 Td(This final rule contains requirements) Tj - 1 - 1.1 Td(that are subject to OMB approval under) Tj
0 - 1.1 TD(the Paperwork Reduction Act of 1995, ) Tj
T * (as amended\ (44 U.S.C.chapter 35\).) Tj
T * (Sections 50.604\ (a\), 50.604\ (b\), ) Tj
T * (50.604\ (c\)\ (1\), 50.604\ (d\), 50.604\ (e\)\ (1\), ) Tj
T * (50.604\ (e\)\ (2\), 50.604\ (e\)\ (3\), 50.604\ (f\), ) Tj
T * (50.605\ (a\)\ (1\), 50.605\ (a\)\ (3\), ) Tj
T * (50.605\ (a\)\ (3\)\ (i\), 50.605\ (a\)\ (3\)\ (ii\), ) Tj
T * (50.605\ (a\)\ (4\), 50.605\ (a\)\ (5\), 50.605\ (b\)\ (1\), ) Tj
T * (50.605\ (b\)\ (2\), 50.605\ (b\)\ (3\), 50.605\ (b\)\ (4\), ) Tj
T * (50.606\ (a\), 50.606\ (c\); 94.4\ (a\), 94.4\ (b\), ) Tj
T * (94.4\ (c\)\ (1\), 94.4\ (d\), 94.4\ (e\)\ (1\), 94.4\ (e\)\ (2\), ) Tj
T * (94.4\ (e\)\ (3\), 94.4\ (f\), 94.5\ (a\)\ (1\), 94.5\ (a\)\ (3\), ) Tj
T * (94.5\ (a\)\ (3\)\ (i\), 94.5\ (a\)\ (3\)\ (ii\), 94.5\ (a\)\ (4\), ) Tj
T * (94.5\ (a\)\ (5\), 94.5\ (b\)\ (1\), 94.5\ (b\)\ (2\), ) Tj
T * (94.5\ (b\)\ (3\), 94.5\ (b\)\ (4\), 94.6\ (a\), and 94.6\ (c\)) Tj
T * (contain reporting and information) Tj
T * (collection requirements that are subject) Tj
0 - 1.111 TD(to OMB approval under the Paperwork) Tj
T * (Reduction Act.) Tj
1 - 1.022 Td(42 CFR 50.604\ (i\), and 45 CFR 94.4\ (i\)) Tj - 1 - 1.111 Td(contain recordkeeping requirements that) Tj
T * (are subject to OMB review under the) Tj
19.667 29.478 Td(Paperwork Reduction Act.The title, ) Tj
0 - 1.122 TD(description, and respondent description) Tj
T * (of the information collection and) Tj
T * (recordkeeping requirements contained) Tj
T * ( in this revised rule have been submitted) Tj
T * (to OMB
for review.Other organizations) Tj
T * (and individuals desiring to submit) Tj
T * (comments on the information collection) Tj
T * (and recordkeeping requirements should) Tj
T * (send their comments to: \ (1\) Mikia) Tj
T * (Currie, Project Clearance Officer, ) Tj
T * (National Institutes of Health, Rockledge) Tj
T * (Center 1, 6705 Rockledge Drive, Room) Tj
T * (3509, Bethesda, MD 20817, telephone) Tj
T * (301\226594\2267949\ (not a toll - free number\);) Tj
T * (and\ (2\) the Office of Information and) Tj
T * (Regulatory Affairs, OMB, ) Tj / T1_4 1 Tf
0 Tw T * (OIRA) Tj / T1_3 1 Tf(_) Tj / T1_4 1 Tf(submission@omb.eop) Tj / T1_1 1 Tf - 0.0045 Tw 13.188 0 Td(or by fax to) Tj - 13.188 - 1.122 Td(202\226395\2266974, and mark\221\221Attention: ) Tj
T * (Desk Officer
for the National Institutes) Tj
T * (of Health, Department of Health and) Tj
T * (Human Services.\222\222 After we obtain OMB) Tj
0 - 1.111 TD(approval, we will publish the OMB) Tj
T * (control number in the) Tj / T1_0 1 Tf(Federal Register.) Tj / T1_1 1 Tf
1 - 1.467 Td(Following are details of the estimated) Tj - 1 - 1.111 Td(burden of implementing the revised) Tj
0 Tw T * (regulations.) Tj / T1_2 1 Tf
0.055 Tw 8 0 0 8 48.08 310.9001 Tm(Section of 42 CFR) Tj - 0.333 - 1 Td(part 50 subpart F or) Tj
1 - 1 Td(45 CFR part 94) Tj
12.463 1 Td(Number of respondents) Tj
16.372 0.5 Td(Frequency of) Tj - 1.112 - 1 Td(response\ (annual\)) Tj
10.198 1 Td(Average burden) Tj
0 Tw 2.333 - 1 Td(hours) Tj
0.055 Tw 10.078 0.5 Td(Annual burden hours) Tj
0 Tw 6.224 0 0 5.2 532.5228 305.0465 Tm(69) Tj
8 0 0 8 539.4437 302.9 Tm() Tj
ET
q
1 0 0 1 45 321.5 cm
0.4 w
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 289.1000061 cm
0.4 w
0 0 m
522 0 l
S
Q
q
1 0 0 1 121.9400024 289.3000031 cm
0.3 w
0 0 m
0 32 l
S
Q
q
1 0 0 1 268.7400055 289.3000031 cm
0.3 w
0 0 m
0 32 l
S
Q
q
1 0 0 1 346.5399933 289.3000031 cm
0.3 w
0 0 m
0 32 l
S
Q
q
1 0 0 1 424.3399963 289.3000031 cm
0.3 w
0 0 m
0 32 l
S
Q
BT / T1_2 1 Tf
0.415 Tw 8 0 0 8 45.3 276.9 Tm[(50.602) 360(or) 360(94.2) - 557(.......) - 1038(Total: approximately 3,
000 applicant)] TJ
0.06 Tw 11.1 - 1.125 Td(Institutions and 2, 000 awardee Insti - ) Tj
0.09 Tw 0 - 1.125 TD(tutions\ (based on FY2008 numbers\)) Tj
0.17 Tw T * (and an estimated 38, 000 Investiga - ) Tj
0 Tw T * (tors.) Tj
17.35 4.5 Td[(NA) - 345(.........................) - 1041(NA.)] TJ
ET
q
1 0 0 1 121.9400024 240.8999939 cm
0.3 w
0 0 m
0 48.4 l
S
Q
q
1 0 0 1 268.7400055 240.8999939 cm
0.3 w
0 0 m
0 48.4 l
S
Q
q
1 0 0 1 346.5399933 240.8999939 cm
0.3 w
0 0 m
0 48.4 l
S
Q
q
1 0 0 1 424.3399963 240.8999939 cm
0.3 w
0 0 m
0 48.4 l
S
Q
BT / T1_2 1 Tf
0.055 Tw 8 0 0 8 45.3 231.3 Tm(50.604 or 94.4) Tj
ET
q
1 0 0 1 121.9400024 231.3000031 cm
0.3 w
0 0 m
0 9.6 l
S
Q
q
1 0 0 1 268.7400055 231.3000031 cm
0.3 w
0 0 m
0 9.6 l
S
Q
q
1 0 0 1 346.5399933 231.3000031 cm
0.3 w
0 0 m
0 9.6 l
S
Q
q
1 0 0 1 424.3399963 231.3000031 cm
0.3 w
0 0 m
0 9.6 l
S
Q
BT / T1_2 1 Tf
0 Tw 8 0 0 8 61.3 221.7 Tm[(\ (a\)) - 560(...................) - 1036(3, 000)] TJ
6.224 0 0 5.2 147.4357 223.8465 Tm(70) Tj
8 0 0 8 157.8165 221.7 Tm[(................................................) - 1042(1) - 345(............................) - 1040(81)] TJ
6.224 0 0 5.2 360.9158 223.8465 Tm(71) Tj
8 0 0 8 371.2366 221.7 Tm[(......................) - 1042(243, 000.)] TJ
ET
q
1 0 0 1 121.9400024 221.6999969 cm
0.3 w
0 0 m
0 9.6 l
S
Q
q
1 0 0 1 268.7400055 221.6999969 cm
0.3 w
0 0 m
0 9.6 l
S
Q
q
1 0 0 1 346.5399933 221.6999969 cm
0.3 w
0 0 m
0 9.6 l
S
Q
q
1 0 0 1 424.3399963 221.6999969 cm
0.3 w
0 0 m
0 9.6 l
S
Q
BT / T1_2 1 Tf
0.055 Tw 8 0 0 8 61.3 212.1 Tm[(\ (b\)) - 560(...................) - 1036(Institutions: 2,
000)] TJ
0 Tw 6.224 0 0 5.2 190.563 214.2465 Tm(72) Tj
8 0 0 8 202.3038 212.1 Tm(............................) Tj
0.055 Tw - 9.525 - 1.125 Td(Investigators: 38,
000) Tj
0 Tw 6.224 0 0 5.2 202.1229 205.2465 Tm(73) Tj
8 0 0 8 213.4237 203.1 Tm(.......................) Tj
0.055 Tw 7.434 1.125 Td[(Institutions: 1) - 515(........)] TJ
0 Tw T * (Investigators) Tj
1 - 1.125 Td(0.25) Tj
6.224 0 0 5.2 297.7878 196.2465 Tm(74) Tj
8 0 0 8 304.7086 194.1 Tm(.) Tj
0.055 Tw 5.749 2.25 Td[(Institutions: 6) - 515(........)] TJ
0 Tw T * (Investigators: ) Tj
1 - 1.125 Td(0.5) Tj
6.224 0 0 5.2 371.1398 196.2465 Tm(75) Tj
8 0 0 8 378.0606 194.1 Tm(.) Tj
0.055 Tw 6.305 2.25 Td(Institutions: 12,
000.) Tj
T * (Investigators: 19,
000.) Tj
T * (Total: 31,
000.) Tj
ET
q
1 0 0 1 121.9400024 194.1000061 cm
0.3 w
0 0 m
0 27.6 l
S
Q
q
1 0 0 1 268.7400055 194.1000061 cm
0.3 w
0 0 m
0 27.6 l
S
Q
q
1 0 0 1 346.5399933 194.1000061 cm
0.3 w
0 0 m
0 27.6 l
S
Q
q
1 0 0 1 424.3399963 194.1000061 cm
0.3 w
0 0 m
0 27.6 l
S
Q
BT / T1_2 1 Tf
8 0 0 8 61.3 184.5 Tm[(\ (c\)\ (1\)) - 450(..............) - 1037(500)] TJ
0 Tw 6.224 0 0 5.2 140.7638 186.6465 Tm(76) Tj
8 0 0 8 151.1446 184.5 Tm[(...................................................) - 1042(1) - 345(............................) - 1040(1) - 342(............................) - 1043(500.)] TJ
ET
q
1 0 0 1 121.9400024 184.5 cm
0.3 w
0 0 m
0 9.6 l
S
Q
q
1 0 0 1 268.7400055 184.5 cm
0.3 w
0 0 m
0 9.6 l
S
Q
q
1 0 0 1 346.5399933 184.5 cm
0.3 w
0 0 m
0 9.6 l
S
Q
q
1 0 0 1 424.3399963 184.5 cm
0.3 w
0 0 m
0 9.6 l
S
Q
BT / T1_2 1 Tf
0.46 Tw 8 0 0 8 61.3 174.9 Tm[(\ (c\)\ (2\)) - 505(...............) - 1037(Included in the burden estimate in )] TJ
0.055 Tw 9.1 - 1.125 Td(50.605 / 94.5\ (b\)\ (3\).) Tj
0 Tw 17.35 1.125 Td[(NA) - 347(.........................) - 1039(NA) - 345(.........................) - 1041(NA.)] TJ
ET
q
1 0 0 1 121.9400024 165.8999939 cm
0.3 w
0 0 m
0 18.6 l
S
Q
q
1 0 0 1 268.7400055 165.8999939 cm
0.3 w
0 0 m
0 18.6 l
S
Q
q
1 0 0 1 346.5399933 165.8999939 cm
0.3 w
0 0 m
0 18.6 l
S
Q
q
1 0 0 1 424.3399963 165.8999939 cm
0.3 w
0 0 m
0 18.6 l
S
Q
BT / T1_2 1 Tf
8 0 0 8 61.3 156.4 Tm[(\ (d\)) - 560(...................) - 1036(3, 000)] TJ
6.224 0 0 5.2 147.4357 158.5465 Tm(77) Tj
8 0 0 8 157.8165 156.4 Tm[(................................................) - 1042(1) - 345(............................) - 1040(1) - 342(............................) - 1043(3, 000.)] TJ
ET
q
1 0 0 1 121.9400024 156.3999939 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 268.7400055 156.3999939 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 346.5399933 156.3999939 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 424.3399963 156.3999939 cm
0.3 w
0 0 m
0 9.5 l
S
Q
BT / T1_2 1 Tf
8 0 0 8 61.3 146.9001 Tm[(\ (e\)\ (1\)) - 450(...............) - 1036(38, 000)] TJ
6.224 0 0 5.2 151.8836 149.0465 Tm(78) Tj
8 0 0 8 162.2644 146.9001 Tm[(..............................................) - 1042(1) - 342(............................) - 1043(4) - 345(............................) - 1040(152, 000.)] TJ
ET
q
1 0 0 1 121.9400024 146.8999939 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 268.7400055 146.8999939 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 346.5399933 146.8999939 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 424.3399963 146.8999939 cm
0.3 w
0 0 m
0 9.5 l
S
Q
BT / T1_2 1 Tf
8 0 0 8 61.3 137.4 Tm[(\ (e\)\ (2\)) - 450(...............) - 1036(38, 000)] TJ
6.224 0 0 5.2 151.8836 139.5465 Tm(79) Tj
8 0 0 8 162.2644 137.4 Tm[(..............................................) - 1042(1) - 342(............................) - 1043(1) - 345(............................) - 1040(38, 000.)] TJ
ET
q
1 0 0 1 121.9400024 137.3999939 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 268.7400055 137.3999939 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 346.5399933 137.3999939 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 424.3399963 137.3999939 cm
0.3 w
0 0 m
0 9.5 l
S
Q
BT / T1_2 1 Tf
8 0 0 8 61.3 127.9 Tm[(\ (e\)\ (3\)) - 450(...............) - 1036(950)] TJ
6.224 0 0 5.2 140.7638 130.0464 Tm(80) Tj
8 0 0 8 151.1446 127.9 Tm[(...................................................) - 1042(1) - 342(............................) - 1043(0.5) - 345(.........................) - 1040(475.)] TJ
ET
q
1 0 0 1 121.9400024 127.8999939 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 268.7400055 127.8999939 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 346.5399933 127.8999939 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 424.3399963 127.8999939 cm
0.3 w
0 0 m
0 9.5 l
S
Q
BT / T1_2 1 Tf
0.055 Tw 8 0 0 8 61.3 118.3999 Tm[(\ (f\)) - 560(....................) - 1036(2, 000 awardee Institutions) - 525(..................) - 1038(1) - 342(............................) - 1043(1) - 345(............................) - 1040(2, )] TJ
0 Tw 46.734 0 Td(000.) Tj
ET
q
1 0 0 1 121.9400024 118.3999939 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 268.7400055 118.3999939 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 346.5399933 118.3999939 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 424.3399963 118.3999939 cm
0.3 w
0 0 m
0 9.5 l
S
Q
BT / T1_2 1 Tf
0.46 Tw 8 0 0 8 61.3 108.8999 Tm[(\ (g\)) - 560(...................) - 1036(Included in the burden estimate in )] TJ
0.055 Tw 9.1 - 1.125 Td(50.605 / 94.5\ (a\)\ (1\).) Tj
0 Tw 17.35 1.125 Td[(NA) - 345(.........................) - 1041(NA) - 347(.........................) - 1039(NA.)] TJ
ET
q
1 0 0 1 121.9400024 99.8999939 cm
0.3 w
0 0 m
0 18.5 l
S
Q
q
1 0 0 1 268.7400055 99.8999939 cm
0.3 w
0 0 m
0 18.5 l
S
Q
q
1 0 0 1 346.5399933 99.8999939 cm
0.3 w
0 0 m
0 18.5 l
S
Q
q
1 0 0 1 424.3399963 99.8999939 cm
0.3 w
0 0 m
0 18.5 l
S
Q
BT / T1_2 1 Tf
0.46 Tw 8 0 0 8 61.3 90.3999 Tm[(\ (h\)) - 560(...................) - 1036(Included in the burden estimate in )] TJ
0.055 Tw 9.1 - 1.125 Td(50.605 / 94.5\ (b\)\ (3\).) Tj
0 Tw 17.35 1.125 Td[(NA) - 345(.........................) - 1041(NA) - 347(.........................) - 1039(NA.)] TJ
ET
q
1 0 0 1 121.9400024 81.3999939 cm
0.3 w
0 0 m
0 18.5 l
S
Q
q
1 0 0 1 268.7400055 81.3999939 cm
0.3 w
0 0 m
0 18.5 l
S
Q
q
1 0 0 1 346.5399933 81.3999939 cm
0.3 w
0 0 m
0 18.5 l
S
Q
q
1 0 0 1 424.3399963 81.3999939 cm
0.3 w
0 0 m
0 18.5 l
S
Q
BT / T1_2 1 Tf
0.055 Tw 8 0 0 8 61.3 71.8999 Tm[(\ (i\)) - 335(.....................) - 1039(2, 000 awardee Institutions) - 525(..................) - 1038(1) - 345(............................) - 1040(4) - 342(............................) - 1043(8)] TJ
0 Tw 46.456 0 Td(, 000.) Tj
ET
q
1 0 0 1 121.9400024 71.8999939 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 268.7400055 71.8999939 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 346.5399933 71.8999939 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 424.3399963 71.8999939 cm
0.3 w
0 0 m
0 9.5 l
S
Q
BT / T1_2 1 Tf
0.46 Tw 8 0 0 8 61.3 62.3999 Tm[(\ (j\)) - 335(.....................) - 1039(Included in the burden estimate in )] TJ
0.055 Tw 9.1 - 1.125 Td(50.604 / 94.4\ (a\).) Tj
0 Tw 17.35 1.125 Td[(NA) - 347(.........................) - 1039(NA) - 345(.........................) - 1041(NA.)] TJ
ET
q
1 0 0 1 121.9400024 53.3999939 cm
0.3 w
0 0 m
0 18.5 l
S
Q
q
1 0 0 1 268.7400055 53.3999939 cm
0.3 w
0 0 m
0 18.5 l
S
Q
q
1 0 0 1 346.5399933 53.3999939 cm
0.3 w
0 0 m
0 18.5 l
S
Q
q
1 0 0 1 424.3399963 53.3999939 cm
0.3 w
0 0 m
0 18.5 l
S
Q
BT
1 g / T1_2 1 Tf
6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(18: 55 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00027) - 1077(Fmt 4701) - 1077(Sfmt 4700) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

// peepdf comment: Javascript code located in object 174 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 45 750 Tm(53282) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
/T1_2
1 Tf
0.055 Tw 8 0 0 8 48.08 723.2 Tm(Section of 42 CFR) Tj - 0.333 - 1 Td(part 50 subpart F or) Tj
1 - 1 Td(45 CFR part 94) Tj
12.463 1 Td(Number of respondents) Tj
16.372 0.5 Td(Frequency of) Tj - 1.112 - 1 Td(response\ (annual\)) Tj
10.198 1 Td(Average burden) Tj
0 Tw 2.333 - 1 Td(hours) Tj
0.055 Tw 10.078 0.5 Td(Annual burden hours) Tj
0 Tw 6.224 0 0 5.2 532.5228 717.3464 Tm(69) Tj
8 0 0 8 539.4437 715.2 Tm() Tj
ET
q
1 0 0 1 45 733.8000031 cm
0.4 w
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 701.3999939 cm
0.4 w
0 0 m
522 0 l
S
Q
q
1 0 0 1 121.9400024 701.6000061 cm
0.3 w
0 0 m
0 32 l
S
Q
q
1 0 0 1 268.7400055 701.6000061 cm
0.3 w
0 0 m
0 32 l
S
Q
q
1 0 0 1 346.5399933 701.6000061 cm
0.3 w
0 0 m
0 32 l
S
Q
q
1 0 0 1 424.3399963 701.6000061 cm
0.3 w
0 0 m
0 32 l
S
Q
BT / T1_2 1 Tf
0.46 Tw 8 0 0 8 61.3 689.8 Tm[(\ (k\)) - 335(....................) - 1039(Included in the burden estimate in )] TJ
0.055 Tw 9.1 - 1.125 Td(50.604 / 94.4\ (a\).) Tj
0 Tw 17.35 1.125 Td[(NA) - 345(.........................) - 1041(NA) - 347(.........................) - 1039(NA.)] TJ
ET
q
1 0 0 1 121.9400024 680.8000031 cm
0.3 w
0 0 m
0 20.8 l
S
Q
q
1 0 0 1 268.7400055 680.8000031 cm
0.3 w
0 0 m
0 20.8 l
S
Q
q
1 0 0 1 346.5399933 680.8000031 cm
0.3 w
0 0 m
0 20.8 l
S
Q
q
1 0 0 1 424.3399963 680.8000031 cm
0.3 w
0 0 m
0 20.8 l
S
Q
BT / T1_2 1 Tf
0.055 Tw 8 0 0 8 45.3 671.2001 Tm(50.605 or 94.5) Tj
ET
q
1 0 0 1 121.9400024 671.1999969 cm
0.3 w
0 0 m
0 9.6 l
S
Q
q
1 0 0 1 268.7400055 671.1999969 cm
0.3 w
0 0 m
0 9.6 l
S
Q
q
1 0 0 1 346.5399933 671.1999969 cm
0.3 w
0 0 m
0 9.6 l
S
Q
q
1 0 0 1 424.3399963 671.1999969 cm
0.3 w
0 0 m
0 9.6 l
S
Q
BT / T1_2 1 Tf
8 0 0 8 61.3 661.7001 Tm[(\ (a\)\ (1\)) - 450(...............) - 1036(2, 000 awardee Institutions)] TJ
0 Tw 6.224 0 0 5.2 221.6826 663.8466 Tm(81) Tj
0.055 Tw 8 0 0 8 233.4434 661.7001 Tm[(..............) - 1040(1) - 342(............................) - 1043(2 hours per disclo - )] TJ
15.657 - 1.125 Td(sure to review) Tj
0 - 1.125 TD(plus 80 hours) Tj
T * (per identified) Tj
T * (FCOI to develop) Tj
0 Tw T * (management) Tj
T * (plan.) Tj
0.1875 Tw 8.725 6.75 Td(76, 000
for reviewing disclosures from) Tj
0.1025 Tw 1 - 1.125 Td(38, 000 Investigators plus 76, 000
for) Tj
0.415 Tw T * (developing management plans
for) Tj
0.055 Tw T * (950 identified FCOIs = 152, 000.) Tj
ET
q
1 0 0 1 121.9400024 607.6999969 cm
0.3 w
0 0 m
0 63.5 l
S
Q
q
1 0 0 1 268.7400055 607.6999969 cm
0.3 w
0 0 m
0 63.5 l
S
Q
q
1 0 0 1 346.5399933 607.6999969 cm
0.3 w
0 0 m
0 63.5 l
S
Q
q
1 0 0 1 424.3399963 607.6999969 cm
0.3 w
0 0 m
0 63.5 l
S
Q
BT / T1_2 1 Tf
0 Tw 8 0 0 8 61.3 598.2002 Tm[(\ (a\)\ (2\)) - 450(...............) - 1036(950)] TJ
6.224 0 0 5.2 140.7638 600.3467 Tm(82) Tj
8 0 0 8 151.1446 598.2002 Tm(...................................................) Tj
0.115 Tw - 3.131 - 1.125 Td(The burden is included in 50.605 / 94.5) Tj
0.055 Tw 1 - 1.125 Td(\ (b\)\ (2\) below.) Tj
0 Tw 17.35 2.25 Td[(NA) - 347(.........................) - 1039(NA) - 345(.........................) - 1041(NA.)] TJ
ET
q
1 0 0 1 121.9400024 580.1999969 cm
0.3 w
0 0 m
0 27.5 l
S
Q
q
1 0 0 1 268.7400055 580.1999969 cm
0.3 w
0 0 m
0 27.5 l
S
Q
q
1 0 0 1 346.5399933 580.1999969 cm
0.3 w
0 0 m
0 27.5 l
S
Q
q
1 0 0 1 424.3399963 580.1999969 cm
0.3 w
0 0 m
0 27.5 l
S
Q
BT / T1_2 1 Tf
8 0 0 8 61.3 570.7002 Tm[(\ (a\)\ (3\)) - 450(...............) - 1036(500)] TJ
6.224 0 0 5.2 140.7638 572.8467 Tm(83) Tj
8 0 0 8 151.1446 570.7002 Tm[(...................................................) - 1042(1) - 342(............................) - 1043(3) - 345(............................) - 1040(1, 500.)] TJ
ET
q
1 0 0 1 121.9400024 570.6999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 268.7400055 570.6999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 346.5399933 570.6999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 424.3399963 570.6999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
BT / T1_2 1 Tf
8 0 0 8 61.3 561.2002 Tm[(\ (a\)\ (3\)\ (i\)) - 395(............) - 1037(50)] TJ
6.224 0 0 5.2 136.3158 563.3467 Tm(84) Tj
8 0 0 8 146.6767 561.2002 Tm[(.....................................................) - 1044(1) - 345(............................) - 1040(80) - 345(..........................) - 1040(4, 000.)] TJ
ET
q
1 0 0 1 121.9400024 561.1999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 268.7400055 561.1999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 346.5399933 561.1999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 424.3399963 561.1999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
BT / T1_2 1 Tf
8 0 0 8 61.3 551.7002 Tm[(\ (a\)\ (3\)\ (ii\)) - 450(...........) - 1038(50)] TJ
6.224 0 0 5.2 136.3158 553.8467 Tm(85) Tj
8 0 0 8 146.6767 551.7002 Tm[(.....................................................) - 1044(1) - 345(............................) - 1040(80) - 345(..........................) - 1040(4, 000.)] TJ
ET
q
1 0 0 1 121.9400024 551.6999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 268.7400055 551.6999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 346.5399933 551.6999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 424.3399963 551.6999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
BT / T1_2 1 Tf
8 0 0 8 61.3 542.2002 Tm[(\ (a\)\ (3\)\ (iii\)) - 507(..........) - 1037(50) - 350(.........................................................) - 1042(1) - 345(............................) - 1040(1) - 342(.................) 1(...........) - 1043(50.)] TJ
ET
q
1 0 0 1 121.9400024 542.1999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 268.7400055 542.1999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 346.5399933 542.1999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 424.3399963 542.1999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
BT / T1_2 1 Tf
8 0 0 8 61.3 532.7003 Tm[(\ (a\)\ (4\)) - 450(...............) - 1036(950)] TJ
6.224 0 0 5.2 140.7638 534.8467 Tm(86) Tj
8 0 0 8 151.1446 532.7003 Tm[(...................................................) - 1042(1) - 342(............................) - 1043(12) - 347(..........................) - 1038(11, 400.)] TJ
ET
q
1 0 0 1 121.9400024 532.6999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 268.7400055 532.6999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 346.5399933 532.6999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 424.3399963 532.6999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
BT / T1_2 1 Tf
8 0 0 8 61.3 523.2003 Tm[(\ (a\)\ (5\)) - 450(...............) - 1036(2, 000)] TJ
6.224 0 0 5.2 147.4357 525.3467 Tm(87) Tj
8 0 0 8 157.8165 523.2003 Tm[(................................................) - 1042(1) - 345(............................) - 1040(5) - 342(............................) - 1043(10, 000.)] TJ
ET
q
1 0 0 1 121.9400024 523.1999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 268.7400055 523.1999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 346.5399933 523.1999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 424.3399963 523.1999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
BT / T1_2 1 Tf
0.5825 Tw 8 0 0 8 61.3 513.7003 Tm[(\ (b\)\ (1\)) - 450(...............) - 1036(Included in 50.605\ (b\)\ (3\) / 94.5\ (b\)\ (3\))] TJ
0 Tw 9.1 - 1.125 Td(below.) Tj
17.35 1.125 Td[(NA) - 347(.........................) - 1039(NA) - 345(.........................) - 1041(NA.)] TJ
ET
q
1 0 0 1 121.9400024 504.6999969 cm
0.3 w
0 0 m
0 18.5 l
S
Q
q
1 0 0 1 268.7400055 504.6999969 cm
0.3 w
0 0 m
0 18.5 l
S
Q
q
1 0 0 1 346.5399933 504.6999969 cm
0.3 w
0 0 m
0 18.5 l
S
Q
q
1 0 0 1 424.3399963 504.6999969 cm
0.3 w
0 0 m
0 18.5 l
S
Q
BT / T1_2 1 Tf
0.055 Tw 8 0 0 8 61.3 495.2003 Tm[(\ (b\)\ (2\)) - 450(...............) - 1036(50 FCOI reports as in a\ (3\)\ (ii\) above)] TJ
0 Tw 6.224 0 0 5.2 255.8741 497.3467 Tm(88) Tj
8 0 0 8 262.7949 495.2003 Tm() Tj
0.055 Tw - 17.087 - 1.125 Td(5 mitigation reports) Tj
0 Tw 6.224 0 0 5.2 196.3229 488.3467 Tm(89) Tj
8 0 0 8 206.7438 486.2003 Tm(..........................) Tj
0.055 Tw 8.27 1.125 Td(1
for reporting) Tj
1 - 1.125 Td(FCOI and 1
for) Tj
T * (mitigation re - ) Tj
T * (ports in the
case) Tj
T * (bias was deter - ) Tj
T * (mined during the) Tj
T * (retrospective re - ) Tj
0 Tw T * (view.) Tj
0.055 Tw 8.725 7.875 Td(2
for FCOI report) Tj
1 - 1.125 Td(and 2
for mitiga - ) Tj
T * (tion report.) Tj
0 Tw 8.725 2.25 Td(50) Tj / T1_3 1 Tf(\327) Tj / T1_2 1 Tf
0.555 Tw(2 = 100
for FCOI report and) Tj
0 Tw 1 - 1.125 Td(5) Tj / T1_3 1 Tf(\327) Tj / T1_2 1 Tf
0.055 Tw(2 = 10
for mitigation report.) Tj - 1 - 1.125 Td(Total = 110.) Tj
ET
q
1 0 0 1 121.9400024 432.1999969 cm
0.3 w
0 0 m
0 72.5 l
S
Q
q
1 0 0 1 268.7400055 432.1999969 cm
0.3 w
0 0 m
0 72.5 l
S
Q
q
1 0 0 1 346.5399933 432.1999969 cm
0.3 w
0 0 m
0 72.5 l
S
Q
q
1 0 0 1 424.3399963 432.1999969 cm
0.3 w
0 0 m
0 72.5 l
S
Q
BT / T1_2 1 Tf
0 Tw 8 0 0 8 61.3 422.7003 Tm[(\ (b\)\ (3\)) - 450(...............) - 1036(950)] TJ
6.224 0 0 5.2 140.7638 424.8467 Tm(90) Tj
8 0 0 8 151.1446 422.7003 Tm[(...................................................) - 1042(1) - 342(............................) - 1043(2) - 345(............................) - 1040(1, 900.)] TJ
ET
q
1 0 0 1 121.9400024 422.6999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 268.7400055 422.6999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 346.5399933 422.6999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 424.3399963 422.6999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
BT / T1_2 1 Tf
8 0 0 8 61.3 413.2003 Tm[(\ (b\)\ (4\)) - 450(...............) - 1036(950)] TJ
6.224 0 0 5.2 140.7638 415.3467 Tm(91) Tj
8 0 0 8 151.1446 413.2003 Tm[(...................................................) - 1042(1) - 342(............................) - 1043(1) - 345(............................) - 1040(950.)] TJ
ET
q
1 0 0 1 121.9400024 413.1999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 268.7400055 413.1999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 346.5399933 413.1999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 424.3399963 413.1999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
BT / T1_2 1 Tf
0.055 Tw 8 0 0 8 45.3 403.7003 Tm(50.606 or 94.6) Tj
ET
q
1 0 0 1 121.9400024 403.6999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 268.7400055 403.6999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 346.5399933 403.6999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 424.3399963 403.6999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
BT / T1_2 1 Tf
0 Tw 8 0 0 8 61.3 394.2003 Tm(\ (a\)) Tj
6.224 0 0 5.2 72.3958 396.3467 Tm(92) Tj
8 0 0 8 82.1967 394.2003 Tm[(................) - 1040(20)] TJ
6.224 0 0 5.2 136.3158 396.3467 Tm(93) Tj
8 0 0 8 146.6767 394.2003 Tm[(.....................................................) - 1044(1) - 345(............................) - 1040(10) - 345(..........................) - 1040(200.)] TJ
ET
q
1 0 0 1 121.9400024 394.1999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 268.7400055 394.1999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 346.5399933 394.1999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 424.3399963 394.1999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
BT / T1_2 1 Tf
8 0 0 8 61.3 384.7003 Tm[(\ (c\)) - 335(....................) - 1039(50)] TJ
6.224 0 0 5.2 136.3158 386.8467 Tm(94) Tj
8 0 0 8 146.6767 384.7003 Tm[(.....................................................) - 1044(3)] TJ
6.224 0 0 5.2 278.6679 386.8467 Tm(95) Tj
8 0 0 8 289.0087 384.7003 Tm[(........................) - 1039(0.3) - 345(.........................) - 1040(45.)] TJ
ET
q
1 0 0 1 121.9400024 384.6999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 268.7400055 384.6999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 346.5399933 384.6999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 424.3399963 384.6999969 cm
0.3 w
0 0 m
0 9.5 l
S
Q
q
1 0 0 1 45.0200043 380.3000031 cm
0.4 w
0 0 m
522 0 l
S
Q
q
1 0 0 1 121.9400024 380.3000031 cm
0.3 w
0 0 m
0 4.4 l
S
Q
q
1 0 0 1 268.7400055 380.3000031 cm
0.3 w
0 0 m
0 4.4 l
S
Q
q
1 0 0 1 346.5399933 380.3000031 cm
0.3 w
0 0 m
0 4.4 l
S
Q
q
1 0 0 1 424.3399963 380.3000031 cm
0.3 w
0 0 m
0 4.4 l
S
Q
BT / T1_2 1 Tf
0.055 Tw 8 0 0 8 53 369.4002 Tm(Total burden hours: 664,
130.) Tj
0 Tw 6.224 0 0 5.2 53 363.0468 Tm(69) Tj
0.055 Tw 8 0 0 8 61.2408 360.9003 Tm(Number of respondents) Tj / T1_3 1 Tf
0 Tw(\327) Tj / T1_2 1 Tf
0.055 Tw 11.746 0 Td(average burden hours) Tj / T1_3 1 Tf
0 Tw(\327) Tj / T1_2 1 Tf
0.055 Tw 11.08 0 Td(frequency of response.) Tj
0 Tw 6.224 0 0 5.2 53 354.5468 Tm(70) Tj
0.085 Tw 8 0 0 8 61.2408 352.4003 Tm[(Assumes 3, 000 applicant Institutions and 80 hours per Institution
for fo\rmulating and maintaining the policy.Also assumes that) 1(most Institu - )] TJ
0.065 Tw - 2.03 - 1 Td[(tions already maintain a public Web site.Therefore, posting the policy\to the Web site or providing it upon request is an incr) 1(emental burden\227es - )] TJ
0.055 Tw 0 - 1 TD(timated at 1 hour annually.) Tj
0 Tw 6.224 0 0 5.2 53 330.0468 Tm(71) Tj
0.055 Tw 8 0 0 8 61.2408 327.9003 Tm(80 h
for policy formulation and maintenance; 1h
for posting the policy o\r providing it upon request.) Tj
0 Tw 6.224 0 0 5.2 53 321.5468 Tm(72) Tj
0.115 Tw 8 0 0 8 61.2408 319.4003 Tm[(Assumes that 2, 000 awardee Institutions: 1.inform Investigators about t\he policy on an annual basis by sending a notification) 1(to all Inves - )] TJ
0.055 Tw - 2.03 - 1 Td(tigators = 1 hour and 2.annually adapt NIH - provided training materials\to institutional needs = 5 hours.) Tj
0 Tw 6.224 0 0 5.2 53 305.0468 Tm(73) Tj
0.1475 Tw 8 0 0 8 61.2408 302.9003 Tm[(Assumes 38, 000 Investigators undergo 2 hours of training every four year\s.This refers to FCOI training only and is based on th) 1(e use of)] TJ
0.055 Tw - 2.03 - 1 Td(training materials developed by the NIH and adapted to the Institution\222\s needs.) Tj
0 Tw 6.224 0 0 5.2 53 288.5468 Tm(74) Tj
0.055 Tw 8 0 0 8 61.2408 286.4003 Tm(Once every 4 years.) Tj
0 Tw 6.224 0 0 5.2 53 280.0468 Tm(75) Tj
0.055 Tw 8 0 0 8 61.2408 277.9003 Tm(2 hours every 4 years.) Tj
0 Tw 6.224 0 0 5.2 53 271.5468 Tm(76) Tj
0.1075 Tw 8 0 0 8 61.2408 269.4003 Tm[(An estimated maximum 25 % of Institutions may have subrecipients in any o\ne year\227assuming 1 hour per Institution to incorporate) 1(the re - )] TJ
0.055 Tw - 2.03 - 1 Td(quirement of the regulations into an already existing written agreement.\Includes burden on subrecipients.) Tj
0 Tw 6.224 0 0 5.2 53 255.0467 Tm(77) Tj
0.055 Tw 8 0 0 8 61.2408 252.9003 Tm(Assuming that 3, 000 Institutions solicit disclosures on an annual basis\by sending a notification to all Investigators.) Tj
0 Tw 6.224 0 0 5.2 53 246.5468 Tm(78) Tj
0.055 Tw 8 0 0 8 61.2408 244.4003 Tm(The financial disclosure burden estimate is based upon an Investigator f\igure of 38, 000 with an average response time of 4 hour) Tj
0 Tw 57.683 0 Td(s.) Tj
6.224 0 0 5.2 53 238.0468 Tm(79) Tj
0.055 Tw 8 0 0 8 61.2408 235.9003 Tm(Assuming that updating a disclosure takes less time / effort than creating\a new one\2271 hour.) Tj
0 Tw 6.224 0 0 5.2 53 229.5467 Tm(80) Tj
0.055 Tw 8 0 0 8 61.2408 227.4003 Tm(Assuming that only a small number of the 38, 000 Investigators will have\a new SFI in any year.) Tj
0 Tw 6.224 0 0 5.2 53 221.0468 Tm(81) Tj
0.135 Tw 8 0 0 8 61.2408 218.9003 Tm[(Although an estimated 950 reports of Conflict of Interest are expected a\nnually, the 2, 000 responding Institutions must review) 1(all financial)] TJ
0.095 Tw - 2.03 - 1 Td[(disclosures associated with PHS - funded awards to determine whether any c\onflicts of interest exist.Thus, the review burden of) 1(76, 000 hours is)] TJ
0.09 Tw T * [(based upon estimates that it will take on the average 2 hours
for an ins\titutional official\ (s\) to review each of 38, 000 financi) 1(al disclosures associ - )] TJ
0.065 Tw T * (ated with PHS funded awards.The burden
for developing a management plan\
for identified FCOI is estimated at 80 hours) Tj / T1_3 1 Tf
0 Tw 55.381 0 Td(\327) Tj / T1_2 1 Tf
0.065 Tw 0.864 0 Td(950 cases = 76, 000) Tj
0 Tw - 56.245 - 1 Td(hours.) Tj
6.224 0 0 5.2 53 180.5468 Tm(82) Tj
0.055 Tw 8 0 0 8 61.2408 178.4003 Tm(Based on 50.604 / 94.4\ (e\)\ (3\) above.) Tj
0 Tw 6.224 0 0 5.2 53 172.0468 Tm(83) Tj
0.055 Tw 8 0 0 8 61.2408 169.9003 Tm(Assuming that this is a rare occurrence based on prior experience.) Tj
0 Tw 6.224 0 0 5.2 53 163.5467 Tm(84) Tj
0.055 Tw 8 0 0 8 61.2408 161.4003 Tm(Assuming only a fraction of the newly identified SFIs will constitute FC\OI.) Tj
0 Tw 6.224 0 0 5.2 53 155.0468 Tm(85) Tj
0.055 Tw 8 0 0 8 61.2408 152.9003 Tm(Assuming only a fraction of the newly identified SFIs will constitute FC\OI.) Tj
0 Tw 6.224 0 0 5.2 53 146.5467 Tm(86) Tj
0.1575 Tw 8 0 0 8 61.2408 144.4003 Tm(Based on previous assumption of 950 FCOI reports annually\227estimated 1\2 hours annually, which may consist of 1 hour monthly or a) Tj
0 Tw 62.119 0 Td(ny) Tj
0.055 Tw - 64.149 - 1 Td(other division the Institution deems appropriate.) Tj
0 Tw 6.224 0 0 5.2 53 130.0467 Tm(87) Tj
0.1175 Tw 8 0 0 8 61.2408 127.9003 Tm[(Since the information could be provided as a simple document or spreadsh\eet, providing the required information to multiple req) 1(uestors or)] TJ
0.055 Tw - 2.03 - 1 Td(adding it to an existing Web site is an incremental burden.Updating ann\ually does have an additional burden.) Tj
0 Tw 6.224 0 0 5.2 53 113.5467 Tm(88) Tj
0.0825 Tw 8 0 0 8 61.2408 111.4003 Tm[(The burden
for subsequent reports of conflicts is significantly less, be\cause we do not expect many additional reportable confl) 1(icts and there)] TJ
0.055 Tw - 2.03 - 1 Td(will be only a limited number of disclosures to review.) Tj
0 Tw 6.224 0 0 5.2 53 97.0467 Tm(89) Tj
0.125 Tw 8 0 0 8 61.2408 94.9003 Tm[(After retrospective review\227the burden of which is accounted
for ina\ (\3\)\ (ii\) above\227we estimate that bias will be found in only a) 1(fraction of)] TJ
0 Tw - 2.03 - 1 Td(cases.) Tj
6.224 0 0 5.2 53 80.5467 Tm(90) Tj
0.055 Tw 8 0 0 8 61.2408 78.4003 Tm(Assumes 950 FCOI reports annually) Tj / T1_3 1 Tf
0 Tw(\327) Tj / T1_2 1 Tf
0.055 Tw 17.524 0 Td(2 hours to prepare the report / complete an NIH - provided Web form.) Tj
0 Tw 6.224 0 0 5.2 53 72.0467 Tm(91) Tj
0.055 Tw 8 0 0 8 61.2408 69.9002 Tm(Assumes it takes less time to update a report than to create a new one\227\1 hour per update.) Tj
0 Tw 6.224 0 0 5.2 53 63.5468 Tm(92) Tj
0.0975 Tw 8 0 0 8 61.2408 61.4003 Tm(This estimate includes inquiries by the PHS Awarding Component as descri\bed in 50.606.\ (b\) and 94.6\ (b\) and in accordance with 50) Tj
0 Tw 60.1 0 Td(.604\ (k\)) Tj
0.055 Tw - 62.13 - 1 Td(and 94.4\ (k\).) Tj
1 g
0 Tw 6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(17: 26 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00028) - 1077(Fmt 4701) - 1077(Sfmt 4700) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

// peepdf comment: Javascript code located in object 177 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 536.42 750 Tm(53283) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
/T1_2
1 Tf
0 Tw 6.224 0 0 5.2 53 728.1465 Tm(93) Tj
0.0725 Tw 8 0 0 8 61.2408 726 Tm[(This burden was originally estimated in the 1995 Final Rule to be no mor\e than 5 instances that the failure of an Investigator) 1(to comply with)] TJ
0.07 Tw - 2.03 - 1 Td[(the Institution\222s conflict of interest policy has biased the design, \conduct or reporting of the research.\221\221Objectivity in Res) 1(earch, Final Rule\222\222 60 FR)] TJ
0.11 Tw 0 - 1 TD[(132\ (July 11, 1995\) pps.35810\22635819.This burden estimate, and oth\ers was increased in 2002\221\221due to increased numbers of Inst) 1(itutions and)] TJ
0.145 Tw T * [(Investigators.\222\222 Although there has been an increase in the number\of cases of noncompliance in the past few years, the number) 1(has not ap - )] TJ
0.055 Tw T * (proached this estimate so we believe it is still reasonable.) Tj
0 Tw 6.224 0 0 5.2 53 688.1465 Tm(94) Tj
0.085 Tw 8 0 0 8 61.2408 686 Tm[(Number based on 50.605 / 94.5\ (a\)\ (3\)\ (i\)\227of those only a fraction\will relate to a project of clinical research whose purpose is t) 1(o evaluate the)] TJ
0.055 Tw - 2.03 - 1 Td(safety or effectiveness of a drug, medical device, or treatment, but we\are calculating the maximum estimated burden.) Tj
0 Tw 6.224 0 0 5.2 53 672.1465 Tm(95) Tj
0.055 Tw 8 0 0 8 61.2408 670.0001 Tm(Assuming an average of 3 publications annually.) Tj / T1_3 1 Tf - 0.0045 Tw 9 0 0 9 45 643.0001 Tm(Environmental Impact) Tj / T1_1 1 Tf
1 - 1.722 Td(We have determined that this action) Tj - 1 - 1.111 Td(is of a type that does not individually) Tj
0 - 1.111 TD(or cumulatively have a significant effect) Tj
T * (on the human environment.Therefore, ) Tj
T * (neither an environmental assessment) Tj
T * (nor an environmental impact statement) Tj
T * (is required.) Tj / T1_3 1 Tf
0 - 1.667 TD(Catalogue of Federal Domestic) Tj
0 Tw 0 - 1.111 TD(Assistance) Tj / T1_1 1 Tf - 0.0045 Tw 1 - 1.722 Td(The Catalogue of Federal Domestic) Tj - 1 - 1.111 Td(Assistance numbered programs) Tj
T * (applicable to this revised rule are: ) Tj - 0.0025 Tw 8 0 0 8 45 494.0001 Tm(93.113\227Environmental Health) Tj
0 - 1.125 TD(93.121\227Oral Diseases and Disorders) Tj
0 Tw 2 - 1.125 Td(Research) Tj - 0.0025 Tw - 2 - 1.125 Td(93.142\227NIEHS Hazardous Waste Worker) Tj
2 - 1.125 Td(Health and Safety Training) Tj - 2 - 1.125 Td(93.143\227NIEHS Superfund Hazardous) Tj
2 - 1.125 Td(Substances\227Basic Research and) Tj
0 Tw T * (Education) Tj - 0.0025 Tw - 2 - 1.125 Td(93.172\227Human Genome Research) Tj
T * (93.173\227Research Related to Deafness and) Tj
2 - 1.125 Td(Communication Disorders) Tj - 2 - 1.125 Td(93.187\227Undergraduate Scholarship Program) Tj
2 - 1.125 Td(
for Individuals from Disadvantaged) Tj
0 Tw T * (Backgrounds) Tj - 0.0025 Tw - 2 - 1.125 Td(93.213\227Research and Training in ) Tj
2 - 1.125 Td(Complementary and Alternative) Tj
0 Tw T * (Medicine) Tj - 0.0025 Tw - 2 - 1.125 Td(93.233\227National Center on Sleep Disorders) Tj
0 Tw 2 - 1.125 Td(Research) Tj - 0.0025 Tw - 2 - 1.125 Td(93.242\227Mental Health Research Grants) Tj
T * (93.271\227Alcohol Research Career) Tj
2 - 1.125 Td(Development Awards
for Scientists and) Tj
0 Tw T * (Clinicians) Tj - 0.0025 Tw - 2 - 1.125 Td(93.272\227Alcohol National Research Service) Tj
2 - 1.125 Td(Awards
for Research Training) Tj - 2 - 1.125 Td(93.273\227Alcohol Research Programs) Tj
T * (93.279\227Drug Abuse and Addiction Research) Tj
0 Tw 2 - 1.125 Td(Programs) Tj - 0.0025 Tw - 2 - 1.125 Td(93.281\227Mental Health Research Career / ) Tj
2 - 1.125 Td(Scientist Development Awards) Tj - 2 - 1.125 Td(93.282\227Mental Health National Research) Tj
2 - 1.125 Td(Service Awards
for Research Training) Tj - 2 - 1.125 Td(93.286\227Discovery and Applied Research
for) Tj
2 - 1.125 Td(Technological Innovations to Improve) Tj
T * (Human Health) Tj - 2 - 1.125 Td(93.307\227Minority Health and Health) Tj
2 - 1.125 Td(Disparities Research) Tj - 2 - 1.125 Td(93.310\227Trans - NIH Research Support) Tj
T * (93.361\227Nursing Research) Tj
T * (93.389\227National Center
for Research) Tj
0 Tw 2 - 1.125 Td(Resources) Tj - 0.0025 Tw - 2 - 1.125 Td(93.393\227Cancer Cause and Prevention) Tj
0 Tw 2 - 1.125 Td(Research) Tj - 0.0025 Tw - 2 - 1.125 Td(93.394\227Cancer Detection and Diagnosis) Tj
0 Tw 2 - 1.125 Td(Research) Tj - 0.0025 Tw - 2 - 1.125 Td(93.395\227Cancer Treatment Research) Tj
T * (93.396\227Cancer Biology Research) Tj
T * (93.397\227Cancer Centers Support Grants) Tj
T * (93.398\227Cancer Research Manpower) Tj
T * (93.399\227Cancer Control) Tj
22.125 73.875 Td(93.701\227Trans - NIH Recovery Act Research) Tj
2 - 1.137 Td(Support RECOVERY) Tj - 2 - 1.137 Td(93.702\227National Center
for Research) Tj
2 - 1.137 Td(Resources, Recovery Act Construction) Tj
0 - 1.137 TD(Support RECOVERY) Tj - 2 - 1.137 Td(93.837\227Cardiovascular Diseases Research) Tj
T * (93.838\227Lung Diseases Research) Tj
T * (93.839\227Blood Diseases and Resources) Tj
0 Tw 2 - 1.137 Td(Research) Tj - 0.0025 Tw - 2 - 1.137 Td(93.846\227Arthritis, Musculoskeletal and Skin) Tj
2 - 1.137 Td(Diseases Research) Tj - 2 - 1.137 Td(93.847\227Diabetes, Digestive, and Kidney) Tj
2 - 1.137 Td(Diseases Extramural Research) Tj - 2 - 1.137 Td(93.853\227Extramural Research Programs in ) Tj
2 - 1.137 Td(the Neurosciences and Neurological) Tj
0 Tw T * (Disorders) Tj - 0.0025 Tw - 2 - 1.137 Td(93.855\227Allergy, Immunology and) Tj
2 - 1.137 Td(Transplantation Research) Tj - 2 - 1.137 Td(93.856\227Microbiology and Infectious) Tj
2 - 1.137 Td(Diseases Research) Tj - 2 - 1.137 Td(93.859\227Biomedical Research and Research) Tj
0 Tw 2 - 1.137 Td(Training) Tj - 0.0025 Tw - 2 - 1.137 Td(93.865\227Child Health and Human) Tj
2 - 1.137 Td(Development Extramural Research) Tj - 2 - 1.137 Td(93.866\227Aging Research) Tj
T * (93.867\227Vision Research) Tj
T * (93.879\227Medical Library Assistance) Tj
T * (93.891\227Alcohol Research Center Grants) Tj
T * (93.989\227International Research and Research) Tj
0 Tw 2 - 1.137 Td(Training) Tj / T1_0 1 Tf - 0.0045 Tw 9 0 0 9 222 365.0001 Tm(List of Subjects in 42 CFR Part 50 and) Tj
0 - 1.111 TD(45 CFR Part 94) Tj / T1_1 1 Tf
1 - 1.911 Td(Colleges and universities, Conflict of) Tj - 1 - 1.111 Td(interests, Contracts, Financial) Tj
T * (disclosure, Grants\227health, Grants) Tj
T * (programs, Non - profit organizations, ) Tj
T * (Research, Scientists, Small businesses.) Tj
1 - 1.689 Td(For the reasons set forth in the) Tj - 1 - 1.111 Td(preamble, HHS is amending 42 CFR) Tj
T * (chapter I, subchapter D, part 50, and 45) Tj
T * (CFR subtitle A, subchapter A, part 94 as) Tj
0 Tw T * (follows: ) Tj / T1_0 1 Tf - 0.0045 Tw 0 - 1.678 TD(TITLE 42\227PUBLIC HEALTH) Tj / T1_4 1 Tf
0 - 2.011 TD(PART 50\227POLICIES OF GENERAL) Tj
0 Tw 0 - 1.111 TD(APPLICABILITY) Tj / T1_5 1 Tf
7 0 0 7 222 178.2001 Tm(\002) Tj / T1_1 1 Tf - 0.0644 Tw 9 0 0 9 230.3271 178.2001 Tm(1.Revise Subpart F to read as follows: ) Tj / T1_4 1 Tf - 0.0025 Tw 8 0 0 8 222 164.1001 Tm(Subpart F\227Promoting Objectivity in ) Tj
0 Tw 0 - 1.125 TD(Research) Tj / T1_1 1 Tf
0 - 1.512 TD(Sec.) Tj
0 - 1.125 TD[(50.601) - 1000(Purpose.)] TJ
T * [(50.602) - 1000(Applicability.)] TJ
T * [(50.603) - 1000(Definitions.)] TJ - 0.0025 Tw T * [(50.604) - 1000(Responsibilities of Institutions)] TJ
2 - 1.125 Td(regarding Investigator financial conflicts) Tj
T * (of interest.) Tj - 2 - 1.125 Td[(50.605) - 1000(Management and reporting of)] TJ
2 - 1.125 Td(financial conflicts of interest.) Tj
0 Tw - 2 - 1.125 Td[(50.606) - 1000(Remedies.)] TJ - 0.0025 Tw T * [(50.607) - 1000(Other HHS regulations that apply.)] TJ / T1_4 1 Tf - 0.0045 Tw 9 0 0 9 399 642 Tm(Subpart F\227Promoting Objectivity in ) Tj
0 Tw 0 - 1.111 TD(Research) Tj / T1_0 1 Tf
8 0 0 8 407 612.0001 Tm(Authority: ) Tj / T1_1 1 Tf - 0.0025 Tw 5.108 0 Td(42 U.S.C.216, 289b\2261, 299c\2264;) Tj - 6.108 - 1.125 Td(Sec.219, Tit.II, Div.D, Pub.L.111\226117, 123) Tj
0 - 1.125 TD(Stat.3034.) Tj / T1_4 1 Tf
0 Tw 0 - 2 TD[(\247) - 165(50.601) - 1000(Purpose.)] TJ / T1_1 1 Tf - 0.0045 Tw 9 0 0 9 408 565.0001 Tm(This subpart promotes objectivity in ) Tj - 1 - 1.111 Td(research by establishing standards that) Tj
0 - 1.111 TD(provide a reasonable expectation that) Tj
T * (the design, conduct, and reporting of) Tj
T * (research funded under Public Health) Tj
T * (Service\ (PHS\) grants or cooperative) Tj
T * (agreements will be free from bias) Tj
T * (resulting from Investigator financial) Tj
T * (conflicts of interest.) Tj / T1_4 1 Tf
0 Tw 8 0 0 8 399 469.0001 Tm[(\247) - 165(50.602) - 1000(Applicability.)] TJ / T1_1 1 Tf - 0.0045 Tw 9 0 0 9 408 456.0001 Tm(This subpart is applicable to each) Tj - 1 - 1.111 Td(Institution that is applying
for, or that) Tj
T * (receives, PHS research funding by) Tj
T * (means of a grant or cooperative) Tj
T * (agreement and, through the) Tj
T * (implementation of this subpart by the) Tj
T * (Institution, to each Investigator who is) Tj
T * (planning to participate in , or is) Tj
T * (participating in , such research;) Tj
T * (provided, however, that this subpart) Tj
T * (does not apply to SBIR Program Phase) Tj
T * (I applications.In those few cases where) Tj
T * (an individual, rather than an Institution, ) Tj
T * (is applying
for, or receives, PHS) Tj
T * (research funding, PHS Awarding) Tj
T * (Components will make
case -by -
case) Tj
T * (determinations on the steps to be taken, ) Tj
T * (consistent with this subpart, to provide) Tj
T * (a reasonable expectation that the design, ) Tj
T * (conduct, and reporting of the research) Tj
T * (will be free from bias resulting from a) Tj
T * (financial conflict of interest of the) Tj
0 Tw T * (individual.) Tj / T1_4 1 Tf
8 0 0 8 399 220.0002 Tm[(\247) - 165(50.603) - 1000(Definitions.)] TJ / T1_1 1 Tf - 0.0045 Tw 9 0 0 9 408 207.0002 Tm(As used in this subpart: ) Tj / T1_3 1 Tf
0 - 1.222 TD(Disclosure of significant financial) Tj
0 Tw - 1 - 1.111 Td(interests) Tj / T1_1 1 Tf - 0.0045 Tw 4.142 0 Td(means an Investigator\222s) Tj - 4.142 - 1.111 Td(disclosure of significant financial) Tj
0 - 1.111 TD(interests to an Institution.) Tj / T1_3 1 Tf
1 - 1.222 Td(Financial conflict of interest) Tj / T1_1 1 Tf
0 Tw(\ (FCOI\)) Tj - 0.0045 Tw - 1 - 1.111 Td(means a significant financial interest) Tj
T * (that could directly and significantly) Tj
T * (affect the design, conduct, or reporting) Tj
T * (of PHS - funded research.) Tj / T1_3 1 Tf
1 - 1.222 Td(FCOI report) Tj / T1_1 1 Tf(means an Institution\222s) Tj - 1 - 1.111 Td(report of a financial conflict of interest) Tj
T * (to a PHS Awarding Component.) Tj / T1_3 1 Tf
1 - 1.222 Td(Financial interest) Tj / T1_1 1 Tf(means anything of) Tj - 1 - 1.111 Td(monetary value, whether or not the) Tj
T * (value is readily ascertainable.) Tj
1 g / T1_2 1 Tf
0 Tw 6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(17: 26 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00029) - 1077(Fmt 4701) - 1077(Sfmt 4700) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

// peepdf comment: Javascript code located in object 185 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 45 750 Tm(53284) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
/T1_2
1 Tf
0 Tw 9 0 0 9 54 725 Tm(HHS) Tj / T1_1 1 Tf - 0.0045 Tw 2.441 0 Td(means the United States) Tj - 3.441 - 1.1 Td(Department of Health and Human) Tj
0 - 1.1 TD(Services, and any components of the) Tj
T * (Department to which the authority) Tj
T * (involved may be delegated.) Tj / T1_2 1 Tf
0 Tw 1 - 1.022 Td(Institution) Tj / T1_1 1 Tf - 0.0045 Tw 5.068 0 Td(means any domestic or) Tj - 6.068 - 1.1 Td(foreign, public or private, entity or) Tj
T * (organization\ (excluding a Federal) Tj
T * (agency\) that is applying
for, or that) Tj
T * (receives, PHS research funding.) Tj / T1_2 1 Tf
1 - 1.022 Td(Institutional responsibilities) Tj / T1_1 1 Tf(means an) Tj - 1 - 1.111 Td(Investigator\222s professional) Tj
0 - 1.111 TD(responsibilities on behalf of the) Tj
T * (Institution, and as defined by the) Tj
T * (Institution in its policy on financial) Tj
T * (conflicts of interest, which may include) Tj
T * (
for example: activities such as research,
) Tj
T * (research consultation, teaching, ) Tj
T * (professional practice, institutional) Tj
T * (committee memberships, and service on) Tj
T * (panels such as Institutional Review) Tj
T * (Boards or Data and Safety Monitoring) Tj
0 Tw T * (Boards.) Tj / T1_2 1 Tf
1 - 1.022 Td(Investigator) Tj / T1_1 1 Tf - 0.0045 Tw 5.662 0 Td(means the project director) Tj - 6.662 - 1.111 Td(or principal Investigator and any other) Tj
T * (person, regardless of title or position, ) Tj
T * (who is responsible
for the design, ) Tj
T * (conduct, or reporting of research funded) Tj
T * (by the PHS, or proposed
for such) Tj
T * (funding, which may include,
for) Tj
T * (example, collaborators or consultants.) Tj / T1_2 1 Tf
0 Tw 1 - 1.022 Td(Manage) Tj / T1_1 1 Tf - 0.0045 Tw 3.885 0 Td(means taking action to) Tj - 4.885 - 1.111 Td(address a financial conflict of interest, ) Tj
T * (which can include reducing or) Tj
T * (eliminating the financial conflict of) Tj
T * (interest, to ensure, to the extent) Tj
T * (possible, that the design, conduct, and) Tj
T * (reporting of research will be free from) Tj
0 Tw T * (bias.) Tj / T1_2 1 Tf
1 - 1.022 Td(PD / PI) Tj / T1_1 1 Tf - 0.0045 Tw 2.939 0 Td(means a project director or) Tj - 3.939 - 1.111 Td(principal Investigator of a PHS - funded) Tj
T * (research project; the PD / PI is included) Tj
T * ( in the definitions of senior / key) Tj
T * (personnel and Investigator under this) Tj
0 Tw T * (subpart.) Tj / T1_2 1 Tf
1 - 1.022 Td(PHS) Tj / T1_1 1 Tf - 0.0045 Tw 2.274 0 Td(means the Public Health Service) Tj - 3.274 - 1.111 Td(of the U.S.Department of Health and) Tj
T * (Human Services, and any components) Tj
T * (of the PHS to which the authority) Tj
T * (involved may be delegated, including) Tj
T * (the National Institutes of Health\ (NIH\).) Tj / T1_2 1 Tf
1 - 1.022 Td(PHS Awarding Component) Tj / T1_1 1 Tf(means the) Tj - 1 - 1.111 Td(organizational unit of the PHS that) Tj
T * (funds the research that is subject to this) Tj
0 Tw T * (subpart.) Tj / T1_2 1 Tf - 0.0045 Tw 1 - 1.022 Td(Public Health Service Act) Tj / T1_1 1 Tf(or PHS Act) Tj - 1 - 1.111 Td(means the statute codified at 42 U.S.C.) Tj
0 Tw T * (201) Tj / T1_2 1 Tf - 0.0045 Tw 1.941 0 Td(et seq.) Tj
0 Tw - 0.941 - 1.022 Td(Research) Tj / T1_1 1 Tf - 0.0045 Tw 4.44 0 Td(means a systematic) Tj - 5.44 - 1.111 Td(investigation, study or experiment) Tj
T * (designed to develop or contribute to) Tj
T * (generalizable knowledge relating) Tj
T * (broadly to public health, including) Tj
T * (behavioral and social - sciences research.) Tj
T * (The term encompasses basic and) Tj
T * (applied research\ () Tj / T1_2 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 10.319 0 Td(a published) Tj - 10.319 - 1.111 Td(article, book or book chapter\) and) Tj
T * (product development\ () Tj / T1_2 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 12.598 0 Td(a diagnostic) Tj - 12.598 - 1.111 Td(test or drug\).As used in this subpart, ) Tj
19.667 74.667 Td(the term includes any such activity
for) Tj
0 - 1.1 TD(which research funding is available) Tj
T * (from a PHS Awarding Component) Tj
T * (through a grant or cooperative) Tj
T * (agreement, whether authorized under) Tj
T * (the PHS Act or other statutory authority, ) Tj
T * (such as a research grant, career) Tj
T * (development award, center grant, ) Tj
T * (individual fellowship award, ) Tj
T * (infrastructure award, institutional) Tj
T * (training grant, program project, or) Tj
T * (research resources award.) Tj / T1_2 1 Tf
1 - 1.022 Td(Senior / key personnel) Tj / T1_1 1 Tf(means the PD / PI) Tj - 1 - 1.1 Td(and any other person identified as) Tj
T * (senior / key personnel by the Institution) Tj
T * ( in the grant application, progress report, ) Tj
T * (or any other report submitted to the PHS) Tj
T * (by the Institution under this subpart.) Tj / T1_2 1 Tf
1 - 1.022 Td(Significant financial interest) Tj / T1_1 1 Tf
0 Tw(means: ) Tj - 0.0045 Tw 0 - 1.022 TD(\ (1\) A financial interest consisting of) Tj - 1 - 1.1 Td(one or more of the following interests of) Tj
0 - 1.1 TD(the Investigator\ (and those of the) Tj
T * (Investigator\222s spouse and dependent) Tj
T * (children\) that reasonably appears to be) Tj
T * (related to the Investigator\222s institutional) Tj
0 Tw T * (responsibilities: ) Tj - 0.0045 Tw 1 - 1.022 Td(\ (i\) With regard to any publicly traded) Tj - 1 - 1.1 Td(entity, a) Tj / T1_2 1 Tf(significant financial interest) Tj / T1_1 1 Tf
T * (exists
if the value of any remuneration) Tj
0 - 1.111 TD(received from the entity in the twelve) Tj
T * (months preceding the disclosure and) Tj
T * (the value of any equity interest in the) Tj
T * (entity as of the date of disclosure, when) Tj
T * (aggregated, exceeds $5, 000.For) Tj
T * (purposes of this definition, ) Tj
T * (remuneration includes salary and any) Tj
T * (payment
for services not otherwise) Tj
T * (identified as salary\ () Tj / T1_2 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 11.425 0 Td(consulting fees, ) Tj - 11.425 - 1.111 Td(honoraria, paid authorship\); equity) Tj
T * (interest includes any stock, stock) Tj
T * (option, or other ownership interest, as) Tj
T * (determined through reference to public) Tj
T * (prices or other reasonable measures of) Tj
T * (fair market value;) Tj
1 - 1.022 Td(\ (ii\) With regard to any non - publicly) Tj - 1 - 1.111 Td(traded entity, a) Tj / T1_2 1 Tf(significant financial) Tj
0 Tw T * (interest) Tj / T1_1 1 Tf - 0.0045 Tw 3.698 0 Td(exists
if the value of any) Tj - 3.698 - 1.111 Td(remuneration received from the entity) Tj
T * ( in the twelve months preceding the) Tj
T * (disclosure, when aggregated, exceeds) Tj
T * ($5, 000, or when the Investigator\ (or the) Tj
T * (Investigator\222s spouse or dependent) Tj
T * (children\) holds any equity interest\ () Tj / T1_2 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw T * (stock, stock option, or other ownership) Tj
T * (interest\); or) Tj
1 - 1.022 Td(\ (iii\) Intellectual property rights and) Tj - 1 - 1.111 Td(interests\ () Tj / T1_2 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 6.601 0 Td(patents, copyrights\), upon) Tj - 6.601 - 1.111 Td(receipt of income related to such rights) Tj
T * (and interests.) Tj
1 - 1.022 Td(\ (2\) Investigators also must disclose) Tj - 1 - 1.111 Td(the occurrence of any reimbursed or) Tj
T * (sponsored travel\ () Tj / T1_2 1 Tf
0 Tw(i.e., ) Tj / T1_1 1 Tf - 0.0045 Tw 10.135 0 Td(that which is paid) Tj - 10.135 - 1.111 Td(on behalf of the Investigator and not) Tj
T * (reimbursed to the Investigator so that) Tj
T * (the exact monetary value may not be) Tj
T * (readily available\), related to their) Tj
T * (institutional responsibilities; provided, ) Tj
T * (however, that this disclosure) Tj
T * (requirement does not apply to travel) Tj
19.667 74.667 Td(that is reimbursed or sponsored by a) Tj
0 - 1.1 TD(Federal, state, or local government) Tj
T * (agency, an Institution of higher) Tj
T * (education as defined at 20 U.S.C.) Tj
T * (1001\ (a\), an academic teaching hospital, ) Tj
T * (a medical center, or a research institute) Tj
T * (that is affiliated with an Institution of) Tj
T * (higher education.The Institution\222s FCOI) Tj
T * (policy will specify the details of this) Tj
T * (disclosure, which will include, at a) Tj
T * (minimum, the purpose of the trip, the) Tj
T * (identity of the sponsor / organizer, the) Tj
T * (destination, and the duration.In) Tj
T * (accordance with the Institution\222s FCOI) Tj
T * (policy, the institutional official\ (s\) will) Tj
T * (determine
if further information is) Tj
T * (needed, including a determination or) Tj
T * (disclosure of monetary value, in order to) Tj
T * (determine whether the travel constitutes) Tj
T * (an FCOI with the PHS - funded research.) Tj
1 - 1.022 Td(\ (3\) The term) Tj / T1_2 1 Tf(significant financial) Tj
0 Tw - 1 - 1.1 Td(interest) Tj / T1_1 1 Tf - 0.0045 Tw 3.698 0 Td(does not include the following) Tj - 3.698 - 1.1 Td(types of financial interests: salary,
) Tj
T * (royalties, or other remuneration paid by) Tj
T * (the Institution to the Investigator
if the) Tj
T * (Investigator is currently employed or) Tj
T * (otherwise appointed by the Institution, ) Tj
T * (including intellectual property rights) Tj
T * (assigned to the Institution and) Tj
T * (agreements to share in royalties related) Tj
T * (to such rights; any ownership interest in ) Tj
T * (the Institution held by the Investigator, ) Tj
T * (
if the Institution is a commercial or
for -) Tj
T * (profit organization; income from) Tj
T * (investment vehicles, such as mutual) Tj
T * (funds and retirement accounts, as long) Tj
T * (as the Investigator does not directly) Tj
T * (control the investment decisions made) Tj
T * ( in these vehicles; income from) Tj
T * (seminars, lectures, or teaching) Tj
T * (engagements sponsored by a Federal, ) Tj
T * (state, or local government agency, an) Tj
T * (Institution of higher education as) Tj
T * (defined at 20 U.S.C.1001\ (a\), an) Tj
T * (academic teaching hospital, a medical) Tj
T * (center, or a research institute that is) Tj
T * (affiliated with an Institution of higher) Tj
T * (education; or income from service on) Tj
T * (advisory committees or review panels) Tj
T * (
for a Federal, state, or local government) Tj
T * (agency, an Institution of higher) Tj
T * (education as defined at 20 U.S.C.) Tj
T * (1001\ (a\), an academic teaching hospital, ) Tj
T * (a medical center, or a research institute) Tj
T * (that is affiliated with an Institution of) Tj
T * (higher education.) Tj / T1_2 1 Tf
1 - 1.022 Td(Small Business Innovation Research) Tj / T1_1 1 Tf - 1 - 1.1 Td(\ (SBIR\) Program means the extramural) Tj
T * (research program
for small businesses) Tj
T * (that is established by the Awarding) Tj
T * (Components of the Public Health) Tj
T * (Service and certain other Federal) Tj
T * (agencies under Public Law 97\226219, the) Tj
T * (Small Business Innovation Development) Tj
T * (Act, as amended.For purposes of this) Tj
T * (subpart, the term SBIR Program also) Tj
T * (includes the Small Business Technology) Tj
0 - 1.111 TD(Transfer\ (STTR\) Program, which was) Tj
T * (established by Public Law 102\226564.) Tj
1 g / T1_3 1 Tf
0 Tw 6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(17: 26 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00030) - 1077(Fmt 4701) - 1077(Sfmt 4700) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

// peepdf comment: Javascript code located in object 188 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 536.42 750 Tm(53285) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
/T1_2
1 Tf - 0.0025 Tw 8 0 0 8 45 726 Tm[(\247) - 165(50.604) - 1000(Responsibilities of Institutions)] TJ
0 - 1.125 TD(regarding Investigator financial conflicts of) Tj
0 Tw T * (interest.) Tj / T1_1 1 Tf - 0.0045 Tw 9 0 0 9 54 695.6001 Tm(Each Institution shall: ) Tj
0 - 1.156 TD(\ (a\) Maintain an up - to - date, written, ) Tj - 1 - 1.111 Td(enforced policy on financial conflicts of) Tj
0 - 1.111 TD(interest that complies with this subpart, ) Tj
T * (and make such policy available via a) Tj
T * (publicly accessible Web site.If the) Tj
T * (Institution does not have any current) Tj
T * (presence on a publicly accessible Web) Tj
T * (site\ (and only in those cases\), the) Tj
T * (Institution shall make its written policy) Tj
T * (available to any requestor within five) Tj
T * (business days of a request.If, however, ) Tj
T * (the Institution acquires a presence on a) Tj
T * (publicly accessible Web site during the) Tj
T * (time of the PHS award, the requirement) Tj
T * (to post the information on that Web site) Tj
T * (will apply within 30 calendar days.If an) Tj
T * (Institution maintains a policy on) Tj
T * (financial conflicts of interest that) Tj
T * (includes standards that are more) Tj
T * (stringent than this subpart\ () Tj / T1_3 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf
14.808 0 Td(that) Tj - 0.0045 Tw - 14.808 - 1.111 Td(require a more extensive disclosure of) Tj
T * (financial interests\), the Institution shall) Tj
T * (adhere to its policy and shall provide) Tj
T * (FCOI reports regarding identified) Tj
T * (financial conflicts of interest to the PHS) Tj
T * (Awarding Component in accordance) Tj
T * (with the Institution\222s own standards and) Tj
T * (within the timeframe prescribed by this) Tj
0 Tw T * (subpart.) Tj - 0.0045 Tw 1 - 1.156 Td(\ (b\) Inform each Investigator of the) Tj - 1 - 1.111 Td(Institution\222s policy on financial) Tj
T * (conflicts of interest, the Investigator\222s) Tj
T * (responsibilities regarding disclosure of) Tj
T * (significant financial interests, and of) Tj
T * (these regulations, and require each) Tj
T * (Investigator to complete training) Tj
T * (regarding the same prior to engaging in ) Tj
T * (research related to any PHS - funded) Tj
T * (grant and at least every four years, and) Tj
T * (immediately when any of the following) Tj
T * (circumstances apply: ) Tj
1 - 1.156 Td(\ (1\) The Institution revises its financial) Tj - 1 - 1.111 Td(conflict of interest policies or) Tj
T * (procedures in any manner that affects) Tj
T * (the requirements of Investigators;) Tj
1 - 1.156 Td(\ (2\) An Investigator is new to an) Tj - 1 - 1.111 Td(Institution; or) Tj
1 - 1.156 Td(\ (3\) An Institution finds that an) Tj - 1 - 1.111 Td(Investigator is not in compliance with) Tj
T * (the Institution\222s financial conflict of) Tj
T * (interest policy or management plan.) Tj
1 - 1.144 Td(\ (c\) If the Institution carries out the) Tj - 1 - 1.111 Td(PHS - funded research through a) Tj
T * (subrecipient\ () Tj / T1_3 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 8.435 0 Td(subcontractors or) Tj - 8.435 - 1.111 Td(consortium members\), the Institution) Tj
T * (\ (awardee Institution\) must take) Tj
T * (reasonable steps to ensure that any) Tj
T * (subrecipient Investigator complies with) Tj
T * (this subpart by: ) Tj
1 - 1.144 Td(\ (1\) Incorporating as part of a written) Tj - 1 - 1.111 Td(agreement with the subrecipient terms) Tj
T * (that establish whether the financial) Tj
T * (conflicts of interest policy of the) Tj
T * (awardee Institution or that of the) Tj
19.667 74.667 Td(subrecipient will apply to the) Tj
0 - 1.1 TD(subrecipient\222s Investigators.) Tj
1 - 1.022 Td(\ (i\) If the subrecipient\222s Investigators) Tj - 1 - 1.1 Td(must comply with the subrecipient\222s) Tj
T * (financial conflicts of interest policy, the) Tj
T * (subrecipient shall certify as part of the) Tj
T * (agreement referenced above that its) Tj
T * (policy complies with this subpart.If the) Tj
T * (subrecipient cannot provide such) Tj
T * (certification, the agreement shall state) Tj
T * (that subrecipient Investigators are) Tj
T * (subject to the financial conflicts of) Tj
T * (interest policy of the awardee) Tj
T * (Institution
for disclosing significant) Tj
T * (financial interests that are directly) Tj
T * (related to the subrecipient\222s work
for the) Tj
T * (awardee Institution;) Tj
1 - 1.022 Td(\ (ii\) Additionally,
if the subrecipient\222s) Tj - 1 - 1.1 Td(Investigators must comply with the) Tj
T * (subrecipient\222s financial conflicts of) Tj
T * (interest policy, the agreement) Tj
T * (referenced above shall specify time) Tj
T * (period\ (s\) for the subrecipient to report) Tj
T * (all identified financial conflicts of) Tj
T * (interest to the awardee Institution.Such) Tj
T * (time period\ (s\) shall be sufficient to) Tj
T * (enable the awardee Institution to) Tj
0 - 1.111 TD(provide timely FCOI reports, as) Tj
T * (necessary, to the PHS as required by this) Tj
0 Tw T * (subpart;) Tj - 0.0045 Tw 1 - 1.022 Td(\ (iii\) Alternatively,
if the subrecipient\222s) Tj - 1 - 1.111 Td(Investigators must comply with the) Tj
T * (awardee Institution\222s financial conflicts) Tj
T * (of interest policy, the agreement) Tj
T * (referenced above shall specify time) Tj
T * (period\ (s\) for the subrecipient to submit) Tj
T * (all Investigator disclosures of significant) Tj
T * (financial interests to the awardee) Tj
T * (Institution.Such time period\ (s\) shall be) Tj
T * (sufficient to enable the awardee) Tj
T * (Institution to comply timely with its) Tj
T * (review, management, and reporting) Tj
T * (obligations under this subpart.) Tj
1 - 1.022 Td(\ (2\) Providing FCOI reports to the PHS) Tj - 1 - 1.111 Td(Awarding Component regarding all) Tj
T * (financial conflicts of interest of all) Tj
T * (subrecipient Investigators consistent) Tj
T * (with this subpart, ) Tj / T1_3 1 Tf
0 Tw(i.e., ) Tj / T1_1 1 Tf - 0.0045 Tw 10.296 0 Td(prior to the) Tj - 10.296 - 1.111 Td(expenditure of funds and within 60) Tj
T * (days of any subsequently identified) Tj
0 Tw T * (FCOI.) Tj - 0.0045 Tw 1 - 1.022 Td(\ (d\) Designate an institutional) Tj - 1 - 1.111 Td(official\ (s\) to solicit and review) Tj
T * (disclosures of significant financial) Tj
T * (interests from each Investigator who is) Tj
T * (planning to participate in , or is) Tj
T * (participating in , the PHS - funded) Tj
0 Tw T * (research.) Tj - 0.0045 Tw 1 - 1.022 Td(\ (e\)\ (1\) Require that each Investigator) Tj - 1 - 1.111 Td(who is planning to participate in the) Tj
T * (PHS - funded research disclose to the) Tj
T * (Institution\222s designated official\ (s\) the) Tj
T * (Investigator\222s significant financial) Tj
T * (interests\ (and those of the Investigator\222s) Tj
T * (spouse and dependent children\) no later) Tj
T * (than the time of application
for PHS - ) Tj
T * (funded research.) Tj
1 - 1.022 Td(\ (2\) Require each Investigator who is) Tj - 1 - 1.111 Td(participating in the PHS - funded) Tj
19.667 74.667 Td(research to submit an updated) Tj
0 - 1.1 TD(disclosure of significant financial) Tj
T * (interests at least annually, in accordance) Tj
T * (with the specific time period prescribed) Tj
T * (by the Institution, during the period of) Tj
T * (the award.Such disclosure shall) Tj
T * (include any information that was not) Tj
T * (disclosed initially to the Institution) Tj
T * (pursuant to paragraph\ (e\)\ (1\) of this) Tj
T * (section, or in a subsequent disclosure of) Tj
T * (significant financial interests\ () Tj / T1_3 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf
16.033 0 Td(any) Tj - 0.0045 Tw - 16.033 - 1.1 Td(financial conflict of interest identified) Tj
T * (on a PHS - funded project that was) Tj
T * (transferred from another Institution\), ) Tj
T * (and shall include updated information) Tj
T * (regarding any previously disclosed) Tj
T * (significant financial interest\ () Tj / T1_3 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf
15.589 0 Td(the) Tj - 0.0045 Tw - 15.589 - 1.1 Td(updated value of a previously disclosed) Tj
T * (equity interest\).) Tj
1 - 1.022 Td(\ (3\) Require each Investigator who is) Tj - 1 - 1.1 Td(participating in the PHS - funded) Tj
T * (research to submit an updated) Tj
T * (disclosure of significant financial) Tj
T * (interests within thirty days of) Tj
T * (discovering or acquiring\ () Tj / T1_3 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf
13.872 0 Td(through) Tj - 0.0045 Tw - 13.872 - 1.1 Td(purchase, marriage, or inheritance\) a) Tj
T * (new significant financial interest.) Tj
1 - 1.022 Td(\ (f\) Provide guidelines consistent with) Tj - 1 - 1.1 Td(this subpart
for the designated) Tj
T * (institutional official\ (s\) to determine) Tj
T * (whether an Investigator\222s significant) Tj
T * (financial interest is related to PHS - ) Tj
T * (funded research and,
if so related, ) Tj
T * (whether the significant financial interest) Tj
T * (is a financial conflict of interest.An) Tj
T * (Investigator\222s significant financial) Tj
T * (interest is related to PHS - funded) Tj
T * (research when the Institution, through) Tj
T * (its designated official\ (s\), reasonably) Tj
T * (determines that the significant financial) Tj
T * (interest: could be affected by the PHS - ) Tj
T * (funded research; or is in an entity) Tj
T * (whose financial interest could be) Tj
T * (affected by the research.The Institution) Tj
T * (may involve the Investigator in the) Tj
T * (designated official\ (s\)\222s determination of) Tj
T * (whether a significant financial interest) Tj
T * (is related to the PHS - funded research.A) Tj
T * (financial conflict of interest exists when) Tj
T * (the Institution, through its designated) Tj
T * (official\ (s\), reasonably determines that) Tj
0 - 1.111 TD(the significant financial interest could) Tj
T * (directly and significantly affect the) Tj
T * (design, conduct, or reporting of the) Tj
T * (PHS - funded research.) Tj
1 - 1.022 Td(\ (g\) Take such actions as necessary to) Tj - 1 - 1.111 Td(manage financial conflicts of interest, ) Tj
T * (including any financial conflicts of a) Tj
T * (subrecipient Investigator pursuant to) Tj
T * (paragraph\ (c\) of this section.) Tj
T * (Management of an identified financial) Tj
T * (conflict of interest requires development) Tj
T * (and implementation of a management) Tj
T * (plan and,
if necessary, a retrospective) Tj
T * (review and a mitigation report pursuant) Tj
T * [(to\247) - 167(50.605\ (a\).)] TJ
1 - 1.022 Td(\ (h\) Provide initial and ongoing FCOI) Tj - 1 - 1.111 Td(reports to the PHS as required pursuant) Tj
T * [(to\247) - 167(50.605\ (b\).)] TJ
1 g / T1_4 1 Tf
0 Tw 6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(17: 26 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00031) - 1077(Fmt 4701) - 1077(Sfmt 4700) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

// peepdf comment: Javascript code located in object 191 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 45 750 Tm(53286) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
-0.0045 Tw 9 0 0 9 54 725 Tm
(\(i\) Maintain records relating to all )Tj
-1 -1.111 Td
(Investigator disclosures of financial )Tj
0 -1.111 TD
(interests and the Institution\222s review of, )Tj
T*
(and response to, such disclosures )Tj
T*
(\(whether or not a disclosure resulted in )Tj
T*
(the Institution\222s determination of a )Tj
T*
(financial conflict of interest\) and all )Tj
T*
(actions under the Institution\222s policy or )Tj
T*
(retrospective review, if applicable, for at )Tj
T*
(least three years from the date the final )Tj
T*
(expenditures report is submitted to the )Tj
T*
(PHS or, where applicable, from other )Tj
T*
(dates specified in 45 CFR 74.53\(b\) and )Tj
T*
(92.42 \(b\) for different situations. )Tj
1 -1.044 Td
(\(j\) Establish adequate enforcement )Tj
-1 -1.111 Td
(mechanisms and provide for employee )Tj
T*
(sanctions or other administrative )Tj
T*
(actions to ensure Investigator )Tj
T*
(compliance as appropriate. )Tj
1 -1.044 Td
(\(k\) Certify, in each application for )Tj
-1 -1.111 Td
(funding to which this subpart applies, )Tj
T*
(that the Institution: )Tj
1 -1.044 Td
(\(1\) Has in effect at that Institution an )Tj
-1 -1.111 Td
(up-to-date, written, and enforced )Tj
T*
(administrative process to identify and )Tj
T*
(manage financial conflicts of interest )Tj
T*
(with respect to all research projects for )Tj
T*
(which funding is sought or received )Tj
T*
(from the PHS; )Tj
1 -1.044 Td
(\(2\) Shall promote and enforce )Tj
-1 -1.111 Td
(Investigator compliance with this )Tj
T*
(subpart\222s requirements including those )Tj
T*
(pertaining to disclosure of significant )Tj
T*
(financial interests; )Tj
1 -1.044 Td
(\(3\) Shall manage financial conflicts of )Tj
-1 -1.111 Td
(interest and provide initial and ongoing )Tj
T*
(FCOI reports to the PHS Awarding )Tj
T*
(Component consistent with this subpart; )Tj
1 -1.056 Td
(\(4\) Agrees to make information )Tj
-1 -1.111 Td
(available, promptly upon request, to the )Tj
T*
(HHS relating to any Investigator )Tj
T*
(disclosure of financial interests and the )Tj
T*
(Institution\222s review of, and response to, )Tj
T*
(such disclosure, whether or not the )Tj
T*
(disclosure resulted in the Institution\222s )Tj
T*
(determination of a financial conflict of )Tj
T*
(interest; and )Tj
1 -1.056 Td
(\(5\) Shall fully comply with the )Tj
-1 -1.111 Td
(requirements of this subpart. )Tj
/T1_2
1 Tf - 0.0025 Tw 8 0 0 8 45 233.0004 Tm[(\247) - 165(50.605) - 1000(Management and reporting of)] TJ
0 - 1.125 TD(financial conflicts of interest.) Tj / T1_1 1 Tf - 0.0045 Tw 9 0 0 9 54 212.5003 Tm(\ (a\) Management of financial conflicts) Tj - 1 - 1.111 Td(of interest.) Tj
1 - 1.056 Td(\ (1\) Prior to the Institution\222s) Tj - 1 - 1.111 Td(expenditure of any funds under a PHS - ) Tj
0 - 1.111 TD(funded research project, the designated) Tj
T * (official\ (s\) of an Institution shall, ) Tj
T * [(consistent with\247) - 167(50.604\ (f\): review all)] TJ
T * (Investigator disclosures of significant) Tj
T * (financial interests; determine whether) Tj
T * (any significant financial interests relate) Tj
T * (to PHS - funded research; determine) Tj
T * (whether a financial conflict of interest) Tj
T * (exists; and,
if so, develop and) Tj
T * (implement a management plan that) Tj
T * (shall specify the actions that have been, ) Tj
T * (and shall be, taken to manage such) Tj
T * (financial conflict of interest.Examples) Tj
19.667 74.667 Td(of conditions or restrictions that might) Tj
T * (be imposed to manage a financial) Tj
T * (conflict of interest include, but are not) Tj
T * (limited to: ) Tj
1 - 1.145 Td(\ (i\) Public disclosure of financial) Tj - 1 - 1.111 Td(conflicts of interest\ () Tj / T1_3 1 Tf
0 Tw(e.g.) Tj / T1_1 1 Tf - 0.0045 Tw(, when) Tj
T * (presenting or publishing the research\);) Tj
1 - 1.144 Td(\ (ii\) For research projects involving) Tj - 1 - 1.111 Td(human subjects research, disclosure of) Tj
T * (financial conflicts of interest directly to) Tj
0 Tw T * (participants;) Tj - 0.0045 Tw 1 - 1.133 Td(\ (iii\) Appointment of an independent) Tj - 1 - 1.111 Td(monitor capable of taking measures to) Tj
T * (protect the design, conduct, and) Tj
T * (reporting of the research against bias) Tj
T * (resulting from the financial conflict of) Tj
0 Tw T * (interest;) Tj - 0.0045 Tw 1 - 1.133 Td(\ (iv\) Modification of the research plan;) Tj
0 - 1.133 TD(\ (v\) Change of personnel or personnel) Tj - 1 - 1.111 Td(responsibilities, or disqualification of) Tj
0 - 1.111 TD(personnel from participation in all or a) Tj
T * (portion of the research;) Tj
1 - 1.133 Td(\ (vi\) Reduction or elimination of the) Tj - 1 - 1.111 Td(financial interest\ () Tj / T1_3 1 Tf
0 Tw(e.g.) Tj / T1_1 1 Tf - 0.0045 Tw(, sale of an equity) Tj
T * (interest\); or) Tj
1 - 1.133 Td(\ (vii\) Severance of relationships that) Tj - 1 - 1.111 Td(create financial conflicts.) Tj
1 - 1.133 Td(\ (2\) Whenever, in the course of an) Tj - 1 - 1.111 Td(ongoing PHS - funded research project, ) Tj
T * (an Investigator who is new to) Tj
T * (participating in the research project) Tj
T * (discloses a significant financial interest) Tj
T * (or an existing Investigator discloses a) Tj
T * (new significant financial interest to the) Tj
T * (Institution, the designated official\ (s\) of) Tj
T * (the Institution shall, within sixty days: ) Tj
T * (review the disclosure of the significant) Tj
T * (financial interest; determine whether it) Tj
T * (is related to PHS - funded research;) Tj
T * (determine whether a financial conflict) Tj
T * (of interest exists; and,
if so, implement, ) Tj
T * (on at least an interim basis, a) Tj
T * (management plan that shall specify the) Tj
T * (actions that have been, and will be, ) Tj
T * (taken to manage such financial conflict) Tj
T * (of interest.Depending on the nature of) Tj
T * (the significant financial interest, an) Tj
T * (Institution may determine that) Tj
T * (additional interim measures are) Tj
T * (necessary with regard to the) Tj
T * (Investigator\222s participation in the PHS - ) Tj
T * (funded research project between the) Tj
T * (date of disclosure and the completion of) Tj
T * (the Institution\222s review.) Tj
1 - 1.133 Td(\ (3\) Whenever an Institution identifies) Tj - 1 - 1.111 Td(a significant financial interest that was) Tj
T * (not disclosed timely by an Investigator) Tj
T * (or,
for whatever reason, was not) Tj
T * (previously reviewed by the Institution) Tj
T * (during an ongoing PHS - funded research) Tj
T * (project\ () Tj / T1_3 1 Tf
0 Tw(e.g.) Tj / T1_1 1 Tf - 0.0045 Tw(, was not timely reviewed or) Tj
T * (reported by a subrecipient\), the) Tj
T * (designated official\ (s\) shall, within sixty) Tj
T * (days: review the significant financial) Tj
T * (interest; determine whether it is related) Tj
T * (to PHS - funded research; determine) Tj
T * (whether a financial conflict of interest) Tj
T * (exists; and,
if so: ) Tj
20.667 74.667 Td(\ (i\) Implement, on at least an interim) Tj - 1 - 1.111 Td(basis, a management plan that shall) Tj
T * (specify the actions that have been, and) Tj
T * (will be, taken to manage such financial) Tj
T * (conflict of interest going forward;) Tj
1 - 1.033 Td(\ (ii\)\ (A\) In addition, whenever a) Tj - 1 - 1.111 Td(financial conflict of interest is not) Tj
T * (identified or managed in a timely) Tj
T * (manner including failure by the) Tj
T * (Investigator to disclose a significant) Tj
T * (financial interest that is determined by) Tj
T * (the Institution to constitute a financial) Tj
T * (conflict of interest; failure by the) Tj
T * (Institution to review or manage such a) Tj
T * (financial conflict of interest; or failure) Tj
T * (by the Investigator to comply with a) Tj
T * (financial conflict of interest) Tj
T * (management plan, the Institution shall, ) Tj
T * (within 120 days of the Institution\222s) Tj
T * (determination of noncompliance, ) Tj
T * (complete a retrospective review of the) Tj
T * (Investigator\222s activities and the PHS - ) Tj
T * (funded research project to determine) Tj
T * (whether any PHS - funded research, or) Tj
T * (portion thereof, conducted during the) Tj
T * (time period of the noncompliance, was) Tj
T * (biased in the design, conduct, or) Tj
T * (reporting of such research.) Tj
1 - 1.033 Td(\ (B\) The Institution is required to) Tj - 1 - 1.111 Td(document the retrospective review; such) Tj
T * (documentation shall include, but not) Tj
T * (necessarily be limited to, all of the) Tj
T * (following key elements: ) Tj
0 Tw 1 - 1.033 Td(\ () Tj / T1_3 1 Tf(1) Tj / T1_1 1 Tf - 0.0045 Tw(\) Project number;) Tj
0 Tw 0 - 1.033 TD(\ () Tj / T1_3 1 Tf(2) Tj / T1_1 1 Tf - 0.0045 Tw(\) Project title;) Tj / T1_3 1 Tf
0 Tw T * (\ (3\)) Tj / T1_1 1 Tf - 0.0045 Tw 1.495 0 Td(PD / PI or contact PD / PI
if a) Tj - 2.495 - 1.111 Td(multiple PD / PI model is used;) Tj / T1_3 1 Tf
0 Tw 1 - 1.033 Td(\ (4\)) Tj / T1_1 1 Tf - 0.0045 Tw 1.495 0 Td(Name of the Investigator with the) Tj
0 Tw - 2.495 - 1.111 Td(FCOI;) Tj / T1_3 1 Tf
1 - 1.033 Td(\ (5\)) Tj / T1_1 1 Tf - 0.0045 Tw 1.495 0 Td(Name of the entity with which the) Tj - 2.495 - 1.111 Td(Investigator has a financial conflict of) Tj
0 Tw 0 - 1.111 TD(interest;) Tj / T1_3 1 Tf
1 - 1.033 Td(\ (6\)) Tj / T1_1 1 Tf - 0.0045 Tw 1.495 0 Td(Reason\ (s\) for the retrospective) Tj
0 Tw - 2.495 - 1.111 Td(review;) Tj / T1_3 1 Tf
1 - 1.044 Td(\ (7\)) Tj / T1_1 1 Tf - 0.0045 Tw 1.495 0 Td(Detailed methodology used
for the) Tj - 2.495 - 1.111 Td(retrospective review\ () Tj / T1_3 1 Tf
0 Tw(e.g.) Tj / T1_1 1 Tf - 0.0045 Tw(, methodology) Tj
T * (of the review process, composition of) Tj
T * (the review panel, documents reviewed\);) Tj / T1_3 1 Tf
0 Tw 1 - 1.044 Td(\ (8\)) Tj / T1_1 1 Tf - 0.0045 Tw 1.495 0 Td(Findings of the review; and) Tj / T1_3 1 Tf
0 Tw - 1.495 - 1.044 Td(\ (9\)) Tj / T1_1 1 Tf - 0.0045 Tw 1.495 0 Td(Conclusions of the review.) Tj - 1.495 - 1.044 Td(\ (iii\) Based on the results of the) Tj - 1 - 1.111 Td(retrospective review,
if appropriate, the) Tj
T * (Institution shall update the previously) Tj
T * (submitted FCOI report, specifying the) Tj
T * (actions that will be taken to manage the) Tj
T * (financial conflict of interest going) Tj
T * (forward.If bias is found, the Institution) Tj
T * (is required to notify the PHS Awarding) Tj
T * (Component promptly and submit a) Tj
T * (mitigation report to the PHS Awarding) Tj
T * (Component.The mitigation report must) Tj
T * (include, at a minimum, the key) Tj
T * (elements documented in the) Tj
T * (retrospective review above and a) Tj
T * (description of the impact of the bias on) Tj
T * (the research project and the Institution\222s) Tj
T * (plan of action or actions taken to) Tj
T * (eliminate or mitigate the effect of the) Tj
T * (bias\ () Tj / T1_3 1 Tf
0 Tw(e.g.) Tj / T1_1 1 Tf - 0.0045 Tw(, impact on the research) Tj
1 g / T1_4 1 Tf
0 Tw 6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(17: 26 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00032) - 1077(Fmt 4701) - 1077(Sfmt 4700) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

// peepdf comment: Javascript code located in object 195 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 536.42 750 Tm(53287) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
-0.0045 Tw 9 0 0 9 45 725 Tm
(project; extent of harm done, including )Tj
0 -1.1 TD
(any qualitative and quantitative data to )Tj
T*
(support any actual or future harm; )Tj
T*
(analysis of whether the research project )Tj
T*
(is salvageable\). Thereafter, the )Tj
T*
(Institution will submit FCOI reports )Tj
T*
(annually, as specified elsewhere in this )Tj
T*
(subpart. Depending on the nature of the )Tj
T*
(financial conflict of interest, an )Tj
T*
(Institution may determine that )Tj
T*
(additional interim measures are )Tj
T*
(necessary with regard to the )Tj
T*
(Investigator\222s participation in the PHS- )Tj
T*
(funded research project between the )Tj
T*
(date that the financial conflict of )Tj
T*
(interest or the Investigator\222s )Tj
T*
(noncompliance is determined and the )Tj
T*
(completion of the Institution\222s )Tj
T*
(retrospective review. )Tj
1 -1.022 Td
(\(4\) Whenever an Institution )Tj
-1 -1.1 Td
(implements a management plan )Tj
T*
(pursuant to this subpart, the Institution )Tj
T*
(shall monitor Investigator compliance )Tj
T*
(with the management plan on an )Tj
T*
(ongoing basis until the completion of )Tj
T*
(the PHS-funded research project. )Tj
1 -1.022 Td
(\(5\)\(i\) Prior to the Institution\222s )Tj
-1 -1.1 Td
(expenditure of any funds under a PHS- )Tj
T*
(funded research project, the Institution )Tj
T*
(shall ensure public accessibility, via a )Tj
T*
(publicly accessible Web site or written )Tj
T*
(response to any requestor within five )Tj
T*
(business days of a request, of )Tj
T*
(information concerning any significant )Tj
T*
(financial interest disclosed to the )Tj
0 -1.111 TD
(Institution that meets the following )Tj
T*
(three criteria: )Tj
1 -1.022 Td
(\(A\) The significant financial interest )Tj
-1 -1.111 Td
(was disclosed and is still held by the )Tj
T*
(senior/key
personnel as defined by this) Tj
0 Tw T * (subpart;) Tj - 0.0045 Tw 1 - 1.022 Td(\ (B\) The Institution determines that the) Tj - 1 - 1.111 Td(significant financial interest is related to) Tj
T * (the PHS - funded research; and) Tj
1 - 1.022 Td(\ (C\) The Institution determines that the) Tj - 1 - 1.111 Td(significant financial interest is a) Tj
T * (financial conflict of interest.) Tj
1 - 1.022 Td(\ (ii\) The information that the) Tj - 1 - 1.111 Td(Institution makes available via a) Tj
T * (publicly accessible Web site or written) Tj
T * (response to any requestor within five) Tj
T * (business days of a request, shall) Tj
T * (include, at a minimum, the following: ) Tj
T * (the Investigator\222s name; the) Tj
T * (Investigator\222s title and role with respect) Tj
T * (to the research project; the name of the) Tj
T * (entity in which the significant financial) Tj
T * (interest is held; the nature of the) Tj
T * (significant financial interest; and the) Tj
T * (approximate dollar value of the) Tj
T * (significant financial interest\ (dollar) Tj
T * (ranges are permissible: $0\226$4,
999;) Tj
T * ($5, 000\226$9, 999; $10, 000\226$19, 999;) Tj
T * (amounts between $20, 000\226$100, 000 by) Tj
T * (increments of $20, 000; amounts above) Tj
T * ($100, 000 by increments of $50, 000\), or) Tj
T * (a statement that the interest is one) Tj
T * (whose value cannot be readily) Tj
T * (determined through reference to public) Tj
19.667 74.667 Td(prices or other reasonable measures of) Tj
0 - 1.1 TD(fair market value.) Tj
1 - 1.022 Td(\ (iii\) If the Institution uses a publicly) Tj - 1 - 1.1 Td(accessible Web site
for the purposes of) Tj
T * (this subsection, the information that the) Tj
T * (Institution posts shall be updated at) Tj
T * (least annually.In addition, the) Tj
T * (Institution shall update the Web site) Tj
T * (within sixty days of the Institution\222s) Tj
T * (receipt or identification of information) Tj
T * (concerning any additional significant) Tj
T * (financial interest of the senior / key) Tj
T * (personnel
for the PHS - funded research) Tj
T * (project that was not previously) Tj
T * (disclosed, or upon the disclosure of a) Tj
T * (significant financial interest of senior / ) Tj
T * (key personnel new to the PHS - funded) Tj
T * (research project,
if the Institution) Tj
T * (determines that the significant financial) Tj
T * (interest is related to the PHS - funded) Tj
T * (research and is a financial conflict of) Tj
T * (interest.The Web site shall note that the) Tj
T * (information provided is current as of the) Tj
T * (date listed and is subject to updates, on) Tj
T * (at least an annual basis and within 60) Tj
T * (days of the Institution\222s identification of) Tj
T * (a new financial conflict of interest.If the) Tj
T * (Institution responds to written requests) Tj
T * (
for the purposes of this subsection, the) Tj
T * (Institution will note in its written) Tj
T * (response that the information provided) Tj
T * (is current as of the date of the) Tj
T * (correspondence and is subject to) Tj
T * (updates, on at least an annual basis and) Tj
T * (within 60 days of the Institution\222s) Tj
T * (identification of a new financial conflict) Tj
T * (of interest, which should be requested) Tj
T * (subsequently by the requestor.) Tj
1 - 1.022 Td(\ (iv\) Information concerning the) Tj - 1 - 1.1 Td(significant financial interests of an) Tj
T * (individual subject to paragraph\ (a\)\ (5\) of) Tj
T * (this section shall remain available,
for) Tj
T * (responses to written requests or
for) Tj
0 - 1.111 TD(posting via the Institution\222s publicly) Tj
T * (accessible Web site
for at least three) Tj
T * (years from the date that the information) Tj
T * (was most recently updated.) Tj
1 - 1.022 Td(\ (6\) In addition to the types of) Tj - 1 - 1.111 Td(financial conflicts of interest as defined) Tj
T * ( in this subpart that must be managed) Tj
T * (pursuant to this section, an Institution) Tj
T * (may require the management of other) Tj
T * (financial conflicts of interest in its) Tj
T * (policy on financial conflicts of interest, ) Tj
T * (as the Institution deems appropriate.) Tj
1 - 1.022 Td(\ (b\) Reporting of financial conflicts of) Tj
0 Tw - 1 - 1.111 Td(interest.) Tj - 0.0045 Tw 1 - 1.022 Td(\ (1\) Prior to the Institution\222s) Tj - 1 - 1.111 Td(expenditure of any funds under a PHS - ) Tj
T * (funded research project, the Institution) Tj
T * (shall provide to the PHS Awarding) Tj
T * (Component an FCOI report regarding) Tj
T * (any Investigator\222s significant financial) Tj
T * (interest found by the Institution to be) Tj
T * (conflicting and ensure that the) Tj
T * (Institution has implemented a) Tj
T * (management plan in accordance with) Tj
T * (this subpart.In cases in which the) Tj
T * (Institution identifies a financial conflict) Tj
19.667 74.667 Td(of interest and eliminates it prior to the) Tj
0 - 1.1 TD(expenditure of PHS - awarded funds, the) Tj
T * (Institution shall not submit an FCOI) Tj
T * (report to the PHS Awarding Component.) Tj
1 - 1.022 Td(\ (2\) For any significant financial) Tj - 1 - 1.1 Td(interest that the Institution identifies as) Tj
T * (conflicting subsequent to the) Tj
T * (Institution\222s initial FCOI report during) Tj
T * (an ongoing PHS - funded research project) Tj
0 Tw T * (\ () Tj / T1_2 1 Tf(e.g.) Tj / T1_1 1 Tf - 0.0045 Tw(, upon the participation of an) Tj
T * (Investigator who is new to the research) Tj
T * (project\), the Institution shall provide to) Tj
T * (the PHS Awarding Component, within) Tj
T * (sixty days, an FCOI report regarding the) Tj
T * (financial conflict of interest and ensure) Tj
T * (that the Institution has implemented a) Tj
T * (management plan in accordance with) Tj
T * (this subpart.Pursuant to paragraph) Tj
0 - 1.111 TD(\ (a\)\ (3\)\ (ii\) of this section, where such) Tj
T * (FCOI report involves a significant) Tj
T * (financial interest that was not disclosed) Tj
T * (timely by an Investigator or,
for) Tj
T * (whatever reason, was not previously) Tj
T * (reviewed or managed by the Institution) Tj
0 Tw T * (\ () Tj / T1_2 1 Tf(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 2.441 0 Td(was not timely reviewed or) Tj - 2.441 - 1.111 Td(reported by a subrecipient\), the) Tj
T * (Institution also is required to complete) Tj
T * (a retrospective review to determine) Tj
T * (whether any PHS - funded research, or) Tj
T * (portion thereof, conducted prior to the) Tj
T * (identification and management of the) Tj
T * (financial conflict of interest was biased) Tj
T * ( in the design, conduct, or reporting of) Tj
T * (such research.Additionally, pursuant to) Tj
T * (paragraph\ (a\)\ (3\)\ (iii\) of this section,
if) Tj
T * (bias is found, the Institution is required) Tj
T * (to notify the PHS Awarding Component) Tj
T * (promptly and submit a mitigation report) Tj
T * (to the PHS Awarding Component.) Tj
1 - 1.022 Td(\ (3\) Any FCOI report required under) Tj - 1 - 1.111 Td(paragraphs\ (b\)\ (1\) or\ (b\)\ (2\) of this section) Tj
T * (shall include sufficient information to) Tj
T * (enable the PHS Awarding Component to) Tj
T * (understand the nature and extent of the) Tj
T * (financial conflict, and to assess the) Tj
T * (appropriateness of the Institution\222s) Tj
T * (management plan.Elements of the FCOI) Tj
T * (report shall include, but are not) Tj
T * (necessarily limited to the following: ) Tj
1 - 1.022 Td(\ (i\) Project number;) Tj
0 - 1.022 TD(\ (ii\) PD / PI or Contact PD / PI
if a) Tj - 1 - 1.111 Td(multiple PD / PI model is used;) Tj
1 - 1.022 Td(\ (iii\) Name of the Investigator with the) Tj - 1 - 1.111 Td(financial conflict of interest;) Tj
1 - 1.022 Td(\ (iv\) Name of the entity with which the) Tj - 1 - 1.111 Td(Investigator has a financial conflict of) Tj
0 Tw 0 - 1.111 TD(interest;) Tj - 0.0045 Tw 1 - 1.022 Td(\ (v\) Nature of the financial interest) Tj
0 Tw - 1 - 1.111 Td(\ () Tj / T1_2 1 Tf(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 2.441 0 Td(equity, consulting fee, travel) Tj - 2.441 - 1.111 Td(reimbursement, honorarium\);) Tj
1 - 1.022 Td(\ (vi\) Value of the financial interest) Tj - 1 - 1.111 Td(\ (dollar ranges are permissible: $0\226) Tj
T * ($4, 999; $5, 000\226$9, 999; $10, 000\226) Tj
T * ($19, 999; amounts between $20, 000\226) Tj
T * ($100, 000 by increments of $20, 000;) Tj
T * (amounts above $100, 000 by increments) Tj
T * (of $50, 000\), or a statement that the) Tj
T * (interest is one whose value cannot be) Tj
T * (readily determined through reference to) Tj
1 g / T1_3 1 Tf
0 Tw 6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(17: 26 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00033) - 1077(Fmt 4701) - 1077(Sfmt 4700) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

// peepdf comment: Javascript code located in object 198 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 45 750 Tm(53288) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
-0.0045 Tw 9 0 0 9 45 725 Tm
(public prices or other reasonable )Tj
0 -1.111 TD
(measures of fair market value; )Tj
1 -1.044 Td
(\(vii\) A description of how the )Tj
-1 -1.111 Td
(financial interest relates to the PHS- )Tj
T*
(funded research and the basis for the )Tj
T*
(Institution\222s determination that the )Tj
T*
(financial interest conflicts with such )Tj
T*
(research; and )Tj
1 -1.044 Td
(\(viii\) A description of the key )Tj
-1 -1.111 Td
(elements of the Institution\222s )Tj
T*
(management plan, including: )Tj
1 -1.044 Td
(\(A\) Role and principal duties of the )Tj
-1 -1.111 Td
(conflicted Investigator in the research )Tj
0 Tw T*
(project; )Tj
-0.0045 Tw 1 -1.044 Td
(\(B\) Conditions of the management )Tj
0 Tw -1 -1.111 Td
(plan; )Tj
-0.0045 Tw 1 -1.044 Td
(\(C\) How the management plan is )Tj
-1 -1.111 Td
(designed to safeguard objectivity in the )Tj
T*
(research project; )Tj
1 -1.056 Td
(\(D\) Confirmation of the Investigator\222s )Tj
-1 -1.111 Td
(agreement to the management plan; )Tj
1 -1.056 Td
(\(E\) How the management plan will be )Tj
-1 -1.111 Td
(monitored to ensure Investigator )Tj
T*
(compliance; and )Tj
1 -1.056 Td
(\(F\) Other information as needed. )Tj
0 -1.056 TD
(\(4\) For any financial conflict of )Tj
-1 -1.111 Td
(interest previously reported by the )Tj
0 -1.111 TD
(Institution with regard to an ongoing )Tj
T*
(PHS-funded research project, the )Tj
T*
(Institution shall provide to the PHS )Tj
T*
(Awarding Component an annual FCOI )Tj
T*
(report that addresses the status of the )Tj
T*
(financial conflict of interest and any )Tj
T*
(changes to the management plan for the )Tj
T*
(duration of the PHS-funded research )Tj
T*
(project. The annual FCOI report shall )Tj
T*
(specify whether the financial conflict is )Tj
T*
(still being managed or explain why the )Tj
T*
(financial conflict of interest no longer )Tj
T*
(exists. The Institution shall provide )Tj
T*
(annual FCOI reports to the PHS )Tj
T*
(Awarding Component for the duration )Tj
T*
(of the project period \(including )Tj
T*
(extensions with or without funds\) in the )Tj
T*
(time and manner specified by the PHS )Tj
T*
(Awarding Component. )Tj
1 -1.056 Td
(\(5\) In addition to the types of )Tj
-1 -1.111 Td
(financial conflicts of interest as defined )Tj
T*
(in this subpart that must be reported )Tj
T*
(pursuant to this section, an Institution )Tj
T*
(may require the reporting of other )Tj
T*
(financial conflicts of interest in its )Tj
T*
(policy on financial conflicts of interest, )Tj
T*
(as the Institution deems appropriate. )Tj
/T1_2
1 Tf
0 Tw 8 0 0 8 45 184.5004 Tm[(\247) - 165(50.606) - 1000(Remedies.)] TJ / T1_1 1 Tf - 0.0045 Tw 9 0 0 9 54 173.0004 Tm(\ (a\) If the failure of an Investigator to) Tj - 1 - 1.111 Td(comply with an Institution\222s financial) Tj
T * (conflicts of interest policy or a financial) Tj
T * (conflict of interest management plan) Tj
T * (appears to have biased the design, ) Tj
T * (conduct, or reporting of the PHS - funded) Tj
T * (research, the Institution shall promptly) Tj
T * (notify the PHS Awarding Component of) Tj
T * (the corrective action taken or to be) Tj
T * (taken.The PHS Awarding Component) Tj
T * (will consider the situation and, as) Tj
T * (necessary, take appropriate action, or) Tj
T * (refer the matter to the Institution
for) Tj
19.667 74.667 Td(further action, which may include) Tj
0 - 1.1 TD(directions to the Institution on how to) Tj
T * (maintain appropriate objectivity in the) Tj
T * (PHS - funded research project.PHS may, ) Tj
T * (
for example, require Institutions) Tj
T * (employing such an Investigator to) Tj
T * (enforce any applicable corrective) Tj
T * (actions prior to a PHS award or when) Tj
T * (the transfer of a PHS grant\ (s\) involves) Tj
T * (such an Investigator.) Tj
1 - 1.022 Td(\ (b\) The PHS Awarding Component) Tj - 1 - 1.1 Td(and / or HHS may inquire at any time) Tj
T * (before, during, or after award into any) Tj
T * (Investigator disclosure of financial) Tj
T * (interests and the Institution\222s review) Tj
T * (\ (including any retrospective review\) of, ) Tj
T * (and response to, such disclosure, ) Tj
T * (regardless of whether the disclosure) Tj
T * (resulted in the Institution\222s) Tj
T * (determination of a financial conflict of) Tj
T * (interest.An Institution is required to) Tj
T * (submit, or permit on site review of, all) Tj
T * (records pertinent to compliance with) Tj
T * (this subpart.To the extent permitted by) Tj
T * (law, HHS will maintain the) Tj
T * (confidentiality of all records of financial) Tj
T * (interests.On the basis of its review of) Tj
T * (records or other information that may be) Tj
T * (available, the PHS Awarding) Tj
T * (Component may decide that a particular) Tj
T * (financial conflict of interest will bias the) Tj
T * (objectivity of the PHS - funded research) Tj
T * (to such an extent that further corrective) Tj
T * (action is needed or that the Institution) Tj
T * (has not managed the financial conflict) Tj
T * (of interest in accordance with this) Tj
T * (subpart.The PHS Awarding Component) Tj
T * (may determine that imposition of) Tj
T * (special award conditions under 45 CFR) Tj
T * (74.14 and 92.12, or suspension of) Tj
0 - 1.111 TD(funding or other enforcement action) Tj
T * (under 45 CFR 74.62 and 92.43, is) Tj
T * (necessary until the matter is resolved.) Tj
1 - 1.022 Td(\ (c\) In any
case inwhich the HHS) Tj - 1 - 1.111 Td(determines that a PHS - funded project of) Tj
T * (clinical research whose purpose is to) Tj
T * (evaluate the safety or effectiveness of a) Tj
T * (drug, medical device, or treatment has) Tj
T * (been designed, conducted, or reported) Tj
T * (by an Investigator with a financial) Tj
T * (conflict of interest that was not managed) Tj
T * (or reported by the Institution as) Tj
T * (required by this subpart, the Institution) Tj
T * (shall require the Investigator involved to) Tj
T * (disclose the financial conflict of interest) Tj
T * ( in each public presentation of the) Tj
T * (results of the research and to request an) Tj
T * (addendum to previously published) Tj
0 Tw T * (presentations.) Tj / T1_2 1 Tf - 0.0025 Tw 8 0 0 8 222 134.6001 Tm[(\247) - 165(50.607) - 1000(Other HHS regulations that apply.)] TJ / T1_1 1 Tf - 0.0045 Tw 9 0 0 9 231 123.4 Tm(Several other regulations and policies) Tj - 1 - 1.111 Td(apply to this subpart.They include, but) Tj
T * (are not necessarily limited to: ) Tj
0 - 1.244 TD(2 CFR part 376\227Nonprocurement) Tj
2 - 1.111 Td(debarment and suspension\ (HHS\)) Tj - 2 - 1.022 Td(42 CFR part 50, subpart D\227Public) Tj
2 - 1.111 Td(Health Service grant appeals) Tj
0 Tw 0 - 1.111 TD(procedure) Tj - 0.0045 Tw 17.667 74.667 Td(45 CFR part 16\227Procedures of the) Tj
2 - 1.111 Td(Departmental Grant Appeals Board) Tj - 2 - 1.111 Td(45 CFR part 74\227Uniform administrative) Tj
2 - 1.111 Td(requirements
for awards and) Tj
T * (subawards to institutions of higher) Tj
T * (education, hospitals, other) Tj
T * (nonprofit organizations, and) Tj
T * (commercial organizations) Tj - 2 - 1.111 Td(45 CFR part 79\227Program fraud civil) Tj
0 Tw 2 - 1.111 Td(remedies) Tj - 0.0045 Tw - 2 - 1.111 Td(45 CFR part 92\227Uniform administrative) Tj
2 - 1.111 Td(requirements
for grants and) Tj
T * (cooperative agreements to State, ) Tj
T * (local, and tribal governments) Tj / T1_0 1 Tf - 2 - 1.667 Td(TITLE 45\227PUBLIC WELFARE) Tj / T1_3 1 Tf
0 Tw 7 0 0 7 399 564.0003 Tm(\002) Tj / T1_1 1 Tf - 0.0644 Tw 9 0 0 9 407.3271 564.0003 Tm(2.Revise Part 94 to read as follows: ) Tj / T1_2 1 Tf - 0.0045 Tw - 0.925 - 2 Td(PART 94\227RESPONSIBLE) Tj
T * (PROSPECTIVE CONTRACTORS) Tj / T1_1 1 Tf
0 Tw 8 0 0 8 399 520.0003 Tm(Sec.) Tj
0 - 1.125 TD[(94.1) - 1000(Purpose.)] TJ
T * [(94.2) - 1000(Applicability.)] TJ
T * [(94.3) - 1000(Definitions.)] TJ - 0.0025 Tw T * [(94.4) - 1000(Responsibilities of Institutions)] TJ
2 - 1.125 Td(regarding Investigator financial conflicts) Tj
T * (of interest.) Tj - 2 - 1.125 Td[(94.5) - 1000(Management and reporting of financial)] TJ
2 - 1.125 Td(conflicts of interest.) Tj
0 Tw - 2 - 1.125 Td[(94.6) - 1000(Remedies.)] TJ / T1_0 1 Tf
1 - 1.625 Td(Authority: ) Tj / T1_1 1 Tf - 0.0025 Tw 5.108 0 Td(42 U.S.C.216, 289b\2261, 299c\226) Tj
0 Tw - 6.108 - 1.125 Td(4.) Tj / T1_2 1 Tf
0 - 2 TD[(\247) - 165(94.1) - 1000(Purpose.)] TJ / T1_1 1 Tf - 0.0045 Tw 9 0 0 9 408 389.0003 Tm(This part promotes objectivity in ) Tj - 1 - 1.111 Td(research by establishing standards that) Tj
0 - 1.111 TD(provide a reasonable expectation that) Tj
T * (the design, conduct, and reporting of) Tj
T * (research performed under PHS contracts) Tj
T * (will be free from bias resulting from) Tj
T * (Investigator financial conflicts of) Tj
0 Tw T * (interest.) Tj / T1_2 1 Tf
8 0 0 8 399 303.0003 Tm[(\247) - 165(94.2) - 1000(Applicability.)] TJ / T1_1 1 Tf - 0.0045 Tw 9 0 0 9 408 291.0003 Tm(This part is applicable to each) Tj - 1 - 1.111 Td(Institution that submits a proposal, or) Tj
T * (that receives, Public Health Service) Tj
T * (\ (PHS\) research funding by means of a) Tj
T * (contract and, through the) Tj
T * (implementation of this part by the) Tj
T * (Institution, to each Investigator who is) Tj
T * (planning to participate in , or is) Tj
T * (participating in such research; provided, ) Tj
T * (however, that this part does not apply) Tj
T * (to SBIR Program Phase I applications.) Tj / T1_2 1 Tf
0 Tw 8 0 0 8 399 175.0003 Tm[(\247) - 165(94.3) - 1000(Definitions.)] TJ / T1_1 1 Tf - 0.0045 Tw 9 0 0 9 408 163.0003 Tm(As used in this part: ) Tj / T1_4 1 Tf
0 Tw T * (Contractor) Tj / T1_1 1 Tf - 0.0045 Tw 5.163 0 Td(means an entity that) Tj - 6.163 - 1.111 Td(provides property or services under) Tj
T * (contract
for the direct benefit or use of) Tj
T * (the Federal Government.) Tj / T1_4 1 Tf
1 - 1.111 Td(Disclosure of significant financial) Tj
0 Tw - 1 - 1.111 Td(interests) Tj / T1_1 1 Tf - 0.0045 Tw 4.142 0 Td(means an Investigator\222s) Tj - 4.142 - 1.111 Td(disclosure of significant financial) Tj
T * (interests to an Institution.) Tj / T1_4 1 Tf
1 - 1.111 Td(Financial conflict of interest) Tj / T1_1 1 Tf
0 Tw(\ (FCOI\)) Tj - 0.0045 Tw - 1 - 1.111 Td(means a significant financial interest) Tj
T * (that could directly and significantly) Tj
1 g / T1_5 1 Tf
0 Tw 6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(17: 26 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00034) - 1077(Fmt 4701) - 1077(Sfmt 4700) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

// peepdf comment: Javascript code located in object 201 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 536.42 750 Tm(53289) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
-0.0045 Tw 9 0 0 9 45 725 Tm
(affect the design, conduct, or reporting )Tj
0 -1.111 TD
(of PHS-funded research. )Tj
/T1_2
1 Tf
1 - 1.022 Td(FCOI report) Tj / T1_1 1 Tf(means an Institution\222s) Tj - 1 - 1.111 Td(report of a financial conflict of interest) Tj
T * (to a PHS Awarding Component.) Tj / T1_2 1 Tf
1 - 1.022 Td(Financial interest) Tj / T1_1 1 Tf(means anything of) Tj - 1 - 1.111 Td(monetary value, whether or not the) Tj
T * (value is readily ascertainable.) Tj / T1_2 1 Tf
0 Tw 1 - 1.022 Td(HHS) Tj / T1_1 1 Tf - 0.0045 Tw 2.441 0 Td(means the United States) Tj - 3.441 - 1.111 Td(Department of Health and Human) Tj
T * (Services, and any components of the) Tj
T * (Department to which the authority) Tj
T * (involved may be delegated.) Tj / T1_2 1 Tf
0 Tw 1 - 1.033 Td(Institution) Tj / T1_1 1 Tf - 0.0045 Tw 5.068 0 Td(means any domestic or) Tj - 6.068 - 1.111 Td(foreign, public or private, entity or) Tj
T * (organization\ (excluding a Federal) Tj
T * (agency\) that submits a proposal, or that) Tj
T * (receives, PHS research funding.) Tj / T1_2 1 Tf
1 - 1.033 Td(Institutional responsibilities) Tj / T1_1 1 Tf(means an) Tj - 1 - 1.111 Td(Investigator\222s professional) Tj
T * (responsibilities on behalf of the) Tj
T * (Institution, and as defined by the) Tj
T * (Institution in its policy on financial) Tj
T * (conflicts of interest, which may include) Tj
T * (
for example: activities such as research,
) Tj
T * (research consultation, teaching, ) Tj
T * (professional practice, institutional) Tj
T * (committee memberships, and service on) Tj
T * (panels such as Institutional Review) Tj
T * (Boards or Data and Safety Monitoring) Tj
0 Tw T * (Boards.) Tj / T1_2 1 Tf
1 - 1.033 Td(Investigator) Tj / T1_1 1 Tf - 0.0045 Tw 5.662 0 Td(means the project director) Tj - 6.662 - 1.111 Td(or principal Investigator and any other) Tj
T * (person, regardless of title or position, ) Tj
T * (who is responsible
for the design, ) Tj
T * (conduct, or reporting of research funded) Tj
T * (by the PHS, or proposed
for such) Tj
T * (funding, which may include,
for) Tj
T * (example, collaborators or consultants.) Tj / T1_2 1 Tf
1 - 1.033 Td(Key personnel) Tj / T1_1 1 Tf(includes the PD / PI and) Tj - 1 - 1.111 Td(any other personnel considered to be) Tj
T * (essential to work performance in ) Tj
T * (accordance with HHSAR subpart) Tj
T * (352.242\22670 and identified as key) Tj
T * (personnel in the contract proposal and) Tj
0 Tw T * (contract.) Tj / T1_2 1 Tf
1 - 1.033 Td(Manage) Tj / T1_1 1 Tf - 0.0045 Tw 3.885 0 Td(means taking action to) Tj - 4.885 - 1.111 Td(address a financial conflict of interest, ) Tj
T * (which can include reducing or) Tj
T * (eliminating the financial conflict of) Tj
T * (interest, to ensure, to the extent) Tj
T * (possible, that the design, conduct, and) Tj
T * (reporting of research will be free from) Tj
0 Tw T * (bias.) Tj / T1_2 1 Tf
1 - 1.033 Td(PD / PI) Tj / T1_1 1 Tf - 0.0045 Tw 2.939 0 Td(means a project director or) Tj - 3.939 - 1.111 Td(principal Investigator of a PHS - funded) Tj
T * (research project; the PD / PI is included) Tj
T * ( in the definitions of key personnel and) Tj
T * (Investigator under this part.) Tj / T1_2 1 Tf
0 Tw 1 - 1.033 Td(PHS) Tj / T1_1 1 Tf - 0.0045 Tw 2.274 0 Td(means the Public Health Service) Tj - 3.274 - 1.111 Td(of the U.S.Department of Health and) Tj
T * (Human Services, and any components) Tj
T * (of the PHS to which the authority) Tj
T * (involved may be delegated, including) Tj
T * (the National Institutes of Health\ (NIH\).) Tj / T1_2 1 Tf
1 - 1.033 Td(PHS Awarding Component) Tj / T1_1 1 Tf(means the) Tj - 1 - 1.111 Td(organizational unit of the PHS that) Tj
T * (funds the research that is subject to this) Tj
0 Tw T * (part.) Tj / T1_2 1 Tf - 0.0045 Tw 20.667 74.667 Td(Public Health Service Act) Tj / T1_1 1 Tf
0 Tw(or) Tj / T1_2 1 Tf - 0.0045 Tw 13.239 0 Td(PHS Act) Tj / T1_1 1 Tf - 14.239 - 1.1 Td(means the statute codified at 42 U.S.C.) Tj
0 Tw 0 - 1.1 TD(201) Tj / T1_2 1 Tf - 0.0045 Tw 1.941 0 Td(et seq.) Tj
0 Tw - 0.941 - 1.022 Td(Research) Tj / T1_1 1 Tf - 0.0045 Tw 4.44 0 Td(means a systematic) Tj - 5.44 - 1.1 Td(investigation, study or experiment) Tj
T * (designed to develop or contribute to) Tj
T * (generalizable knowledge relating) Tj
T * (broadly to public health, including) Tj
T * (behavioral and social - sciences research.) Tj
T * (The term encompasses basic and) Tj
T * (applied research\ () Tj / T1_2 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 10.319 0 Td(a published) Tj - 10.319 - 1.1 Td(article, book or book chapter\) and) Tj
T * (product development\ () Tj / T1_2 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 12.598 0 Td(a diagnostic) Tj - 12.598 - 1.1 Td(test or drug\).As used in this part, the) Tj
T * (term includes any such activity
for) Tj
T * (which research funding is available) Tj
T * (from a PHS Awarding Component) Tj
T * (through a contract, whether authorized) Tj
T * (under the PHS Act or other statutory) Tj
0 Tw T * (authority.) Tj / T1_2 1 Tf - 0.0045 Tw 1 - 1.022 Td(Significant financial interest) Tj / T1_1 1 Tf
0 Tw(means: ) Tj - 0.0045 Tw 0 - 1.022 TD(\ (1\) A financial interest consisting of) Tj - 1 - 1.1 Td(one or more of the following interests of) Tj
0 - 1.1 TD(the Investigator\ (and those of the) Tj
T * (Investigator\222s spouse and dependent) Tj
T * (children\) that reasonably appears to be) Tj
T * (related to the Investigator\222s institutional) Tj
0 Tw T * (responsibilities: ) Tj - 0.0045 Tw 1 - 1.022 Td(\ (i\) With regard to any publicly traded) Tj - 1 - 1.111 Td(entity, a) Tj / T1_2 1 Tf(significant financial interest) Tj / T1_1 1 Tf
0 - 1.111 TD(exists
if the value of any remuneration) Tj
T * (received from the entity in the twelve) Tj
T * (months preceding the disclosure and) Tj
T * (the value of any equity interest in the) Tj
T * (entity as of the date of disclosure, when) Tj
T * (aggregated, exceeds $5, 000.For) Tj
T * (purposes of this definition, ) Tj
T * (remuneration includes salary and any) Tj
T * (payment
for services not otherwise) Tj
T * (identified as salary\ () Tj / T1_2 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 11.425 0 Td(consulting fees, ) Tj - 11.425 - 1.111 Td(honoraria, paid authorship\); equity) Tj
T * (interest includes any stock, stock) Tj
T * (option, or other ownership interest, as) Tj
T * (determined through reference to public) Tj
T * (prices or other reasonable measures of) Tj
T * (fair market value;) Tj
1 - 1.022 Td(\ (ii\) With regard to any non - publicly) Tj - 1 - 1.111 Td(traded entity, a) Tj / T1_2 1 Tf(significant financial) Tj
0 Tw T * (interest) Tj / T1_1 1 Tf - 0.0045 Tw 3.698 0 Td(exists
if the value of any) Tj - 3.698 - 1.111 Td(remuneration received from the entity) Tj
T * ( in the twelve months preceding the) Tj
T * (disclosure, when aggregated, exceeds) Tj
T * ($5, 000, or when the Investigator\ (or the) Tj
T * (Investigator\222s spouse or dependent) Tj
T * (children\) holds any equity interest\ () Tj / T1_2 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw T * (stock, stock option, or other ownership) Tj
T * (interest\); or) Tj
1 - 1.022 Td(\ (iii\) Intellectual property rights and) Tj - 1 - 1.111 Td(interests\ () Tj / T1_2 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 6.601 0 Td(patents, copyrights\), upon) Tj - 6.601 - 1.111 Td(receipt of income related to such rights) Tj
T * (and interests.) Tj
1 - 1.022 Td(\ (2\) Investigators also must disclose) Tj - 1 - 1.111 Td(the occurrence of any reimbursed or) Tj
T * (sponsored travel\ () Tj / T1_2 1 Tf
0 Tw(i.e., ) Tj / T1_1 1 Tf - 0.0045 Tw 10.135 0 Td(that which is paid) Tj - 10.135 - 1.111 Td(on behalf of the Investigator and not) Tj
T * (reimbursed to the Investigator so that) Tj
T * (the exact monetary value may not be) Tj
T * (readily available\), related to their) Tj
T * (Institutional responsibilities; provided, ) Tj
19.667 74.667 Td(however, that this disclosure) Tj
0 - 1.1 TD(requirement does not apply to travel) Tj
T * (that is reimbursed or sponsored by a) Tj
T * (Federal, state, or local government) Tj
T * (agency, an Institution of higher) Tj
T * (education as defined at 20 U.S.C.) Tj
T * (1001\ (a\), an academic teaching hospital, ) Tj
T * (a medical center, or a research institute) Tj
T * (that is affiliated with an Institution of) Tj
T * (higher education.The Institution\222s FCOI) Tj
T * (policy will specify the details of this) Tj
T * (disclosure, which will include, at a) Tj
T * (minimum, the purpose of the trip, the) Tj
T * (identity of the sponsor / organizer, the) Tj
T * (destination, and the duration.In) Tj
T * (accordance with the Institution\222s FCOI) Tj
T * (policy, the Institutional official\ (s\) will) Tj
T * (determine
if further information is) Tj
T * (needed, including a determination or) Tj
T * (disclosure of monetary value, in order to) Tj
T * (determine whether the travel constitutes) Tj
T * (an FCOI with the PHS - funded research.) Tj
1 - 1.022 Td(\ (3\) The term) Tj / T1_2 1 Tf(significant financial) Tj
0 Tw - 1 - 1.1 Td(interest) Tj / T1_1 1 Tf - 0.0045 Tw 3.698 0 Td(does not include the following) Tj - 3.698 - 1.1 Td(types of financial interests: salary,
) Tj
T * (royalties, or other remuneration paid by) Tj
T * (the Institution to the Investigator
if the) Tj
T * (Investigator is currently employed or) Tj
T * (otherwise appointed by the Institution, ) Tj
T * (including intellectual property rights) Tj
T * (assigned to the Institution and) Tj
T * (agreements to share in royalties related) Tj
T * (to such rights; any ownership interest in ) Tj
T * (the Institution held by the Investigator, ) Tj
T * (
if the Institution is a commercial or
for -) Tj
T * (profit organization; income from) Tj
T * (investment vehicles, such as mutual) Tj
T * (funds and retirement accounts, as long) Tj
T * (as the Investigator does not directly) Tj
T * (control the investment decisions made) Tj
T * ( in these vehicles; income from) Tj
T * (seminars, lectures, or teaching) Tj
T * (engagements sponsored by a Federal, ) Tj
T * (state, or local government agency, an) Tj
T * (Institution of higher education as) Tj
T * (defined at 20 U.S.C.1001\ (a\), an) Tj
T * (academic teaching hospital, a medical) Tj
T * (center, or a research institute that is) Tj
T * (affiliated with an Institution of higher) Tj
T * (education; or income from service on) Tj
T * (advisory committees or review panels) Tj
T * (
for a Federal, state, or local government) Tj
T * (agency, an Institution of higher) Tj
T * (education as defined at 20 U.S.C.) Tj
T * (1001\ (a\), an academic teaching hospital, ) Tj
T * (a medical center, or a research institute) Tj
T * (that is affiliated with an Institution of) Tj
T * (higher education.) Tj / T1_2 1 Tf
1 - 1.022 Td(Small Business Innovation Research) Tj / T1_1 1 Tf - 1 - 1.1 Td(\ (SBIR\) Program means the extramural) Tj
T * (research program
for small businesses) Tj
T * (that is established by the Awarding) Tj
T * (Components of the Public Health) Tj
T * (Service and certain other Federal) Tj
T * (agencies under Public Law 97\226219, the) Tj
T * (Small Business Innovation Development) Tj
T * (Act, as amended.For purposes of this) Tj
0 - 1.111 TD(part, the term SBIR Program also) Tj
T * (includes the Small Business Technology) Tj
1 g / T1_3 1 Tf
0 Tw 6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(17: 26 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00035) - 1077(Fmt 4701) - 1077(Sfmt 4700) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

// peepdf comment: Javascript code located in object 204 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 45 750 Tm(53290) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
-0.0045 Tw 9 0 0 9 45 725 Tm
(Transfer \(STTR\) Program, which was )Tj
0 -1.111 TD
(established by Public Law 102\226564. )Tj
/T1_2
1 Tf - 0.0025 Tw 8 0 0 8 45 699 Tm[(\247) - 165(94.4) - 1000(Responsibilities of Institutions)] TJ
0 - 1.125 TD(regarding Investigator financial conflicts of) Tj
0 Tw T * (interest.) Tj / T1_1 1 Tf - 0.0045 Tw 9 0 0 9 54 669.5001 Tm(Each Institution shall: ) Tj
0 - 1.056 TD(\ (a\) Maintain an up - to - date, written, ) Tj - 1 - 1.111 Td(enforced policy on financial conflicts of) Tj
0 - 1.111 TD(interest that complies with this part, ) Tj
T * (and make such policy available via a) Tj
T * (publicly accessible Web site.If the) Tj
T * (Institution does not have any current) Tj
T * (presence on a publicly accessible Web) Tj
T * (site\ (and only in those cases\), the) Tj
T * (Institution shall make its written policy) Tj
T * (available to any requestor within five) Tj
T * (business days of a request.If, however, ) Tj
T * (the Institution acquires a presence on a) Tj
T * (publicly accessible Web site during the) Tj
T * (time of the PHS award, the requirement) Tj
T * (to post the information on that Web site) Tj
T * (will apply within 30 calendar days.If an) Tj
T * (Institution maintains a policy on) Tj
T * (financial conflicts of interest that) Tj
T * (includes standards that are more) Tj
T * (stringent than this part\ () Tj / T1_3 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 13.197 0 Td(that require) Tj - 13.197 - 1.111 Td(a more extensive disclosure of financial) Tj
T * (interests\), the Institution shall adhere to) Tj
T * (its policy and shall provide FCOI) Tj
T * (reports regarding identified financial) Tj
T * (conflicts of interest to the PHS) Tj
T * (Awarding Component in accordance) Tj
T * (with the Institution\222s own standards and) Tj
T * (within the timeframe prescribed by this) Tj
0 Tw T * (part.) Tj - 0.0045 Tw 1 - 1.056 Td(\ (b\) Inform each Investigator of the) Tj - 1 - 1.111 Td(Institution\222s policy on financial) Tj
T * (conflicts of interest, the Investigator\222s) Tj
T * (responsibilities regarding disclosure of) Tj
T * (significant financial interests, and of) Tj
T * (these regulations, and require each) Tj
T * (Investigator to complete training) Tj
T * (regarding the same prior to engaging in ) Tj
T * (research related to any PHS - funded) Tj
T * (contract and at least every four years, ) Tj
T * (and immediately when any of the) Tj
T * (following circumstances apply: ) Tj
1 - 1.056 Td(\ (1\) The Institution revises its financial) Tj - 1 - 1.111 Td(conflict of interest policies or) Tj
T * (procedures in any manner that affects) Tj
T * (the requirements of Investigators;) Tj
1 - 1.056 Td(\ (2\) An Investigator is new to an) Tj - 1 - 1.111 Td(Institution; or) Tj
1 - 1.056 Td(\ (3\) An Institution finds that an) Tj - 1 - 1.111 Td(Investigator is not in compliance with) Tj
T * (the Institution\222s financial conflict of) Tj
T * (interest policy or management plan.) Tj
1 - 1.056 Td(\ (c\) If the Institution carries out the) Tj - 1 - 1.111 Td(PHS - funded research through a) Tj
T * (subrecipient\ () Tj / T1_3 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 8.435 0 Td(subcontractors, or) Tj - 8.435 - 1.111 Td(consortium members\), the Institution) Tj
T * (\ (awardee Institution\) must take) Tj
T * (reasonable steps to ensure that any) Tj
T * (subrecipient Investigator complies with) Tj
T * (this part by) Tj
1 - 1.056 Td(\ (1\) Incorporating as part of a written) Tj - 1 - 1.111 Td(agreement with the subrecipient terms) Tj
T * (that establish whether the financial) Tj
19.667 74.667 Td(conflicts of interest policy of the) Tj
T * (awardee Institution or that of the) Tj
T * (subrecipient will apply to the) Tj
T * (subrecipient\222s Investigators.) Tj
1 - 1.156 Td(\ (i\) If the subrecipient\222s Investigators) Tj - 1 - 1.111 Td(must comply with the subrecipient\222s) Tj
T * (financial conflicts of interest policy, the) Tj
T * (subrecipient shall certify as part of the) Tj
T * (agreement referenced above that its) Tj
T * (policy complies with this part.If the) Tj
T * (subrecipient cannot provide such) Tj
T * (certification, the agreement shall state) Tj
T * (that subrecipient Investigators are) Tj
T * (subject to the financial conflicts of) Tj
T * (interest policy of the awardee) Tj
T * (Institution
for disclosing significant) Tj
T * (financial interests that are directly) Tj
T * (related to the subrecipient\222s work
for the) Tj
T * (awardee Institution;) Tj
1 - 1.156 Td(\ (ii\) Additionally,
if the subrecipient\222s) Tj - 1 - 1.111 Td(Investigators must comply with the) Tj
T * (subrecipient\222s financial conflicts of) Tj
T * (interest policy, the agreement) Tj
T * (referenced above shall specify time) Tj
T * (period\ (s\) for the subrecipient to report) Tj
T * (all identified financial conflicts of) Tj
T * (interest to the awardee Institution.Such) Tj
T * (time period\ (s\) shall be sufficient to) Tj
T * (enable the awardee Institution to) Tj
T * (provide timely FCOI reports, as) Tj
T * (necessary, to the PHS as required by this) Tj
0 Tw T * (part;) Tj - 0.0045 Tw 1 - 1.144 Td(\ (iii\) Alternatively,
if the subrecipient\222s) Tj - 1 - 1.111 Td(Investigators must comply with the) Tj
T * (awardee Institution\222s financial conflicts) Tj
T * (of interest policy, the agreement) Tj
T * (referenced above shall specify time) Tj
T * (period\ (s\) for the subrecipient to submit) Tj
T * (all Investigator disclosures of significant) Tj
T * (financial interests to the awardee) Tj
T * (Institution.Such time period\ (s\) shall be) Tj
T * (sufficient to enable the awardee) Tj
T * (Institution to comply timely with its) Tj
T * (review, management, and reporting) Tj
T * (obligations under this part.) Tj
1 - 1.144 Td(\ (2\) Providing FCOI reports to the PHS) Tj - 1 - 1.111 Td(Awarding Component regarding all) Tj
T * (financial conflicts of interest of all) Tj
T * (subrecipient Investigators consistent) Tj
T * (with this part, ) Tj / T1_3 1 Tf
0 Tw(i.e., ) Tj / T1_1 1 Tf - 0.0045 Tw 8.685 0 Td(prior to the) Tj - 8.685 - 1.111 Td(expenditure of funds and within 60) Tj
T * (days of any subsequently identified) Tj
0 Tw T * (FCOI.) Tj - 0.0045 Tw 1 - 1.144 Td(\ (d\) Designate an institutional) Tj - 1 - 1.111 Td(official\ (s\) to solicit and review) Tj
T * (disclosures of significant financial) Tj
T * (interests from each Investigator who is) Tj
T * (planning to participate in , or is) Tj
T * (participating in , the PHS - funded) Tj
0 Tw T * (research.) Tj - 0.0045 Tw 1 - 1.144 Td(\ (e\)\ (1\) Require that each Investigator) Tj - 1 - 1.111 Td(who is planning to participate in the) Tj
T * (PHS - funded research disclose to the) Tj
T * (Institution\222s designated official\ (s\) the) Tj
T * (Investigator\222s significant financial) Tj
T * (interests\ (and those of the Investigator\222s) Tj
T * (spouse and dependent children\) no later) Tj
T * (than date of submission of the) Tj
19.667 74.667 Td(Institution\222s proposal
for PHS - funded) Tj
0 Tw T * (research.) Tj - 0.0045 Tw 1 - 1.167 Td(\ (2\) Require each Investigator who is) Tj - 1 - 1.111 Td(participating in the PHS - funded) Tj
T * (research to submit an updated) Tj
T * (disclosure of significant financial) Tj
T * (interests at least annually, in accordance) Tj
T * (with the specific time period prescribed) Tj
T * (by the Institution, during the period of) Tj
T * (the award.Such disclosure shall) Tj
T * (include any information that was not) Tj
T * (disclosed initially to the Institution) Tj
T * (pursuant to paragraph\ (e\)\ (1\) of this) Tj
T * (section, or in a subsequent disclosure of) Tj
T * (significant financial interests\ () Tj / T1_3 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf
16.033 0 Td(any) Tj - 0.0045 Tw - 16.033 - 1.111 Td(financial conflict of interest identified) Tj
T * (on a PHS - funded project that was) Tj
T * (transferred from another Institution\), ) Tj
T * (and shall include updated information) Tj
T * (regarding any previously disclosed) Tj
T * (significant financial interest\ () Tj / T1_3 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf
15.589 0 Td(the) Tj - 0.0045 Tw - 15.589 - 1.111 Td(updated value of a previously disclosed) Tj
T * (equity interest\).) Tj
1 - 1.167 Td(\ (3\) Require each Investigator who is) Tj - 1 - 1.111 Td(participating in the PHS - funded) Tj
T * (research to submit an updated) Tj
T * (disclosure of significant financial) Tj
T * (interests within thirty days of) Tj
T * (discovering or acquiring\ () Tj / T1_3 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf
13.872 0 Td(through) Tj - 0.0045 Tw - 13.872 - 1.111 Td(purchase, marriage, or inheritance\) a) Tj
T * (new significant financial interest.) Tj
1 - 1.167 Td(\ (f\) Provide guidelines consistent with) Tj - 1 - 1.111 Td(this part
for the designated institutional) Tj
T * (official\ (s\) to determine whether an) Tj
T * (Investigator\222s significant financial) Tj
T * (interest is related to PHS - funded) Tj
T * (research and,
if so related, whether the) Tj
T * (significant financial interest is a) Tj
T * (financial conflict of interest.An) Tj
T * (Investigator\222s significant financial) Tj
T * (interest is related to PHS - funded) Tj
T * (research when the Institution, through) Tj
T * (its designated official\ (s\), reasonably) Tj
T * (determines that the significant financial) Tj
T * (interest: Could be affected by the PHS - ) Tj
T * (funded research; or is in an entity) Tj
T * (whose financial interest could be) Tj
T * (affected by the research.The Institution) Tj
T * (may involve the Investigator in the) Tj
T * (designated official\ (s\)\222s determination of) Tj
T * (whether a significant financial interest) Tj
T * (is related to the PHS - funded research.A) Tj
T * (financial conflict of interest exists when) Tj
T * (the Institution, through its designated) Tj
T * (official\ (s\), reasonably determines that) Tj
T * (the significant financial interest could) Tj
T * (directly and significantly affect the) Tj
T * (design, conduct, or reporting of the) Tj
T * (PHS - funded research.) Tj
1 - 1.167 Td(\ (g\) Take such actions as necessary to) Tj - 1 - 1.111 Td(manage financial conflicts of interest, ) Tj
T * (including any financial conflicts of a) Tj
T * (subrecipient Investigator pursuant to) Tj
T * (paragraph\ (c\) of this section.) Tj
T * (Management of an identified financial) Tj
T * (conflict of interest requires development) Tj
T * (and implementation of a management) Tj
T * (plan and,
if necessary, a retrospective) Tj
1 g / T1_4 1 Tf
0 Tw 6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(17: 26 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00036) - 1077(Fmt 4701) - 1077(Sfmt 4700) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

// peepdf comment: Javascript code located in object 207 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 536.42 750 Tm(53291) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
-0.0045 Tw 9 0 0 9 45 725 Tm
(review and mitigation report pursuant )Tj
0 -1.111 TD
[(to \247)-167(94.5\(a\). )]TJ
1 -1.056 Td
(\(h\) Provide initial and ongoing FCOI )Tj
-1 -1.111 Td
(reports to the PHS as required pursuant )Tj
T*
[(to \247)-167(94.5\(b\). )]TJ
1 -1.056 Td
(\(i\) Maintain records relating to all )Tj
-1 -1.111 Td
(Investigator disclosures of financial )Tj
T*
(interests and the Institution\222s review of, )Tj
T*
(and response to, such disclosures )Tj
T*
(\(whether or not a disclosure resulted in )Tj
T*
(the Institution\222s determination of a )Tj
T*
(financial conflict of interest\), and all )Tj
T*
(actions under the Institution\222s policy or )Tj
T*
(retrospective review, if applicable, for at )Tj
T*
(least three years from the date of final )Tj
T*
(payment or, where applicable, for the )Tj
T*
(time periods specified in 48 CFR part 4, )Tj
T*
(subpart 4.7. )Tj
1 -1.056 Td
(\(j\) Establish adequate enforcement )Tj
-1 -1.111 Td
(mechanisms and provide for employee )Tj
T*
(sanctions or other administrative )Tj
T*
(actions to ensure Investigator )Tj
T*
(compliance as appropriate. )Tj
1 -1.056 Td
(\(k\) Certify, in each contract proposal )Tj
-1 -1.111 Td
(to which this part applies, that the )Tj
0 Tw T*
(Institution: )Tj
-0.0045 Tw 1 -1.056 Td
(\(1\) Has in effect at that Institution an )Tj
-1 -1.111 Td
(up-to-date, written, and enforced )Tj
T*
(administrative process to identify and )Tj
T*
(manage financial conflicts of interest )Tj
T*
(with respect to all research projects for )Tj
T*
(which funding is sought or received )Tj
T*
(from the PHS; )Tj
1 -1.056 Td
(\(2\) Shall promote and enforce )Tj
-1 -1.111 Td
(Investigator compliance with this part\222s )Tj
T*
(requirements including those pertaining )Tj
T*
(to disclosure of significant financial )Tj
0 Tw T*
(interests; )Tj
-0.0045 Tw 1 -1.067 Td
(\(3\) Shall manage financial conflicts of )Tj
-1 -1.111 Td
(interest and provide initial and ongoing )Tj
T*
(FCOI reports to the PHS Awarding )Tj
T*
(Component consistent with this part; )Tj
1 -1.067 Td
(\(4\) Agrees to make information )Tj
-1 -1.111 Td
(available, promptly upon request, to the )Tj
T*
(HHS relating to any Investigator )Tj
T*
(disclosure of financial interests and the )Tj
T*
(Institution\222s review of, and response to, )Tj
T*
(such disclosure, whether or not the )Tj
T*
(disclosure resulted in the Institution\222s )Tj
T*
(determination of a financial conflict of )Tj
T*
(interest; and )Tj
1 -1.067 Td
(\(5\) Shall fully comply with the )Tj
-1 -1.111 Td
(requirements of this part. )Tj
/T1_2
1 Tf - 0.0025 Tw 8 0 0 8 45 193.2004 Tm[(\247) - 165(94.5) - 1000(Management and reporting of)] TJ
0 - 1.125 TD(financial conflicts of interest.) Tj / T1_1 1 Tf - 0.0045 Tw 9 0 0 9 54 172.6003 Tm(\ (a\) Management of financial conflicts) Tj - 1 - 1.111 Td(of interest.) Tj
1 - 1.067 Td(\ (1\) Prior to the Institution\222s) Tj - 1 - 1.111 Td(expenditure of any funds under a PHS - ) Tj
0 - 1.111 TD(funded research project, the designated) Tj
T * (official\ (s\) of an Institution shall, ) Tj
T * [(consistent with\247) - 167(94.4\ (f\): review all)] TJ
T * (Investigator disclosures of significant) Tj
T * (financial interests; determine whether) Tj
T * (any significant financial interests relate) Tj
T * (to PHS - funded research; determine) Tj
T * (whether a financial conflict of interest) Tj
T * (exists; and,
if so, develop and) Tj
19.667 74.667 Td(implement a management plan that) Tj
0 - 1.1 TD(shall specify the actions that have been, ) Tj
T * (and shall be, taken to manage such) Tj
T * (financial conflict of interest.Examples) Tj
T * (of conditions or restrictions that might) Tj
T * (be imposed to manage a financial) Tj
T * (conflict of interest include, but are not) Tj
T * (limited to: ) Tj
1 - 1.022 Td(\ (i\) Public disclosure of financial) Tj - 1 - 1.1 Td(conflicts of interest\ () Tj / T1_3 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf
11.536 0 Td(when) Tj - 0.0045 Tw - 11.536 - 1.111 Td(presenting or publishing the research\);) Tj
1 - 1.022 Td(\ (ii\) For research projects involving) Tj - 1 - 1.111 Td(human subjects research, disclosure of) Tj
0 - 1.111 TD(financial conflicts of interest directly to) Tj
0 Tw T * (participants;) Tj - 0.0045 Tw 1 - 1.022 Td(\ (iii\) Appointment of an independent) Tj - 1 - 1.111 Td(monitor capable of taking measures to) Tj
T * (protect the design, conduct, and) Tj
T * (reporting of the research against bias, ) Tj
T * (resulting from the financial conflict of) Tj
0 Tw T * (interest;) Tj - 0.0045 Tw 1 - 1.022 Td(\ (iv\) Modification of the research plan;) Tj
0 - 1.022 TD(\ (v\) Change of personnel or personnel) Tj - 1 - 1.111 Td(responsibilities, or disqualification of) Tj
0 - 1.111 TD(personnel from participation in all or a) Tj
T * (portion of the research;) Tj
1 - 1.022 Td(\ (vi\) Reduction or elimination of the) Tj - 1 - 1.111 Td(financial interest\ () Tj / T1_3 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 10.484 0 Td(sale of an equity) Tj - 10.484 - 1.111 Td(interest\); or) Tj
1 - 1.022 Td(\ (vii\) Severance of relationships that) Tj - 1 - 1.111 Td(create financial conflicts.) Tj
1 - 1.022 Td(\ (2\) Whenever, in the course of an) Tj - 1 - 1.111 Td(ongoing PHS - funded research project, ) Tj
T * (an Investigator who is new to) Tj
T * (participating in the research project) Tj
T * (discloses a significant financial interest) Tj
T * (or an existing Investigator discloses a) Tj
T * (new significant financial interest to the) Tj
T * (Institution, the designated official\ (s\) of) Tj
T * (the Institution shall, within sixty days: ) Tj
T * (review the disclosure of the significant) Tj
T * (financial interest; determine whether it) Tj
T * (is related to PHS - funded research;) Tj
T * (determine whether a financial conflict) Tj
T * (of interest exists; and,
if so, implement, ) Tj
T * (on at least an interim basis, a) Tj
T * (management plan that shall specify the) Tj
T * (actions that have been, and will be, ) Tj
T * (taken to manage such financial conflict) Tj
T * (of interest.Depending on the nature of) Tj
T * (the significant financial interest, an) Tj
T * (Institution may determine that) Tj
T * (additional interim measures are) Tj
T * (necessary with regard to the) Tj
T * (Investigator\222s participation in the PHS - ) Tj
T * (funded research project between the) Tj
T * (date of disclosure and the completion of) Tj
T * (the Institution\222s review.) Tj
1 - 1.022 Td(\ (3\) Whenever an Institution identifies) Tj - 1 - 1.111 Td(a significant financial interest that was) Tj
T * (not disclosed timely by an Investigator) Tj
T * (or,
for whatever reason, was not) Tj
T * (previously reviewed by the Institution) Tj
T * (during an ongoing PHS - funded research) Tj
T * (project\ () Tj / T1_3 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 5.881 0 Td(was not timely reviewed or) Tj - 5.881 - 1.111 Td(reported by a subrecipient\), the) Tj
T * (designated official\ (s\) shall, within sixty) Tj
T * (days: review the significant financial) Tj
T * (interest; determine whether it is related) Tj
19.667 74.667 Td(to PHS - funded research; determine) Tj
T * (whether a financial conflict of interest) Tj
T * (exists; and,
if so: ) Tj
1 - 1.033 Td(\ (i\) Implement, on at least an interim) Tj - 1 - 1.111 Td(basis, a management plan that shall) Tj
T * (specify the actions that have been, and) Tj
T * (will be, taken to manage such financial) Tj
T * (conflict of interest going forward;) Tj
1 - 1.033 Td(\ (ii\)\ (A\) In addition, whenever a) Tj - 1 - 1.111 Td(financial conflict of interest is not) Tj
T * (identified or managed in a timely) Tj
T * (manner including failure by the) Tj
T * (Investigator to disclose a significant) Tj
T * (financial interest that is determined by) Tj
T * (the Institution to constitute a financial) Tj
T * (conflict of interest; failure by the) Tj
T * (Institution to review or manage such a) Tj
T * (financial conflict of interest; or failure) Tj
T * (by the Investigator to comply with a) Tj
T * (financial conflict of interest) Tj
T * (management plan, the Institution shall, ) Tj
T * (within 120 days of the Institution\222s) Tj
T * (determination of noncompliance, ) Tj
T * (complete a retrospective review of the) Tj
T * (Investigator\222s activities and the PHS - ) Tj
T * (funded research project to determine) Tj
T * (whether any PHS - funded research, or) Tj
T * (portion thereof, conducted during the) Tj
T * (time period of the noncompliance, was) Tj
T * (biased in the design, conduct, or) Tj
T * (reporting of such research.) Tj
1 - 1.044 Td(\ (B\) The Institution is required to) Tj - 1 - 1.111 Td(document the retrospective review; such) Tj
T * (documentation shall include, but not) Tj
T * (necessarily be limited to, all of the) Tj
T * (following key elements: ) Tj / T1_3 1 Tf
0 Tw 1 - 1.044 Td(\ (1\)) Tj / T1_1 1 Tf - 0.0045 Tw 1.495 0 Td(Project number;) Tj / T1_3 1 Tf
0 Tw - 1.495 - 1.044 Td(\ (2\)) Tj / T1_1 1 Tf - 0.0045 Tw 1.495 0 Td(Project title;) Tj / T1_3 1 Tf
0 Tw - 1.495 - 1.044 Td(\ (3\)) Tj / T1_1 1 Tf - 0.0045 Tw 1.495 0 Td(PD / PI or contact PD / PI
if a) Tj - 2.495 - 1.111 Td(multiple PD / PI model is used;) Tj / T1_3 1 Tf
0 Tw 1 - 1.044 Td(\ (4\)) Tj / T1_1 1 Tf - 0.0045 Tw 1.495 0 Td(Name of the Investigator with the) Tj
0 Tw - 2.495 - 1.111 Td(FCOI;) Tj / T1_3 1 Tf
1 - 1.044 Td(\ (5\)) Tj / T1_1 1 Tf - 0.0045 Tw 1.495 0 Td(Name of the entity with which the) Tj - 2.495 - 1.111 Td(Investigator has a financial conflict of) Tj
0 Tw T * (interest;) Tj / T1_3 1 Tf
1 - 1.044 Td(\ (6\)) Tj / T1_1 1 Tf - 0.0045 Tw 1.495 0 Td(Reason\ (s\) for the retrospective) Tj
0 Tw - 2.495 - 1.111 Td(review;) Tj / T1_3 1 Tf
1 - 1.044 Td(\ (7\)) Tj / T1_1 1 Tf - 0.0045 Tw 1.495 0 Td(Detailed methodology used
for the) Tj - 2.495 - 1.111 Td(retrospective review\ () Tj / T1_3 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf
12.042 0 Td(methodology) Tj - 0.0045 Tw - 12.042 - 1.111 Td(of the review process, composition of) Tj
T * (the review panel, documents reviewed\);) Tj / T1_3 1 Tf
0 Tw 1 - 1.044 Td(\ (8\)) Tj / T1_1 1 Tf - 0.0045 Tw 1.495 0 Td(Findings of the review; and) Tj / T1_3 1 Tf
0 Tw - 1.495 - 1.044 Td(\ (9\)) Tj / T1_1 1 Tf - 0.0045 Tw 1.495 0 Td(Conclusions of the review.) Tj - 1.495 - 1.044 Td(\ (iii\) Based on the results of the) Tj - 1 - 1.111 Td(retrospective review,
if appropriate, the) Tj
T * (Institution shall update the previously) Tj
T * (submitted FCOI report, specifying the) Tj
T * (actions that will be taken to manage the) Tj
T * (financial conflict of interest going) Tj
T * (forward.If bias is found, the Institution) Tj
T * (is required to notify the PHS Awarding) Tj
T * (Component promptly and submit a) Tj
T * (mitigation report to the PHS Awarding) Tj
T * (Component.The mitigation report must) Tj
T * (include, at a minimum, the key) Tj
T * (elements documented in the) Tj
T * (retrospective review above and a) Tj
T * (description of the impact of the bias on) Tj
T * (the research project and the Institution\222s) Tj
1 g / T1_4 1 Tf
0 Tw 6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(17: 26 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00037) - 1077(Fmt 4701) - 1077(Sfmt 4700) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

// peepdf comment: Javascript code located in object 210 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 45 750 Tm(53292) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
-0.0045 Tw 9 0 0 9 45 725 Tm
(plan of action or actions taken to )Tj
0 -1.1 TD
(eliminate or mitigate the effect of the )Tj
T*
(bias \()Tj
/T1_2
1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 4.547 0 Td(impact on the research) Tj - 4.547 - 1.1 Td(project; extent of harm done, including) Tj
T * (any qualitative and quantitative data to) Tj
T * (support any actual or future harm;) Tj
T * (analysis of whether the research project) Tj
T * (is salvageable\).Thereafter, the) Tj
T * (Institution will submit FCOI reports) Tj
T * (annually, as specified elsewhere in this) Tj
T * (part.Depending on the nature of the) Tj
T * (financial conflict of interest, an) Tj
T * (Institution may determine that) Tj
T * (additional interim measures are) Tj
T * (necessary with regard to the) Tj
T * (Investigator\222s participation in the PHS - ) Tj
T * (funded research project between the) Tj
T * (date that the financial conflict of) Tj
T * (interest or the Investigator\222s) Tj
T * (noncompliance is determined and the) Tj
T * (completion of the Institution\222s) Tj
T * (retrospective review.) Tj
1 - 1.022 Td(\ (4\) Whenever an Institution) Tj - 1 - 1.1 Td(implements a management plan) Tj
T * (pursuant to this part, the Institution) Tj
T * (shall monitor Investigator compliance) Tj
T * (with the management plan on an) Tj
T * (ongoing basis until the completion of) Tj
T * (the PHS - funded research project.) Tj
1 - 1.022 Td(\ (5\)\ (i\) Prior to the Institution\222s) Tj - 1 - 1.1 Td(expenditure of any funds under a PHS - ) Tj
T * (funded research project, the Institution) Tj
T * (shall ensure public accessibility, via a) Tj
T * (publicly accessible Web site or written) Tj
T * (response to any requestor within five) Tj
0 - 1.111 TD(business days of a request, of) Tj
T * (information concerning any significant) Tj
T * (financial interest disclosed to the) Tj
T * (Institution that meets the following) Tj
T * (three criteria: ) Tj
1 - 1.022 Td(\ (A\) The significant financial interest) Tj - 1 - 1.111 Td(was disclosed and is still held by key) Tj
T * (personnel as defined in this part;) Tj
1 - 1.022 Td(\ (B\) The Institution determines that the) Tj - 1 - 1.111 Td(significant financial interest is related to) Tj
T * (the PHS - funded research; and) Tj
1 - 1.022 Td(\ (C\) The Institution determines that the) Tj - 1 - 1.111 Td(significant financial interest is a) Tj
T * (financial conflict of interest.) Tj
1 - 1.022 Td(\ (ii\) The information that the) Tj - 1 - 1.111 Td(Institution makes available via a) Tj
T * (publicly accessible Web site or written) Tj
T * (response to any requestor within five) Tj
T * (business days of a request, shall) Tj
T * (include, at a minimum, the following: ) Tj
T * (The Investigator\222s name; the) Tj
T * (Investigator\222s title and role with respect) Tj
T * (to the research project; the name of the) Tj
T * (entity in which the significant financial) Tj
T * (interest is held; the nature of the) Tj
T * (significant financial interest; and the) Tj
T * (approximate dollar value of the) Tj
T * (significant financial interest\ (dollar) Tj
T * (ranges are permissible: $0\226$4,
999;) Tj
T * ($5, 000\226$9, 999; $10, 000\226$19, 999;) Tj
T * (amounts between $20, 000\226$100, 000 by) Tj
T * (increments of $20, 000; amounts above) Tj
T * ($100, 000 by increments of $50, 000\), or) Tj
T * (a statement that the interest is one) Tj
19.667 74.667 Td(whose value cannot be readily) Tj
0 - 1.1 TD(determined through reference to public) Tj
T * (prices or other reasonable measures of) Tj
T * (fair market value.) Tj
1 - 1.022 Td(\ (iii\) If the Institution uses a publicly) Tj - 1 - 1.1 Td(accessible Web site
for the purposes of) Tj
T * (this subsection, the information that the) Tj
T * (Institution posts shall be updated at) Tj
T * (least annually.In addition, the) Tj
T * (Institution shall update the Web site) Tj
T * (within sixty days of the Institution\222s) Tj
T * (receipt or identification of information) Tj
T * (concerning any additional significant) Tj
T * (financial interest of the senior / key) Tj
T * (personnel
for the PHS - funded research) Tj
T * (project that was not previously) Tj
T * (disclosed, or upon the disclosure of a) Tj
T * (significant financial interest of senior / ) Tj
T * (key personnel new to the PHS - funded) Tj
T * (research project,
if the Institution) Tj
T * (determines that the significant financial) Tj
T * (interest is related to the PHS - funded) Tj
T * (research and is a financial conflict of) Tj
T * (interest.The Web site shall note that the) Tj
T * (information provided is current as of the) Tj
T * (date listed and is subject to updates, on) Tj
T * (at least an annual basis and within 60) Tj
T * (days of the Institution\222s identification of) Tj
T * (a new financial conflict of interest.If the) Tj
T * (Institution responds to written requests) Tj
T * (
for the purposes of this subsection, the) Tj
T * (Institution will note in its written) Tj
T * (response that the information provided) Tj
T * (is current as of the date of the) Tj
T * (correspondence and is subject to) Tj
T * (updates, on at least an annual basis and) Tj
T * (within 60 days of the Institution\222s) Tj
T * (identification of a new financial conflict) Tj
T * (of interest, which should be requested) Tj
T * (subsequently by the requestor.) Tj
1 - 1.022 Td(\ (iv\) Information concerning the) Tj - 1 - 1.1 Td(significant financial interests of an) Tj
T * (individual subject to paragraph\ (a\)\ (5\) of) Tj
0 - 1.111 TD(this section shall remain available,
for) Tj
T * (responses to written requests or
for) Tj
T * (posting via the Institution\222s publicly) Tj
T * (accessible Web site
for at least three) Tj
T * (years from the date that the information) Tj
T * (was most recently updated.) Tj
1 - 1.022 Td(\ (6\) In addition to the types of) Tj - 1 - 1.111 Td(financial conflicts of interest as defined) Tj
T * ( in this part that must be managed) Tj
T * (pursuant to this section, an Institution) Tj
T * (may require the management of other) Tj
T * (financial conflicts of interest in its) Tj
T * (policy on financial conflicts of interest, ) Tj
T * (as the Institution deems appropriate.) Tj
1 - 1.022 Td(\ (b\) Reporting of financial conflicts of) Tj
0 Tw - 1 - 1.111 Td(interest.) Tj - 0.0045 Tw 1 - 1.022 Td(\ (1\) Prior to the Institution\222s) Tj - 1 - 1.111 Td(expenditure of any funds under a PHS - ) Tj
T * (funded research project, the Institution) Tj
T * (shall provide to the PHS Awarding) Tj
T * (Component an FCOI report regarding) Tj
T * (any Investigator\222s significant financial) Tj
T * (interest found by the Institution to be) Tj
T * (conflicting and ensure that the) Tj
T * (Institution has implemented a) Tj
T * (management plan in accordance with) Tj
19.667 74.667 Td(this part.In cases in which the) Tj
0 - 1.1 TD(Institution identifies a financial conflict) Tj
T * (of interest and eliminates it prior to the) Tj
T * (expenditure of PHS - awarded funds, the) Tj
T * (Institution shall not submit an FCOI) Tj
T * (report to the PHS Awarding Component.) Tj
1 - 1.022 Td(\ (2\) For any significant financial) Tj - 1 - 1.1 Td(interest that the Institution identifies as) Tj
T * (conflicting subsequent to the) Tj
T * (Institution\222s initial FCOI report during) Tj
T * (an ongoing PHS - funded research project) Tj
0 Tw T * (\ () Tj / T1_2 1 Tf(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 2.441 0 Td(upon the participation of an) Tj - 2.441 - 1.1 Td(Investigator who is new to the research) Tj
T * (project\), the Institution shall provide to) Tj
T * (the PHS Awarding Component, within) Tj
T * (sixty days, an FCOI report regarding the) Tj
T * (financial conflict of interest and ensure) Tj
T * (that the Institution has implemented a) Tj
0 - 1.111 TD(management plan in accordance with) Tj
T * (this part.Pursuant to paragraph\ (a\)\ (3\)\ (ii\)) Tj
T * (of this section, where such FCOI report) Tj
T * (involves a significant financial interest) Tj
T * (that was not disclosed timely by an) Tj
T * (Investigator or,
for whatever reason, was) Tj
T * (not previously reviewed or managed by) Tj
T * (the Institution\ () Tj / T1_2 1 Tf
0 Tw(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 9.262 0 Td(was not timely) Tj - 9.262 - 1.111 Td(reviewed or reported by a subrecipient\), ) Tj
T * (the Institution also is required to) Tj
T * (complete a retrospective review to) Tj
T * (determine whether any PHS - funded) Tj
T * (research, or portion thereof, conducted) Tj
T * (prior to the identification and) Tj
T * (management of the financial conflict of) Tj
T * (interest was biased in the design, ) Tj
T * (conduct, or reporting of such research.) Tj
T * (Additionally, pursuant to paragraph) Tj
T * (\ (a\)\ (3\)\ (iii\) of this section,
if bias is found, ) Tj
T * (the Institution is required to notify the) Tj
T * (PHS Awarding Component promptly) Tj
T * (and submit a mitigation report to the) Tj
T * (PHS Awarding Component.) Tj
1 - 1.022 Td(\ (3\) Any FCOI report required under) Tj - 1 - 1.111 Td(paragraphs\ (b\)\ (1\) or\ (b\)\ (2\) of this section) Tj
T * (shall include sufficient information to) Tj
T * (enable the PHS Awarding Component to) Tj
T * (understand the nature and extent of the) Tj
T * (financial conflict, and to assess the) Tj
T * (appropriateness of the Institution\222s) Tj
T * (management plan.Elements of the FCOI) Tj
T * (report shall include, but are not) Tj
T * (necessarily limited to the following: ) Tj
1 - 1.022 Td(\ (i\) Project / Contract number;) Tj
0 - 1.022 TD(\ (ii\) PD / PI or Contact PD / PI
if a) Tj - 1 - 1.111 Td(multiple PD / PI model is used;) Tj
1 - 1.022 Td(\ (iii\) Name of the Investigator with the) Tj - 1 - 1.111 Td(financial conflict of interest;) Tj
1 - 1.022 Td(\ (iv\) Name of the entity with which the) Tj - 1 - 1.111 Td(Investigator has a financial conflict of) Tj
0 Tw 0 - 1.111 TD(interest;) Tj - 0.0045 Tw 1 - 1.022 Td(\ (v\) Nature of the financial interest) Tj
0 Tw - 1 - 1.111 Td(\ () Tj / T1_2 1 Tf(e.g., ) Tj / T1_1 1 Tf - 0.0045 Tw 2.441 0 Td(equity, consulting fee, travel) Tj - 2.441 - 1.111 Td(reimbursement, honorarium\);) Tj
1 - 1.022 Td(\ (vi\) Value of the financial interest) Tj - 1 - 1.111 Td(\ (dollar ranges are permissible: $0\226) Tj
T * ($4, 999; $5, 000\226$9, 999; $10, 000\226) Tj
T * ($19, 999; amounts between $20, 000\226) Tj
T * ($100, 000 by increments of $20, 000;) Tj
T * (amounts above $100, 000 by increments) Tj
T * (of $50, 000\), or a statement that the) Tj
1 g / T1_3 1 Tf
0 Tw 6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(17: 26 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00038) - 1077(Fmt 4701) - 1077(Sfmt 4700) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

// peepdf comment: Javascript code located in object 213 (version 0)

q
1 0 0 1 45 744 cm
2.2 w / GS0 gs
0 0 m
522 0 l
S
Q
q
1 0 0 1 45 740 cm
0.3 w / GS0 gs
0 0 m
522 0 l
S
Q
BT / GS0 gs / T1_0 1 Tf
11 0 0 11 536.42 750 Tm(53293) Tj
0.2265 Tw 9.8 0 0 10 101.04 750 Tm(Federal Register) Tj / T1_1 1 Tf
8.001 0 Td[(/)-165(Vol. 76, No. 165)-165(/) - 165(Thursday, August 25, 2011) - 165(/)-165(Rules and Regulations )]TJ
-0.0045 Tw 9 0 0 9 45 725 Tm
(interest is one whose value cannot be )Tj
0 -1.111 TD
(readily determined through reference to )Tj
T*
(public prices or other reasonable )Tj
T*
(measures of fair market value; )Tj
1 -1.022 Td
(\(vii\) A description of how the )Tj
-1 -1.111 Td
(financial interest relates to the PHS- )Tj
T*
(funded research and the basis for the )Tj
T*
(Institution\222s determination that the )Tj
T*
(financial interest conflicts with such )Tj
T*
(research; and )Tj
1 -1.022 Td
(\(viii\) A description of the key )Tj
-1 -1.111 Td
(elements of the Institution\222s )Tj
T*
(management plan, including: )Tj
1 -1.022 Td
(\(A\) Role and principal duties of the )Tj
-1 -1.111 Td
(conflicted Investigator in the research )Tj
0 Tw T*
(project; )Tj
-0.0045 Tw 1 -1.022 Td
(\(B\) Conditions of the management )Tj
0 Tw -1 -1.111 Td
(plan; )Tj
-0.0045 Tw 1 -1.022 Td
(\(C\) How the management plan is )Tj
-1 -1.111 Td
(designed to safeguard objectivity in the )Tj
T*
(research project; )Tj
1 -1.022 Td
(\(D\) Confirmation of the Investigator\222s )Tj
-1 -1.111 Td
(agreement to the management plan; )Tj
1 -1.022 Td
(\(E\) How the management plan will be )Tj
-1 -1.111 Td
(monitored to ensure Investigator )Tj
T*
(compliance; and )Tj
1 -1.033 Td
(\(F\) Other information as needed. )Tj
0 -1.033 TD
(\(4\) For any financial conflict of )Tj
-1 -1.111 Td
(interest previously reported by the )Tj
0 -1.111 TD
(Institution with regard to an ongoing )Tj
T*
(PHS-funded research project, the )Tj
T*
(Institution shall provide to the PHS )Tj
T*
(Awarding Component an annual FCOI )Tj
T*
(report that addresses the status of the )Tj
T*
(financial conflict of interest and any )Tj
T*
(changes to the management plan for the )Tj
T*
(duration of the PHS-funded research )Tj
T*
(project. The annual FCOI report shall )Tj
T*
(specify whether the financial conflict is )Tj
T*
(still being managed or explain why the )Tj
T*
(financial conflict of interest no longer )Tj
T*
(exists. The Institution shall provide )Tj
T*
(annual FCOI reports to the PHS )Tj
T*
(Awarding Component for the duration )Tj
19.667 47 Td
(of the project period \(including )Tj
0 -1.1 TD
(extensions with or without funds\) in the )Tj
T*
(time and manner specified by the PHS )Tj
T*
(Awarding Component. )Tj
1 -1.022 Td
(\(5\) In addition to the types of )Tj
-1 -1.1 Td
(financial conflicts of interest as defined )Tj
T*
(in this part that must be reported )Tj
T*
(pursuant to this section, an Institution )Tj
T*
(may require the reporting of other )Tj
T*
(financial conflicts of interest in its )Tj
T*
(policy on financial conflicts of interest, )Tj
T*
(as the Institution deems appropriate. )Tj
/T1_2
1 Tf
0 Tw 8 0 0 8 222 601.0001 Tm[(\247) - 165(94.6) - 1000(Remedies.)] TJ / T1_1 1 Tf - 0.0045 Tw 9 0 0 9 231 589.8 Tm(\ (a\) If the failure of an Investigator to) Tj - 1 - 1.1 Td(comply with an Institution\222s financial) Tj
T * (conflicts of interest policy or a financial) Tj
T * (conflict of interest management plan) Tj
T * (appears to have biased the design, ) Tj
T * (conduct, or reporting of the PHS - funded) Tj
T * (research, the Institution shall promptly) Tj
T * (notify the PHS Awarding Component of) Tj
T * (the corrective action taken or to be) Tj
T * (taken.The PHS Awarding Component) Tj
T * (will consider the situation and, as) Tj
T * (necessary, take appropriate action, or) Tj
T * (refer the matter to the Institution
for) Tj
T * (further action, which may include) Tj
T * (directions to the Institution on how to) Tj
0 - 1.111 TD(maintain appropriate objectivity in the) Tj
T * (PHS - funded research project.) Tj
1 - 1.022 Td(\ (b\) The PHS Awarding Component) Tj - 1 - 1.111 Td(and / or HHS may inquire at any time) Tj
T * (\ (before, during, or after award\) into any) Tj
T * (Investigator disclosure of financial) Tj
T * (interests and the Institution\222s review of, ) Tj
T * (and response to, such disclosure, ) Tj
T * (regardless of whether or not the) Tj
T * (disclosure resulted in the Institution\222s) Tj
T * (determination of a financial conflict of) Tj
T * (interest.An Institution is required to) Tj
T * (submit, or permit on site review of, all) Tj
T * (records pertinent to compliance with) Tj
T * (this part.To the extent permitted by) Tj
19.667 47 Td(law, HHS will maintain the) Tj
0 - 1.133 TD(confidentiality of all records of financial) Tj
T * (interests.On the basis of its review of) Tj
T * (records or other information that may be) Tj
T * (available, the PHS Awarding) Tj
T * (Component may decide that a particular) Tj
T * (financial conflict of interest will bias the) Tj
T * (objectivity of the PHS - funded research) Tj
T * (to such an extent that further corrective) Tj
T * (action is needed or that the Institution) Tj
T * (has not managed the financial conflict) Tj
T * (of interest in accordance with this part.) Tj
0 - 1.122 TD(The PHS Awarding Component may) Tj
T * (determine that issuance of a Stop Work) Tj
T * (Order by the Contracting Officer or) Tj
T * (other enforcement action is necessary) Tj
T * (until the matter is resolved.) Tj
1 - 1.467 Td(\ (c\) In any
case inwhich the HHS) Tj - 1 - 1.122 Td(determines that a PHS - funded project of) Tj
T * (clinical research whose purpose is to) Tj
T * (evaluate the safety or effectiveness of a) Tj
T * (drug, medical device, or treatment has) Tj
T * (been designed, conducted, or reported) Tj
T * (by an Investigator with a financial) Tj
T * (conflict of interest that was not managed) Tj
T * (or reported by the Institution as) Tj
T * (required by this part, the Institution) Tj
T * (shall require the Investigator involved to) Tj
T * (disclose the financial conflict of interest) Tj
T * ( in each public presentation of the) Tj
T * (results of the research and to request an) Tj
T * (addendum to previously published) Tj
0 Tw T * (presentations.) Tj - 0.0025 Tw 8 0 0 8 407 383.8002 Tm(Dated: February 24,
2011.) Tj / T1_0 1 Tf - 1 - 1.475 Td(Francis S.Collins, ) Tj / T1_3 1 Tf - 0.0575 Tw 0 - 1.475 TD(Director, National Institutes of Health.) Tj / T1_1 1 Tf - 0.0025 Tw 1 - 1.475 Td(Approved: March 2,
2011.) Tj / T1_0 1 Tf - 1 - 1.475 Td(Kathleen Sebelius, ) Tj / T1_3 1 Tf
0 Tw T * (Secretary.) Tj / T1_1 1 Tf - 0.0029 Tw 7 0 0 7 399 313.8002 Tm([FR Doc.2011\22621633 Filed 8\22623\22611; 8: 45 am]) Tj / T1_2 1 Tf
0.1633 Tw 6 0 0 6 399 302.0002 Tm(BILLING CODE 4140\22601\226P) Tj
1 g / T1_4 1 Tf
0 Tw 6.5 0 0 6.5 25 20 Tm[(VerDate Mar < 15 > 2010) - 1077(17: 26 Aug 24,
2011) - 1077(Jkt 223001) - 1077(PO 00000) - 1077(Frm 00039) - 1077(Fmt 4701) - 1077(Sfmt 9990) - 1077(E: \\FR\\FM\\25AUR3.SGM) - 1077(25AUR3)] TJ
0.0001 Tc - 0.0001 Tw 0 5 - 5 0 22 18 Tm(mstockstill on DSK4VPTVN1PROD with RULES3) Tj
ET

